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Exposure to ultraviolet-B light (UVB) suppresses immune responses to a variety
of antigens, including contact sensitisers, in both mice and humans. A number of
mediators of UVB-induced immunosuppression have been proposed including DNA
damage, cA-urocanic acid, TNF-a and IL-10. UVB irradiation also causes the loss of
Langerhans cells (LC) from the skin and the accumulation of LC-derived dendritic cells
(DC) in the draining lymph nodes (DLN).
A chronic UVB exposure protocol, using broadband (270-350nm) and
narrowband (31 l-312nm) sources, was used to examine the effect of UVB on the skin
immune system. Exposure to both sources reduced the numbers of LC in the epidermis.
Exposure to broadband but not narrowband UVB induced epidermal thickening in a dose
dependent manner. Although damage measured by thickening resulted from broadband
UVB only, both sources led to a small increase in sunburn cells, which may represent an
apoptotic keratinocyte population. Both sources were equally efficient at inducing the
conversion of mrnv-urocanic acid to the cA-isomer, but only the broad band source
suppressed contact hypersensitivity (CH) responses. Thus LC loss and the isomerization
of urocanic acid may not be the primary mediators of immunosuppression during chronic
UVB exposure.
An acute UVB exposure protocol was used to examine the effect of UVB on DC
in vivo. Mice were irradiated with an immunosuppressive dose of UVB, and the function
and phenotype of DC accumulating in the DLN was examined. Exposure to UVB prior to
sensitisation did not reduce the ability of DC to induce proliferative responses of hapten
sensitized lymph node cells (LNC). The accessory function of DC in mixed lymphocyte
reactions was also unaffected by prior exposure to an immunosuppressive dose of UVB.
The expression of MHC class II, intercellular adhesion molecule-1 and B7-2 (CD86) on
DC was also examined. UVB failed to affect the percentage of DC expressing these
markers or the surface density of their expression. Thus UVB failed to affect the function
or phenotype of DC draining the site of exposure. From these results there was no clear
evidence to support the view that the immunosuppression following low-dose UVB
exposure in vivo results from UVB-induced changes in DC .
The induction phase of CH is associated with proliferation and interleukin-6 (IL-
6) production by LNC draining the sensitised site. Accumulating DC provide the main
source of IL-6 within the sensitised lymph node. Since IL-6 is important in the early
stages of antigen presentation, it is possible that its production by DC is important in the
generation of effector T lymphocyte populations. Consistent with previous studies, it was
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shown that LNC from UVB-resistant BALB/c mice proliferated and produced high levels
of IL-6 in response to the sensitiser, oxazolone. In contrast, LNC from UVB-susceptible
C3H/HeN mice produced low-levels of IL-6 following sensitisation but showed similar
proliferative activity to BALB/c LNC. The lack of IL-6 activity was not attributable to a
congenital variation between these strains with respect to IL-6 production as comparable
levels of constitutive and inducible cutaneous expression of this cytokine were measured
in BALB/c and C3H/HeN mice, following, respectively, topical exposure to vehicle alone
or oxazolone. Sonicating LNC from sensitised BALB/c and C3H/HeN caused the release
of similar levels of IL-6. The levels of intracellular IL-6 in C3H/HeN LNC following 24
hours in culture, failed to account for the deficit in IL-6 production. It is unlikely therefore
that the lack of IL-6 production by C3H/HeN LNC represents an inability to secrete this
cytokine. To clarify the role of IL-6 production in UVB-induced immunosuppression,
further UVB-resistant (AKR) and UVB-susceptible (C57BL/6 and DBA/2) strains were
examined, all of which showed low-levels of IL-6 production following sensitisation with
oxazolone. Therefore no correlation was shown between the level of IL-6 production
following sensitisation, and the susceptibility or resistance of mice to the
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This chapter provides a general introduction to cutaneous immunity and in
particular describes the role of dendritic cells within the skin immune system. In
addition some background information on ultraviolet light (UV) is included. A detailed
review of the literature relating to UVB and the suppression of skin immune responses
follows, which should provide a clear understanding of the concepts which underlie
the work contained in this thesis.
1.0 The skin immune system
1.0.1 Skin physiology
The skin is the largest organ in the body providing a relatively impermeable
barrier to the external environment. The skin consists of the dermis, mainly connective
tissue perfused by blood and lymph vessels, which is overlaid by the epidermis. The
physical structure of the epidermis is provided by keratinocytes in distinct stages of
differentiation. The most terminally differentiated keratinocytes form the horny layers
of the skin called the stratum corneum, which together with substances on the skin
surface, provides defence against many chemical and biological agents.
1.0.2 Skin associated lymphoid tissue (SALT)
The skin is an important point of entry for infectious microorganisms and is
subject to the actions of environmental factors that can act as tumour initiators and
promoters. Therefore the skin requires active immune function to provide protection
against infection and immune surveillance of transformed cells. Like other organs in
the body, notably the gut and respiratory tract, the skin has its own associated immune
system.
The concept of SALT was first suggested by Streilein in 1978. The hypothesis
was built on two observations, firstly that lymphoid malignancies which showed
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cutaneous tropism were always T cell derived, and secondly the identification of a
population of so-called 'passenger leukocytes' within the skin. These passenger
leukocytes mediated graft rejection when skin from chimeric mice was grafted onto
non-chimeric recipients. Streilein, knowing that specific T cell migration patterns
existed for both gut and bronchial associated lymphoid tissue (GALT and BALT),
hypothesised the existence of a third T-cell recirculation pathway, serving the skin,
under the control of SALT (Streilein, 1978). This hypothesis was later confirmed with
the discovery of T cell populations which expressed the marker cutaneous lymphocyte
antigen (CLA) a ligand for E-selectin, which mediated their migration into the skin
(Rossiter et al. 1994). The identification of CLA and its ligand meant that dermal high
endothelial venules which express E-selectin, and which mediate T cell infiltration into
the skin, were included in SALT.
As more came to be known about the skin, key-components of the skin
immune system were revealed. In 1980 came the first direct evidence that the
epidermal Langerhans cell (LC), which was first identified over 100 years previously
(Langerhans, 1868), was required for skin immune function (Toews et al. 1980). This
work and later studies, showed that the migration of antigen-bearing LC to the skin-
draining lymph nodes was vital for the induction of skin immune responses. Now, the
LC has been joined by other cells such as dermal dendritic cells and macrophages
which have been proposed as alternative cutaneous APC populations (Streilein, 1991)
By the late eighties and early nineties there was increasing evidence that
keratinocytes were an important source of cutaneous cytokine production and there
were suggestions that these cytokines might be important in the control of cutaneous
immune responses (Streilein, 1991). This has proved to be the case and their role in
the SIS will be discussed more fully later in the introduction.
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Therefore these features; specialised skin-homing T cells, LC and other
cutaneous APC, skin-draining lymph nodes and keratinocytes are the component
features of SALT and are required for the induction of skin immunity (Figure 1.1).
1.0.3 Cutaneous immune responses
Contact hypersensitivity (CH) responses are used commonly as a model to
explore the integrity of cutaneous immune responses. The induction of CH follows the
application of a sensitising chemical (contact allergen) to the skin. Chemicals, because
of their simple structure and small size are generally not recognised by the immune
system in their native form. However, the individual molecules (haptens) of
sensitising chemicals are reactive, forming bonds with proteins in the skin to produce
hapten derivatised self-proteins. These derivatised proteins act as epitopes, generating
a hapten/protein-specific immune response. The induction of a CH response following
a primary exposure to a hapten requires the presentation of the antigen in the DLN.
Hapten derivatised proteins are processed in the skin by APC including LC (section
1.1.2.2), the LC then receive a signal to migrate out of the skin (section 1.3.2) and
antigen-bearing LC migrate out of the skin and present the antigen to T cells in the
DLN (sections 1.4, 1.5).
The antigen-processing pathway for CH responses is thought to model the
mechanisms of antigen presentation for other antigens. DH responses are induced
following the intradermal injection of an immunogenic antigen (usually protein).
Foreign protein, like hapten derivatised protein, is processed by APC in the skin, these
APC then migrate out of the skin and activate effector T cells in the DLN.
In the DLN, LC cause the proliferation and differentiation of T cells into an
effector population with specificity for the skin (section 1.5.3). These T cells provide
an immunological memory for the antigen, and, following a secondary sensitisation
with the same hapten , they will be activated by interactions with hapten-bearing APC
in the periphery. These activated T cells then help orchestrate the effector response.
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In most experimental protocols the effector phase of CH is measured 5-7 days
following the original hapten sensitisation, when the animal is challenged with a sub-
inflammatory concentration of the same chemical. The site of challenge is usually the
ears or the foot pad, as it is easy to quantitate the inflammatory reaction by measuring
the increase in ear or footpad thickness. The effector phase of DH responses are
measured later, between 8-14 days, again by measuring increases in ear or footpad
thickness following challenge. In humans CH responses are generally measured by
scoring the features of inflammation (erythema, oedema, vesicle formation, epidermal
necrosis) following clinical examination (Tie et al. 1995).
CH and DH responses are cell-mediated and can be transferred to naive
syngeneic animals with T cells populations from the spleen and lymph nodes of
sensitised animals. The effector phase of both CH and DH responses are associated
with the infiltration of T cells and cells of the monocyte/macrophage lineage into the
dermis and epidermis. The activation of macrophages by T-cell-derived IFN-y causes
them to produce pro-inflammatory cytokines and increases their phagocytic activity.
This infiltration of T cells and activated macrophages into the skin is the main effector
response, and results in the clinical features associated with CH and DH responses.
1.0.3.1 Effector cells of CH and DH responses
The identification of the effector cell population which induces CH responses
is complicated by conflicting data. The classical CH effector cell which induces
responses 24-48hrs after challenge is a CD3+, CD4+, TCR o.p+ and IL-2R+ T cell (Ptak
et al. 1996). The role of CD4 T lymphocytes has been confirmed using CD4 knockout
mice which displayed reduced CH responses to DNFB (Cavanagh et al. 1996).
Sensitisation in these mice was associated with increased numbers of CD8+ and CD4"
CD8" double negative cells. However, work by another group suggests a role for
CD8+ T cells in CH responses. Monoclonal antibodies recognising CD4 and CD8 T
lymphocytes were administered to BALB/c mice to deplete the relevant cell population
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(Gocinsky and Tigelaar, 1990; Xu et al. 1996). Mice depleted of CD4 T cells showed
more intense and longer lasting CH responses than control animals, indicating that
CD4 T cells could act as negative regulators of CH responses. Importantly, the
depletion of CD 8 T cells abrogated CH responses, suggesting that these cells are
required for effective responses. The second study concluded that the induction of CH
responses was accompanied by the generation of IFN-y producing CD8 effector cells
and IL-4 and IL-10 producing regulatory CD4+ T cells (Xu et al. 1996).
Since CD8 cells are considered to be MHC class I restricted, this result
challenges the theory that MHC class I is involved only in the presentation of
intracellular contents to the immune system. Though MHC class I undoubtedly fulfils
this role, the possibility that CD8 cells can act as effector cells in responses to an
exogenous antigen suggest a wider role for immunity mediated via class I MHC
presentation. Reactive chemicals gain immunogenicity by binding with self proteins in
the skin. It remains possible that the generation of CD8+ effector cells by these
sensitising chemicals is the result of mechanisms not available to other groups of
antigens. For instance chemical haptens may bind the self proteins which are present in
the binding groove of MHC class I on the surface of cells. The derivatisation of self
proteins in these grooves, particularly on migrating APC populations, may result in
CD8 responses without the requirement for the antigen to be present in the cytoplasm.
Alternatively, un-derivatised haptens may be able to penetrate cellular membranes and
derivatise proteins in the intracellular compartment.
The effector phase of DH responses is similar to that of CH responses and the
ability to transfer DH responses with T cells, suggests that these cells are the primary
mediators. Since IFN-y production is vital for CH and DH responses it is likely that
similar effector T cell populations are induced in both responses. Classically DH
responses are mediated by CD4+ T-lymphocytes, however it is possibly that IFN-y
secreting CD8+cells may also play a role.
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1.1. Dendritic cells.
1.1.1 The dendritic cell lineage
DC which were named because of their dendritic morphology, form APC
populations present at low concentrations (1-2%) in the blood (blood DC), afferent
lymph (veiled cells), lymphoid organs such as the spleen, lymph node, tonsil and
thymus (interdigitating cells) and non-lymphoid organs such as the heart, lung, liver,
gut and dermis (DC) and the epidermis (LC) (Steinman, 1991). The enrichment of DC
relies on their low buoyant density, lack of adherence to plastic or the absence of
markers found on other leukocytes (Steinman, 1991). These techniques have been
used alone or in combination to produce enriched and highly enriched DC populations.
There are few reliable markers for DC. Positive identification of DC requires
examination of the morphology, function and phenotype of cells. MHC class II is used
as a marker of LC in normal skin (Klareskog et al. 1977). LC have also been identified
by their ATPase activity (Chaker et al. 1984), Birbeck granules (Birbeck et al. 1961)
and in humans by their expression of CDla (Furue et al. 1992). All DC populations
share a number of distinguishing features. DC exhibit specialised APC activity with
the ability to activate naive T cells, though some DC gain this ability following a
functional maturation stage. This specialised accessory activity means that DC are very
potent APC for a variety of in vitro proliferative responses. Associated with this
activity, DC express very high levels of MHC gene products including MHC class I
and II and CD1 (Steinman, 1991; Witmer-Pack et al. 1988; Cumberbatch et al. 1991),
along with high levels of accessory molecules such as (intracellular adhesion molecule-
1) ICAM-1, lymphocyte function associated (LFA) antigens and members of the B7
family of molecules. In addition DC lack markers for T cells (CD3), B cells (CD 19),
NK cells (CD16) and macrophages (CD14) (Steinman, 1991).
DC are bone marrow derived (Katz et al. 1979) and arise, in common with
macrophages and granulocytes, from a bone-marrow myeloid progenitor (Inaba et
al. 1993). Granulocyte/macrophage-colony stimulating factor (GM-CSF) alone or in
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combination with interleukin (IL)-l, tumour-necrosis factor-a (TNF-a) and IL-4
seems to be important for the generation of DC progenitors in vitro (Inaba et al. 1993)
and may be important in the differentiation into DC in vivo.
The prime function of all non-lymphoid DC is to inform the immune system of
events happening in the periphery. Injury and antigen exposure causes antigen-bearing
DC to migrate out of organs via the afferent lymph or blood to lymphiod organs. In the
lymphoid organs DC associate with T cells and initiate immune responses. Because
DC are specialised APC they can associate with, and activate naive T cells , a unique
ability which means that DC are vital for the induction of primary immune responses.
1.1.2 Langerhans cells
LC are regularly spaced throughout the epidermis forming a semi-continuous
network via long dendritic processes. LC are defined by their dendritic morphology
and the presence of a unique intracytoplasmic organelle, the Birbeck granule (Birbeck
et al. 1961). In addition to their appearance, they are distinguished by their phenotype
being MHC class II+, CD45+- Thy-l", CD3~ (Elbe et al. 1989), CD1 lb+, with Fc
receptors for IgG (Stingl et al. 1977) and IgE (Bergstresser et al. 1995) (Table 1.1).
Human LC express CDla and stain faintly with anti-CDlc (Furue et al. 1992).
1.1.2.1 Evidence suggesting that Langerhans cells play an important
role in cutaneous immunity.
The first clues that LC were involved in cutaneous immunity came from
experiments examining contact sensitivity responses in mice. When haptens were
applied through sites naturally deficient in LC expression, such as the hamster cheek
pouch epithelium and mouse tail skin, specific unresponsiveness to hapten challenge
was observed (Toews et al. 1980; Bergstresser et al. 1980; Streilein and Bergstresser,
1981). It was noted, that a regime of UVB treatment could deplete LC from normal
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Table1.1(V).Phenotypeofcutaneousdendritellpopulationsx r ssion,exp ssion)
(100 J/m2/day) caused a highly significant depletion of ATPase+ epidermal LC in mice
(Toews et al. 1980). Haptens applied to UVB treated skin induced hapten specific
unresponsiveness on subsequent challenge to an unirradiated site (Toews et al. 1980).
The ability of UVB to induce unresponsiveness was dependent on the strain of mouse
used, leading to the classification of UVB 'susceptible' and 'resistant' strains (section
1.7.5).
1.1.2.2 Antigen processing in the epidermis by LC.
The first stage in the recognition of antigen by the immune system is the
processing of that antigen by APC. Processing refers to the internalisation and
degradation of antigen into immunogenic peptide fragments which are then displayed
with MHC molecules. This takes place intracellularly in acidified endosomes /
lysosomes, although the exact compartment where peptides and MHC class II
associate has not yet been defined. Freshly isolated murine LC are able to process and
present the protein ovalbumin (OVA), to an OVA peptide specific MHC-restricted T
cell hybridoma in vitro , an ability that is lost during culture (Streilein and Grammer,
1989). LC taken from the epidermis and cultured for 72 hrs are much less efficient at
processing native OVA (Streilein and Grammer, 1989). Similarly, the ability to
process antigen from Leishmania major amastigotes is found in freshly isolated murine
epidermal LC, but is lost after 12 hrs in culture (Moll, 1993). Haptens such as nickel
are able to bind MHC class II associated peptides directly (Sinigaglia, 1994)
suggesting that antigen processing may not be required for all forms of contact
sensitisation. As LC have phagocytic activity when freshly isolated, it seems likely that
epidermal LC have the capacity to process native antigen in vivo. In contrast, like
cultured LC, murine lymph node DC are generally poorly phagocytic, although freshly
isolated splenic DC show phagocytic activity for zymosan and latex beads (Reis e
Sousa etal. 1993).
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1.1.3 Dendritic epidermal T cells (DETC)
DETC are found in the epidermis of rodents where they comprise 1-2% of the
cells (Bergstresser et al. 1983; Tschachler et al. 1989; Shimada et al. 1992), and are
CD45+, Thy-1+ and CD3+. The CD3 molecule is predominantly associated with the
35KD/45KD TCR y/5 heterodimer (Tschachler et al. 1989). DETC do not express CD4
or CD8 antigens (Tschachler et al. 1989), nor MHC class II (Elbe et al. 1989). Their T
cell lineage is confirmed by evidence that numbers of DETC are reduced significantly
in athymic nude mice and that they proliferate in vitro when stimulated with a mixture
of concanavalin A and interleukin-2 (IL-2) (Tschachler et al. 1989). It has been
suggested that DETC are involved in the induction of tolerance (Welsh and Kripke,
1990) and that the ratio of DETC to LC in the epidermis influences the intensity, but
not the duration, of skin sensitisation in mice (Bigby et al. 1987).
1.1.4 Dermal dendritic cells (DDC)
There are a number of cell types including macrophages, fibroblasts, dermal
APC, and stromal cells that exhibit dendritic morphology in the dermis. In the past
these populations may have been grouped together under the convenient, but
uninformative, classification of dermal dendrocytes. In human skin they are factor
XIII antigen+, sometimes express class II antigen (Braverman and Keh-Yen, 1992)
and are CDla+, CDlb+ and CDlc+ (Bergstresser et al. 1995). Factor XIII is involved
in scab formation, crosslinking fibrin with structural proteins, which suggests a
possible role for dermal dendrocytes in wound healing. Although the term dermal
dendrocyte describes more than one cell type, a human LC-like dermal APC has been
found that shares dendrocyte features. This population makes up around 2.7% of total
dermal cells and expresses LC-associated markers (MHC class IT, CD45+, CDla+,
CDlc+) as well as markers not expressed by LC (CDlb+, CD1 lb+ and factor XI1 la+)
(Meunier et al. 1993). In another human study three distinct DDC populations were
found within the factor XIIIa+ subset. The majority of such cells (65-75% XIIIa+cells)
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did not express the myelo-monocytic marker CD 14 or LC marker CD la. The second
subset that made up around 15-20% of these cells expressed CDla but not CD 14 and
may correspond to the LC-like subset already described. The final subset expressed
CD14 but not CDla, suggesting a monocyte/macrophage lineage (Nestle et al. 1993).
Similar populations are found in mice, with 2.5% of cells in the normal murine
dermis being MHC class IT (Duraiswamy et al. 1994). The MHC class IT population
comprises two phenotypically distinct lineages. Both populations are MHC class n+,
pl50/95+ (used as a DC marker), CD45+ (bone-marrow derived) but GR-1" (non-
neutrophil) and CD3" (Duraiswamy et al. 1994). However, one subset expresses
CD1 lb and the other does not. The CD1 lb+ subset expresses Ly6c a
monocyte/endothelial antigen, has no activity in syngeneic mixed lymphocyte reactions
(MLR) and is thought to be a dermal monocyte derived population. Cells in the
CD1 lb" subset act as potent stimulators in the syngeneic MLR and have dendritic
morphology, but do not display Birbeck granules (Duraiswamy et al. 1994). Unlike the
mouse, CD lib is expressed by both macrophages and LC-like cells in the human
dermis (Meunier et al. 1993) and so can not be used to differentiate dermal
macrophages from dermal LC-like APC. However, the expression of CDlc (a marker
expressed by epidermal LC) on dermal MHC class IT cells marked a population which
did not co-express CD36 and which were the most potent accessory cells for
alloantigen responses in the dermis (Meunier et al. 1993).
Therefore, in both murine and human dermis there exist a number of dendritic
cell populations, including heterogeneous MHC class II populations which can be
differentiated phenotypically by their accessory function. The MHC class IT, CD1 lb"
and MHC class IT, CDlc LC-like dermal cell populations in mice and humans
respectively still require further classification. It is uncertain whether these dermal
APC represent a separate APC, population or if they are a migratory DC population
trafficking to, or from, the epidermis. However, there is increasing evidence that the
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dermis may be important in the regulation of cutaneous immune responses, a
hypothesis which will be addressed again later in the introduction with reference to
UVB.
1.2. Other cutaneous APC
1.2.1 MHC Class ir keratinocytes
Prior to the work showing that freshly isolated LC were capable of processing
native antigen (section 1.1.2.2), the lack of phagocytic activity in lymphoid DC led to
speculation about the identity of the cell population that processed antigen in the
epidermis with the suggestion that keratinocytes may provide this function (Luger et
al. 1983; Streilein, 1991). Since freshly isolated LC are capable of phagocytosis, it
seems unlikely that epidermal LC would require a source of peptides. However,
processing by keratinocytes may affect the immune response, depending on whether
the peptide fragments are degraded, released into the extracellular matrix or presented
on the surface of keratinocytes. Although keratinocytes do not express MHC class II
molecules constitutively, they can be induced to do so by interferon y (IFN-y)
(Nickoloff and Turka, 1994). MHC class II bearing keratinocytes can provide
accessory function for T cells that have been stimulated previously with superantigens
or anti-CD3 monoclonal antibody (Nickoloff and Turka, 1994). Keratinocytes are
therefore equipped to play an important role in secondary, but not primary, immune
responses.
1.2.2 Macrophages
Monocyte and macrophage populations are found in the dermis of mice and
humans. In the human dermis there are MHC class IT, CD45+ CD1 lb+, CD36+
macrophages which are distinguished from the LC-like APC (section 1.1.4) by their
lack of CDlc expression (Meunier etal. 1993), or by their expression of CD 14 but not
CD la (Nestle et al. 1993). There are two monocyte/macrophage populations in the
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normal murine dermis one of which has been described in section 1.1.4 as an MHC
class II+, GR-1-, CDllb+cell population which makes up 1.7% of the total dermal
cell population (Duraiswamy et al. 1994). The other macrophage population shows
similar expression of CD 1 lb and lack of GR-1 but in addition fails to express MHC
class II (Duraiswamy et al. 1994). Although these macrophage populations generally
lack accessory cell activity (Duraiswamy et al. 1994; Nestle et al. 1993; Meunier et
al. 1993), they may be important in the regulation of cutaneous immune responses.
Indeed, the expansion of these populations in the dermis following UVB irradiation
may be relevant to UVB-induced immunosuppression and will be covered in section
1.8.1.2.
1.3. Cutaneous microenvironment
1.3.1 Factors that support LC presence in epidermis
It is interesting that while LC constitute a long-lived population in the skin,
donor LC surviving for months in skin allo-grafts (Kreuger and Emam, 1984) their
lifespan in vitro is short with their viability dropping to less than 30% following 3
days of culture (Schuler and Steinman, 1985; Heufler et al. 1988). This has provoked
interest in the mechanisms by which LC are maintained in the epidermis, particularly in
the role of keratinocyte-derived cytokines in the promotion of LC viability. GM-CSF,
a cytokine produced constitutively by keratinocytes (Matsue et al. 1992) plays an
important role in maintaining the viability of LC in vitro. Enriched murine LC cultured
in the presence of recombinant GM-CSF or keratinocyte conditioned medium (KCM)
showed around 60% viability on day 3 of culture compared with around 10% viability
in cultures lacking GM-CSF (Heufler et al. 1988). In the same study the addition of a
neutralising antibody to GM-CSF to cultures together with the KCM abrogated the
increased viability.
TNF-a is another cytokine produced constitutively by keratinocytes (Enk and
Katz, 1992c; Matsue et al. 1992) which may be important in maintaining epidermal LC
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viability. Murine TNF-a increased the survival rate of murine LC in vitro in a
GM-CSF independent manner, but unlike LC cultured with GM-CSF or in bulk
epidermal cell (EC) culture, did not show the increased accessory activity in a MLR
(Koch et al. 1990). However, there is conflicting evidence from an in vitro model in
which human peripheral blood mononuclear cells (PBMC ) were cultured in GM-CSF
and IL-4 to produce DC lines. These DC lines showed a number of similarities to
immature DC such as LC, particularly in their ability to capture and process antigen
(Steinman et al. 1995). Exposure of these DC to TNF-a increased their accessory
activity in MLR but reduced their ability to present soluble antigens (Steinman et
al. 1995), which is likely to be due to the ability of TNF-a to down-regulate antigen
capture mechanisms such as macropinocytosis (Sallusto and Lanzavecchia, 1994;
Caux et al. 1994a).
1.3.2 Signals that cause the migration of Langerhans cells out
of the skin.
A number of stimuli, including UVB and contact sensitisers, causes the
induction or up-regulation of cytokines including IL-la, IL-3, IL-6, IL-8, GM-CSF,
IFN-a, TNF-a and TGF-p by keratinocytes (Bos and Kapsenberg, 1993; Enk and
Katz, 1992c; Kock et al. 1990). Using polymerase chain reaction (PCR), it was shown
that topical exposure of mice to contact sensitisers resulted in increased epidermal
mRNA for IL-la, IL-ip, GM-CSF, TNF-a, macrophage inflammatory protein-2
(MIP-2), interferon-induced protein-10 (IP-10) and I-Aa (Enk and Katz, 1992b; Enk
and Katz, 1992c). Tolerogens and chemical irritants also induce an increase in
epidermal mRNA for some, but not all, of these cytokines (Enk and Katz, 1992b).
Interestingly a LC derived cytokine seems to be an important initiating signal
for this cascade of epidermal cytokines. The expression of IL-ip mRNA in the
epidermis is up-regulated within 15 minutes of hapten application, preceding changes
in TNF-a mRNA expression which are found after 30 minutes (Enk and Katz,
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1992b). Depletion of epidermal cell subsets revealed that IL-ip activity is mainly
restricted to LC (Enk and Katz, 1992c). When IL-ip is injected intradermally, it causes
similar changes in cytokine production to those that occur after sensitisation, with
increased expression of mRNA for IL-la, MIP-2, IL-10, TNF-a and Class II, while
intradermal injection of IL-la or TNF-a did not affect the cytokine pattern (Enk et
al. 1993). In addition, a neutralising antibody to IL-ip was able to block sensitisation
(Enk et al. 1993), suggesting that LC-derived IL-ip is an important initiation signal for
the induction of contact sensitisation.
The migration of LC out of the epidermis seems likely to be TNF-a dependent,
though there is still controversy surrounding this issue. As stated previously message
for TNF-a is up-regulated following exposure to contact sensitisers, UVB and
possibly physical injury. An intradermal injection of TNF-a causes an accumulation of
DC in the DLNs of mice (Cumberbatch and Kimber, 1995) and a decrease in
epidermal LC numbers (Cumberbatch et al. 1994). In addition, UVB induced
accumulation of DC in the DLN could be blocked by pre-treatment of mice with
neutralising antibodies to TNF-a before irradiation (Moodycliffe et al. 1994). This
evidence in the skin is corroborated in a model of DC migration from the gut to the
mesenteric lymph nodes of rats (Macpherson et al. 1995). It was shown that the
injection of 50mg of endotoxin caused an 8-15 fold increase in DC numbers in the
lymph between 10-15 hrs after injection. An injection of neutralising antibody directed
against TNF-a into these rats prior to injection of the endotoxin abrogated the
increased DC migration. However, in contrast to these results, TNF-a has been
suggested to act on LC by immobilising them in the epidermis, as an intradermal
injection of TNF-a prior to sensitisation prevents hapten induced loss of LC from the
epidermis and so blocks the induction of CH (Streilein, 1993). Supporters of this
hypothesis argue that TNF-a causes a loss of marker expression (la and ATPase)
rather than an actual loss of LC. However, the case for TNF-a inducing DC migration
is strong. TNF-a fails to downregulate la expression on LC in vitro (Koch
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et al. 1990), and the rapid loss of la staining and the presence of a population of la
positive cells in the epidermis following TNF-a treatment suggests a subset of LC are
migrating out of the skin, rather than the induction of the rapid and selective loss of la
expression by TNF-a (Cumberbatch et al. 1994). In addition, the administration of a
neutralising polyclonal antibody to TNF-a blocks DC accumulation in DLN of
oxazolone or sodium lauryl sulphate (SLS) treated mice, showing that TNF-a is not
only involved in the loss of LC from the skin, but also in the accumulation of DC in
the DLN (Cumberbatch and Kimber, 1995).
1.3.3 Mechanism of LC migration
Although the mechanism of LC migration is not fully understood, it is likely
that adhesion molecules play a role. It has been postulated that the migration signal acts
to alter the phenotype of the epidermal LC, causing them to exit from the epidermis.
Recent evidence has shown that LC bind to keratinocytes via E-cadherin and that the
expression of this molecule is down-regulated on LC during culture (Tang et al. 1993)
(Table 1.2). Since keratinocytes are the predominant cell population in the epidermis
(Todd et al. 1993), E-cadherin could tether LC in the epidermis and may influence the
morphology of LC in the epidermis. Cytokine signals, which could include TNF-a
and GM-CSF, may induce the down-regulation of E-cadherin, weaken adhesive bonds
between LC and keratinocytes, and allow migration of LC from the epidermis.
ICAM-1, and to a lesser extent LFA-1, may be involved in the migration of LC to local
lymph nodes. Intravenous injection of monoclonal antibodies directed against these
molecules caused a reduction in the numbers of FITC+, Ia+ DC found in lymph nodes
after FITC skin painting, and an inhibition of the induction of CH (Ma et al. 1994).
Molecules that have roles in the homing and recirculation of cell populations, are
upregulated on LC during culture. There is increased expression of the surface
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Surface marker murine DC human DC
MHC class I
T (spleen and thymic DC)
Crowley etal. 1989
t (spleen DC)




t (lymph node DC)
Cumberbatch et al. 1991
t (cultured LC and spleen
DC) Schuler and Steinman,
1985
T (spleen DC)
Witmer-Pack et al. 1988
T (cultured LC)
Romani et al. 1989
CD45
V (blood DC) Freudenthal
and Steinman, 1990
V (blood and lymph node
DC) Wood et al. 1991
ICAM-1 t (lymph node DC)
Cumberbatch et al. 1992
V (blood and tonsil DC)
Hart and Prickett, 1993
ICAM-2 V (weak on blood and
tonsil DC)
Hart and Prickett, 1993
ICAM-3
V Caux etal. 1994a
LFA-1 V (spleen DC)
Medaycra/. 1990
V (blood DC) Freudenthal
and Steinman, 1990
MAC-1
I (cultured LC and spleen
DC) Schuler and Steinman,
1985
V (blood DC) Freudenthal
and Steinman, 1990




V (blood DC) Freudenthal
and Steinman, 1990
V (25% of spleen DC)
De Panfilis et al. 1989
LFA-3 V (blood DC)
De Panfilis etal. 1989
Table 1.2 (i) Phenotype of various DC populations in comparison with freshly
isolated LC [T expression up-regulated (compared with LC), i expression down-
regulated (compared with LC), V expression, x no expression.
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Surface marker murine DC human DC
CDla
x (blood DC) Freudenthal
and Steinman, 1990
CDlb









V Caux etal. 1994a
CD40 T (cultured LCI
Inaba et al. 1994
V (cultured LC)
Romanies al. 1989








CD86 T (cultured LC)
Inaba etal. 1994
V (CD34+ progenitors
cultured with GM-CSF and
TNFa)
Caux et al. 1994b
E-cadherin i (lymph node DC)
Borkowski et al. 1994
-1 (cultured LC) Blauvelt et
al. 1995
Table 1.2 (ii) Phenotype of various DC populations in comparison with freshly
isolated LC [T expression up-regulated (compared with LC), i expression down-
regulated (compared with LC), V expression, x no expression.
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molecules CD44 and a4 integrin (the a-chain of LPAM-l/VLA-4) and ICAM-1 (Aiba
et al. 1993). CD44 is a transmembrane glycoprotein with a molecular weight around
85000 (Omary et al. 1988). Evidence points to this molecule being involved in cell
recirculation, by binding specific carbohydrate residues on high endothelial venules
(Springer, 1990). VLA-4 has two ligands, VCAM-1 a cell adhesion molecule induced
on endothelium by inflammatory mediators, and the extracellular matrix protein
fibronectin (Springer, 1990). Adhesive interactions between these molecules on
differentiated LC and their ligands may play a role in the migration of LC to the DLN.
1.4. Migration of DC to DLN.
To induce a primary immune response, antigen processed by epidermal cells
has to be transported to the local draining lymph node (DLN), where competent
antigen-bearing APC can stimulate MHC-restricted proliferation and differentiation of
antigen-specific T cell clones. There is good evidence, that will be presented later in
this section, that antigen-bearing LC transport antigen to the DLN. Certainly, LC are
capable of migration out of the skin; a number of stimuli cause a loss of LC from the
epidermis including exposure to low dose UVB light and skin painting with contact
sensitisers (Bergstresser etal. 1980). Depletion of murine epidermal LC using these
treatments results in a subsequent accumulation of DC in the lymph nodes draining the
treated site (Kinnaird et al. 1989; Moodycliffe etal. 1992), which has been attributed to
an influx of DC from the skin. However, skin painting with haptens causes an influx
of DC into lymph nodes that drain non-sensitised sites, in addition to inducing an
increase in DC numbers in DLNs (Hill et al. 1990). Therefore, some of the increase in
DC numbers seen in lymph nodes draining a sensitised or irradiated site, may result
from migration of non-LC derived DC into the lymph node.
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1.4.1 DC cords in dermis
Whole skin biopsies can be cultured in vitro by floating the skin dermal side
down on medium, so that the epidermal face exposed to the air. Within 24 h of culture
LC in epidermal sheets increased in size and expression of MHC class II molecules,
and their numbers were markedly decreased (Larsen et al. 1990). Explant culture has
provided a good source of murine and human DC, since DC migrate out of the skin
and can be harvested from the medium after 1-3 days in culture (Larsen et al. 1990;
Pope et al. 1995). This system has also provided a model to examine the migration of
LC out of the skin. After 24 hr of culture, cells with LC morphology were found close
to the epidermal-dermal junction, and by 3 days, the dermal lymphatics were filled
with strings of LC leaving the skin (Larsen et al. 1990). T cells also emigrate out of
skin organ culture, mostly y5 T cells in mice (Larsen et al. 1990), while in humans the
migrating T cells are mostly ap TCR with a 'memory' phenotype (Pope et al. 1995). In
both systems DC and T cells migrating out of the skin form clusters. The possible
contribution of this to immune responses in vivo is still a subject for speculation.
1.4.2 DC in afferent lymphatics
After an appropriate signal, LC migrate into the afferent lymphatics where they
are described as veiled cells (due to their long actively moving processes which
resemble veils). Following cannulation of the afferent lymphatics of rabbits it was
found that large mononuclear cells, many displaying surface veils, accounted for 53%
of total cells (Kelly et al. 1978). In addition, 3% of cells contained Birbeck granules
(Kelly et al. 1978). There seem to be major differences in the estimates of the numbers
of DC migrating under normal conditions in the afferent lymph. One paper (Steinman
et al. 1995) reviews evidence that 105 DC/hr accumulate from cannulated afferent
lymph of an unnamed species and argues that this number of DC cannot be derived
from the available pool of epidermal LC. Similarly, studies in the sheep (Dandie et
al. 1994) have shown a background level of around 9xl04 LC/hr in afferent lymph.
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Following treatment with a chemical carcinogen (7,12-dimethylbenz(a)anthracene) LC
numbers in the afferent lymph peaked at day 5 with 3.7 xl07LC per hour. Although
this number of DC represented migration from 50cm2 of carcinogen treated skin, the
slow-turnover of LC in the epidermis makes it unlikely that all these DC are
epidermally derived. However (Kelly et al. 1978) report the collection of around
2xl04-4xl05 veiled mononuclear cells/hour from from the afferent lymph of rabbits,
since 3% of these cells have Birbeck granules, this means that around 600-12000 LC-
derived cells migrate via the afferent lymph of rabbits each hour.
Cells migrating via the afferent lymph already display maturational changes
enabling them to efficiently induce antigen specific proliferation. In one study the
afferent lymph ducts of calves were cannulated, enabling the afferent lymph veiled
cells (ALVC) to be studied (McKeever et al. 1992). The ability of the ALVC draining
from the site of intradermal antigen challenge [variable surface glycoprotein (VSG)
from 7rypanasoma brucei ], to induce peripheral blood mononuclear cell (PBMC)
proliferation, was measured in monozygotic bovine twins. It was found that
proliferation in PBMC from VSG immunised calves was induced, within 30 minutes
of intradermal application of antigens. There was no proliferation of PBMC from VSG
naive calves. Similar work has been carried out in sheep, using the protein antigens
ovalbumin (OVA) and purified protein derivative (PPD) from bacillus Calmette Guerin
(Bujdoso et al. 1989). There was a marked proliferation of OVA and PPD specific T
cell lines when incubated with afferent lymph cells from OVA and PPD challenged
animals. Afferent lymph cells collected prior to challenge did not induce significant
proliferation in the antigen-specific T cell lines. The stimulation was antigen specific as
the afferent lymph cells of OVA challenged sheep did not induce proliferation of PPD
specific T cells, and vice-versa. In addition, the ability of ALVC to cluster with
primary resting T cells was described, a property which is not shared by non¬
professional APC and one of the reasons why antigen presentation by DC is essential
for the initiation of primary responses.
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1.4.3 Differentiation of LC
The changes in the morphology, phenotype and function of DC as they migrate
to the DLN are thought to be similar to the changes seen in vitro when freshly isolated
epidermal LC are cultured. Cultured LC lose the ability to process antigen (section
1.1.2.2) and most lose their Birbeck granules (Streilein et al. 1990). However,
cultured LC are significantly better at stimulating autologous and allogeneic T cell
responses than are freshly isolated LC. These changes in function are associated with
alterations in the phenotype of LC during their migration from the skin and their
differentiation into DC.
The changes in the phenotype of murine and human DC, induced during their
migration to the lymph node, or after 3 days culture with keratinocyte derived
cytokines is shown in Table 1.2. Several molecules that are essential for antigen-
presentation are up-regulated on DC during in vivo or in vitro maturation. ICAM-1
which may be involved in providing the initial antigen independent interaction between
DC and T cells (section 1.5.1), is up-regulated on cultured epidermal LC (Aiba et
al. 1993) and DC isolated from LN have higher levels of ICAM-1 than LC isolated
from the epidermis (Cumberbatch et al. 1992). MHC class I and II are upregulated on
cultured LC (Shimada et al. 1987; Schuler and Steinman, 1985) and DC isolated from
the lymph nodes show increased expression compared with epidermal LC
(Cumberbatch et al. 1991). Other molecules such as members of the B7 family of
costimulatory molecules that are required to induce the differentiation of naive T cells
into functional effector cells, are also up-regulated on DC compared with LC.
The cytokines produced by keratinocytes after treatment with haptens or UVB
are important in the differentiation of LC into lymphoid DC. Differentiation of murine
LC in vitro requires the presence of GM-CSF, produced by contaminating
keratinocytes (Witmer-Pack etal. 1988). Culturing highly purified murine LC in GM-
CSF increases their ability to stimulate MLRs and LC purified from bulk epidermal cell
cultures, where contaminating keratinocytes provide cytokines, are also good
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stimulators of MLR (Heufler et al. 1988). This ability is not only due to improved
viability and increased la expression (Heufler et al. 1988). If LC are cultured in the
presence of both GM-CSF and IL-1, a two-fold enhancement in their capacity to
stimulate MLR is induced compared with LC cultured in GM-CSF alone (Heufler et
al. 1988). Further evidence of a role for GM-CSF in the differentiation/maturation of
LC is provided by the inability of LC from unprimed mice to induce an immune
response to a tumour associated antigen, unless the cells are pre-incubated with GM-
CSF (Grabbe and Granstein, 1993). Pre-incubation of unprimed LC with IL-la,
TNF-a, IFNy and TGFp does not affect their ability to induce a response and, indeed,
some combinations of cytokines cause a reduction in the immune response (Grabbe
and Granstein, 1993). If murine LC are cultured in TNF-a alone, the viability of the
cells is maintained, but they do not mature functionally and are poor stimulators of
MLR (Koch et al. 1990). However, TNF-a does induce LC differentiation, causing the
down-regulation of macropinocytosis (Caux et al, 1994a). Culture of human DC
progenitors, CD34+ cells isolated from peripheral blood, in GM-CSF and TNF-a
causes their differentiation into cells with DC activity (Caux et al. 1992). TNF-a
synergises with other cytokines, notably GM-CSF (Caux et al. 1992), IL-1 and IL-4,
in the differentiation of human CD34+ haematopoietic cells into dendritic Langerhans
cells in vitro (Caux et al. 1992). This function may be ascribed to its ability to induce
IL-3 and GM-CSF responsiveness which may be important in the early stages of
differentiation of these cells in vitro (Caux et al. 1990). After 12 days of culture with
TNF-a and GM-CSF the total cell number and the proportion of CDla+ cells within
the population were increased compared to cells to which only GM-CSF was added
(Caux et al, 1992).
1.4.4 Accumulation of DC in DLN
Although the presence of FITC-bearing DC in the DLN of FITC-sensitised
mice is not necessarily a marker for epidermal derivation, it is likely, though still a
matter of some contention, that most of these DC cells bind FITC in the skin prior to
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their migration to the DLN. Two populations of FITC+ DC have been identified in the
DLN after skin painting (Macatonia et al. 1987), one with low levels of FITC and
another intensely fluorescent population. DC bearing high levels of FITC first
appeared 2-8 hrs after skin painting and they were the only cells able to induce T cell
proliferation. In another study, two populations of FITC+ DC were found in the DLN
of mice after skin painting; 75% of these DC expressed the antigen F4/80, a marker of
LC but not lymph node DC, which suggests a skin derived population (Kripke et
al. 1990). The remaining 25% did not express F4/80. These cells may represent a
resident lymph node population that bind free FITC in the lymph node. These skin-
derived DC, which bear high levels of FITC, are required for the induction of FITC-
specific CFI responses (Macatonia et al. 1986). Further evidence that lymph node DC
are predominantly LC derived comes from a model using a monoclonal antibody to
deplete Ia+ cells in mice (Aberer et al. 1986). This resulted in the loss of Ia-t- cells from
the spleen and lymph nodes but not the depletion of LC from the skin. Following skin
painting, Ia+ FITC bearing cells appeared in the lymph nodes that could stimulate a
FTTC specific hybridoma in an MHC class II restricted manner (Aberer et al, 1986).
Although FITC rapidly associates with proteins in vivo, it has been claimed
that FITC can move freely to the lymph node without necessarily binding to LC in the
epidermis. After ear painting FITC found in the DLN is associated predominantly with
IDC. Therefore, free FITC entering the lymph node would have to bind interdigitating
DC with a high affinity and high selectivity. Although FITC is a popular contact
sensitiser because it can be visualised, other antigens have also been used to study
migration. Leishmania major (L. major) amastigotes, administered intradermally,
induced migration of DC from the skin to the DLN. DC isolated from these nodes
were immunostimulatory for L. major specific T cells (Moll, 1993). In other studies in
sheep and cattle, the afferent lymph veiled cells (ALVC) draining a site challenged
intradermally with antigen were collected and used to induce antigen specific
proliferation (Bujdoso et al. 1989; McKeever et al, 1992).
29
The most compelling evidence for epidermal LC migrating to the DLN after
antigen challenge, is provided in experiments using athymic nude BALB/c mice
grafted with skin from C3H mice (Kripke et al. 1990). When the BALB/c mice were
contact sensitised with FITC through the graft tissue, the cells binding FITC in the
DLN were found to be of graft donor phenotype. Isolated FITC binding cells from the
DLN of BALB/c mice could induce a CH response in C3H but not in BALB/c mice. In
the same study it was shown that at least some of the FITC binding cells found in the
DLN contained Birbeck granules, a feature of epidermal LC. Similarly, cells bearing
rhodamine B (a fluorescent contact sensitiser) and MHC class II have been detected in
murine lymph nodes following sensitisation through human skin grafted on nude mice
(Hoefakker et al. 1995). However the numbers of LC in the human skin were very
low and it is impossible to derive the number of human DC per lymph node from the
presented data. Taking all the evidence from this section as a whole, it seems likely
that most of DC which accumulate in the lymph nodes following contact sensitisation
are derived from cutaneous APC.
1.5. The induction of primary immune responses
The veiled cells drain into the lymph node and localise in the paracortex where
they are called IDC as their dendritic projections show extensive contact with
surrounding cells. The IDC present antigen in a MHC-restricted manner to T cells in
the lymph node. T cells which are specific for the antigen / MHC complex and which
receive the correct signals from the APC (soluble signals and cell-cell interactions) are
induced to proliferate and differentiate.
The requirement for professional APC, and in particular DC, in the induction
of primary immune responses has been demonstrated. Transgenic mice were bred that
differed in the amounts of I-E MHC expressed on the surface of the major APC
populations (DC, B cells and macrophages) (Levin et al. 1993). These mice were then
immunised with an I-E restricted peptide antigen. After eight days the CD4+ T cells
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were removed from LN draining the site of immunisation and cultured with the
immunising antigen. There was a correlation between the in vitro proliferative
response of the CD4+ T cells and the percentage of I-E expressing cells in the mouse.
However, there was no correlation between I-E expression on B cells or macrophages,
and the extent of the CD4 T cell recall response. This evidence is indicative of the
requirement for DC in the induction of primary immune responses. In the following
two sections the process of antigen presentation will be described and related to the
features of DC which make them efficient APC.
1.5.1 Clustering with naive T cells
The ability of DC to initiate primary immune responses can be explained, in
part, by their capacity to form stable clusters with resting antigen-specific T cells.
Splenic DC from mice form clusters with T cells and B cells in vitro in the absence of
exogenous antigen (Inaba et al. 1984), while other APC can only cluster with
sensitised T cells (Inaba and Steinman, 1984). Antigen-independent adhesion between
T cells and the APC precedes antigen-dependent clustering, and may allow DC to
"sample" different T cells (Inaba and Steinman, 1986). In vitro assays have shown
that clustering occurs prior to, and is essential for, T cell proliferation (Austyn et
al. 1988). The interaction between LFA-1 and its ligands ICAM-1,2,3 may be
important in this first stage of antigen presentation. The requirement for ICAM-1
expression on APC has been shown by examining the function of mutant APC from
mice which had an 80-95% reduction in ICAM-1 expression (Dang et al. 1990). The
ICAM-1low APC had a greatly impaired ability to present antigen to T cells.
Reconstitution of ICAM-1 by transfection of the gene into these cells restored normal
antigen presentation. ICAM-1 induces important costimulatory signals through the
LFA-1 molecule on T cells (Van Seventer et al. 1992). The ICAM-1 / LFA-1
interaction is also necessary in the clustering of T lymphocytes with other cells (Lorenz
etal. 1993), and it has been suggested that antigen independent adhesion is the first
31
step toward recognition of the antigen /MHC complex by T cells (Makgoba
et al. 1989). However, antibodies to LFA-1 fail to block antigen-independent clustering
of murine spleen DC although they do block the function of clusters by causing a
decrease in cell proliferation and cluster stability (Inaba and Steinman, 1987).
1.5.2 Antigen presentation.
It is generally accepted that functional effector cells are generated from naive T
cells only after the cell receives signals through both the antigen restricted TCR/MHC
pathway and through separate non-antigen specific costimulatory pathways. One such
pathway that seems to be important in a number of systems is mediated by interactions
between CD28 and molecules of the B7 family. The up-regulation of adhesion
molecules on the surface of DC during their migration to the lymph node, provides DC
with the ability to induce the proliferation and differentiation of antigen-specific naive
T cells in the paracortex of the draining lymph node. In this section the role of MHC
molecules and costimulation via B7 molecules will be discussed. However, other
costimulatory pathways have been proposed including signalling via CD2/LFA-3
interactions and through heat stable antigen binding its ligand (Enk and Katz, 1994).
In addition, soluble signals mediated by cytokines such as IL-1, IL-2 and IL-6 are
important in the activation of T cells (Van Snick, 1990), but will not be covered here.
DC express high levels of MHC class II and class I. Indeed, freshly isolated
murine LC express around 2-4xl05 MHC class II molecules/cell (Witmer-Pack
et al. 1988; Schuler and Steinman, 1985) and MHC class II is up-regulated 5-fold
during bulk EC culture (Witmer-Pack et al. 1988) and around 2-fold in enriched LC
cultures (Schuler and Steinman, 1985). Similar levels of up-regulation are seen in vivo
when the density of MHC class II on DC are compared with that on LC (Cumberbatch
et al. 1991). MHC class I levels on LC in bulk EC suspensions also increase around
five-fold during overnight culture though constitutive levels of MHC class I are low on
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LC (Witmer-Pack et al. 1988). Therefore DC entering the lymph nodes following
migration from the skin are well equipped to provide signalling via the TCR.
There has been much interest recently in the costimulatory functions of
members of the B7 family which are ligands for CD28 and CTLA-4 on T-cells. B7-2
(CD86) expression is found within 24 hrs of activation of human B-cells, while B7-1
(CD80) expression peaks several days later (June et al. 1994). B7-2 is found on
peripheral blood DC (Young et al. 1992), resting human monocytes and on activated T
cells, B cells and NK cells (Azuma et al. 1993). CD28 is expressed widely on both
human and mouse resting T cells, while CTLA-4 expression seems to be limited to
activated T cells (June et al. 1994). While both B7-1 and B7-2 are ligands for CD28
and CTLA-4, in vivo interactions may be influenced by the availability of the ligands.
B7-2 is found constitutively at low levels on murine epidermal LC, and after 24 hrs in
culture there is a dramatic up-regulation in its expression (Inaba et al. 1994) (Table
1.2). B7-1 is not found on epidermal LC normally, but it is induced (to lower levels
than B7-2) during culture (Larsen et al. 1992; Symington et al. 1993; Inaba et al. 1994),
and is present on splenic DC (Larsen et al. 1992).
The up-regulation of B7-1 and B7-2 during LC culture and their expression on
lymphoid DC suggests the involvement of keratinocyte-derived cytokines. B7-2 up-
regulation can be partially decreased during culture in the presence of an anti-GM-CSF
antibody (Inaba et al. 1994), which may reflect a minor role for GM-CSF in the
induction of B7-2. Alternatively the isolated LC may have received a signal to up-
regulate B7-2 expression during isolation which then may be difficult to reverse (Inaba
etal. 1994). Lipopolysaccharide does not seem to up-regulate B7-2 on DC although it
does increase expression of B7-2 on macrophages and B cells (Hathcock et al. 1994).
Therefore, both B7-1 and B7-2 are expressed on DC in lymphoid tissue with
up-regulation during in vitro culture of LC, associated with increased APC activity.
Freshly isolated LC are less able to stimulate allo-responses than are cultured LC
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(Freeman et al. 1991; Larsen et al.1992; Symington et al. 1993) and cultured LC induce
similar allo-responses to freshly isolated LC when B7-1 and B7-2 interactions are
blocked using CTLA4-Ig (Symington et al. 1993). CTLA-4Ig is a fusion protein with
the extracellular portion of CTLA-4 spliced to the constant region of human IgGl
molecule, which acts as a soluble ligand for B7-1 and B7-2 (Lane et al. 1993).
Interestingly, the allo-response induced by fresh or cultured LC could be abrogated
using CTLA4-Ig and anti-ICAM-1 (Symington et al. 1993).
There is some evidence that B7-1 signalling induces Thl type responses, while
B7-2 mediates Th2 responses. There has been some confusion in the use of CTLA-4Ig
to block signalling through the CD28/B7 pathway. Using this method two groups
produced conflicting data, the first group used a model of rat allograft where graft
rejection was mediated by infiltrating T cells expressing the Thl type cytokine IFN-y
and mononuclear cells (Sayegh et al. 1995). Treatment of these animals with
CTLA-4Ig increased graft survival, which was associated not with a reduction in graft
infiltrate, but with an increase in Th2 cytokine production (IL-4) by infiltrating T
cells. In a separate study a similar method was used to prolong survival of BALB/c
mice following infection with L. Major (Corry et al. 1994). BALB/c mice are
susceptible to Leishmaniasis due to their development of Th2-type responses
following infection. CTLA-4Ig given in the first week of infection halted disease
progression and was associated with a reduction in IL-4 and IgE levels (Corry et
al. 1994). Although these two results appear to be conflicting the ability of CTLA-4 to
bind both B7-1 and B7-2 may explain why treatment with CTLA-4Ig blocked a Thl
response in the first model and a Th2 response in the second. These models represent
highly diverged Thl and Th2 immune responses that become locked into an
immunopathogenic response, because of the ability of each response to negatively
regulate the other. In these models it is possible that CTLA-4Ig is acting to block the
predominant response allowing a more balanced response. While CTLA-4Ig blocks
signal mediated by B7-1 and B7-2, the use of specific monoclonals to these molecules
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has allowed their roles in the generation of Thl and Th2 responses to be dissected
more completely. In a mouse model of experimental allergic encephalomyelitis (EAE)
in which Th2 T cells are associated with the suppression of disease, blocking B7-1
signals during the initiation of disease reduced subsequent symptoms, while blocking
signalling through the B7-2 pathway increased disease severity (Kuchroo et al. 1995).
Blockade of the B7-1 pathway was associated with the generation of Th2 type T cell
clones, while Th-1 T cell clones were generated following blockade of B7-2
signalling. This evidence suggests that B7-1 preferentially induces Thl type
responses, with B7-2 reciprocating by favouring the induction of Th2 responses.
The above results may help to explain the disparate effects on accessory cell
activity induced by the blockade of B7-1 (CD80) and B7-2 (CD86) activity. The ability
of human DC, obtained by culturing CD34+ peripheral blood progenitor cells with
GM-CSF and TNF-a, to induce allo-responses was inhibited by monoclonal
antibodies against CD28 (Caux et al. 1994b). However, though monoclonal antibodies
against CD80 had little effect on the allo-response, monoclonal antibodies against
CD86 suppressed the allo-response by 70% (Caux et al. 1994b). When used together
monoclonal antibodies to CD80 and CD86 caused a 90% reduction in allo-response
(Caux etal. 1994b). CTLA4-Ig binding was completely inhibited in the presence of
monoclonals to CD80 and CD86, suggesting that there is not a third ligand for CTLA-
4 on DC.
Due to the these and other changes in phenotype summarised in Table 1.2, IDC
and cultured LC become specialised at presenting antigen to T cells, and are efficient at
activating unprimed LNC and in the induction of alloresponses in vitro (Streilein and
Grammer, 1989).
1.5.3 Production of a cutaneous immune response.
T cells that recognise, and bind to, the specific antigen/MHC complex on the
IDC and receive the necessary costimulatory signals, are induced to proliferate.
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Activation signals also induce differentiation of the T cells which undergo changes in
both morphology and phenotype. These T cells exit the lymph node in the efferent
lymph and enter the bloodstream via the thoracic duct. Recently activated CD45RO+ T
cells, the so called memory subset, have been shown to exhibit specialised
recirculation patterns. In the sheep the loss of L-selectin on these cells means that they
are less likely to recirculate to peripheral lymph nodes and instead they circulate
preferentially through tissue sites including the skin (Mackay etal, 1992). Once at the
site they orchestrate adaptive immunity, inducing responses such as CH and DH,
whose effector mechanisms were described in section 1.0.3.1.
1.5.4 Secondary cutaneous responses.
The antigen presenting pathway that has been described, LC processing
antigen in the periphery and presentation to specific T cells in the DLN, is relevant to
all cutaneous immune responses. However, this mechanism may be augmented by
alternative antigen presentation pathways in a secondary response, where there will be
a pool of activated or semi-activated T cells specific for the antigen. It was noted in the
previous section that sub-populations of these cells show preferential recirculation to
tissue sites including the skin. Therefore in a secondary response, T cells could
encounter antigen in the periphery bound to LC or other antigen presenting cell
populations such as B cells, macrophages and keratinocytes. Memory/activated T cells
expressing CD45RO can be activated by a wide range of APC, while activation of
naive T cells requires dendritic cells (Bradley et al. 1993). Therefore skin homing
populations of T cells, after being presented with antigen in the periphery, could
release inflammatory factors that initiate a cascade response leading to the migration of
effector cells through the endothelium into the skin.
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1.6. Ultraviolet light
1.6.1 Sources of UVB
Ultraviolet light comprises wavelengths of electromagnetic radiation between
200-400nm. The spectrum of UV light is divided in to 3 arbitrary units UVA, UVB
and UVC. The longest wavelengths (315-400nm) lie within the UVA range. These are
present at the highest intensity in terrestrial sunlight. Light in the UVB range (290-
315nm) is present in sunlight at a lower intensity than UVA (100-1000 times less) but
UVB wavelengths have the largest biological effects per unit of irradiation. The
shortest wavelengths of UV light, UVC (200-290nm), would be very damaging to
biological systems, but fortunately are efficiently blocked by atmospheric ozone.
There are a number of artificial sources of UVB light, which differ in their
outputs. In this study the Philips TL-20W/12 was used as a source of broadband
UVB. These bulbs emit a broad-band of UV with peak output in the UVB range.
However, there is some output in the UVC and UVA ranges. In addition a TL01 lamp,
which emits predominantly at 31 l-312nm, was used in the chronic UVB exposure
study. The output spectra for both sources are presented in Figure 1.2.
As the surface of the earth is likely to become more exposed to UVB radiation
with a decrease in the protective ozone layer, concern is growing about the impact of
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1.7. UVB and immunosuppression
1.7.1 UVB: Role in the induction and promotion of tumours
1.7.1.1 Epidemiology of skin cancer
The incidence of all skin cancers (melanoma and non-melanoma) has been
rising for the last 20 years. The epidemiological evidence suggests an association
between exposure to sunlight and the development of all types of cutaneous
malignancy. The most direct relationship is seen in the development of squamous cell
carcinomas (SCC) which result from accumulated sun exposure. Therefore these
cancers are seen more often in people living in sunny areas of the world and appear at
chronically exposed body sites e.g. the head, neck and backs of hands. There is also a
weaker relationship between accumulated sun exposure and the incidence of basal cell
carcinomas (BCC) (de Gruijl, 1993). BCC appear mainly on the face and neck but
rarely on the backs of hands; additionally 10% of these cancers are found on the trunk
(de Gruijl, 1993). There is no strong evidence to link the development of melanomas
with accumulated exposure. Immunocompetent hairless mice, chronically exposed to
UVB, never develop melanoma, and outdoor workers are less at risk from melanoma
than urban white collar workers (de Gruijl, 1993). Epidemiological evidence supports
the connection of childhood sunburn with melanoma development in later life.
However this relies on the recall of 'burning episodes' by patients with melanoma (de
Gruijl, 1993)
1.7.1.2 UVB and tumour induction
With regard to the induction of cancer, UVB has received the most attention
because the peak carcinogenicity per unit of ultraviolet exposure (J/m2) occurs at
293nm. Also the action spectrum for carcinogenicity in mice closely follows the action
spectrum for erythema which is induced most potently by the UVB component of
sunlight. However, more interest is being shown in the role of UVA because,
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although carcinogenicity drops by a factor of 104 for wavelengths over 340nm (de
Gruijl, 1993), the high intensity of UVA in sunlight and the inability of certain
sunscreens to block UVA wavelengths means that individuals could be exposed to
high doses. However, in mice UVA has a protective effect, delaying the appearance of
tumours induced by chronic UVB exposure (Bech-Thompsen etal.1911). This
protective effect of co-exposing mice to UVB and UVA together was seen at all but the
highest dose of UVA (45.6 kJ/m2 daily). There has been little or no attention given to
UVC because although UVC wavelengths are carcinogenic, they are blocked
efficiently by atmospheric ozone and so are unlikely to be of importance in terrestrial
sunlight.
UV light is absorbed by a number of biological proteins, the most critical of
which is DNA. The role of DNA damage in UVB-induced immunosuppression will be
discussed in section 1.8.2.1. However, the importance of UVB as an initiator of
tumourigenesis may result from its ability to cause mutations in the p53 gene affecting
the ability of this locus to control the cell cycle. Cells that lack functional p53 are
unable to arrest in the G1 phase of their cycle. G1 arrest is required to institute DNA
repair mechanisms, and therefore cells with mutant p53 accumulate DNA damage with
an increased chance of transformation. Photodamage caused by UVB has been shown
in the p53 gene in all skin cancer types.
1.7.1.3 UVB and tumour promotion
The spontaneous regression of melanomas in occasional patients and the
development of a variety of cancers, mainly cutaneous cancers and lymphomas, in
immunosuppressed individuals has led to the acceptance that the immune system is
involved in the control of certain tumours, particularly in the skin. Inate (natural killer
cells, lymphokine activated killer cells and proinflammatory cytokines) and adaptive (T
and B cell) mechanisms are thought to be involved in immunity to tumours. The role
of the SIS in tumour control may be to monitor the cells in the skin for changes
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associated with transformation, and to destroy any transformed cells that are found
(tumour surveillance). If such tumour surveillance exists, the outgrowth of a tumour
from a transformed cell would require either a weak immune response, or the ability of
a transformed cell or tumour to avoid or outgrow the immunological response. Initial
experiments showing that UVB light weakened the immune response to tumours, and
that UVB was acting as a tumour promotor, resulted from work on SCC induced by
chronic irradiation of mice (Fisher and Kripke, 1977). These SCC were immunogenic,
being rapidly rejected after transplantation into syngeneic recipients, but were not
rejected in syngeneic recipients that had been pre-irradiated. Therefore as well as
initiating tumours by causing damage to DNA, UVB may promote of tumour growth
by inhibiting tumour surveillance.
The experimental evidence that UVB decreases anti-tumour immune responses
is corroborated by clinical studies in which a clear link between susceptibility to UVB-
induced immunosuppression and the development of all forms of cutaneous carcinoma
has been found. Over 90% of individuals with a previous history of cutaneous
neoplasms show susceptibility to UVB, as indicated by suppressed CH response
following UVB, compared with 40% of the general population (Streilein et al. 1994).
Assuming both groups have been exposed to similar levels of UVB-induced DNA
damage, the fact that UVB-resistant individuals are barely represented in the cancer
group, infers that UVB-resistance is an advantage in coping with the damaging effects
of UVB on DNA. The loss of tumour immunity, during the immunosuppression that
follows exposure to UVB in certain individuals, may allow transformed cells to escape
immune control, accumulate further mutations, and become cancerous.
1.7.2 Suppression of immune responses to infectious disease
Because of the ability of low-doses of UVB to induce suppression of cell-
mediated immunity, modulation of immune responses to infectious agents may also
occur. There is now evidence from a number of rodent models that UVB can affect
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immune responses to viruses, bacteria, fungi and parasites. One virus that has received
attention in this area is herpes simplex virus-1 (HSV-1). It infects the epithelial cells of
the skin causing local lesions and persists in the ganglia in a latent form. It can
recrudesce at intervals and exposure to sunlight is one common stimulus for
reappearence of lesions (Norval, 1992). In a mouse model it has been shown that a
low-dose of UVB prior to infection with HSV induces suppression of DH to the virus
when the mice are subsequently challenged (Howie et al. 1987) (see section 1.8.2.2).
The suppression of responses in this model was associated with the generation of
splenic T cells which transfered suppression of DH to naive recipients. UVB may be
of importance principally in reactivating the latent virus. However, it is possible that
reduced immune responses to HSV which follow exposure to UVB provide a more
permissive environment for viral replication, thus converting a non-clinical infection
into an overt one.
The role of UVB in the progression of disease in HIV+ individuals has been
studied, not only because of the concern that UVB may affect responses to the virus,
but also because it may increase susceptibility to the opportunistic pathogens that infect
immunocompromised individuals. Interestingly, low-doses of UVB (400J/m2) activate
the human HIV promoter causing the transcription of HIV within infected cells (Miller
et al. 1992). Since the virus has been detected in the skin of HIV+ individuals and LC
have been proposed as a reservoir of infection (Weber and Weiss, 1988), it is possible
that UVB may directly increase the titre of virus by activating transcription within cells
in the skin. In addition to its ability to promote viral transcription, the
immunosuppression caused by UVB may well exacerbate the suppression caused by
HIV. This is certainly true in the mouse model of AIDS (MAIDS) where exposure to
low-doses of UVB was shown to enhance the immunosuppression and the
progression of the disease (Brozek et al. 1992). Because of these effects there have
been warnings that HIV+ individuals, and other immunocompromised individuals
should avoid sun-exposure. There has been an interesting study examining the
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mechanism of immunosuppression in Rauscher leukaemia virus (RLV) infected mice
(Gabrilovich et al. 1994). Following intravenous infection RVL DNA was detected in
Langerhans cells and lymph node DC. CH responses were suppressed in infected
mice. Suppression was associated with a reduction in LC accessory function in MLR.
In addition, the suppression reflected an inability of LC to migrate from the skin
following epicutaneous FITC application and an accompanying lack in DC
accumulation in lymph nodes draining the sensitised sites (Gabrilovich et al. 1994).
Since HIV and RLV are retroviruses and both infect LC, it would be interesting to
speculate whether HIV and RLV cause similar effects on cutaneous immunity. If this
is the case, then it may help explain the inability of symptomatic HIV+ individuals to
control the growth of warts and cutaneous neoplasms.
There have also been a number of studies that have reported suppression of
immune responses to bacterial infections. In an experimental model, the causative
agent of Lyme disease Borrelia burgdorferi (Bb), was used to examine the effect of
UVB on both DH and humoral responses in mice (Brown et al. 1995). The proposed
ability of UVB to cause a switch from a Thl to Th2 response (section 1.8.3.2) has
been hypothesised to be responsible for UVB-induced suppression of immune
responses in a number of disease states. In this model exposure to a single high-dose
of UVB (10kJ/m2) 4 days prior to immunisation suppressed DH responses to Bb
(Brown et al. 1995). The role of a Th2 switch in this suppression was supported by
evidence that IL-10, a Th2-type cytokine, was important in the suppression of DH
responses following UVB. UVB and IL-10 also suppressed the production of IgG2a
and 2b antibodies that are associated with Thl responses (Brown et al. 1995). In
another study, DH responses to the mycobacterium Bacillus Calmette-Guerin (BCG)
were unaffected following subcutaneous inoculation through skin exposed to 400 J/m2
UVB for 4 consecutive days (Jeevan et. al. 1992). However, the course of BCG
infection in UVB treated mice was different, with greater numbers of mycobacterium
in the lymph nodes and the infection taking longer to clear.
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Systemic fungal infections are a problem associated mainly with
immunocompromised individuals. The only fungal pathogen that has been studied,
Candida albicans (C. albicans), causes infections of the mucous membranes but in
compromised individuals can cause systemic disease. The DH response to C.albicans
is reduced if a single dose of UVB (46.8 kJ/nr) is given immediately before or after
sensitisation (Denkins etal. 1989). In a model of lethal C.albicans infection,
immunisation of mice with formaldehyde-fixed C.albicans 6 days prior to i.v.
challenge of mice with a lethal dose of the fungus increased the LD50 from 15 days to
over 25 days (Denkins and Kripke, 1993). Exposure to UVB prior to sensitisation
reduced DH responses, but did not affect survival, while exposure to UVB 1 day
before challenge reduced survival time by 50% (Denkins and Kripke, 1993).
However, in both these studies the high dose of UVB, approximately 31 minimal
erythemal doses (MED), required to affect DH responses and the course of disease,
suggests UVB may have a limited impact on C. albicans infection following
environmental exposure.
The parasitic infections which have been studied most frequently are L. Major,
and Schistosoma mansoni (S.mansoni) in mice models and the worm Trichinella
spiralis (T.spiralis) in the rat. In L. major infections, chronic low-dose UVB reduced
the size of lesions but increased the numbers of animals that died from the disease,
while acute low-dose UVB failed to affect infection with S.mansoni (Jeevan et
al, 1995). Exposure of rats to UVB reduced their resistance to T. Spiralis infection
(Goettsch et al. 1994).
1.7.3 Suppression of CH and DH responses
The suppression of CH responses by UVB is a well characterised phenomenon
in mice (Toews et al. 1980; Moodycliffe et al. 1994; Schimizu and Streilein, 1994) and
in humans (Tie et al. 1995; Cooper et al. 1992). Early experiments showed that
exposure to sub-erythemal doses of UVB on four consecutive days induced a decrease
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in the number of epidermal Langerhans cells in exposed skin (Toews et al. 1980), and
that these sites were unable to support the induction of contact hypersensitivity, a
property shared by skin sites that are naturally deficient in Langerhans cells (Toews et
al. 1980). This same study elucidated a number of features of UVB-induced
suppression of CH that are relevant. Firstly, the induction of immunosuppression
immediately following low dose (400 J/m2 for 4 conscecutive days) UVB exposure
was confined to the irradiated site (local immunosuppression). Secondly, mice were
not simply unresponsive to DNFB, the sensitising chemical, following exposure
through LC-deficient skin but showed antigen specific tolerance. Unresponsiveness to
an antigen would imply the immune system had failed to recognize the antigen.
However, since mice which were first sensitised through LC-deficient skin were still
unable to respond to DNCB, but not other unrelated sensitisers such as oxazolone,
following resensitisation through an unirradiated skin site 14 days later, it is obvious
that the suppression of CH responses in these mice is not due simply to
unresponsiveness, but to an active tolerance. Similarly in humans, UVB can suppress
CH responses to DNFB in certain individuals and results in long-term (up to 4
months) tolerance to the sensitiser in around 30% of people who were exposed to the
chemical through irradiated skin (Cooper et al. 1992). Another important feature of
UVB-induced immunosuppression following exposure to low doses and high doses of
UVB is the induction of a T cell population in the spleen that transfers reduced CH
responses to naive syngeneic recipients, so called 'suppressor T cells'(Elmets et
al. 1983; Glass et al. 1990). However, while these suppressor cells are found in all
strains of mice following UVB irradiation (Glass et al. 1990), only certain strains
actually show suppressed CH responses in response to UVB (Streilein and
Bergstresser, 1988; Noonan and Hoffman, 1994).
UVB-induced suppression of DH responses to a number of agents including
HSV (Howie et al. 1987) and C. albicans (Denkins and Kripke, 1993) has been
demonstrated. DH responses are different in a number of respects from CH responses
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(section 1.0.3) and generally they require lower doses of UVB to induce suppression.
A single dose of 960 J/m2 3 days prior to infection with HSV caused a 50-90%
suppression in DH response (Howie et al. 1987), while in CH responses two doses of
1440J/m2 were required to suppress the elicitation response to the same extent
(Moodycliffe et al. 1994). Similarly, Kripke's group, which use 10kJ/m2 to cause
systemic suppression of CH responses, use 5kJ/m2 to suppress DH responses to
C. albicans (Strickland et al. 1994). Like CH responses, the suppression of DH is
associated with the induction of a T cell population in the spleen that transfers
immunosuppression of DH responses (Howie et al. 1987)
1.7.4 Local and systemic immunosuppression
The phenomenom of UVB-induced immunosuppression is complicated further
by evidence that UVB causes not only local suppression to agents sensitised through
irradiated sites, but also, under certain conditions causes systemic
immunosuppression. Though initially thought to be dependent on UVB dosage with
high-doses being associated with systemic immunosuppression, the main determinant
of whether UVB has local or systemic effects seems to be the time between irradiation
and sensitisation. It has been shown that UVB-dose responses for local and systemic
immunosuppression are identical (Noonan and De Fabo, 1990). Therefore,
irrespective of dosage, suppression was confined to the irradiated site immediately
following irradiation and up to 2 days later. However, if sensitisation was delayed
until 3 days after the last irradiation CH responses were suppressed whether they were
induced at local or distant sites (Shimizu and Streilein, 1994; Noonan and De Fabo,
1990; Kripke and Morrison, 1986). The mediators of local and systemic
immunosuppression may be different. Thus, treatment of mice with antiserum to
TNF-a failed to abrogate systemic UVB-induced CH impairment (Shimizu and
Streilein, 1994), but protected against local CH impairment (Moodycliffe et al. 1994).
A number of mediators of systemic immunosuppression have been suggested,
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including cis- UCA and IL-10. The role of these mediators in UVB-induced
immunosuppression will be discussed in sections 1.8.2.2 and 1.8.3.2 respectively,
and TNF-a in section 1.8.3.1.
1.7.5 Strain differences in UVB induced immune suppression
Strain differences in the susceptibility to UVB induced suppression of CH
responses have been reported in mice (Streilein and Bergstresser, 1988; Noonan and
Hoffman, 1994) and appear to be similar in humans (Tie et al. 1995; Cooper et
al. 1992). In both mice and man, the use of differing protocols results in some
anomalies which will be discussed. In mice two main methods have been used; a
model of local immmunosuppression where the mice are sensitised immediately
following irradiation on the exposed site (Streilein and Bergstresser, 1988), and a
model of systemic immunosuppression in which mice are sensitised 3 days after
irradiation on an unexposed site (Noonan and Hoffman, 1994). In the first model
(Streilein and Bergstresser, 1988), a number of inbred mice received 150-600 J/m2
UVB for 4 days on their shaved backs prior to sensitisation on the same site. Two
groups were identified; UVB susceptible strains (C57BL/6, C57BL/10 and C3H/HeN
strains) that showed over 80% suppression of CH responses following UVB, and
resistant mice (A/J, BALB/c and DBA/2 strains) which showed less than 10%
suppression. Results from crosses of resistant and susceptible animals suggested that
at least two independent loci were involved in the trait and experiments using congenic
animals that differed only at their MHC loci suggested that the H-2d haplotype
conferred resistance (Streilein and Bergstresser, 1988). The genetic basis for UVB-
susceptibility was of continued interest and later studies by the same group suggested
the involvement of two loci, the Ips locus which codes for lipopolysaccharide (LPS)
responsiveness in mice and the tnfa locus which is contained within the H-2 region on
chromosome 17 (Yoshikawa and Streilein, 1990; Vincek et al. 1993). The Ips locus
was proposed because of the differing susceptibility of C3H/HeN and C3H/HeJ mice
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to UVB (around 90% and 50% suppression of CH responses respectively). These
strains differ only at the Ips locus. The expression of Ips" by C3H/HeN, which makes
these mice responsive to the effects of LPS (lethality, B cell activation and pro¬
inflammatory cytokine secretion by macrophages) also makes them more susceptible to
the effects of UVB. In contrast, the expression of Ipsd by C3H/HeJ mice makes them
less responsive to endotoxin and partially protects them against the
immunosuppressive effects of UVB (Yoshikawa and Streilein, 1990).
Although the proposal that differences in the tnfa locus confer resistance or
susceptibility to UVB-induced immunosuppression is widely accepted, the evidence is
not decisive and the mechanisms speculative. The initial indication was the
identification of differing H-2 loci as being important in strain differences in responses
to UVB (Streilein and Bergstresser, 1988). C3H/HeN and C3H/HeJ mice were
examined for their response to TNF- a. Locally administered TNF-a suppressed CH
responses in both strains (see section 1.8.3.1), but there was some evidence that
C3H/HeN mice were more susceptible than C3H/HeJ mice to TNF-a mediated
suppression of CH (Yoshikawa and Streilein, 1990). By analysing the sequence of
the tnfa gene in UVB-resistant and suseptible mice, a polymorphism at position 329
was identified (a C-T change in UVB susceptible strains) and a minirepeat was found
in the 5' untranslated region of the tnfa locus in resistant but not susceptible strains
(Vincek et al. 1993). The relevance of these polymorphisms is uncertain. However, the
tnfa locus seems to be unimportant in systemic UVB-induced immunosuppression
(Noonan and Hoffman, 1994) as the model which is described in the paragraph below
failed to associate differences in H-2 haplotype with responses to UVB.
The results from the systemic model in which trinitrochlorobenzene (TNCB)
was used as a sensitiser (Noonan and Hoffman, 1994) were similar in many respects
to those shown in the local model (Yoshikawa and Streilein, 1990). Three subsets of
mice were reported; a high susceptibility group (50% suppression with 0.7-2.3 kJ/m2)
which included C57BL/6 and C57BL/10 mice, a group showing intermediate
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susceptibility (50% suppression with 4.7-6.9 kJ/m2) which included DBA/2, C57BR,
C3H/HeN, C3H/HeJ, CBA/N and A/J mice, and a low susceptibility group (50%
suppression with 9.6-12.3 kJ/m2) which included BALB/c, AKR, SJL and NZW
mice. Comparison of the results from the local and systemic studies showed some
notable differences which may result from the differing protocols used. The most
interesting difference is that the C3H/HeN and C3H/HeJ strains each show similar
dose responses to UVB, suggesting that the Ips locus is not involved in systemic
UVB-induced immunosuppression. The second difference between the results is in the
status of DBA/2 mice which were resistant in the local study (Yoshikawa and Streilein,
1990) but intermediately susceptible in the systemic study (Noonan and Hoffman,
1994).
Just as inbred mice show differing susceptibilities to UVB-induced
immunosuppression, outbred human populations seem to show a similar pattern.
Around 40% of the total population show a suppression of CH responses following
exposure to a low-dose UVB regimen (4x1440 J/m2) (Tie et al. 1995). Interestingly,
susceptibility to UVB-induced immunosuppression is a risk factor in the development
of skin cancers (section 1.7.1.3). However, as with mice, the data are complicated in
so far as differing protocols have been used by investigators . In a separate study
(Cooper et al. 1992), exposure to 0.75-4 MED of UVB suppressed CH responses to
DNCB in most individuals. Only at the lowest dose of UVB was there a population
(31%) of people who were sensitised successfully. However, the concentrations of
DNFB used to sensitise the subjects were very different; 30gg (Cooper et al. 1992)
compared with 2mg (Tie et al. 1995), and, without knowing the MEDs in both studies,
it is difficult to compare the levels of radiation given.
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1.8 Mechanisms of UVB-induced immunosuppression.
1.8.1 UVB and cutaneous APC
1.8.1.1 UYB and LC
For the last 16 years, since UVB was first shown to deplete LC from the skin
(Toews et al.1980), there has been much interest in these cells as mediators of
immunosuppression. UVB induces the depletion of LC from both UVB sensitive and
UVB resistant strains of mice (Streilein and Bergstresser, 1988). Exposing mice to
100 J/m2 of UVB on 4 consecutive days caused LC numbers to drop from between
750-1100 LC/mnr prior to irradiation, to between 50-250 LC/mm2 immediately
following the final dose (Streilein and Bergstresser, 1988). Generally, slightly more
LC remained in the skin of resistant mice following UVB treatment, though the
differences were small with a mean of 75 LC/mm2 in sensitive strains and 193
LC/mm2 in resistant mice following UVB. In addition to the depletion, those LC that
remained in the skin showed altered morphology, with a loss or attenuation of
dendritic processes (Toews et al.1980; Streilein and Bergstresser, 1988).
As already mentioned (section 1.7.3), the application of haptens through LC-
deficient skin results in the generation of antigen-specific tolerance to the hapten,
suggesting that the suppression of CH may be directly related to loss of the epidermal
LC. However the loss of LC does not fully explain UVB-induced
immunosuppression. Firstly, UVB resistant mice are still able to induce hapten
responses through LC depleted skin. Secondly, it seems that it is not a lack of antigen
presentation, but altered antigen presentation that results in suppressed immune
responses following UVB. A loss or lessening of an immune response to a hapten
would account for the suppression seen after UVB, but does not explain why hapten-
specific immunosuppression is still found in mice after a secondary exposure to the
hapten via an unirradiated skin site (Toews et al. 1980). This generation of hapten-
specific tolerance following UVB suggests the alteration of, rather than the lack of, an
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immune response. Tolerance generated in this way is associated with the induction of
regulatory/suppressor T cells which can transfer suppression of CH (Elmets et
al. 1983) and DH responses (Howie et al. 1987). Finally, the ability of UVB to
generate both local and systemic immunosuppression, suggests that in some cases
UVB influences immune responses without acting directly on the APC.
The effect of UVB on LC function
In view of the difficulties of reconciling the disparate effects of UVB exposure
and LC numbers in the skin, a number of studies have examined LC function directly.
Thus, irradiation of human epidermal cell suspensions (8-20% LC) and purified LC
populations (70-90% LC) with 100-200J/m2 of UVB in vitro inhibits significantly
their ability to stimulate primary alloresponses, mitogen-induced proliferation and
proliferative responses to recall antigens (Rattis etal. 1995). Similarly, exposure of
murine epidermal cell suspensions to a low dose of UVB (25 J/m2) inhibits anti-CD3
induced proliferation of T cells, while 100-200 J/m2 abrogates completely their
stimulatory capacity (Tang and Udey, 1991). It has also been demonstrated in vitro
that UVB (50-100 J/m2) inhibits the up-regulation of intercellular adhesion molecule-1
(ICAM-1) expression by LC a molecule that is normally up-regulated during culture
(Tang and Udey, 1991) or during the migration of LC to the DLN following skin
sensitisation (Cumberbatch et al. 1992). However, in vitro exposure of LC to 100
J/m2 of UVB is cytotoxic to LC, causing their eventual loss from cultures after 48-72
hrs (Tang and Udey, 1992).
Other evidence suggests that UVB-irradiated LC lose their ability to stimulate T
helper 1 (Thl) cells, a CD4+ T cell subset that has been identified in mouse and man
(Mosmann and Moore, 1996; Romagnani, 1991). The concept of Thl and Th2
immunity will be discussed in greater detail in section 1.8.3.2, but briefly the secretion
of IL-2 and IFN-yby Thl cells make them potent activators of cell-mediated
inflammatory responses. In contrast, the cytokines secreted by Th2 cells (IL-4, 5, 6
and 10) favour the production of humoral immune responses. LC were purified from




epidermal cell suspensions and exposed to 200 J/m2 of UVB. When these cells were
used to present keyhole limpet haemocyanin (KLH) to Thl T cell clones specific for
the antigen, the irradiated LC induced long-term tolerance (up to 16 days) (Simon et
al. 1991). Using the same system it was shown that the ability of UVB-irradiated LC to
induce antigen specific tolerance was restricted to Thl cells and that the irradiated LC
were capable of activating Th2 cells (Simon et al. 1992)
All the evidence presented so far has been generated in in vitro systems, but the
action of UVB on skin and cell suspensions is likely to be different and difficult to
compare. However, in vivo studies have suggested a functional change in APC
function following UVB by assay of cytokines produced by LNC from normal and
irradiated mice (Simon et al. 1994). Mice were exposed to four consecutive doses of
200 J/m2 of broadband UVB followed by skin painting with DNFB on the day of the
last irradiation and 24 hrs later. Treatment with UVB suppressed CH responses, and
the LNC proliferative response to DNBS in vitro. In addition LNC from UVB
irradiated mice produced lower levels of the Thl cytokines IL-2 and IFN-y, following
stimulation with the antigen in vitro .
1.8.1.2 DDC and macrophages
Secondary antigen-presentation pathways have also been proposed as an
explanation for the UVB resistance found in certain strains of mice. It has been
suggested that UV resistant mice possess a second antigen presentation pathway,
separate from epidermal LC, possibly mediated by DC in the dermis (Streilein, 1989).
Tape stripped skin which is selectively depleted of epidermal cells, was able to support
CH in UVB resistant but not UVB sensitive mice. However surgical excision of
hapten painted skin within 1 hr of application, which removes both the dermis and
epidermis, prevented the induction of contact hypersensitivity. Recently, it has been
shown that dermal cells, haptenated in vitro, from UVB-exposed UV-resistant mice
can transfer CH responses to naive mice. In contrast haptenated dermal cells from
52
UYB-exposed UV-susceptible strains were unable to transfer CH and instead induced
tolerance (Kurimoto et al. 1994). These results suggest that in resistant strains the
dermal populations are able to provide a secondary antigen presenting pathway, while
in susceptible strains these cells induce tolerance.
MHC class II+ APC have been identified in the dermis of mice. Around 2% of
cells in murine dermal cell suspensions normally express MHC class II (Kurimoto et
al. 1994). This population contains MHC class H+ LC-like interstitial dendritic APC
and dermal macrophages (Duraiswamy et al. 1994). The LC-like population has APC
function, with the dermal macrophage population having no accessory function in
syngeneic MLR. However, LC-like cells were found in the perivascular and interstitial
dermis of resistant and susceptible strains (Duraiswamy et al. 1994), so UVB
susceptibility cannot be attributed to a lack of antigen presentation by this population.
Following UVB irradiation there is an alteration in the balance of APC
populations with the loss of LC from the epidermis accompanied by an increase in
macrophage populations in the dermis. Exposure to UVB results in the expansion of
the CD36+ subset of MHC class IP dermal cells which rises from 17 to around 40% of
total dermal DR+ cells by day 3 after exposure (Meunier et al. 1995). Neutrophils
(MHC class IP5 CD1 lb+, GR-1+), macrophage-like APC (MHC class IIW, CDllb+)
and macrophages (MHC class II10, CD1 lb+) also infiltrate into the murine epidermis 3
days after exposure of BALB/c mice to relatively high doses of UVB (Cooper et
al. 1993) and after low doses (1380 J/m2) in C3H/HeN mice (Hammerberg et al. 1994)
and may be involved in tolerance induction. The role of these cells in tolerance
induction was shown by transferring hapten derivatised EC from irradiated and
unirradiated mice, into naive syngeneic recipients. Tolerance was only transferable
with EC from mice treated 3 days earlier with UVB, a time when the leukocyte
infiltrate was maximal (Hammerberg et al. 1994). By depleting 3 day UV-EC cell
suspensions with an isotype control or a rat-anti mouse CD 1 lb or MHC class II
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monoclonal antibody, it was shown that macrophages were responsible for the
induction of tolerance (Hammerberg et al. 1994). Macrophages also appear in the
human epidermis during the elicitation phase of the CH response, are CD1~ OKM5+
(CD36 monocyte/platelet marker) DR+ (Baadsgaard et al. 1990). They were found not
to suppress the CH response and were shown to be responsible for up to 50% of
antigen presentation capacity during hypersensitivity responses (Baadsgaard et
al. 1990). However, a cell population with the same phenotype, which is found in the
epidermis after irradiation by certain wavelengths of UV light (UVB and UVC)
(Baadsgaard et al. 1987), activates a suppressor T cell population (Baadsgaard et
al. 1988). In another study, UVB induced a loss of cells with LC markers and the
appearance of macrophages that may have antigen-presenting activity (Cooper et
al. 1986).
The mechanism by which infiltrating macrophages induce tolerance still
remains unclear. It has been reported that macrophages represent the main source of
IL-10 in human EC suspensions following UVB exposure (Kang et al. 1994).
Presumably, the induction of suppressor cell circuits by macrophages (Baadsgaard et
al. 1988) would require their migration to DLN. There has been little work in this area,
although an increased proportion of macrophages in lymph nodes draining irradiated
skin has been reported (Bucana et al. 1994). While the precise mechanism of
macrophage induced tolerance is unclear, the alteration in dermal and epidermal APC
populations may be responsible for the local immunosuppressive effects induced by
UVB. The differences in these populations following exposure of UVB sensitive and
resistant mice has still to be determined.
1.8.2 UVB photoreceptors
1.8.2.1 Induction of UVB induced suppression by DNA damage
UVB has been described as a complete carcinogen because of its ability to
damage DNA and suppress immune responses to tumours, which means it acts as both
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an initiator and promotor of carcinogenesis. It induces a variety of damage to DNA
including the induction of cyclobutane thymine dimers, single strand breaks and DNA-
protein crosslinking. The suppression of CH and DH responses induced following a
single exposure to 10 kJ/m2 of broadband UVB is reversed by immediate treatment of
the irradiated site with liposomes containing T4N5, a dimer specific repair enzyme
(Kripke et al. 1992). Spleen cells taken from T4N5 treated, UVB irradiated mice, failed
to transfer immunosuppression of CH responses. Evidence has been presented earlier
that initiation of cutaneous carcinomas, particularly non-melanoma skin cancers, may
involve UVB induced damage to the p53 gene. The data using T4N5 suggest that
DNA damage also suppresses immune responses, with the possibility that DNA
damage also acts as a promoter of tumourigenesis.
Using a monoclonal antibody to cyclobutyl thymine dimers, DC with DNA
damage have been located in lymph nodes sections and in low-bouyant density cell
populations following UVB irradiation (Sontag et al. 1995). However the numbers of
DC displaying damage to their DNA was low. They peaked 24 hrs following
irradiation, when 0.025% of cells in metrizamide enriched DC cell suspensions stained
positively for thymine dimers. The percentage of DC showing DNA damage may be
underestimated, expressed as it was as a percentage of total cells in a metrizamide cell
suspension, which is not a pure DC population. Even if this so, the numbers of DC
with DNA damage are still minute. The data showing actual numbers of DC
accumulating in the lymph nodes following the irradiation of the mice, were not
presented. However assuming that there are an average of 10000-15000 DC in DLN
24 hrs following exposure to a sub-erythemal dose of UVB, then the total numbers of
DC with DNA damage would be between 0.25 and 7.5. Whether the low numbers of
DC with damage is a result of rapid DNA repair or an accurate reflection of the
numbers of LC-derived cells in the lymph node is uncertain. However, though these
cells are found at low concentrations within the lymph node it is possible that they
55
contribute to the altered antigen presentation which has been proposed as a mechanisim
of UVB-induced immunosuppression.
1.8.2.2 Cis-urocanic acid (UCA)
UV-B light exposure causes the isomerisation of trans-UCA, the naturally
occuring isomer of UCA in the stratum corneum, to the more soluble cis-isomer. This
is dose-dependent until the photostationary state is reached when about 50% of UCA
is in the cis form (Norval et al. 1989). CA-UCA is found locally at high concentrations
at the irradiated site, circulating systemically in the serum (Moodycliffe et al. 1993) and
is excreted in the urine. Cis-UCA was first proposed to be a mediator of UVB induced
immunosuppression in 1983 (De Fabo and Noonan, 1983), because the action
spectrum for UVB induced suppression of CH matched the absorbance spectrum for
trans-UCA in vitro, both of which peaked at 270 nm. Further evidence for cA-UCA's
involvement was gained using congenic mice which lack the gene that catalyses the
formation of trans-UCA from histidine (De Fabo et al. 1983). These mice had only
10% of the normal levels of UCA, and unlike the parent strain, the congenic mice were
resistant to UVB-induced immunosuppression. However, this evidence has been
followed by some conflicting data. Recently it has been found that the action spectrum
for the isomerisation of trans to cA-UCA in mouse skin peaked at 310-315nm (Gibbs
et al. 1993). In addition, cA-UCA is produced in the skin of mice following irradiation
with lamps emitting in the UVB and UVA range (290-400). However shielded lamps
emitting mainly in the UVA range (320-400nm), induced similar levels of cA-UCA as
lamps emitting UVB, but failed to suppress CH responses (Reeve et al. 1994).
Though the previous results suggest a complex relationship between cA-UCA
production and immunosuppression, cA-UCA mimics some of the effects of UVB
including depletion of LC from the epidermis (Kurimoto and Streilein, 1992;
Moodycliffe et al. 1993), suppression of CH responses via a TNF-a dependent
mechanism (Kurimoto and Streilein, 1992) and the suppression of DH responses
(Ross et al. 1986). The production of a monoclonal antibody specific for cA-UCA has
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provided clearer evidence for the action of cis-UCA. The reduction of LC numbers in
the epidermis induced by UVB light (1440 J/m2) or painting with cis-UCA (O.lmg in
acetone painted onto the dorsum of each ear) (Moodycliffe et al. 1993) was blocked by
prior treatment with an anti-civ- UCA (El-Ghorr and Norval, 1995). In addition the
anti-cA-UCA antibody blocked UVB-induced suppression of DH responses to HSV
(El-Ghorr and Norval, 1995). However, unlike exposure to UVB, painting cis or
trans-UCA (20 pg/car) onto the ears does not induce accumulation of DC in draining
lymph nodes (Moodycliffe et al, 1992) and i.p injection of anti-cA-UCA did not block
UVB induced DC accumulation (El-Ghorr and Norval, 1995).
In addition to the suppression of cutaneous DH and CH responses, there have
been reports of cis-UCA suppressing allo-graft (Guymer and Mandel, 1993) and
natural killer cell (Gilmour et al. 1993) responses. Therefore though the mechanism by
which d.v-UCA exerts its immunosuppressive effects is complex, its ability to
suppress a range of immune responses may make it a useful molecule for use
therapeutically.
1.8.3 UVB-induced soluble suppressor factors
1.8.3.1 TNF-a
TNF-a is a pro-inflammatory cytokine which acts locally at sites of
inflammation to activate endothelial cells to become adhesive for leukocytes. It induces
phagocytic activity in a variety of cells, and cytokine production (IL-1, IL-6 and IL-8)
from monocytes/macrophages. At higher concentrations it acts systemically on the
hypothalamus and liver inducing fever and acute phase protein production
respectively. High systemic concentrations of TNF-a, together with the other
pro-inflammatory cytokines IL-1 and IL-6, are found during Gram-negative bacterial
sepsis, and are associated with leukostasis, multi-organ failure and circulatory
collapse. The TNF-receptor family (TNF-R) are glycoproteins with a single membrane
spanning hydrophobic segment (Heller and Kronke, 1994). Recently there has been
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evidence for the p55 TNF-R and the p75 receptor mediating different signals. It is
interesting therefore, and may be of relevance to the effects of TNF-a reported in
section 1.3.2, that there is epidermal/dermal specific TNF-R expression in human
skin. The p55 TNF-R is expressed throughout the epidermis in normal human skin
and on dendritic cells in the dermis, while the p75 TNF-R is expressed weakly on
dermal DC and sweat ducts but there is no expression in the epidermis (Kristensen et
al. 1993).
TNF-a production is important in the skin immune system, being required for
the induction (Cumberbatch and Kimber, 1995; Chavin et al. 1991) and elicitation of
contact sensitisation (Piguet et al. 1991) in mice. TNF-a is produced in the skin in
response to a wide variety of stimuli including; UVB exposure (Kock et al. 1990) and a
range of chemicals with sensitising, irritant and tolerogeneic properties (Enk and Katz,
1992b). TNF-a mRNA is detected 30 minutes after the application of hapten and
peaks at 2-4 hrs (Enk and Katz, 1992b). In normal skin TNF-a activity is limited to
the basal layers of the epidermis, while in involved psoriatic skin, activity is seen
throughout the epidermis (Kristensen et al. 1993). Keratinocytes are the main source of
TNF-a in the epidermis (Oxholm et al. 1991).
The role of TNF-a in UVB-induced immunosuppression is complex, as was
described in section 1.3.2, it mediates LC migration from the epidermis and the
accumulation of DC in the DLN (a requirement for the induction of immune
responses), though it is also argued that it is involved in trapping LC in the epidermis.
Although it is induced in the skin by treatments that result in the induction of immune
responses and is vital for the induction of CH responses in mice in some systems
(Piguet et al. 1991), the local application of TNF-a to mice prior to sensitisation
suppresses subsequent CH responses (Yoshikawa and Streilein, 1990). In addition
neutralising antibodies to TNF-a can abrogate the effects of UVB-induced
immunosuppression (Streilein, 1993; Moodycliffe et al. 1994). The ability of TNF-a to
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cause these disparate effects is possibly concentration dependent, with the resistance
and susceptibility to UVB shown by different mice strains (section 1.7.5) being due to
their differing responsiveness to the cytokine. There is some evidence for lower
concentrations of TNF-a being active in suppressing CH responses in susceptible
compared with resistant mice strains (Yoshikawa and Streilein, 1990).
In addition to causing the loss of LC from the skin, TNF-a may play a role in
the recruitment of DETC into the skin. Investigators used clobetazole propionate to
deplete DETC from the skin of C3H/HeN mice (Tamaki et al. 1994). DETC-depleted
skin was harvested and cultured with syngeneic epidermal cell suspensions for 3 days,
during which time DETC migrated into the epidermis. DETC migration into the skin
explants could be blocked using a neutralising antibody to TNF-a (Tamaki et al. 1994).
Although the role of DETC is not fully characterised, these cells express the y§ TCR
which recognizes conserved epitopes such as heat shock proteins and therefore they
may be involved in innate immune responses to infectious microorganisms. TNF-a,
which is induced early in cutaneous inflammatory responses, may increase DETC
migration into the skin, to provide an important innate immune mechanism to protect
against disease. However, as discussed in section 1.1.2. there is evidence that DETC
can alter the intensity of CH responses with the ratio of DETC to LC in the skin being
the important variable. Therefore the ability of TNF-a to increase the numbers of
DETC in the skin may detrimentally affect the ability of the skin to induce CH
responses which may in part explain the immunosuppressive effects of TNF-a.
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1.8.3.2 IL-10
There is now good evidence in mouse and human systems, that subsets of both
CD4 and CD8 T cells exist which have differing functional activities. The most fully
characterised of these is found in murine CD4 T cell clones which can be
differentiated into 3 main subsets; ThO, Thl and Th2, characterised by their ability to
secrete certain patterns of cytokines. Though these cells have been easier to identify in
mice, Thl and Th2 subsets have also been described in humans (Romagnani, 1991).
The ThO subset represents an unrestricted phenotype which secretes IL-2, IFN-y,
GM-CSF, IL-3, IL-4, IL-5 and IL-10 (Mosmann and Moore, 1996). The two other
subsets are identified by the cytokines that they secrete; Thl cells secrete IL-2 and
IFN-y, Th2 cells secrete IL-4, IL-5, IL-6 and IL-10, while the cytokines IL-3, GM-
CSF and TNF are secreted by both Thl and Th2 clones (Mosmann and Moore, 1996).
The development of Thl and Th2 subsets seems to be dependent on the
microenvironment that T cells are surrounded by during their activation, the
concentration of IL-12 and IL-4 is particularly important, because IL-12 induces Thl
cells and IL-4 induces Th2 cells (Miiller et al. 1995). Once induced, the cytokines
produced by Thl cells such as IFN-y, and IL-12 (produced by activated bystander
macrophages) act to block cytokine synthesis by Th2 cells. Similarly Th2 effector cells
inhibit Thl cytokine synthesis by their production of IL-4 and IL-10. Hence the
cytokines produced by each subset, act to increase the number of effector cells
committed to their subset while acting as an antagonist to the induction of effector cells
of the other subset. In a similar manner the effector responses induced by each subset
will, due the cytokines that they secrete, inhibit the action of the other subset.
The functional activities of these clones are closely related to the cytokines they
secrete. The secretion of IL-2 and IFN-y, means that Thl cells are potent activators of
monocytes/macrophages and hence of cell-mediated inflammatory responses such as
classical DH responses. Th2 cytokines on the other hand favour the production of
humoral immune responses, with IL-4 being particularly important in class switching
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to IgE. The description of Thl and Th2 responses has provided a new framework for
the control and fine-tuning of immune responses. Many of the concepts of Th l and
Th2 immunity fit with what is seen in cutaneous immune responses following UVB,
with the suppression of cell-mediated responses and the alteration in humoral
responses (Brown et al. 1995), suggestive of a shift towards a Th2 type of response.
The cytokine IL-10 has been implicated with this shift to Th2-type immunity. The
evidence for this will be discussed below.
IL-10 is a Th2-type cytokine, DNA coding for this cytokine has been isolated
from mice and humans. Sequencing has shown a high level of conservation in the
DNA coding for IL-10 in these species (Spits and de Waal Malefyt, 1992). IL-10 is
produced by a wide variety of cells including B cells, cells of the monocyte
/macrophage lineage, keratinocytes (Enk and Katz, 1992a; Grewe et al. 1995; Enk et
al 1995), Th2 clones (Mosmann and Moore, 1996), and, in humans, Thl and
cytotoxic T cell clones (Spits and de Waal Malefyt, 1992). It was first identified in
1989 as a cytokine synthesis inhibiting factor (CSIE) due to its ability to inhibit the
production of ILN-y by Thl clones (Liorentino et al. 1989). Since then, IL-10 has
been shown to block most or all cytokine synthesis by Thl and cytotoxic cell clones,
by acting through an APC dependent mechanism (Liorentino et al. 1991).
There are a number of studies which suggest that IL-10 contributes to the
suppression of DH and CH responses which follows UVB exposure. Recombinant
murine IL-10 (rIL-10) given i.p. suppressed the induction phase of DH but not CH
responses (Schwartz et al. 1994). Thus IL-10 fails to mediate all the effects of UVB.
However the results are interesting, infering that DH and CH responses may utilize
different induction pathways. However, the effector phase of both DH and CH
responses are suppressed by IL-10 (Schwartz et al. 1994), suggesting that their
effector mechanisms are similar.
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There seems to be good evidence that IL-10 acts as a down-regulatory signal in
a wide variety of cutaneous immune responses. Certainly it is produced by
keratinocytes, the main source of IL-10 in skin, not just following UVB (Enk et
al. 1995) but also in response to contact sensitisers (Enk and Katz, 1992a).Therefore
IL-10 production in itself is not associated with the suppression of cell-mediated
immune responses which follows UVB. Instead, it is likely to provide an anti¬
inflammatory check to reduce damaging inflammation. Indeed mice which lack IL-10
show unrestrained irritant responses which in some cases results in irreparable tissue
damage (Berg et al. 1995). This anti-inflammatory activity of IL-10 may reflect its
ability to reduce pro-inflammatory and chemotactic cytokine production by
macrophages (Spits and de Waal Malefyt, 1992).
In order to understand the different effects of IL-10, induced by antigen
challenge and by UVB, it is necessary to consider the kinetics of IL-10 production. It
is produced late in the normal inflammatory response following sensitisation, with no
transcription of IL-10 mRNA within the first 4 hrs and peak production at 12 hrs (Enk
and Katz, 1992a). Thus in primary responses, keratinocyte-derived cytokines such as
TNF-a and GM-CSF will have been up-regulated, LC will have processed antigen,
received their signal to migrate and be initiating contacts with T cells in the DLN before
IL-10 is induced. Similarly in secondary responses the presence of IL-10 between 4-
24 hrs following challenge will correspond with the inflammatory response on its
upward sweep or at its peak and provide a beneficial anti-inflammatory effect.
This contrasts with what is seen following UVB exposure, IL-10 mRNA
transcription is induced in keratinocytes 8 hrs after irradiation (Enk et al 1995). When
an irradiated site is sensitised, the presence of UVB-induced IL-10 results in LC
processing antigen in a cutaneous environment rich in IL-10. This alteration in the
epidermal microenvironment may affect the activity of LC as APC. Certainly it has
been reported that IL-10 reduces the ability of DC to induce IFN-y production from
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CD4 and CD8 T cells in a primary MLR in vitro (Macatonia et al. 1993). The role of
UVB-induced IL-10 in the secondary response seems clearer. The pre-emptive
production of IL-10 prior to challenge in the secondary response means that the anti¬
inflammatory signal is present before the inflammation process begins and hence
causes the suppression of the normal inflammatory response.
1.9 The aims of this investigation
1.9.1 Chronic UVB exposure
Chronic UV exposure protocols have been used to look at skin ageing and UV-
induced cancers, but little work is available on the effects of chronic UVB on the SIS.
Therefore, the aim of this study was to examine the effect of chronic broad- and
narrowband UVB on LC numbers, SBC numbers and cw-UCA isomerisation at
exposed skin sites. In addition the ability of chronically irradiated skin to support the
induction and elicitation of CH responses will be studied.
1.9.2 The effect of acute UVB-exposure on DC function
Acute low-dose UVB-exposure causes the suppression of a variety of immune
responses (section 1.7), by mechanisms involving multiple mediators (section 1.8). In
vitro studies have suggested a role for UVB-induced alterations in LC function in the
induction of immunosuppression. These studies demonstrated that the exposure of
freshly isolated epidermal LC to low-dose UVB in vitro reduced the subsequent up-
regulation of their accessory activity during culture (Tang and Udey, 1991; Rattis et
al. 1995). However the effect of in vivo UVB exposure on the function of LC-derived
DC, has not been addressed directly. Therefore in this study an in vivo model has been
used in an attempt to determine the effect of acute UVB-exposure on the accessory
activity of DC in lymph nodes draining UVB-exposed skin.
1.9.3 The effect of acute UVB exposure on DC phenotype
In addition to altering the function of LC, in vitro UVB exposure also alters their
phenotype. The exposure of freshly isolated murine LC to low-doses of UVB in vitro
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inhibits the up-regulation of ICAM-1 expression (Tang and Udey, 1991), B7-1 and B7-2
expression (Weiss et al. 1995) which occurs during culture. However no studies have
addressed whether UVB exposure affects the phenotype of LC-derived DC
in vivo. Therefore the aim of this study was to examine the phenotype of DC in skin-
DLN following acute low-dose UVB-exposure.
1.9.4 Strain differences in IL-6 production
The application of sensitising chemicals to the skin of mice results in the induction of
proliferative responses in the DLN (Scholes et al. 1992). The lymph node proliferative
response is associated with the production of IL-6 (Hope et al. 1994), the main source of
which appears to be DC (Hope et al. 1995; Cumberbatch et al. 1996). Therefore it is
possible that the production of IL-6 by lymph node DC plays a role in the initiation of the
T cell proliferation, and their differentiation into effector cells. Because of this it was
decided to examine the effect of UVB-exposure on IL-6 production in lymph nodes and
also to address whether strain differences in the production of this cytokine exist in UVB
susceptible and UVB resistant strains of mice.
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Chapter 2. Materials and methods
2.1. General
2.1.1 Mice
Female C3H/HeN, BALB/c, C57BLK/6 strain mice aged 6-8 weeks, were obtained from
the specific pathogen-free animal breeding facility at the Medical Microbiology Transgenic
Unit, University of Edinburgh. Mice of DBA/2 and AKR strains were purchased (B&K
Universal Ltd, Hull, UK) at 3 weeks of age and housed in the Transgenic unit until they
were ready for use.
2.1.2 Contact sensitisers
Fluorescein isothiocyanate (FTTC) and 4-ethoxymethylene-2-phenyloxazol-5-one
(oxazalone) were obtained from Sigma-Aldrich Co. (Poole, UK). FITC was dissolved in
1:1 acetone:dibutylphthalate (DBT) at 5%, 2.5% and 1% w/v and oxazolone was made up
in the same vehicle at 1% and 0.25% w/v. In some experiments sensitisers were
dissolved in 4:1 acetone:olive oil (AOO).
2.1.3 Growth media
2.1.3.1 Standard RPMI-FCS
RPMI-1640 medium (Flow Laboratories Ltd., Irvine, Ayrshire) was supplemented with
100 i.u./ml penicillin, 200pg/ml streptomycin, 2mM L-glutamine, lOOpg/ml gentamicin
and 10% heat-inactivated foetal calf serum (Gibco BRL, Paisley, UK).
2.1.3.2 RPMI-HEPES
RPMI-FCS was supplemented with 25mM HEPES.
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2.1.3.4 UVB sources and exposure
Mice were irradiated on the ears or shaved backs under two Philips TL-20W/12 bulbs
with an output range of 270-350nm, peak 305nm, emitting 80mW/ cm2. The output of
this source was determined by Dr. Neil Gibbs (Photobiology Unit, University of
Dundee) using a filtered photodiode meter, calibrated against measurements made with a
UV-visible spectroradiometer (model 742, Optronic Laboratories Inc.) across the spectral
range 250-400nm. The tube to target distance was 16 cm and mice were contained in
separate compartments in a perspex box to prevent shielding by littermates. One minimal
erythema dose (MED) for C3H/HeN mice under these conditions was 1500 J/m2.
In the chronic UVB exposure studies a single Philips TL01 lamp was used as a
source of narrow-band UVB (Van Weelden et al. 1988). This lamp emitted
predominantly at 311-312nm, and the total irradiance was 200 pW/cnr (1 watt=lJ/sec).
One MED for C3H/HeN mice was 10080 J/m2 of TL01.
2.2. Chronic UVB exposure study
2.2.1 UVB exposure
Mice were exposed on their shaved backs to 500 or 1000 J/m2 of broadband UVB (TL12)
or 3000 J/m2 narrow-band UVB (TL01), 3 times a week (Monday, Wednesday and
Friday) for up to 6 weeks. The backs of mice were shaved on the Monday of each week,
prior to their first UVB exposure. Their ears were not protected from irradiation.
2.2.2 Staining epidermal sheets for ATPase activity
Three days after the last irradiation, the ears of four mice were removed and split into
dorsal and ventral halves. Epidermal sheets were prepared from the dorsal halves by
floating them epidermal side down in 0.76% tetrasodium ethylenediamine tetraacetic acid
(EDTA) in phosphate buffered saline (PBS), pH 7.2 for 2 hrs at 37°C. Epidermal sheets
were then removed carefully with a scalpel blade and stained for adenine triphosphatase
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(ATPase) using adenine diphosphate (ADP) as a substrate (Chaker et al. 1984). Briefly,
the epidermal sheets were fixed in sodium cacodylate/formaldehyde solution (6.85%
sucrose, 1.6% sodium cacodylate and 0.1% formaldehyde in distilled water) at 4°C for 1
hour. The sheets were rinsed 3 times in PBS and incubated with ADP-lead at 37°C for
70 minutes. The sheets were rinsed 3 times and incubated in ammonium polysulphide for
20 minutes at room temperature. The epidermal sheets were finally rinsed in tap water,
and mounted in 50% glycerol under a glass cover slip. The specimens were coded and
examined 'blind' under the microscope. The number of ATPase+ cells were counted in at
least 40 fields per group (1 field=0.1mm2)
2.2.3 Quantitation of sunburn cell (SBC) density and epidermal
thickness
Single ears from each of three mice per group were removed 3 days following the last
irradiation and were fixed in 10% formyl saline before routine histological processing.
To avoid duplicate sectioning of the same SBC only every fifth 8pm section was taken
and stained with haematoxylin and eosin. The stained sections were examined on a light
microscope attached to a See-Scan Image analyser. This computer was used to calculate
the number of SBC per cm of interfollicular epidermis. Twelve sections were scored for
SBC for each group. This represented between 30-50 cm of interfollicular epidermis.
For each section, the number of SBC/cm was calculated and the data expressed as the
mean number of SBC/cm± standard error mean (SEM). The SBC were characterised as
having a pyknotic nucleus surrounded by an eosinophilic and/or vacuolated cytoplasm. In
addition the thickness of the epidermis was measured by the computer at approximately
100 sites per group.
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2.2.4 Analysis of urocanic acid isomers
Single ears from each of three mice in each group were collected 3 days after the last
irradiation, weighed and their concentration of cis and trans-UCA analysed by HPLC by
Dr. John Crosby (Department of Chemistry, University of Bristol). The mean amount of
each isomer measured in mg/g wet weight of ear and the percentage a.v-UCA was
calculated for each group.
2.2.5 Measurement of contact hypersensitivity
The contact hypersensitivity (CH) reaction to oxazolone was measured 5 hrs after the last
irradiation. Briefly, 9 mice per group received a sensitising dose of 5()pl 1% oxazolone in
vehicle (AOO) on their shaved backs. A negative control group received 50pl of the
vehicle (AOO) alone. Six days later the ears of each mouse were measured using an
engineers' micrometer (Draper SM-510, Japan) and challenged with 25pl 0.25%
oxazolone in vehicle. Twenty four hrs later the thickness of each ear was remeasured, the
increase in ear thickness was calculated, and the results expressed as the mean challenge-
induced increase of ear thickness in mm"2± SEM.
2.3. Dendritic cells and UVB-induced immunosuppression
2.3.1 Contact hypersensitivity responses
To measure the effect of acute UVB-exposure on CH responses, the shaved backs of
C3H/HeN and BALB/c mice were exposed to two doses of 1440 J/m2 of UVB, 48 and
24 hrs prior to sensitisation. In initial experiments mice were exposed to UVB without
ear protection. However, the ears of BALB/c mice showed UVB-induced damage, so in
subsequent experiments the ears were protected. To do this, the mice were anaesthetised
by interperitoneal injection of 0.1 ml sterile distilled water containing 0.83 mg/ml
hypnovel (Roche, Welwyn Garden City, UK) and 1.67 mg/ml hypnorm (Janssen
Pharmaceutical, Oxford, UK). One group (n=7) were irradiated in a perspex box, and
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their heads were covered with aluminium foil to protect the ears from UVB exposure.
The other two groups (n=7) were anaesthetised but were not irradiated. Twenty four hrs
later the irradiated group and one of the unirradiated control groups were sensitised on the
back with 50pl 1 % oxazolone, the backs of the third group were painted with 50pl
vehicle (AOO).
Schematic of CH protocol
Day -2, -1 Day 0 Day 6
anaesthetised UVB 1% Ox 0.25% Ox
Group 1 + + + +
Group 2 + — + +
Group 3 + — — +
Six days later the ears of each mouse were measured (see section 2.2.5) and challenged
with 25(jl 0.25% oxazolone in vehicle. Twenty four hrs later the ears of each mouse
were remeasured, the increase in ear thickness was calculated, and the results expressed
as the mean challenge-induced increase of ear thickness in mmf2± SEM. Percentage
suppression of CH= 100—[(a—b)/(c—b)xl00], where a=the mean increase in ear
thickness from Group 1 (UVB) above, b=the mean increase in ear thickness from group
3 (—ve) and c=the mean increase in ear thickness from Group 2 (+ve).
2.3.2 UVB-induced changes in DC function and phenotype
2.3.2.1 Enrichment of DC
The method of Macatonia et al. 1986 was followed in outline to prepare enriched DC
populations from pooled auricular or peripheral lymph nodes following a variety of
treatments, see sections 2.3.2.2, 2.3.5.2. A single cell suspension of LNC was prepared
by mechanical disaggregation through 200-mesh stainless steel gauze (J. Stanier and Co.
Manchester, UK.). Cells were washed and viable cells counted by exclusion of 0.5%
trypan blue. Cells were resuspended in standard RPMI-FCS. DC-enriched populations
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were prepared by density gradient centrifugation on Metrizamide (Nygaard, Oslo,
Norway). Briefly LNC were adjusted to 5xl06 cells/ml in RPMI-FCS and 8ml of the cell
suspension was gently underlayed with 2ml of 14.5% Metrizamide in RPMI-FCS and
centrifuged for 20 minutes (600g) at room temperature. The low buoyant density
population (DC+) that accumulated at the interface was collected and washed twice with
RPMI-FCS. This population comprised 50-70% DC as judged by morphology using
light microscopy. Analysis of these enriched DC populations by flow cytometry (see
section 2.3.4) revealed a corresponding population of large granular cells with high levels
of membrane la expression. In some experiments the pellet, which comprised LNC
depleted of DC (DC), was collected and washed in RPMI-FCS. This population
contained around 2% of cells with DC morphology. Flow cytometric analysis confirmed
that around 2% of cells in this population had the characteristics of DC- large granular
cells with high la expression.
2.3.2.2 DC as antigen specific accessory cells
The method described by Jones et al 1989 was used. The ears of C3H/HeN mice (n=3-5)
were painted with 25pl of FITC or oxazolone. Seven days later mice were killed, and
LNC prepared from the auricular lymph nodes as described above and used as responder
populations. These sensitised LNC were resuspended at 5xl06cells/ml in RPMI-FCS and
lOOpl of cells added per well in a round bottomed 96-well microplate (Nunclon,
Roskilde, Denmark). DC were enriched as described (section 2.3.2.1) from the auricular
lymph nodes of C3H/HeN mice sensitised with FITC or oxazolone 18 hrs previously. In
some experiments the ears of mice were irradiated with 1440 J/m2 of UVB 48 and 24 hrs
prior to sensitisation. These enriched DC+ populations were added to wells to provide
DC:responder ratios of either 1:20,1:40,1:55 or 1:100. Plates were cultured for 48 hrs in
a humidified atmosphere of 5% C02 in air, and, 18 hrs prior to culture termination,
0.7pCi 3H-methyl thymidine, specific activity 84Ci/mmol (Amersham Life Science, Little
69
Chalfont, UK) were added to all wells. Cultures were terminated by automatic harvesting
and 3H-methyl thymidine incorporation measured in counts per minute (CPM) using a
liquid scintillation analyser (Canberra Packard, Zurich, Switzerland). The data are
presented as the mean CPM±SD from 5 replicate cultures. Results are expressed as the
mean counts per minute (CPM)± standard deviation (SD) from 5 replicate cultures.
2.3.3 Identification of FITC-bearing cells in the draining lymph
node
DC-enriched and depleted populations were prepared (see section 2.3.2.1) from the DLN
of mice sensitised with 2.5% FITC or 1% oxazolone 18 hrs previously. A minimum of
104 cells from each population was analysed using a Coulter XL flow cytometer. Non¬
viable cells were gated out, and background controls were set at 1% using DC-enriched
and depleted populations isolated from the DLN of oxazolone-sensitised mice. DC were
identified by forward and side angle light scatter characteristics. The percentage of DC
bearing FITC and the intensity of FITC staining were recorded.
2.3.4 Phenotypic analyses
DC were enriched, as described above, from the auricular or pooled peripheral lymph
nodes of naive C3H/HeN mice, or from the auricular lymph nodes following irradiation
with the broadband UVB source (TL-12) 48 and 24 hrs previously. In some experiments
DC were enriched from the auricular lymph nodes 18-24 hrs after sensitization with
oxazolone (n=10-15). The effect of UVB on this system was examined by exposing mice
to UVB 48 and 24 hrs before sensitisation. A minimum of 10s DC was incubated on ice
for 30 minutes with the appropriate isotype control (anti-human MHC class I or anti-
dinitrophenyl (DNP)), or the primary monoclonals listed in Table 2.1. Monoclonal
antibodies recognising la (Serotec, Oxford, UK) and B7-2 (CD86) (Pharmingen, San
Diego, USA) were purchased, and the ICAM-1 monoclonal was acquired as a hybridoma
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Specificity Species/Isotype Clone Supplier
human MHC class I Rat/IgG2b YTH862.2 Serotec
DNP hapten Rat/IgG2a LO-DNP-16 Serotec
murine ICAM-1 Rat/IgG2b YN-11.7.4 (Takei, 1985)
murine la Rat/IgG2a YE2/36HLK Serotec
murine B7-2 Rat/IgG2a GL1 Pharmingen
Table 2.1 Monoclonal antibodies used in this study.
71
culture supernatant (Takei, 1985). The cells were washed once with 2ml of RPMI-FCS
and incubated with an affinity purified F(ab')2 rabbit anti rat IgG-FITC conjugate
(Serotec, Oxford, UK) for 30 minutes on ice. Finally, the cells were washed once more
in RPMI-FCS, fixed in 1% formyl saline and analysed using a Coulter XL flow
cytometer.
Cells were identified first using their forward scatter (FS) and side angle light
scatter (SS) characteristics to quantify their size and granularity. Regions were placed
around cells with low FS and SS (contaminating cell population), cells with high FS and
SS (putative DC) and around the total cell population. The events within each region were
then displayed on histograms of log fluorescence intensity (x-axis) against cell count
(y-axis). A minimum of 5000 events in the DC region was accumulated. Isotype controls
were routinely set at 1%. The percentage of DC expressing each marker and the density
of expression (mean fluorescence intensity) of the marker were recorded.
In some experiments enriched DC populations were resuspended to around
105 cells/ml and cytospins of 10-154 cells prepared. Cytospin slides were air dried and
fixed in acetone. They were then stained for ICAM-1 and MHC class n expression using
peroxidase conjugated avidin staining with a Sequenza (Shandon, Life Science
International, Basingstoke, UK). The Sequenza is a semi-automated apparatus for
histochemical staining, slides are placed in disposable holders which allow a controlled
flow of solution over the sample. The slides were first rinsed with distilled water and then
with Tris buffered saline (TBS) for 5 minutes. The slides were then blocked for 20
minutes with normal rabbit serum diluted 1:5 in TBS. Next the slides were incubated for
30 minutes with 100pl of the monoclonal antibodies against la or ICAM-1 or an isotype
control antibody (sources described above) diluted optimally. Each slide was then
incubated for 30 minutes with 100pl of biotinylated rabbit-anti-mouse immunoglobulin
(Vector Laboratories, Peterborough, UK) diluted to 1:400 in TBS. Next every slide was
incubated for 30 minutes with horseradish peroxidase labelled avidin (Vector
72
Laboratories) at 1:1000 in TBS. The slides were washed with TBS, and incubated with
the peroxidase substrate (1x10 mg 3,3'-diaminobenzidine tetrahydrochloride tablet
(Sigma, St Louis, USA) in 10ml of distilled water with 14pl of hydrogen peroxide
added). Finally the slides were rinsed in distilled water, counterstained with haematoxylin
and mounted under a coverslip. Using this technique positive staining appeared brown.
2.3.5 The effect of UVB on mixed lymphocyte reactions
2.3.5.1 Preparation of LNC
In initial experiments LNC were isolated from the pooled peripheral lymph nodes of
BALB/c mice. Later, responder LNC were prepared from pooled auricular lymph nodes
isolated from BALB/c strain mice (n=3-5) which had been painted 48 hrs earlier with
1% oxazolone on the dorsum of both ears. LNC were prepared as described above
(section 2.3.2.1) and cultured at 1.5xl05 cells/ml in RPMI-FCS, unless otherwise stated
in the text.
2.4.5.2 Mixed lymphocyte reaction
C3H/HeN DC+ populations were prepared from the auricular lymph nodes of
unsensitised mice (n=10-15), mice exposed to low dose (1440 J/m2, -48, -24 hrs) or to
high dose (15 kJ/m2, -24 hrs) UVB treatment or another stated protocol. Control DC+
populations were enriched from the skin draining lymph nodes of unirradiated and
unsensitised mice (n=10). Cells with DC morphology were counted and a known number
of C3H/HeN DC was cultured with BALB/c responder LNC at various stimulator:
responder ratios. DC" populations were also used as stimulators. These cells were
cultured alone or with BALB/c LNC at matching stimulatonresponder ratios as with the
DC+. Plates were cultured for 120 hrs in a humidified atmosphere of 5% C02 in air. Cells
were treated for the final 18 hrs of culture with 0.7 pCi 3Fl-methyl thymidine. The cells
were harvested and thymidine incorporation was measured as described in section
2.3.2.2. Results were expressed as mean CPM±SD from 5 replicate cultures.
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2.4. Analysis of cytokine production during the induction
phase of contact sensitisation.
2.4.1 Cytokine production and proliferation of draining lymph
node cells
Groups of mice (n=5) received either 25pi of oxazolone, or an equal volume of vehicle
(AOO) alone (n=10), on the dorsum of both ears. At various times thereafter (2, 3 and 5
days later), mice were killed and their auricular lymph nodes excised and pooled for each
experimental group. Single cell suspensions of LNC were prepared by mechanical
disaggregation through 200 mesh stainless steel gauze, cells were then washed and
resuspended in RPMI-FCS. Viable cell counts were performed by exclusion of 0.5%
trypan blue. Cells were resuspended at lxlO7 LNC per ml in RPMI-HEPES and seeded
into separate plates for measurement of cytokine production and LNC proliferation. To
analyse cytokine production, 1ml of cell suspension from each group was cultured for
24 or 48 hrs in 24 well tissue culture plates (Costar, Cambridge, Ma.). Culture was
terminated by centrifugation and the supernatants were stored at -70°C until analysis.
The concentration of IL-6 and IFN-y in the supernatant was analysed by ELISA (section
2.4.5 and 2.4.6 respectively), and results expressed as nanograms of cytokine per ml
(ng/ml). To measure proliferation, 5 aliquots of 200gl of LNC at lxlO7 cells/ml were
seeded into 96 well round bottomed tissue culture plates (Nunc, Roskilde, Denmark).
Cells were cultured for 24 hrs with lpCi/well 3H-methyl thymidine. The cultures were
terminated by automatic harvesting and 3H-methyl thymidine incorporation measured (see
section 2.3.2.2). The data are presented as the mean CPM±SD from 5 replicate cultures.
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2.4.2 Intracellular IL-6 in draining LNC
Mice received either 25pl of oxazolone (n=10-15) or an equal volume of vehicle control
(n=10-15) on the dorsum of both ears. Three days later groups of mice were killed and
their auricular lymph nodes excised and pooled. Single cell suspensions were prepared
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as above and cells were resuspended at 2x10 LNC in 1ml of RPMI-HEPES. The cell
suspensions were put on ice and sonicated for 3x10 second cycles (Sanyo Soniprep 150,
Japan). Finally, the suspensions were microfuged at 1.5x104g for 5min, the
supernatant was collected and stored at -70°C until analysis for IL-6 by ELISA (see
section 2.4.5). In some experiments LNC from oxazalone sensitised mice were cultured
for 24 hrs at lxlO7 cells/ml. Following culture the cells were washed once, resuspended
at 2xl08 cells/ml and sonicated as above.
2.4.3 The effect of UVB on LNC proliferation, IL-6 production and
intracellular IL-6 levels
Groups of mice (n=5) were exposed to a single dose of 1440 J/m2 UVB using the TL-12
source described earlier, or were not irradiated (n=3). One, three and five days later the
auricular lymph nodes from irradiated animals and the peripheral lymph nodes from
unirradiated animals were collected and pooled for each group. To examine IL-6
production, a single cell suspension was prepared and separate cultures were prepared
for supernatants and proliferation as described above (section 2.4.1). Intracellular levels
of LL-6 were examined by sonicating LNC suspensions (see section 2.4.2). The
supernatants were collected and stored at -70°C until analysis for IL-6 by ELISA
(section 2.5.5).
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2.4.4 Kinetics of cytokine production in the skin
The backs of mice were shaved 24 hrs prior to sensitisation and any mice with lesions
were discarded. Mice were sensitised with lOOpl of oxazolone, the same volume of
vehicle (AOO) or were left unpainted. Groups of mice (n=4) were killed 0, 1, 2, 4, 8
or 24 hrs later, and samples of skin weighing between 0.04 and 0. lg were collected
from the treated site. Each sample was chopped finely, weighed and resuspended in 1ml
of RPMI-FCS medium in a 1.5ml eppendorf cuvette (Alpha Laboratories, Eastleigh,
UK). Each cuvette was snap frozen in liquid nitrogen, thawed and the contents were
homogenised with a tissue grinder. The homogenised sample was snap frozen again,
thawed and the contents sonicated for 10 seconds (Soniprep 150, Sanyo). Debris was
removed by centrifugation (5min at 1.5xl04g) and the supernatant was assayed for IL-6
by ELISA (section 2.4.5) and the results expressed as nanograms of cytokine per gram
of original tissue (ng/g).
2.4.5 Measurement of IL-6 using a cytokine-specific sandwich enzyme-
linked immunosorbent assay (ELISA)
IL-6 was analysed by a cytokine-specific sandwich ELISA, developed originally by Dr.
R. J. Dearman, Zeneca Central Toxicology Laboratory, Macclesfield (Dearman et
al. 1993). Flat-bottomed 96-well maxisorb plates (Nunc, Roskilde, Denmark) were
coated overnight at 4°C with 50pl/well of rat anti-murine-IL-6 at 2.5 jag/ml (Genzyme,
West Mailing, UK) diluted in 0.1 M carbonate buffer (pH 9.6). The plates were given
3x3minute washes using PBS with 0.05% w/v Tween 20. This process will be referred
to as washing throughout this section. Plates were then blocked with 100pl/well of 10%
FCS in PBS and incubated at 37°C for 30 minutes. For each experiment doubling
dilutions of recombinant murine-IL-6 (rIL-6), specific activity 10xl08 units/mg
(Genzyme) covering a concentration range of 78-20000pg/ml were plated out in triplicate
(lOOpl/well) in RPMI-FCS which was used for all the ELISA experiments. Sample
supernatants were also plated out in triplicate (lOOgl/well) and the control wells received
RPMI-FCS. All the plates were incubated at room temperature (RT) for 2hrs. After
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washing, lOOgl/well of goat anti-murine-IL-6 (R&D Systems, Abingdon, UK) at
Sgg/ml diluted in RPMI-FCS were added to each well and the plates incubated at RT for
2hrs. The plates were washed and lOOpl/well of 1:500 dilution of donkey anti-goat
IgG/horseradish peroxidase conjugate (Serotec, Oxford, UK) in RPMI-FCS were added
to all wells and plates incubated at RT for 2hrs. The plates were washed and lOOgl/well
of enzyme substrate (o-phenylenediamine dihydrochloride and urea hydrogen peroxide)
was added. The substrate was added to all wells except column 1 which received
lOOpl/well of 0.5 M citric acid. After 15 minutes incubation in the dark, 50pl/well of
citric acid was added to all wells to stop development of colour. The optical density (OD)
of each sample was measured using a plate reader at 450nm and a standard curve plotted
using the OD450nm against the concentration of IL-6 in ng/ml on a log scale. The
standard curve was used to calculate the concentration of IL-6 in ng/ml ± standard
deviation (SD) in the triplicate samples. The limit of detection of IL-6 was 0.15ng/ml.
2.4.6 Measurement of IFN-y using ELISA
IFN-y was analysed by cytokine-specific sandwich ELISA, developed originally by Dr.
R. J. Dearman, Zeneca Central Toxicology Laboratory, Macclesfield (Hodgson et
al. 1996). Flat-bottomed 96-well maxisorb plates (Nunc, Roskilde, Denmark) were
coated overnight at 4°C with lOOgl/well of rat anti-murine-IFN-y at 0.5pg/ml (Genzyme)
diluted in 0.1 M carbonate coating buffer (pH 9.6). The plates were washed using PBS
with 0.05% w/v Tween 20. Plates were then blocked with lOOgl/well of 5% FCS in
PBS and incubated at 37°C for 30 minutes. For each experiment doubling dilutions of
recombinant murine-IFN-y(rlFN-y), specific activity 0.33xl08 units/mg (Genzyme)
covering a concentration range of 39- lOOOOpg/ml were plated out in triplicate (lOOpl/well)
in RPMI-FCS. Sample supernatants were also plated out in triplicate (lOOpl/well) and the
control wells received RPMI-FCS. All the plates were incubated at room temperature
(RT) for 2hrs. After washing, 1 OOpl/well of goat anti-murine-IFN-y (Genzyme) diluted
in RPMI-FCS were added to each well and the plates incubated at RT for 2hrs. The
77
plates were washed and lOOpl/well of 1:500 dilution of donkey anti-goat IgG/horseradish
peroxidase conjugate (Serotec, Oxford, UK) in RPMI-FCS was added to all wells and
plates incubated at RT for 2hrs. The plates were washed and lOOpl/well of substrate (as
above) lOOpl/well of citric acid. After 15 minutes incubation in the dark, 50pl/wcll of
citric acid was added to all wells to stop development of colour. The optical density (OD)
of each sample was measured using a plate reader at 450nm and a standard curve plotted
using the OD450nm against the concentration of IFN-y in ng/ml on a log scale. The
standard curve was used to calculate the concentration of IFN-y in ng/ml ± standard
deviation (SD) in the triplicate samples. The limit of detection of IFN-y was 0.15ng/ml.
2.5 Statistics
The non-parametric Mann-Whitney test was used for the analysis of differences between
groups. Mean differences were considered statistically significant if p<0.05.
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Chapter 3. Results
3.0. The effect of chronic exposure to UVB on the skin and
cutaneous immune responses
3.0.1 Introduction
The effect of UVB on the immune system of mice has been studied mainly
following acute exposure, either after a single dose of UVB, or up to 4 consecutive daily
exposures. The immunosuppressive effects of acute UVB exposure have been discussed
in section 1.7 and include the inhibition of responses to infectious agents, tumours and
contact sensitisers. UVB alters the cutaneous microenvironment, causing the loss of LC,
specialised epidermal APC, from the skin. It also isomerises trans-UCA, present in the
stratum corneum, to the more soluble cA-isomer. Both of these changes have been
proposed as mediators of UVB-induced immunosuppression (section 1.8).
A narrowband UV lamp (TL01) emitting at 311-312 nm has been developed for use in
phototherapy (Van Weelden et al. 1988) This source causes less skin damage, measured
as a function of erythema and sunburn cell (SBC) induction, but efficiently converts
trans-UCA to cis-UCA (Gibbs et al. 1993). In addition, acute TL01 exposure has been
reported to reduce the density, but not the antigen presenting function, of epidermal LC
(El-Ghorr et a1.1994). The output of the broad- and narrowband sources are shown in
Figure 3.0.1.
The effects of chronic suberythemal UVB have received little attention and there
have been no attempts to examinine the effects of chronic narrowband irradiation.
However, since most individuals are exposed to UVB in a chronic low-dose form in their
everyday lives, the effects of chronic UVB on the skin and the SIS are of importance. It
was decided therefore to compare the effect of chronic low-dose broadband UVB and
narrowband TL01 exposure on the number of LC and SBC in the epidermis, the























Figure 3.0.1 The emission spectra for the broadband UVB lamp (TL12 dotted line)
and the narrowband TL01 lamp (solid line) as in Figure 1.2 in the introduction.
Reproduced from Moodycliffe et al. 1994.
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responses following six weeks of irradiation was also investigated. To do this, the shaved
backs of mice were exposed to 500 or 1000 J/m2 of broadband UVB (TL12 source) or to
3000 J/m2 of narrowband UVB (TL01 source) three times a week (Monday, Wednesday
and Friday) for up to 6 weeks. The MED for C3H/HeN was 1500 J/m2 of broadband
UVB (TL12) and 10080 J/m2 of narrowband UVB (TL01). At various timepoints skin
samples were taken for analysis and after 6 weeks CH responses were examined.
3.0.2 The effect of broadband and narrowband UV on the number
of ATPase+ cells
In the epidermis only LC express the ATPase enzyme on their cell surface.
Ultraviolet-B irradiation with 500 or 1000 J/m2 three times weekly resulted in
approximately 50% and 70% reduction in the density of ATPase+ cells, respectively, after
2-3 weeks (Figure 3.0.2). This reduction was statistically significant (p<0.01) and
maintained throughout the period of UVB irradiation although there was a tendency for
LC numbers to begin to return to background levels as the number of exposures
continued. Morphologically, between 20-40% of LC appeared to lose their dendrites
following 1-4 weeks of UVB exposure. After 5-6 weeks, however, this number was 7-
10%. Exposure to TL01 resulted in a steady decline in the density of LC at the three time
points tested (Figure 3.0.2) but there was no effect on dendritic morphology.
3.0.3 The effect of the two UVB sources on SBC and epidermal
cell thickness
One indication of photodamage is the presence of SBC in the epidermis
(Young, 1986) and are thought to represent apoptotic cells (Schwartz et al. 1995). Figure
3.0.3 shows a SBC in the epidermis following 2 weeks of broadband UVB (1000 J/m2)
After 1 week of exposure to UVB (500 J/m2 or 1000 J/m2) SBC had started to appear and
their numbers increased with further exposure in a dose-dependent manner (Figure
3.0.4). One week of 3000 J/m2 of TL01 exposure, however, induced few SBC. After 2
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Figure 3.0.2 The effect of chronic UVB on the number of LC in murine
epidermis. Ears were removed 3 days after the last irradiation and
epidermal sheets stained for ATPase activity. Triangles represent
500 J/m2 UVB, squares 1000 J/m2 UVB and circles 3000 J/m2 TL01
exposure. The standard error of the mean at each time point was <25.
All values were significantly lower (p<0.05) than non-irradiated
age-matched controls (time point 0).
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Figure 3.0.3 Sunburn cell in murine epidermis following two weeks of broadband










Figure 3.0.4 The number of SBC per cm of interfollicular
epidermis following irradiation with 500 J/m2 UVB (triangles),
1000 J/m2 UVB (squares) or 3000 J/m2 TL01 (circles). Bars
represent the SEM, n=12. Three different values at time point 0
are presented because three separate control groups were used,
one for each irradiation procedure; these values are not significantly
different from each other.
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obtained following broadband UVB exposure throughout the irradiation period (Figure
3.0.4). After 3 weeks of irradiation, the numbers of SBC started to decline despite
continued exposure with all three lamps. The maximum density of SBC obtained after
chronic irradiation was 0.58 SBC/cm. In contrast, 24 hr after one acute dose of 1500 J/m2
UVB, 5.4 SBC/cm were found.
The thickness of the epidermis is an indicator of the response of the skin to UV
radiation. Epidermal thickness increased initially after both doses of broadband UVB
irradiation (Figure 3.0.5). The overall increase with 1000 J/m2 UVB was significantly
higher than with 500 J/m2 exposures and led to a doubling of the thickness of the
epidermis in these mice. After a slight, but significant (p=0.05) increase, TL01 exposure
did not affect epidermal thickness.
3.0.4 The effect of the two UV sources on UCA isomers
Chronic UVB exposure with 500 J/m2 or 1000 J/m2 increased the cis-UCA
concentration in mouse ears from 10 pg/g wet weight of tissue to 54-57 pg/g or 160 pg/g,
respectively (Figure 3.0.6). This amount of ds-UCA was maintained throughout the six
weeks of irradiation and was equivalent to 25% and 38% of total UCA, respectively.
Exposure to TL01 was equally efficient at isomerising UCA and 170 pg ds-UCA per
gram of ear was detected after 1-3 weeks of irradiation. This was equivalent to 35% of
total UCA in this experiment. However, after 5 weeks of TL01 exposure the cis-UCA
concentration was reduced to 100 pg/g (Figure 3.0.6). The total UCA concentration
remained relatively constant throughout the 6 weeks of irradiation.
3.0.5 The effect of the two UV sources on the CH response
Six weeks of chronic UVB exposure of the shaved backs of mice with either
500 J/m2 or 1000 J/m2 of broadband UVB suppressed the CH response to oxazolone by
over 60% (Figure 3.0.7). This was statistically significant in both cases. In contrast,


























Figure 3.0.5 The thickness of the epidermis following irradiation
with 500 J/m2 UVB (triangles), 1000 J/m2 (squares) or 3000 J/m2
TL01 (circles). The bars represent SEM, n is approximately 100.
Using the UVB source all values were significantly higher (p<0.05)
than nonirradiated controls (time point 0), but only the time point
at 1 week was significantly higher (p=0.05) using the TL01 source.
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Figure 3.0.6 The d.v-UCA concentration in C3H/HeN mouse ears following
irradiation with 500 J/m2 UVB (triangles), 1000 J/m2 UVB (squares) or 3000 J/m2
TL01 (circles). The standard errors of all the timepoints on the figure were below
22 pg/g, n=3.
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Figure 3.0.7 The CH ear swelling response to oxazolone after 6 weeks of
irradiation with UVB and TL01 lamps on shaved dorsal surfaces of mice.
The bars indicate the standard error of the mean. *P<0.05 compared with
nonirradiated controls, n=9.
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3.0.6 Summary of chronic UVB results
A chronic UVB exposure protocol, using broadband (270-350 nm) and
narrowband UV (311-312 nm) sources, was used to examine the effect of UVB on the
SIS. Exposure to both sources reduced the number of LC in the epidermis. Exposure to
the broadband but not the narrowband source induced skin damage, measured by skin
thickening, in a dose dependent manner. Although this damage resulted from broadband
UVB only, both sources led to a small increase in SBC, which are thought to represent an
apoptotic keratinocyte population. Both sources were equally efficient at inducing the
conversion of trans-UCA to the c/s-isomer, but only the broadband source suppressed
CH responses. Thus LC loss and isomerisation of UCA may not be the primary
mediators of immunosuppression during chronic UVB exposure.
In addition, there appeared to be an adaptive response to chronic UVB exposure.
LC were not completely eliminated from the epidermis during the six week period. They
fell to a minimum at 2-3 weeks of chronic broadband exposure, but numbers were )
beginning to increase again by week 5. SBC numbers peaked by week two of exposure
to both sources, but were barely detectable by week 6. Similarly m-UCA levels peaked
at weeks 1-2, but failed to reach the photostationary state (where 50% of the total UCA is
in the cis form, a point beyond which no further isomerisation takes place), during the 6
weeks of exposure. This adaptation to chronic UV exposure is possibly related to the
tanning and increased epidermal thickness induced by the broadband source. However,
though the narrowband source failed to induce either tanning or thickening, the skin of
mice exposed to this source showed similar adaptive responses to those mice exposed to
broadband UVB. Hence, narrowband UVB failed to completely deplete LC, failed to
induce the isomerisation of UCA to the photostationary point and showed a reduced
ability to induce SBC by 4-6 weeks of exposure. Therefore it is possible that other
adaptive mechanisms exist, which are separate from the development of pigmentation or
skin thickening.
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3.1. The effect of UVB on DC function and phenotype
3.1.1 Introduction
As described in the introduction cutaneous exposure to contact sensitisers
induces the migration of antigen-bearing LC from the epidermis into the afferent lymph
and their accumulation as immunostimulatory DC in the DLN (Kripke et al. 1990;
Macatonia et al. 1986). During migration, LC are subject to changes in both phenotype
and function. They become efficient antigen presenting cells and acquire the ability to
cluster with, and activate, naive T lymphocytes (Inaba et al. 1984). The ability of DC to
induce the expansion of an effector T cell population from naive T cells in the DLN is
required for the initiation of primary immune responses. The changes that DC undergo
during their migration to the DLN are thought to be mirrored by those induced by
culture of freshly isolated epidermal LC in vitro for several days in the presence of
keratinocytes or appropriate epidermal cytokines (Romani et al. 1989).
Irradiation with ultraviolet B light (UVB) compromises primary cutaneous
immune responses in certain strains of mice. These changes correspond to the
induction of anergy or antigen-specific unresponsiveness to a variety of antigens,
including skin allergens (Streilein and Bergstresser, 1988). It has been known for
many years that following UVB irradiation, there is a reduction in the number of LC in
the epidermis (Toews et al. 1980). In addition, an increased number of DC accumulate
in lymph nodes draining the site of exposure (Moodycliffe et al. 1992). In vitro studies
have shown clearly that UVB is able to inhibit culture-induced expression of a variety
of important LC surface molecules, and their activity as antigen-presenting cells (Tang
and Udey, 1991). Primary cutaneous immune responses are induced in lymph nodes
draining the skin, and lymph node DC are considered to be essential for the stimulation
of naive antigen-responsive T lymphocytes. Therefore, it was decided to examine
whether the irradiation of C3H/HeN mice with doses of UVB which were sufficient to
cause the suppression of both CH (Moodycliffe et al. 1994) and DH responses (Ross et
al. 1986), were associated with changes in the function or phenotype of DC in the
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DLN. The function of the DC was analysed in two ways. First, the ability of
oxazolone and FITC-sensitised DC from control and irradiated mice to initiate antigen
specific secondary proliferative responses by LNC from sensitised mice was
measured. Second, the ability of DC from unirradiated and irradiated mice to act as
allostimulators in primary mixed lymphocyte reactions (MLR) was examined. In
addition, the phenotypic characteristics of the DC in DLN from irradiated and
unirradiated skin were compared. Three determinants were analysed, namely
MHC class n, ICAM-1 and B7-2. MHC class II was examined due to its role in
presentation of antigen to CD4+ T lymphocytes. ICAM-1 is an adhesion molecule
known to facilitate the antigen-independent interaction between DC and T lymphocytes
(Van Seventer et al. 1992). Furthermore, expression by LC of this determinant may be
important in guiding their directed movement to, and accumulation in, DLN (Ma et
al. 1994). B7-2 (CD86) provides an important second signal for T cell activation
(Lanier et al. 1995).
3.1.2 Immunosuppression following acute UVB-exposure
C3H/HeN mice have been categorised as being susceptible to the effects of
UVB in local and systemic models of immunosuppression (Streilein and Bergstresser,
1988; Noonan and Hoffman, 1994). In addition, exposure to the doses of UVB used
widely in this study (1440 J/nr UVB 48 and 24 hrs prior to sensitisation) caused a
50% suppression of CH responses in C3H/HeN mice in previous studies (Moodycliffe
et al. 1994). In order to confirm that C3H/HeN mice were susceptible to the effects of
low-dose UVB, CH responses were carried out. Figure 3.1.1 shows the results from
the first experiment. Exposure to UVB caused a non significant (p=0.05), 31%
suppression of the CH response. In Figure 3.1.2 the same CH protocol was carried
out except that the cars of mice were covered during irradiation. Using the new
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compared with the positive control.
3.1.3 Identification of hapten-bearing DC in the DLN of
sensitised mice
To determine whether the accumulation of DC in the DLN after sensitisation
could be attributed to an influx of DC from the skin, mice were painted on the dorsum
of both ears with FITC or oxazolone. Eighteen hrs later draining auricular lymph
nodes were removed and DC and DC+ populations prepared. Background
fluorescence levels were set at 1% on DC" and DC+ populations from oxazolone
sensitised mice. Around 28% of LNC in the DC-population displayed FITC on their
surface, but the intensity of staining was low with a mean fluorescence of 1.12 on a
log10 scale (histogram not shown). Around 37% of all the cells in the DC enriched
population had FITC on their surface and the intensity of staining was high with a
mean fluorescence of 24.7 on a log10 scale (Figure 3.1.3a). Of the cells with DC
characteristics (the large granular population), 73% bore FITC (Figure 3.1.3b).
3.1.4 The effect of UVB on the antigen specific accessory
activity of DC
3.1.4.1 The ability of FITC-bearing DC to stimulate proliferative
responses
The aim of the initial experiment was to determine whether FITC-bearing DC
could stimulate antigen-specific proliferation of FITC-sensitised LNC. Figure 3.1.4
shows the results from this experiment. It can be seen that DC from untreated mice
were poor stimulators of proliferative responses, whether they were used to stimulate
unsensitised or FITC-sensitised LNC. In contrast, DC from FITC-sensitised mice
were significantly (p=0.01) better than naive DC at stimulating FITC-sensitised and
unsensitised LNC. Although there was no difference in the background proliferation
between sensitised and non-sensitised LNC populations, FTTC-sensitised DC showed
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Figure 3.1.3 The expression of FITC on DC enriched from the DLN
following skin painting with FITC. Mice (n-10) were ear painted with
oxazolone or FITC. 18 hrs later enriched oxazolone (filled area) and
FITC (open area) sensitised DC populations were prepared from lymph
nodes and their fluorescence was analysed using a flow cytometer.
Figure 3.1.3.a shows the fluorescence on all cells within the enriched












Figure 3.1.4 The ability of DC from lymph nodes draining
FITC-sensitised or unsensitised sites to stimulate lymphoproliferation
in vitro. Responder LNC from unsensitised mice (Naive LNC) or
FITC-sensitised mice (FLNC) were cultured alone Q, with FITC-
bearing DC flZD or naive DC (®. LNC were prepared from groups of 3
mice, and DC from groups of 10 mice. DC were added at a
stimulatonresponder ratio of 1:55. The cells were cultured for 48 hours
and 3H-methyl thymidine was added to all wells 18 hours prior to
termination of culture. The results are expressed as mean CPM±SD for
5 replicate cultures.
No LNC Naive LNC FLNC
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spontaneous proliferation of around 400 CPM compared with approximately 150 CPM
for naive DC
3.1.4.2 The ability of UVB to suppress DC-induced proliferative
responses
Having shown that FITC-bearing DC could induce lymphoproliferation, it was
decided to examine the effect of UVB on the system. In this experiment the
concentration of FITC used to sensitise animals was reduced from 5% to 1% and in
addition the antigen specificity of DC and the UVB-induced suppression of CH
responses to oxazolone was examined by sensitising some groups of responder and
stimulator mice with 0.25% oxazolone. It was decided to reduce the concentration of
FITC used because when used at 5% the FITC tended to cake onto the ears and
provoked intense washing in the mice. The net effect of this was to spread the FITC
around both the mouse and the cage. Using a lower concentration of FITC minimised
this problem. The effect of UVB on this system was examined by exposing certain
groups of stimulator mice to a single dose of UVB (1440 J/m2) 24 hrs prior to the
sensitisation. DC from these mice and from mice that were not irradiated prior to
sensitisation, were used as accessory cells.
It can be seen that a single dose of UVB failed to suppress the ability of hapten-
bearing DC to stimulate proliferation (Figure 3.1.5). FITC-bearing DC from irradiated
mice induced twice as much proliferation of FITC-sensitised LNC and oxazolone
sensitised LNC as FITC-bearing DC from unirradiated control animals, oxazolone-
sensitised DC from irradiated mice induced slightly more proliferation from oxazolone
and FITC-sensitised LNC as oxazolone-sensitised DC from unirradiated control mice.
However, oxazolone-sensitised DC performed poorly as APC, lacking potency in the
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3.1.4.3 Changes in the protocol to improve the specificity and
magnitude of proliferative responses
Because of the lack of antigen specificity and the low proliferative responses
shown in Figures 3.1.4 and 3.1.5, a number of changes were made to the protocol. In
initial experiments responder and stimulator lymph nodes were harvested at the same
time and LNC suspensions were prepared. This meant that suspensions that were to be
enriched for DC sat on ice while responder populations were counted and plated out.
To reduce the time between removal of lymph nodes and the addition of enriched DC
to cultures, the protocol was changed. In all the following experiments, responder
lymph nodes and stimulator lymph nodes were prepared separately. Responder lymph
nodes were harvested first, processed into LNC suspensions and seeded into wells.
Once the first stage was completed, stimulator lymph nodes were harvested and
enriched DC cell suspensions were prepared. In this way DC processing time was
minimised. Further changes to the protocol included raising the concentration of
responder cells from 1.25x10s to 2.5x10s cells/well, DC were still added at a 1:55
stimulator: responder ratio unless otherwise stated. Finally the concentration of FITC
was raised to 2.5%, in order to increase the magnitude of proliferative responses, as it
was noted that proliferation fell when 1% FITC (Figure 3.1.5) was used instead of 5%
FITC (Figure 3.1.4) to sensitise mice. FITC was used at 2.5% in all subsequent
experiments.
Figure 3.1.6 shows the results produced using the changed protocol. The
reduced processing time may be reflected in the increased hapten specificity of
responses. In this experiment both FITC and oxazolone-sensitised DC are
significantly (P<0.01) better at inducing hapten-specific proliferative responses than
they are at inducing non-specific proliferative responses. FITC-bearing DC fail to
induce a significant increase in the proliferation of oxazolone-sensitised LNC over
background counts. However oxazolone-sensitised DC showed some lack of
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Figure 3.1.6 The ability of DC from lymph nodes draining
FITC- or oxazolone- sensitised sites to stimulate specific
lymphoproliferation in vitro. Responder LNC from FITC-
sensitised mice (n=3) (FLNC) or oxazolone-sensitised mice
(n=3) (OLNC) were cultured alone O, or with FITC-(FT) or
oxazolone-®) sensitised DC (10 mice per group). DC were
added at a stimulator:responder ratio of 1:55. The cells were
cultured for 48 hours and 3H-methyl thymidine was added to
all wells 18 hours prior to termination of culture. The results
are expressed as mean CPM+SD for 5 replicate cultures.
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specificity, causing a significant (p=0.01) increase in the proliferative responses of
FITC-sensitised LNC, compared with background counts.
3.1.4.4 The effect of UVB on DC function using the new protocol
In the previous experiment the revised protocol provided a population of DC
that was capable of inducing antigen-specific proliferative responses. Therefore, using
the same protocol, the effect of UVB on the ability of DC to induce proliferation was
examined. Previously stimulator mice had been exposed to a single dose of UVB
(1440 J/m2) 24 hrs prior to sensitisation. In this experiment two consecutive doses
were used, 1440 J/m2 at -48 and -24 hrs prior to sensitisation. This exposure has been
shown to suppress CH responses by around 50% in C3H/HeN mice (Moodycliffe et
al. 1994), and has suppressed CH responses in C3H/HeN mice to a similar extent in
my hands (Figure 3.1.2). Figures 3.1.7a and 3.1.7b show the results from this
experiment. In Figure 3.1.7 a, FITC-bearing DC from normal and irradiated mice were
used to stimulate the proliferation of FITC and oxazolone-sensitised LNC. Exposure
of mice to UVB did not reduce significantly the ability of DC to induce FITC-specific
proliferation. In addition, DC from irradiated animals were significantly (p=0.025)
better at inducing non-specific proliferation from oxazolone-sensitised LNC.
In Figure 3.1.7b, oxazolone-sensitised DC were used instead of FITC DC. A
notable feature of these data is the lack of immunostimulatory activity of the oxazolone-
sensitised DC population. These DC failed to induce proliferative responses above
background levels. The failure of the oxazolone DC may have been due to a problem in
the enrichment stage, that yielded between 9-18xl03 DC per LN for the other DC
populations, but only 2700 DC per LN from oxazolone-sensitised mice. Although this
provided enough DC to use in the assay, the unusually low numbers raise doubts
about the quality of the enrichment. Due to the inability of the oxazolone-sensitised DC
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induced significant increases in antigen-specific (p=0.01) and non-specific (p=0.01)
proliferative responses.
The other possibility is that the concentration of oxazolone selected was too
low. In this experiment (Figure 3.1.7) and the previous one (Figure 3.1.6) oxazolone
was used to sensitise stimulator and responder mice at a concentration of 0.25%. Since
both experiments feature poor oxazolone responses, it is possible that this
concentration of oxazolone is failing to sensitise responder mice. A feature of this
experiment (Figure 3.1.7) but not the previous experiment (Figure 3.1.6) was the lack
of DC accumulation in the DLN of oxazolone-sensitised mice. This may have had an
effect on the accessory activity of these DC.
3.1.4.5 Titration of DC function
In the previous two experiments the culture of FITC-specific immune
responses were larger and more-antigen specific than oxazolone-specific response. It
was decided therefore to limit the three following experiments to measurements of
responses to FITC.
Initially, the proliferative responses were optimised by altering the numbers of
DC and responder cells in the assay. Figure 3.1.8 shows the ability of FITC-bearing
DC+ to stimulate the proliferation of FITC sensitised LNC. Increasing the ratio of
stimulator DC to responder cells results in an increase in proliferative responses
dependent on DC numbers. In addition, doubling the number of responder cells and
DC+ per well caused increased proliferative responses. When DC-depleted populations
were used as stimulator cells, they failed to induce proliferative responses over
background. From this experiment it was decided to double the number of responder
LNC to 5x10s cells/well, and to add DC at a 1:55 stimulatonresponder ratio. This
protocol was adopted in all subsequent experiments described in this section.
It is apparent from the data in Figure 3.1.8 that proliferative responses were
generally higher compared with those in the preceding experiment. The sensitised
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Figure 3.1.8 The ability of DC enriched from mice sensitised with FITC
to stimulate FITC-specific lymphoproliferation in vitro. FITC-sensitised
responder LNC (from 5 mice) were cultured at two concentrations 2.5x10^
Q and 5x10^ (Q) cells/well. The LNC were cultured alone (—), or with
FITC- bearing DC (DC+) (from 15 mice) at a variety of stimulator:
responder ratios (1:100, 1:55 and 1:40). Responder LNC at 2.5x10s were
cultured with DC depleted populations (DC-) at a stimulator:responder
ratio of 1:55. The cells were cultured for 48 hours and 3H-methyl
thymidine was added to all wells 18 hours prior to termination of culture.
The results are expressed as mean CPM±SD for 5 replicate cultures.
Responses for DC cultured alone were below 500 CPM.
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LNC were harvested on day 6 rather than day 7 following FTTC sensitisation and
show higher background or spontaneous proliferative responses than in the previous
experiments. This may be attributable to the presence of higher numbers of activated
cells within the lymph node because of the early harvest.
3.1.4.6 The effect of UVB on FITC-specific responses
Figure 3.1.9 shows the results of two independent experiments in which
enriched FITC-DC isolated from control and UVB irradiated mice were used to
stimulate the proliferation of LNC from FITC-sensitised mice. In the first experiment
(Figure 3.1.9a) there was no significant difference between the accessory cell activity
of DC isolated from control or irradiated mice. Similarly in the second experiment
(Figure 3.1.9b), the accessory activity of DC was not significantly affected following
exposure to UVB in vivo.
3.1.4.7 The effect of limiting DC numbers on oxazolone specific
responses
Since UVB failed to modulate responses to FITC, its effect on responses to
oxazolone were studied. In this experiment DC were used at 2 stimulatonresponder
concentrations, namely 1:55 and 1:100. It was decided to use DC at a concentration of
1:100 because it was thought possible that using DC at 1:55 was providing
super-optimal stimulation of LNC, and masking therefore, conceivable differences
between the DC populations. In previous experiments the proliferative responses of
oxazolone-sensitised LNC were smaller than FITC-sensitised LNC. Therefore the
concentration of oxazolone used to sensitise mice was raised from 0.25% to 1%. In
addition, the concentration of responder LNC was increased to 5x10s cells/well. In
Figure 3.1.10, DC were used at 2 stimulatonresponder ratios, 1:100 and 1:55, and the
antigen specificity of the response was examined by using oxazolone- and FITC-
sensitised DC as stimulator cells for LNC from oxazolone-sensitised mice.
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Figure 3.1.10a shows the proliferative response of LNC cultured in the presence of
oxazolone-sensitised DC from control and irradiated mice. Oxazolone-sensitised DC
stimulated good proliferative responses by LNC from mice sensitised with oxazolone
in a dose-dependent manner. UVB treatment did not inhibit this ability. The failure of
UVB to affect the accessory activity of DC was seen when DC were present at both
stimulator:responder ratios. The hapten specificity of the response is shown in Figure
3.1.10b. Although FITC-sensitised DC were able to induce limited antigen non¬
specific proliferative responses from oxazolone-sensitised LNC, their capacity to
induce proliferation was poor when compared with the antigen specific proliferative
responses illustrated in Figure 3.1.10a.
3.1.4.8 The effect of UVB on DC function: titration of DC
concentration
In order to examine whether UVB would influence proliferative responses over
a range of stimulatonresponder ratios, mice were either left unirradiated or were
irradiated (1440 J/m2, -48 and -24 hrs) prior to FITC- or oxazolone sensitisation.
Eighteen hrs after sensitisation DC were enriched from the DLN. These DC were then
cultured with FITC-sensitised LNC at 4 stimulatonresponder ratios of (1:20,1:40,
1:55, and 1:100). Oxazolone-sensitised DC were not used at 1:20 due to lack of cell
numbers.
In this particular experiment, the responder LNC were harvested on day 8
rather than day 7, which may explain the low proliferative responses which were
obtained (Figure 3.1.11). However, as in previous experiments, it can be seen that
exposure to UVB failed to affect DC accessory function in this assay. At all
concentrations except 1:100, FITC-bearing DC from control and irradiated mice
showed no significant difference in their ability to induce proliferation from FITC-
sensitised DC. At the stimulatonresponder ratio of 1:100, DC from irradiated mice
were significantly (p<0.01) better at inducing proliferation, though the difference in
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(1:55) in Figure 3.1.11, stimulated less proliferation from FITC-sensitised LNC than
either FITC-bearing DC population.
Figure 3.1.1 lb shows the specificity of the response with all except the
highest concentration (1:20 stimulator:responder ratio) of FITC-bearing DC from the
control group only, failing to induce proliferative responses from oxazolone-sensitised
LNC. As expected, oxazolone-sensitised DC were significantly (p<0.01) better than
FlTC-bearing DC at inducing the proliferation of oxazolone-sensitised LNC at all the
concentrations tested.
3.1.4.9 The effect of UVB exposure on the induction of effector cell
populations in the lymph nodes
The previous experiments examined the influence of UVB exposure on the
ability of DC to stimulate the proliferation of sensitised T cells. Circulating effector T
cells are re-activated in the periphery by non-professional APC. In the same way
sensitised T lymphocytes may have less stringent requirements for activation in vitro.
Therefore sensitised LNC may not be the most appropriate population in which to
examine UVB-induced defects in APC activity.
To examine whether UVB exposure could affect the primary induction of
effector cell populations, the previous protocol was altered. Responder mice were
irradiated with the standard immunosuppressive dose of UVB (1440 J/m2 UVB, -48
and -24 hrs) or were not irradiated. UVB treated and control mice were sensitised,
and, seven days later, their lymph nodes were removed and their LNC were re-
stimulated in vitro with antigen-bearing DC.
Figure 3.1.12 shows the results from this experiment. It can be seen that FITC
and oxazolone-DC induce significant (p<0.01) antigen specific proliferative responses
from FITC and oxazolone-sensitised LNC respectively, compared with the responses
of the appropriate LNC population cultured alone. The proliferative
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response of FITC-bearing LNC from irradiated mice cultured with FITC-bearing DC
was significantly more vigorous (p<0.01) than the response generated when FITC-
bearing LNC from unirradiated mice were cultured with the same accessory cells.
There was good antigen-specificity with oxazolone-sensitised DC being considerably
less able than FITC-bearing DC to stimulate proliferation of FITC-sensitised LNC.
Similarly FITC-bearing DC were poor stimulators of oxazolone-sensitised LNC. The
difference in proliferative activity between LNC from irradiated and non-irradiated
oxazolone-sensitised mice cultured with oxazolone-sensitised DC was not significant.
Therefore, an antigen specific effector T cell population is induced in the DLN
of mice sensitised via irradiated or normal skin. These LNC populations are able to
proliferate in response to antigen specific stimuli. The experiment was repeated to
confirm this conclusion. The data are shown in Figure 3.1.13 The protocol was the
same as in Figure 3.1.12 except that the DC were used at two concentrations (1:55 and
1:100). The results confirm the findings from the previous experiment; that an antigen
specific LNC population is induced in the draining lymph nodes of sensitised mice
irrespective of whether they have been exposed to UVB or not. The difference in
proliferative activity between LNC from irradiated and non-irradiated FITC-sensitised
mice cultured with FITC-sensitised DC was not significant.
3.1.5 Effect of UVB on DC accessory function in mixed
lymphocyte reactions (MLR)
3.1.5.1 Murine MLR
Initial experiments using both spleen and lymph node cell populations from
C3H/HeN mice as stimulators in MLR failed. A number of variables were tested to
establish whether proliferative responses could be induced. A variety of stimulator cell
and responder cell concentrations were used (0.75, 1.5, 3 and 6xl05 cells/well).
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Timepoints from 3-6 days were tested. C3H/HeN LNC and spleen cells were used as
accessory cells in MLR with LNC and spleen cells from BALB/c, C57BL/6, LTSV,
129/OLA, RBB, and transgenic mice as responders.
Because one of the defining features of DC is their ability to stimulate potently
MLR, it was decided to use enriched DC populations from C3H/HeN mice as
accessory cells in this assay. Initial results were disappointing with only very high
concentrations of DC (1:20 stimulatonresponder ratio) having any activity (see Figure
3.1.14). However, although the potency of accessory activity was low, it was specific
to DC, as populations depleted of DC failed to induce proliferation at any
concentration. In a previous experiment it was noted that LNC from BALB/c mice
sensitised with oxazolone 48 hrs previously could be induced to proliferate by
C3H/HeN DC (data not shown). It was decided therefore to examine whether
sensitising BALB/c mice could increase their ability to act as responders.
3.1.5.2 The effect of antigen-priming on MLR
LNC were prepared from the auricular lymph nodes of mice sensitised with
oxazolone 48 hrs earlier. In addition peripheral lymph nodes were prepared from the
same mice to measure the response of non-sensitised LNC. It can be seen in Figure
3.1.15 that LNC draining oxazolone sensitised sites from BALB/c mice proliferate
well in response to DC from C3H/HeN mice. In contrast LNC isolated from the
peripheral lymph nodes of the same mice fail to respond under identical conditions.
Therefore in all the MLR which follow, responder BALB/c mice were sensitised with
1% oxazolone 48 hrs prior to each experiment.
3.1.5.3 The effect of UVB on the stimulatory capacity of DC in antigen
primed primary MLR.
When enriched DC from C3H mice were cultured with LNC from BALB/c
mice sensitised previously with oxazolone, significant proliferative responses were
seen using a range of stimulator to responder cell concentrations (1:15 to 1:100)
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Figure 3.1.14 The ability of DC to act as allostimulatory cells in vitro. Responder
LNC from BALB/c mice (n=3) were cultured alone or with various numbers of DC
<D or a matching number of DC depleted cells (#) from the peripheral lymph nodes
of C3H/HeN mice (n=10). Enriched A) and depleted (Q) DC were also cultured alone.
The cells were cultured for 120 hrs and 3H-methyl thymidine was added to all wells
24 hrs prior to termination of the culture. The results are expressed as mean CPM±SD
for 5 replicate cultures. The proliferative CPM for BALB/c responnder LNC cultured
alone was less than 100 CPM.
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Figure 3.1.15 Responder LNC from the auricular lymph nodes
(■) and peripheral lymph nodes (□) of oxazolone sensitised
BALB/c mice (n=4) were cultured alone or with various numbers
of DC enriched C3H/HeN mice (n=15). The cells were cultured for
120 hrs and 3H-methyl thymidine was added to all wells 24 hrs
prior to termination of the culture. The results are expressed as
mean CPM±SD for 5 replicate cultures. The proliferative CPM for
DC cultured alone were below 200 CPM.
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Figure 3.1.16). The stimulation of alloresponses was dependent upon the presence of
DC, as stimulator populations depleted of DC failed to induce proliferative activity.
However, when DC were isolated from mice given a suppressive dose of UVB
radiation, their ability to induce alloresponses was unimpaired. Even exposure of mice
to a much higher dose of UVB (15 kJ/m2) 24 hrs prior to enrichment of DC from the
draining lymph nodes failed to affect the function of the DC as allostimulator cells
(Figure 3.1.17).
3.1.5.4 Kinetics of antigen primed MLR
All of the antigen primed MLR were harvested on day 5 following the initiation
of culture, a timepoint which is commonly used for MLR (Young and Steinman,
1988). However, because of the requirement for antigen-priming of responder LNC in
this particular protocol, it was decided to look at the kinetics of this response. MLRs
were prepared at a variety of stimulatonresponder ratios and cultured for 3-6 days
(Figure 3.1.18). It can be seen that there is a good dose response curve for the MLR.
However, peak proliferation is seen at day 4 rather than day 5, although the differences
in the proliferative activity on these days were not significant. Although in previous
experiments UVB failed to affect the mixed lymphocyte response at a variety of
stimulatonresponder ratios, including those which, in this experiment, produced
comparable proliferative responses at day 4 and day 5. It is possible that by missing
the peak proliferative response the validity of the assay was questioned. Therefore it
was decided to examine the effect of the low-dose immunosuppressive UVB protocol
(1440J/nr, -48 and -24 hrs prior to DC preparation) on the antigen primed MLR at
days 4 and 5.
3.1.5.5 The effect of UVB on antigen-primed MLR at day 4 and 5.
The results from this experiment are shown in Ligure 3.1.19a and b indicating
the proliferative responses at day 4 and 5 respectively. In Ligure 3.1.19a, the
proliferative responses induced by DC from unirradiated and irradiated mice differ
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Figure 3.1.16 The effect of low dose UVB on the allostimulatory
capacity of enriched DC in vitro. Responder LNC from oxazolone
sensitised BALB/c mice (n=5) were cultured alone or with various
numbers of DC from unirradiated C3H mice (n=15) (■) or UVB
(1440 J/m2 , -48 and -24 hrs) irradiated C3H mice (n=15) (A).
Responder LNC were also cultured with DC depleted populations
from unirradiated (n=15) (□) and UVB irradiated mice (n=15) (A)-
The cells were cultured for 120 hrs and 3H-methyl thymidine was
added to all wells 24 hrs prior to termination of the culture. The results
are expressed as mean CPM±SD for 5 replicate cultures. The
proliferative CPM for DC enriched and depleted populations cultured
alone were below 500 CPM.
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Figure 3.1.17 The effect of high dose UVB on the allostimulatory capacity of
enriched DC in vitro. Responder LNC from oxazolone sensitised BALB/c mice
(n=4) were cultured alone or with various numbers of DC from unirradiated C3H
mice (n=15) (■) or UVB (15 kJ/m2 total) irradiated C3H mice (n=15) (A)-
Responder LNC were also cultured with DC depleted populations from
unirradiated (n=15) (□) and UVB irradiated mice (n=15) (A)- The cells were
cultured for 120 hrs and 3H-methyl thymidine was added to all wells 24 hrs prior
to termination of the culture. The results are expressed as mean CPM±SD for 5
replicate cultures. The proliferative CPM for DC enriched and depleted
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Figure 3.1.18 Kinetics of MLR. Responder BALB/c LNC (from 5
mice) were cultured alone (#) or were incubated with C3H/HeN DC
(from 15 mice) at various stimulatonresponder ratios; 1:20 (O, 1:40
(■), 1:55 AX 1:100 (O) and 1:1000 (A)- The cells were cultured for
3, 4, 5 and 6 days and 3H-methyl thymidine was added to all the
wells 24 hrs prior to the termination of culture. The results are
expressed as mean CPM±SD for 5 replicate cultures. The
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only at the 1:55 stimulatonresponder ratio. At this ratio DC from irradiated animals
induced significantly higher (p=0.025) responses. In Figure 3.1.19b, the proliferative
responses were again similar at all stimulatonresponder concentrations.
3.1.6 The effect of acute in vivo UVB exposure on the
phenotype of lymph node DC
3.1.6.1 The characteristics of enriched DC populations
Table 3.1.1a and b show the proportion of cells within enriched DC
populations that exhibits DC morphology and the percentage of cells within the large
granular population (measured by flow-cytometry). There is an association between
the percentage of cells with DC morphology and the proportion of cells within the DC
enriched population that are large and granular, measured as a function of forward-
angle and side-angle light scatter by flow-cytometry. In untreated peripheral lymph
nodes (Table 3.1.1a) 53±12% of cells exhibit DC morphology by microscopy and a
similar number of the enriched DC population (44±13%) were large and granular.
UVB treatment failed to influence the percentage of cells with DC morphology 49±5%,
or the percentage of large granular cells (38±10%) within the enriched population
(Table 3.1.1b).
3.1.6.2 The characteristics of DC-depleted populations
The pellet of cells which was collected following Metrizamide centrifugation
provided a DC-depleted population. Figure 3.1.20 shows the forward-angle versus
side-angle light scatter plot of a DC-depleted population. DC-depletion reduces the
percentage of large granular cells (region B) from around 40% to 5% . The unlabelled
region contains cells with the size and granularity of lymphocytes.
3.1.6.3 The expression of ICAM-1 on DC isolated from unsensitised
lymph nodes.
The effect of UVB on ICAM-1 expression on DC was examined by comparing
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Figure 3.1.20 The size and granularity of a DC-depleted
population from the peripheral lymph nodes of untreated
mice (n=10). Region A was placed around the total
population, and region B around the depleted large
granular cell population.The unlabelled region contains
cells with the size and granularity that is characteristic of
lymphocytes.
123
populations from the auricular lymph nodes of mice exposed to UVB (1440 J/m2,48
and 24 hrs previously). Enriched DC populations were analysed first by their forward-
angle and side-angle light scatter characteristics (Figure 3.1.21). Regions were placed
around the total enriched population (excluding debris) and around the semi-discrete
cell population which were large and granular (regions A and B respectively in Figure
3.1.21). Within the total enriched DC population (region A) the percentage of cells
expressing ICAM-1 is raised from 37 to 55% following UVB irradiation (Figure
3.1.22). This may reflect the increased proportion of DC within enriched DC
populations from irradiated animals, the percentage of large granular cells in region B
(Figure 3.1.21) were raised from 34 to 58% of total cells following irradiation of mice.
Similarly, ICAM-1 expression on the large granular cells (region B) is raised from 77
to 89% following irradiation (Figure 3.1.23). The intensity of ICAM-1 staining on
total enriched DC populations or on the large granular cells within those populations,
was not influenced by UVB (Figures 3.1.22 and 3.1.23).
Table 3.1.2 summarises the data examining the role of UVB in the alteration of
ICAM-1 expression on DC. In all cases the expression of ICAM-1 by DC is
unaffected or raised following UVB. In addition the intensity of ICAM-1 staining is
comparable on DC from untreated and UVB irradiated mice. In three out of four
experiments over 77% of DC expressed ICAM-1. In experiment 3 , where only 43-
45% of DC expressed ICAM-1, there was alot of background fluorescence with the
isotype control, therefore approximately half of the ICAM-1 expression was within the
region set using this control. In Figure 3.1.24b, ICAM-1 expression on DC is shown
by immunohistochemistry.
3.1.6.4 The effect of prior UVB prior to sensitisation with 1%
oxazolone on ICAM-1 expression on DC.
In the previous experiments DC draining irradiated ears were compared with
DC in pooled skin draining lymph nodes. The following experiments differ in that
control mice were sensitised with oxazolone 18 hrs earlier while the other group were
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Table 3.1.2 The effect of UVB on the percentage of DC expressing ICAM-1. DC
were enriched by density gradient centrifugation from the peripheral lymph nodes of
untreated mice (n=10) or from the auricular lymph nodes of C3H/HeN mice (n=10)
exposed to UVB (1440 J/m2, -48 and -24 hours). ICAM-1 expression was analyzed by
indirect fluorescent labelling and flow-cytometry. The percentage of cells expressing
ICAM-1 (%) is shown, the results have been adjusted for background fluorescence by





Figure 3.1.24 The expression of ICAM-1 and MHC class II on enriched DC
populations. DC were enriched by Metrizamide centrifugation of LNC from the auricular
lymph nodes of mice 18 hrs following oxazolone sensitisation. Cytospins were prepared
and the expression of dinitrophenol (isotype control for ICAM-1) (a), murine ICAM-1 (b)
or murine la was examined (c), using an immunoperoxidase method. Staining with the
isotype control for MHC class II gave similar results as seen in Figure 3.1.24a.
Magnification x25 (a and c), x40 (b).
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exposed to UVB (1440 J/m2, -48 and -24 hrs) prior to ear painting with oxazolone.
Enriched DC populations were prepared from the auricular lymph nodes of each group
and ICAM-1 expression was examined. Table 3.1.3 shows the results from these
experiments. In experiments 5 and 7 it can be seen that UVB exposure has little effect
on the percentage of DC expressing ICAM-1. Indeed, the mean percentage of DC that
express ICAM-1 was 89% in the control group and 92% in the irradiated group.
Similarly there was no significant change in the intensity of ICAM-1 expression (data
not shown)
3.1.6.5 The effect of UVB on the expression of MHC class II on DC
isolated from unsensitised and oxazolone sensitised lymph nodes.
It can be seen in Table 3.1.4 that in experiments 12 and 13 that UVB failed to
affect significantly the expression of MHC class II on DC. Like ICAM-1 expression
MHC class II expression is variable, but the variability tended to arise from
background staining using the isotype controls. The very low level of MHC class II in
experiment 14 for example, reflects high background staining (histogram not shown).
The histograms from experiment 12 are presented in Figure 3.1.25. It can be seen
from the histograms that the intensity of MHC class II expression on DC was similar
on DC from unirradiated and UVB irradiated mice. This result was reproduced in
experiment 13 in Table 3.1.4 (data not shown). Looking at the enriched population as
a whole, UVB exposure causes the percentage of MHC Class IT cells to rise from 30-
46% (data from experiment 12). In Figures 3.1.24a and c respectively, the expression










Table 3.1.3 DC were enriched from auricular lymph nodes 18 hours following
oxazolone sensitisation of unirradiated C3H/HeN mice (n=10) or from mice (n=10)
exposed to UVB (1440 J/m2, -48 and -24 hours) prior to sensitisation. The percentage of
cells expressing ICAM-1 (%) is shown, the results have been adjusted for background













Table 3.1.4 The effect of UVB on the percentage of MHC class II expression on DC. In Table a, DC
were enriched by density gradient centrifugation from the peripheral lymph nodes of untreated mice (n=10)
or from the auricular lymph nodes of C3H/HeN mice (n=15) exposed to UVB (1440 J/m2, -48 and -24
hours). In Table b, DC were enriched from auricular lymph nodes 18 hours following oxzazolone
sensitisation of unirradiated C3H/HeN mice or from mice exposed to UVB (1440 J/m2, -48 and -24 hours)
prior to sensitisation. Cells were stained for MHC class II expression and analysed by flow-cytometry.
The percentage of cells expressing MHC class II (%) is shown, the results have been adjusted for
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3.1.6.6 The effect of UVB on the expression of B7-2 (CD86) on DC
isolated from oxazolone sensitised lymph nodes.
Table 3.1.5 shows the results from experiments examining the effect of prior
UVB exposure on DC expression of B7-2 in lymph nodes draimng an oxazolonc
sensitised site. In no experiments does UVB cause a meaningful reduction in the
percentage of cells expressing B7-2. The mean percentage expression (ignoring the
low value in experiment 15) was 58±16 and 57±13% for the control and UVB treated
groups respectively. While 80-90% of DC express ICAM-1 and MHC class II, only
around 60% of DC express B7-2. Again there are large inter-experimental difference in
the % of DC expressing B7-2, as previously this reflected the background fluorescence
which tended to vary between experiments. The histograms from experiment 16 are
shown (Figure 3.1.26). It can be seen in the histograms that the intensity of B7-2
expression on DC was not altered by UVB exposure, this was similar in all
experiments (experiments 15, 17 in Table 3.1.5).
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3.1.6.7 Summary
In Figure 3.1.27 the histograms showing ICAM-1 (experiment 4), MHC class
II (experiment 12) and B7-2 (experiment 16) expression were overlaid in order to
emphasise the similarity in the expression of these molecules on DC taken from
untreated and UVB irradiated mice.
3.1.7 Overall summary of the effect of UVB on DC function and
phenotype
An acute UVB exposure protocol was used to examine the effect of UVB on
DC in vivo. Mice were irradiated with an immunosuppressive dose of UVB, and the
function and phenotypc of DC accumulating in the DLN was examined. Exposure to
UVB prior to sensitisation did not reduce the ability of DC to induce proliferative
responses of hapten sensitised LNC. The accessory function of DC in MLR was also
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unaffected by prior exposure to an immunosuppressive dose of U VB. The expression of
MHC class II, ICAM-1 and B7-2 (CD86) on DC was also examined. UVB failed to
affect the percentage of DC expressing these markers or the surface density of their
expression. Therefore, in the absence of study limitations (discussed in section 4.1.5),
these results provide no evidence to support the view that the immunosuppression
following low-dose UVB exposure results from direct UVB-induced changes in DC.
This contradicts in vitro studies using LC isolated from the skin of mice and humans
(Tang and Udey, 1991; Rattis etal. 1995). In those studies, low-doses of UVB inhibited
the culture-induced differentiation of LC into cells with the accessory function and
phenotype associated with lymph node DC. However, since the in vitro and in vivo
systems differ so markedly, it is possible that the results gained in the in vitro system








Table 3.1.5 The effect of UVB on B7-2 expression on DC isoloated from sensitised
lymph nodes. DC were enriched from auricular lymph nodes 18 hours following
oxazolone sensitisation of unirradiated C3H/HeN mice (n=10) or from mice exposed to
UVB (1440 J/m2, -48 and -24 hours) prior to sensitisation (n=10). The percentage of
cells expressing B7-2 (%) is shown, the results have been adjusted for background
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Figure 3.1.2 7 The effect of local UVB exposure on the phenotype of DC enriched
from the draining lymph node. Mice were unirradiated or exposed to UVB (2880 J/m2
total) prior to ear painting with oxazolone. DC were enriched from DLN 18 hrs later. The
phenotype of the DC was analysed using flow cytometric analysis. Ia (a), ICAM-1 (b)
and B7-2 (c) expression on DC from control (thick solid line ) and UVB irradiated mice
(thin solid line) was examined. The appropriate isotype controls were included for control
DC (thick hatched line) and UVB DC (dotted line).
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3.2 The production of cytokines in the lymph nodes and
skin of mice during the induction phase of contact
sensitisation
3.2.1 Introduction
Interleukin-6 (IL-6) is a cytokine produced by a wide variety of cells in response to
injury, infection and a range of other cytokines. It acts on a number of cell populations
and tissues, with its main effects being the stimulation of growth and differentiation of B
and T lymphocytes, the initiation of acute phase protein production by hepatocytes and
the induction of responsiveness to IL-3 in bone marrow stem cells (Van Snick, 1990).
The production of IL-6 in DLN following contact sensitisation may be important in the
induction of effector T cell populations. This hypothesis is supported by three
observations. Firstly, that the induction phase of skin sensitisation in BALB/c mice is
characterised by the stimulation of proliferative responses in lymph nodes draining the
site of exposure (Scholes et al. 1992) and that this proliferative response is associated
with the production of IL-6 (Hope et al. 1994). Secondly, that the predominant source of
IL-6 within LNC is the immunostimulatory DC population that accumulates in the DLN
following sensitisation (Hope et al 1995; Cumberbatch et al. 1996). Thirdly, that IL-6 is
important in the early stages of T cell activation, particularly in the induction of IL-2
responsiveness in T lymphocytes (Van Snick, 1990).
UVB-induced immunosuppression may reflect the induction of altered effector cell
populations in lymph nodes following UVB exposure. In mice irradiation prior to
infection with HSV induced the appearance of a T cell population in the spleen which
could transfer suppression of DTH responses (Howie et al. 1986). Since IL-6 is
important in the early stages of effector T cell activation, the purpose of these
investigations was to investigate the production of IL-6 in two strains of mice which
show differing susceptibility to the immunosuppressive effects of UVB, namely
C3H/HeN which are UVB susceptible and BALB/c which are UVB resistant (Streilein
and Bergstresser, 1988; Noonan and Hoffman, 1994).
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3.2.2 Suppression of CH responses by low-dose UVB
C3H/HeN and BALB/c mice have been characterised as being, respectively, UVB
susceptible and UVB resistant to low-dose local UVB-induced immunosuppression
(Streilein and Bergstresser, 1988) and to systemic UVB-induced inmmunosuppression
(Noonan and Hoffman, 1994) over a range of UVB doses. To confirm that these mice
display consistent differences in susceptibility to UVB, the shaved backs of mice were
exposed to 2x1440 J/m2 of broadband UVB 48 and 24 hrs prior to sensitisation on the
irradiated site with oxazolone. The results for C3H/HeN mice have been shown in an
earlier section (Figures 3.1.1 and 3.1.2), but will be reproduced here for convenience.
Figure 3.2.1 shows the suppression of CH reactions in C3H/HeN but not BALB/c mice
following exposure to UVB. CH responses were suppressed by around 31% (p=0.05)
in C3H/HeN mice, while in BALB/c mice which showed comparable CH responses,
UVB-exposure prior to sensitisation failed to suppress the CH response. In the first
experiment, BALB/c mice were exposed to UVB without ear protection, it was noted that
BALB/c mice, unlike C3H/HeN mice, showed UVB-induced damage (erythema) to their
ears by day 6 following sensitisation. This damage may be reflected in the large SEM
seen in the UVB irradiated BALB/c mice in Figure 3.2.1. Because of this it was decided
to anaesthetise mice and cover their ears during the irradiation. The results from this
experiment are shown in Figure 3.2.2. In this experiment the ear swelling of C3H/HeN
mice was comparable to that seen in the previous experiment (Figure 3.2.1), however in
BALB/c mice the swelling responses were much lower, but again UVB failed to cause a
suppression of the CH response.
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3.2.3 Proliferation and IL-6 production by LNC in vitro
In both C3H/HeN and BALB/c strains, the kinetics of oxazolone induced
proliferation were similar, peaking at 2-3 days after sensitisation and decreasing by 5
days (Figure 3.2.3 a and b). Peak responses were around 65000 CPM for C3H/HeN
mice and 38000 CPM for BALB/c mice. Despite exhibiting vigorous proliferation, LNC
from C3H/HeN mice produced very small amounts of IL-6; 0.3-0.4 ng/ml on days 2 and
3, and below the limits of detection (<0.15 ng/ml) by day 5 after sensitisation (Figure
3.2.3 a). In contrast, while LNC from BALB/c mice produced low levels of IL-6, 0.3
and <0.15 ng/ml on day 2 and 5 respectively, they produced comparatively large amounts
of IL-6 (8-10 ng/ml) on day 3 after ear painting with oxazolone (Figure 3.2.3b).
Proliferative responses were below 5000 CPM and the concentration of IL-6 in
supernatants was below detectable levels (0.15 ng/ml) at all times following vehicle
treatment (data not shown).
This experiment was performed with similar results on four separate occasions.
The data for the day 3 timepoint are presented in Table 3.2.1. It can be seen that the LNC
proliferative responses induced by oxazolone were highly variable in both strains (20000-
70000 CPM). However the mean proliferative responses for both strains were around
40000 CPM and there was no significant inter-strain difference. There was considerably
less variability in cytokine levels, with C3H/HeN mice producing low to undetectable
levels and BALB/c mice producing significantly (p<0.025) higher amounts of IL-6 in
each of the 4 independent experiments (around 35-40 fold higher). Similar levels of IL-6
production following oxazolone sensitisation of BALB/c mice have been reported
previously (Hope et al. 1994).
To ascertain whether the level of IL-6 produced by LNC following sensitisation
with oxazolone could be correlated with the responsiveness of strains to the
immunosuppressive effects of UVB, the proliferative responses and IL-6 production by
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66730 0.16 36727 8.00
22838 0.26 30779 8.10
63816 0.35 72199 7.10
22265 0.15 20365 10.5
mean+SEM 43912±12347 0.23±0.05 40018±11242 8.42±0.72
Table 3.2.1 Strain differences in LNC proliferative activity and IL-6 production in
vitro following oxazolone sensitisation. Three days after ear painting with oxazolone
auricular lymph nodes were removed, single cell suspensions of LNC prepared and
cultured for 24 hours. The proliferative activity was analysed by 3H-thymidine
incorporation and supematants were examined for IL-6 activity by ELISA. The mean
CPM (n=5) and mean IL-6 (n=3) levels from four separate experiments are shown for
each strain. In the final row these figures have been used to provide the mean proliferative
response and IL-6 concentration ± SEM for the four separate experiments for both
C3H/HeN and BALB/c mice.
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C57BL/6 mice were examined, which are susceptible to UVB-induced
immunosuppression in both local and systemic models (Streilein and Bergstresser, 1988;
Noonan and Hoffman, 1994). It can be seen (Figure 3.2.4) that oxazolone-induced
proliferative responses which peaked on day 2 at 27000 CPM and then dropped to 24000
CPM on day 3 and to 8000 CPM on day 5 following oxazolone treatment. The vehicle-
induced (AOO) proliferative response on day 3 was 8700 CPM (data not shown), in
other strains vehicle-induced proliferation varied between 2-5000 CPM. It can be seen
that C57BL/6 mice produced low levels (<0.4 ng/ml) of IL-6 following oxazolone
treatment.
DBA/2 strain mice were tested next, these mice are susceptible to UVB in the
systemic model (Noonan and Hoffman, 1994) and resistant in the local model (Streilein
and Bergstresser, 1988) of UVB-induced immunosuppression. Again oxazolone-induced
good LNC proliferative responses which peaked at around 48000 CPM on day 3 (Figure
3.2.5). The proliferative response of vehicle treated LNC was 17000±243 CPM at the
same timepoint, which is very high compared to other vehicle controls (data not shown).
However, DBA/2 mice failed to produce appreciable levels of IL-6 following oxazolone-
sensitisation (<0.25 ng/ml) or vehicle treatment (<0.15 ng/ml).
Mice of the AKR strain were also tested, which are UVB resistant in the systemic
model (Noonan and Hoffman, 1994), and were not examined in the local model (Streilein
and Bergstresser, 1988) of UVB-induced immunosuppression. In Figure 3.2.6
oxazolone treatment resulted in LNC proliferative responses which peaked on day 3
following sensitisation (30000 CPM), with LNC from vehicle treated mice proliferating
less (7000 CPM) at the same timepoint. However, LNC from oxazolone-sensitised AKR
mice produced low levels (<0.45 ng/ml) of IL-6. Table 3.2.2 summarises the








Figure 3.2.4 Kinetics of IL-6 production and proliferative activity of
C57BL/6 LNC in vitro. LNC were taken from oxazolone treated mice at
2, 3 and 5 days after sensitisation and cultured for 24 hours. Proliferative
responses in CPM±SD (solid lines) and IL-6 production in ng/ml±SD










Figure 3.2.5 Kinetics of IL-6 production and proliferative activity of
DBA/2 LNC in vitro. LNC were taken from oxazolone treated mice at
2, 3 and 5 days after sensitisation and cultured for 24 hours. Proliferative
responses in CPM±SD (solid lines) and IL-6 production in ng/ml±SD







Figure 3.2.6 Kinetics of IL-6 production and proliferative activity of
AKR LNC in vitro. LNC were taken from oxazolone treated mice at 2, 3
and 5 days after sensitisation and cultured for 24 hours. Proliferative
responses in CPM±SD (solid lines) and IL-6 production in ng/ml±SD


























Table 3.2.2 A summary of reported strain differences in local and systemic
UVB-induced immunosuppression, and in vitro proliferative responses and IL-6
production by LNC following oxazolone sensitisation.
149
3.2.4 Interferon-y production by LNC
To determine whether the strain differences in cytokine production were selective
for IL-6, the production of IFN-y by sensitised LNC was examined. In both strains
IFN-y peaked on day 2-3 following oxazolone sensitisation and fell to below detectable
levels by day 5 (Figure 3.2.7). Table 3.2.3 shows the oxazolone-induced proliferative
responses and IFN-y levels produced by C3H/HeN and BALB/c LNC in three separate
experiments. There was no significant difference in IFN-y levels in the LNC supernatants
of both strains, with C3H/HeN mice producing 0.65±0.13 and BALB/c mice producing
0.95±0.42 ng/ml of IFN-y. Therefore unlike IL-6, IFN-y production by LNC was
comparable for both C3H/HeN and BALB/c mice.
3.2.5 DC numbers in naive and sensitised lymph nodes
Since IL-6 produced by allergen-activated LNC populations is derived
predominantly from DC (Hope et al. 1995), it was decided to examine DC numbers in the
draining lymph nodes of C3H/HeN and BALB/c mice following sensitisation with
oxazolone. In both strains, treatment with oxazolone-induced a comparable increase in
DC numbers in the DLN 18 hrs later. In C3H/HeN mice DC numbers increased from a
mean of 2759 to 23479 per node, whereas in BALB/c mice identical treatment caused an
increase in mean DC numbers from 2127 to 22920 per node.
3.2.6 Intracellular IL-6 in oxazolone-sensitised LNC
Sonication of LNC taken from both strains 3 days after sensitisation with
oxazolone, resulted in detectable levels of IL-6 in the supernatant (Figure 3.2.8). IL-6
levels were significantly higher (p<0.01) in LNC from sensitised C3H/HeN and BALB/c
mice, compared with LNC from vehicle treated mice. In addition sonication of LNC
from sensitised C3H/HeN mice resulted in significantly (p<0.01) higher levels of IL-6
being released into supernatant than released from BALB/c LNC after identical treatment.
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Figure 3.2.7 Kinetics of oxazolone-induced IFN-y production by C3H/HeN (A)
and BALB/c (•) LNC in vitro. LNC were taken from oxazolone treated mice and
cultured for 24 hours. IFN-y levels in ng/ml are shown. Limit of detection for











66730 0.80 30779 1.06
63816 0.58 34613 0.49
15338 0.57 72199 1.31
mean±SEM 48628±16666 0.6510.08 45864113214 0.9510.24
Table 3.2.3 Strain differences in LNC proliferative activity and IFN-y production in
vitro following oxazolone sensitization. Three days after ear painting with oxazolone,
auricular lymph nodes were removed, single cell suspensions of LNC were prepared and
cultured for 24 hours. The proliferative activity was analysed by 3H-thymidine
incorporation and supernatants were examined for IFN-y activity by ELISA. The mean
CPM (n=5) and mean IFN-y (n=3) levels from three separate experiments are shown for
each strain. In the final row these figures have been used to provide the mean proliferative
response and IFN-y concentration ± SEM for the three separate experiments for both
C3H/HeN and BALB/c mice.
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IL-6 ng/ml
Figure 3.2.8 Intracellular IL-6 content of LNC from C3H/HeN and
BALB/c mice. The results show IL-6 levels (ng/ml±SD) in supernatants
following sonication of LNC. Draining LNC were removed from mice 3d
after skin painting with oxazolone (Ox) or vehicle (AOO). IL-6 was below
detectable levels in sonicates of C3H/HeN LNC from AOO treated mice.
153
In order to investigate further the strain differences in IL-6 secretion, C3H/HeN
and BALB/c mice were sensitised with oxazolone and 3 days later LNC were prepared
and cultured for 24 hrs. Again, there was a marked difference in the secretion of IL-6 by
the two strains, with IL-6 being below the detectable limits in the supernatants from
C3H/HeN LNC and BALB/c producing around 4.3 ng/ml of IL-6. Sonication of
C3H/HeN and BALB/c LNC after the 24 hr culture period released 0.72 and 2.83 ng/ml
of IL-6 respectively into solution. Because the lack of IL-6 secretion by C3H/HeN LNC
in culture is not associated with the accumulation of IL-6 within these cells, it seems
likely that the strain difference in IL-6 secretion reflects a lack of IL-6 protein production
by C3H/HeN LNC.
3.2.7 IL-6 production and intracellular levels of IL-6 following
UVB
Exposure to a single dose of 1440 J/m2 UVB results in the accumulation of DC in
the DLN peaking around 48 hrs after exposure (Moodycliffe et a/. 1994). In both strains,
exposure to a single dose of 1440 J/m2 of UVB caused an increase in DC numbers in
DLN. In C3H/HeN mice DC numbers rose from 2083 to 7524 per LN, and from 2530 to
6223 per LN in BALB/c mice.
Although UVB causes the accumulation of DC and the induction of LNC
proliferation in the DLN, there was no induction of IL-6 activity in either strain. In
C3H/HeN mice IL-6 levels were below the detectable limits at all timepoints. In BALB/c
mice IL-6 levels were just above the detectable limits on day 1 and 2 (0.25±0.07 and
0.29±0.09 ng/ml respectively) but fell to below the detection limits by day 5.
In separate experiments LNC suspensions prepared from the auricular lymph
nodes of C3H/HeN and BALB/c mice 3 days after a single dose of UVB (1440 J/m2)
were sonicated. UVB treatment of C3H/HeN mice raised the intracellular IL-6 levels
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from below the detectable limits to 0.17+0.03 ng/ml. In BALB/c IL-6 levels were
increased from 0.18±0.01 to 0.32±0.01 following UVB treatment.
3.2.8 IL-6 production in the skin of C3H/HeN and BALB/c mice
IL-6 is produced constitutively by epidermal LC (Schreiber et al. 1992) and
keratinocytes can be induced to synthesise IL-6 (Bos and Kapsenberg, 1993). Figure
3.2.9 shows that similar amounts of IL-6 were produced constitutively in the skin by
both C3H/HeN mice (3.84±0.21 mean ng/g tissue±SEM, n=4, range=0.95 ng/g) and
BALB/c mice (3.37± 0.29 mean ng/g tissue±SEM, n=4, range=1.29 ng/g). Painting the
skin of C3H/HeN or BALB/c mice with vehicle did not cause a substantial increase in IL-
6 production over constitutive levels. In C3H/HeN mice, sensitisation with 1%
oxazolone induced significant increases (when compared with vehicle controls) in IL-6
levels (p<0.025) at all timepoints except 0 hr. In BALB/c mice, oxazolone induced a
significant increase (p<0.025) in IL-6 levels compared with the vehicle control at all
timepoints. The kinetics but not the magnitude of IL-6 production were similar in both
strains, with IL-6 levels in both strains peaking 4-8 hrs post-sensitisation and decreasing
by 24 hrs. C3H/HeN mice produced higher levels of IL-6 following sensitisation than
BALB/c mice. At the peak 4 hr timepoint, skin from C3H/HeN mice contained almost
twice as much IL-6 as skin from BALB/c mice (36 ng/g and 22 ng/g tissue respectively).
This reflected an increase in IL-6 levels of 40 and 18 ng/g tissue in C3H/HeN and
BALB/c mice, respectively following oxazolone sensitisation.
This experiment was repeated (Figure 3.2.10). The kinetics of cytokine induction
in this experiment were similar to those shown previously (Figure 3.2.9), with IL-6
activity in both strains peaking at 4-8 hrs after sensitisation. Vehicle treatment failed to
cause substantial increases in IL-6 activity, except in BALB/c mice where there were
significant (p<0.025) increases in IL-6 activity in the skin 0 and 1 hrs following vehicle
treatment when compared with levels in untreated mice. Unlike the previous experiment,
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Time following exposure (hrs)
Figure 3.2.9 Kinetics of IL-6 production in the skin of
C3H/HeN (triangles) and BALB/c mice (circles) after painting
with oxazolone (closed) and AOO (open), naive mice were
unpainted. IL-6 levels are shown as ng per gram tissue±SD.
Limit of detection for IL-6 = 0.15 ng/ml.
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Figure 3.2.10 Kinetics of IL-6 production in the skin of
C3H/HeN (triangles) and BALB/c mice (circles) after painting
with oxazolone (closed) and AOO (open), naive mice were
unpainted. IL-6 levels are shown as ng per gram tissue±SD.
Limit of detection for IL-6 = 0.15 ng/ml.
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the constitutive IL-6 levels were significantly (p=0.025) higher in the skin of BALB/c
mice compared with C3H/HeN mice. In addition, the magnitude of IL-6 production was
generally higher in BALB/c mice than C3H/HeN mice, significantly (p<0.025) at 1,4,
and 24 hrs. The increase in IL-6 levels following oxazolone sensitisation was 35 and
30 ng/g tissue in C3H/HeN and BALB/c mice, respectively at the 4 hr timepoint. These
levels were similar to those seen in the previous experiment (Figure 3.2.9).
3.2.9 The effect of UVB on IL-6 production in the skin
Because the cutaneous microenvironment is an important component in the skin
immune system, the effect of UVB on IL-6 activity in the skin was examined. In the
initial experiment C3H/HeN and BALB/c mice were either unirradiated or exposed to
UVB (1440 J/m2, -48 and -24 hrs) prior to sensitisation (Figure 3.2.11). The effect of
UVB on constitutive, vehicle and oxazolone-induced IL-6 production was measured 4
hrs after the appropriate sensitisation treatment.
The magnitude of the 4 hr oxazolone responses (Figure 3.2.11) was comparable
to those seen in Figure 3.2.9 with C3H/HeN mice producing around 30 ng/g tissue
weight (around 35 ng/g previously) and BALB/c mice producing around 14 ng/g tissue
weight (compared with 21ng/g IL-6 in Figure 3.2.9). From this experiment it appears
that UVB is having a differential effect on IL-6 in the skin of C3U/HeN and BALB/c
mice. IL-6 production in naive, vehicle treated and oxazolone-treated and UVB irradiated
mice was significantly increased (p=0.025) in C3H/HeN but not BALB/c mice.
However repeating the experiment failed to confirm the findings (Figure 3.2.12).
The magnitude of the response was much higher than in previous experiments with
oxazolone inducing 107 and 79ng of IL-6 per gram tissue in C3H/HeN and BALB/c mice
respectively. There was no statistically significant inter-strain difference in the effect of
UVB on constitutive, AOO and oxazolone-induced IL-6. UVB caused a significant
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C3H/HeN BALB/c
Figure 3.2.11 The effect of UVB exposure on constitutive and oxazolone-
induced IL-6 production in the skin of C3H/HeN and BALB/c mice. The
shaved backs of mice were not irradiated Q or were exposed to UVB
(1440J/m2, -48 and -24 hrs) ® prior to sensitisation. Mice were then left
untreated (naive), were sensitised with vehicle (AOO) or with oxazolone (Ox).
Skin samples were taken at 4 hrs following sensitisation, weighed, processed

















Figure 3.2.12 The effect of UVB exposure on constitutive and oxazolone-
induced IL-6 production in the skin of C3H/HeN and BALB/c mice. The
shaved backs of mice were not irradiated Q or were exposed to UVB
(1440J/m2, -48 and -24 hrs) flZD prior to sensitisation. Mice were then left
untreated (naive), were sensitised with vehicle (AOO) or with oxazolone (Ox).
Skin samples were taken at 4 hrs following sensitisation, weighed, processed










increase (p=0.025) in constitutive and AOO-induccd IL-6 activity , but failed to
significantly increase oxazolone-induccd cutaneous IL-6 in either strain.
The wide differences in the magnitude of IL-6 levels in the skin may reflect
differences in the protocol used. The protocol used for the first kinetics experiment and
the first UVB experiment (Figures 3.2.9 and 3.2.11) differed from the protocol used to
repeat these respective experiments (Figures 3.2.10 and 3.2.12). In the first experiments
the skin samples from 4 mice (0.5- lg) were chopped up, pooled and stored at -70°C
before they were homogenised and sonicated. Following discussion (personal
communication Dr. R Dcarman) it was decided that lower weights of skin between 0.05
and O.lg would be more suitable for analysis. Therefore before the homogenisation, skm
from each sample was blotted dry and known weights of sample redistributed to four
eppendorfs. In the later experiments (Figures 3.2.10 and 3.2.12), the samples from each
of the four mice were processed separately and at no point in the proceedings were
samples pooled. The effect of the protocol change on IL-6 levels will be discussed later,
i
but briefly the increased processing time, extra freeze/thaw cycles and the innaccuracies
incurred by re-weighing samples may possibly be reflected in the lower levels of IL-6
detected in Figures 3.2.9 and 3.2.11 compared with Figures 3.2.10 and 3.2.12.
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3.2.10 Summary
The induction phase of CH is associated with proliferation (Scholes etcil. 1992)
and IL-6 production by LNC draining the sensitised site (Hope etal. 1994).
Accumulating DC provide the main source of IL-6 within the sensitised lymph node
(Hope etal. 1995; Cumberbatch etal. 1996). Since IL-6 is important in the early stages
of antigen presentation (Van Snick, 1990), it is possible that its production by DC is
important in the generation of effector T lymphocyte populations. Consistent with
previous studies (Hope etal. 1994), it was shown that LNC from UVB-resistant BALB/c
mice proliferated and produced high levels of IL-6 in response to the sensitiser,
oxazolone. In contrast, LNC from UVB-susceptible C3H/HeN mice produced low-levels
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of IL-6 following sensitization but showed similar proliferative activity to BALB/c LNC.
The lack of IL-6 activity was not attributable to a congenital variation between these
strains with respect to IL-6 production as comparable levels of constitutive and inducible
expression of this cytokine were measured in BALB/c and C3H/HeN mice, following
respectively, topical exposure to vehicle alone or oxazolone. Sonicating LNC from
sensitised BALB/c and C3H/HeN mice, immediately alder removal from the mice, caused
the release of similar levels of IL-6. The total amount of IL-6 produced by LNC during
24 hrs, was measured by sonicating LNC following culture and by analysing the levels of
IL-6 in culture supernatants. The failure of C3H/HeN LNC to secrete IL-6 into culture
was not reflected by the accumulation of the cytokine within cells. Therefore it seems
likely that the low levels of IL-6 produced by C3H/HeN LNC reflect a lack of IL-6
production by LNC, rather than a failure in IL-6 secretion. To clarify the role of IL-6
production in UVB-mduced immunosuppression, further UVB-resistant (AKR) and
UVB-susceptible (C57BL/6 and DBA/2) strains were examined, all of which showed low
i
levels of IL-6 production following sensitisation with oxazolone. Therefore no correlation
was shown between the levels of IL-6 production following sensitisation, and the




4.0.1 The effect of UVB exposure on LC density in the epidermis
Exposure to single doses of broadband UVB or TL01 has been reported to
decrease the density of LC in the epidermis (El-Ghorr et al. 1994). Similarly chronic UV
exposure, by the broad- and narrowband sources, reduced the density of ATPase+ LC
throughout the period of irradiation (Figure 3.0.2). The reduction was dose dependent for
the broadband source, with the higher dose (1000 J/m2) causing the greatest loss in LC
numbers at all timepoints examined. For mice exposed to the broadband source, LC
dropped to a minimum during the first 2-3 weeks of chronic exposure. After this LC
numbers began to rise, suggesting that LC may have started to repopulate the epidermis,
but they had not reached pre-irradiation levels by 6 weeks. Other studies have reported
that the LC density returned to normal levels after about 15 weeks of chronic UVB
treatment (Alcalay et al, 1989). The TL01 lamp was less effective than the broadband
lamp at reducing the density of LC at early timepoints, but by 6 weeks the numbers had
decreased to a similar extent as with the higher-dose (1000 J/m2) broadband source.
4.0.2 The effect of UVB on sunburn cell (SBC) induction
SBC are thought to represent apoptotic keratinocytes and are induced in the
mammalian epidermis in a UV-dose dependent manner (Young, 1986; Woodcock and
Magnus, 1976). SBC were found during chronic irradiation with both broad- and narrow
band sources (Figure 3.0.4). They were induced in a dose-dependent manner by
broadband UVB. Fewer SBC were formed after TL01 exposure compared with
broadband UVB. The induction of SBC is wavelength dependent, peaking between 260-
280nm and droping dramatically from 290 to 310nm (Woodcock and Magnus, 1976).
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Because SBC induction plateaus between 260-280nm it is not possible on this evidence to
separate DNA or protein as the main chromophore involved. TL01 has a restricted
emission spectrum and is likely to be less effective than broadband UVB in the induction
of SBC, though in this study it was only slightly less effective than the lower dose (500
J/nr) of broadband UVB (Figure 3.0.4).
Following acute exposure to around one MED (1500 J/m2 UVB), 24hrs
previously, 5.4 SBC/cm of epidermis were found, while in BALB/c mice, exposure to
2000 J/m2 of broadband UVB resulted in around 70 SBC/cm of epidermis 24 hrs later
(Schwartz et al. 1995). Therefore, the numbers of SBC found in this study following
chronic irradiation seem very low (Figure 3.0.4). However, in the protocol, the ears were
removed from the mice three days after the last irradiation. In other studies peak numbers
of SBC were found 8h after UVC and 24 hrs after UVB exposure (Young, 1986). The
peak values must represent the minimum time to SBC formation and clearance, though
the mechanism for SBC removal is unclear. The most obvious route would be removal by
desquamation. However the minimum transit time of cells from the basal layer to the
surface is 6 days (Potten, 1975). Although in this study SBC were observed supra-
basally, the rapid removal of SBC suggests a more dynamic clearance mechanism, and,
there is evidence for keratinocyte-mediated phagocytosis of SBC (Young, 1986).
Whatever the mechanism of SBC removal, it seems likely that the 3 day gap between the
last UVB exposure and the preparation of skin sections allowed clearance of some SBC,
and resulted in the low numbers of SBC identified after chronic UVB.
4.0.3 Chronic UVB, skin ageing/damage and epidermal thickness
Chronic low dose UVB exposure results in photoageing which is marked by
histological and biochemical changes in the skin (Kligman, 1991). The appearance of
photoaged skin reflects UVB-induced damage to collagen and glycoaminoglycans (GAG)
in the dermis (Kligman, 1991). In hairless Skh mice, most of the features of photoageing
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(wrinkling, skin fold and epidermal thickening, collagen damage, GAG increases,
increased dermal cellularity) are induced efficiently by wavelengths of between 290-300
J/m2 in the UVB range (Bissett et al. 1989). Only one measure of photoageing, skin
sagging, is dependent on exposure to UVA with a peak induction at 340nm.
The effect of multiple exposures of C3H/HeN mice to broad- and narrowband
UVB was investigated. While each dose of irradiation was suberythemal, it was noted
that, after 2 weeks' exposure of mice to 1000 J/m2 of the broadband source, the skin
showed some reddening, before pigmentation developed. Exposure to 500 J/m2 of
broadband UVB did not produce erythema, although tanning was evident after 3 weeks.
The narrowband TL01 lamp did not produce reddening or tanning.
The TL01 lamp was developed for use in phototherapy treatment, to minimize the
damaging effects of UV light (Van Weelden et al. 1988). Because the TL01 lamp emits a
very narrow peak around 311-312 nm, exposure to narrowband UV causes less skin
damage than broadband sources. Previous studies have shown broadband UVB to be
more efficient than UV from the TL01 source in the induction of epidermal thickening
(Sternborg and van der Leun, 1986). This was confirmed in our study with chronic
exposure to 1000 J/m2 of broadband UVB causing a doubling of epidermal thickness,
while TL01 exposure failed to increase epidermal thickness (Figure 3.0.5).
4.0.4 UVB exposure and cis-UCA concentration
UCA in the stratum corneum is isomerized by UVB from the naturally occurring
trans form to cis-UCA. A number of studies have suggested ax-UCA to be a mediator of
UVB-induced immunosuppression. Some of these studies were discussed in the
introduction (section 1.8.2.2).
UVB causes a dose dependent conversion of UCA to the cA-isomer both in vitro
and in vivo until the photostationary state is reached, when approximately 50% of the
total UCA is in the cis form (Morrison et al. 1980). Interestingly in this study, cis-UCA
seems not to have reached a photostationary state. The concentration of cis-UCA peaked
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at 1-2 weeks of chronic broadband UVB (1000 J/m2) and TL01 exposure (Figure 3.0.6)
at which point cis-UCA represented around 35-38% of total UCA . However, even
though UVB exposure was continued up to 6 weeks the concentration of cA-UCA
remained constant in mice exposed to broadband UVB, and dropped in those exposed to
the TU01 source (Figure 3.0.6). The drop in cis-UCA levels in TU01 exposed mice
occurred in the absence of epidermal thickening (Figure 3.0.5) or tanning. Following the
formation of cis-UCA in the epidermis, it has been shown to persist in the epidermis for 7
days, returning to background levels by 14 days (Norval et al. 1988). It is eliminated by
desquamation and in sweat, but the increased solubility of the cA-isomer compared with
the trans-UCA means that cis-UCA is found transiently in the serum of mice following
UVB (Moodycliffe et al. 1993).
Previous studies have shown an increase in total UCA in the skin of humans and
guinea pigs respectively following insolation and irradiation with a hot quartz mercury arc
lamp (Hais et al. 1970, Baden and Pathak, 1967). These increases occurred several days
alter irradiation and were thought to correlate with the increased epidermal thickness of
irradiated skin. Interestingly although broadband UVB caused an increase in epidermal
thickness (Figure 3.0.5) the total UCA concentration remained unchanged throughout the
study (Figure 3.0.6). This agrees with results from a human study which showed
comparable concentrations of total UCA in epidermal sites which are commonly exposed
to the sun, such as the forehead, compared with sites that receive little sun exposure, such
as the upper thigh (Kavanagh et al. 1995).
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4.0.5 Chronic UVB and CH responses.
CH responses to oxazolone were suppressed to a similar extent in mice exposed
to 500 and 1000 J/m2 of broadband UVB for six weeks (Figure 3.0.7). In contrast,
TL01 exposure for 3 or 6 weeks did not cause a suppression of CH responses (Figure
3.0.7). The failure of TL01 exposure to suppress CH responses has also been observed
following acute exposure (El-Ghorr et al. 1994). In this study CH responses were elicited
on the ears of mice, which were not protected during UVB exposure. This is more likely
to reflect environmental UVB exposure and has previously been shown not to affect CH
responses following acute UVB. However, the effect, of protecting the ears during
chronic broadband UVB exposure on CH responses were not examined in this study.
Therefore it is impossible to distinguish between UVB-induced effects on the induction
versus the elicitation of CH responses.
Both broad- and narrowband sources reduced LC density by around 50% by
week 6 of exposure (Figure 3.0.2). Since broadband but not TL01 exposure resulted in
suppression of CH responses (Figure 3.0.7), it seems unlikely that the reduction in
epidermal LC density alone is responsible for the loss of CH responses following UVB.
Similarly the fact that CH responses were not suppressed at 3 (data not shown) or
6 weeks in TL01 exposed mice (Figure 3.0.7), even though the levels of cis-UCA after
3 weeks of TL01 exposure were similar to the maximum levels induced by broadband
UVB (Figure 3.0.6), suggests that ds-UCA is not the main mediator of chronic
UVB-induced suppression of CH.
There has been relatively little work studying the effects of chronic UVB exposure
on the SIS. However, a chronic low-dose protocol is far more likely to reflect the type of
exposure that individuals receive from terrestrial sunlight. One of the interesting results
from this study was the adaptation of murine skin to chronic UVB exposure. Chronic
UVB failed to deplete completely LC from the skin, and by week 5 and 6 numbers were
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beginning to return to normal in mice exposed to broadband UVB. SBC numbers peaked
after 1-2 weeks of UV exposure and by 6 weeks were returning to the levels seen in un¬
irradiated mice. The other marker of photodamage, increased epidermal thickness,
reached a plateau 1-3 weeks into broadband UVB exposure. Finally cis-UCA, which has
been been shown to reach its photostationary state following acute irradiation both in vitro
and in vivo, failed to reach this level during chronic exposure. The most likely
explanations for this ability of murine skin to adapt to UVB is the epidermal thickening
and pigmantation induced by the broadband UVB source. The TL01 source failed to
induce either epidermal thickening or tanning, which may explain why LC numbers were
still dropping in the latter stages narrowband exposure. Interestingly however, SBC
began to return to normal levels by 5 weeks of TL01 exposure, and the level of clv-UCA
in the mice remained stable after the first week of narrowband UV exposure. It is possible
therefore that chronic narrowband exposure induces an adaptive response from the skin
separate from epidermal thickening or pigmentation.
167
4.1 UVB exposure and DC function and phenotype
4.1.0 In vivo UVB exposure and DC function
UVB exposure causes the suppression of cutaneous immune responses to a
variety of agents. Of particular relevance to this study is the ability of UVB to suppress
immune responses to contact sensitisers. The importance of DC in UVB-induced
suppression of CH responses was apparent from the initial experiments in this area by
Toews et al. (1980). They demonstrated the failure of CH induction through sites
naturally deficient in LC, such as mouse tail skin. This observation was extended in the
same study by exposing the shaved skin of mice to UVB on 4 consecutive days, a
treatment which resulted in a depletion of LC from the exposed site. Like skin that was
naturally deficient in LC, sensitisation through skin exposed to UVB, did not result in the
induction of CH responses. This work suggested that it was the density of LC in the skin
that determines whether immune responses will be induced to particular antigens. There is
no doubt that LC density is important in the induction of immune responses, but the
examination of UVB-resistant mice has suggested that other factors are also critical. In
both UVB susceptible and resistant strains, exposure to low-doses of UVB causes the
depletion of LC from the skin, but only in susceptible strains does this LC depletion
result in suppression of cutaneous immunity (Streilein and Bergstresser, 1988). There is
growing evidence that dermal cells in UVB resistant but not susceptible mice provide a
secondary pathway of CH induction following exposure to UVB. Dermal cell
suspensions prepared from C57BL/6 (UVB susceptible) and BALB/c (UVB resistant)
mice and haptenated in vitro transferred CH responses to syngeneic mice (Kurimoto
et al. 1994). Complement depletion experiments showed that the transfer of CH responses
in this model was dependent on dermal MHC class IT cells. Exposure of mice to
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400 J/nr of UVB on 4 consecutive days suppressed the ability of dermal cells from
C57BL/6 but not BALB/c mice to transfer CH responses to syngeneic recipients
(Kurimoto et al. 1994).
4.1.1 Functional changes in LC
Because the loss of LC from the skin fails to explain fully the immunosuppressive
effects of UVB, it was of interest to examine the effects of UVB on the antigen presenting
activity of DC in vivo. Murine DC were enriched from the auricular lymph nodes, which
drain the ears, following a variety of treatments. In mice the ears provide a useful surface
for skin treatments. First they offer an easily accessible, hairless and semi-discrete site for
exposure of mice to UVB and chemical allergens. Secondly, treatments which cause the
loss of LC from the ears result in the accumulation of DC in the auricular lymph nodes
(Macatonia et al. 1987). This being the case there is the possibility of examining changes
in APC populations initiated in the skin by UVB exposure, at the level of DC in the DLN.
A system was developed therefore in which an immunosuppressive dose of UVB was
given to mice prior to sensitisation using either FITC or oxazolone. The APC activity of
DC isolated from mice that received UVB from the DLN prior to sensitisation was
compared with the APC activity of sensitised DC from non-irradiated mice.
4.1.2 Are DC populations in skin draining lymph nodes derived
from LC?
Identifying UVB-induced changes in DC accumulating in the DLN assumes that at
least some of these cells derive from cutaneous DC. The techniques that have been used
to study this are limited, particularly in mice because of the inability to examine the
lymphatic drainage of their skin. The migration of LC out of sensitised skin of mice has
been investigated using the fluorescent chemical allergen FITC (Macatonia et al. 1987). In
addition UVB-induced LC migration has been examined by identifying DC with thymine
dimers in the DLN (Sontag et al. 1995).
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Macatonia et al. (1987), reported two populations of FITC+ DC in the DLN after
skin painting, one with low levels of FITC and another intensely fluorescent population.
DC with high fluorescent intensity first appeared 2-8 hrs after skin painting and induced
T cell proliferation. Kripke et al. (1990), reported two populations of FITC+ DC in the
DLN after skin painting; 75% of these DC expressed the antigen F4/80, a marker of LC
but not lymph node DC, which suggested that they are a skin-derived population. The
remaining 25% of the DC did not express F4/80 and may represent a resident lymph node
population. In agreement with the studies of Macatonia et al. (1987), ear painting with
FITC resulted in the appearance of FITC-bearing cells in the DLN with the size and
granularity of DC (Figure 3.1.3b). In addition in Figure 3.1.3b, two distinct populations
of DC can be seen which show low and high fluorescent intensity, which is similar to the
report of Macatonia et al. (1987). It is possible that free, non cell-associated FITC reaches
the lymph node following skin painting. Cells with low-intensity fluorescence may
therefore represent a resident lymph node population which have bound FITC in situ.
Certainly they appear rapidly (30 min) following skin painting and are unable to induce
FITC specific responses (Macatonia et al. 1987). However epicutaneous exposure to
FITC caused the accumulation of DC systemically in both local and distant lymph nodes
(Hill et al. 1990), though only DC in DLN expressed FITC, and stimulated FITC-specific
T cell responses.
Contrasting results were obtained in a study using a monoclonal antibody to
thymine dimers to identify DC with UVB-induced DNA damage in the DLN of hairless
mice (Sontag et al. 1995). Less than 0.3 cells per 1000 enriched DC showed thymine
dimers. Although the study did not report the numbers of DC in lymph nodes following
UVB, assuming that UVB causes an increase in DC numbers from around 2500 to 10000
DC per LN (Moodycliffe et al. 1992) and that all skin-derived DC show thymine dimers,
then the result suggests that only around 3 DC accumulating in the DLN following UVB
were skin derived. This seems fairly unlikely and suggests that the assumptions are
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flawed. Since the first assumption results from published observations, it seems likely
that the second assumption, that all skin-derived DC should exhibit DNA damage, needs
rethinking. The study was carried out in hairless HRA/skh mice, and it would be of
considerable interest to carry out the same study in DNA repair deficient mice. In normal
inbred mouse strains it is impossible to know whether the low numbers of DNA damaged
DC in DLN reflect a low level of migration from the skin, or effective DNA repair.
However a second possibility exists, that the ability of LC to migrate out of the skin in
response to UVB exposure means that the DC accumulating in the DLN will be unlikely
to show DNA damage whether they are from normal or DNA repair deficient mice.
Because of the technical limitations involved in using monoclonal antibodies to
thymine dimers to identify LC-derived DC, it seems likely that the evidence from the
FITC studies more accurately reflects the numbers of LC-derived DC in the DLN. The
FITC studies are in line with those in sheep (Dandie et al. 1992) which have shown large
numbers of CDla+ LC, migrating via the afferent lymph following treatment of skin with
chemical allergens and carcinogens. Though still a point of controversy, it seems likely
that the majority of DC in the DLN after skin painting with a contact sensitiser is skin
derived. Therefore it was considered that they constitute an appropriate APC population
with which to examine the immunomodulatory effects of UVB in vivo.
4.1.3 UVB-induced suppression of cutaneous immune responses
In order to examine the effect of UVB treatment in vivo it was important to expose
mice to sufficient UVB to cause suppression of CH responses. Previously it has been
shown that exposure of C3H/HeN mice to 2 doses of 1440 J/m2 of UVB 48 and 24 hrs
prior to sensitisation results in around a 50% suppression of CH responses (Moodycliffe
et al. 1994). In the present study, exposure to the same dose of UVB caused significant
suppression of CH responses on two separate occasions (Figure 3.1.1 and Figure 3.1.2).
The mice were irradiated and then sensitised on their shaved backs and CH responses
were elicited on the ears. The standard laboratory protocol, in which the ears were not
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protected during irradiation, resulted in a 31% suppression of CH response by UVB
(Figure 3.1.1). Adapting the protocol so that the ears were protected during irradiation
increased UVB-induced suppression to 46% (Figure 3.1.2).
4.1.4 The effect of in vivo UVB exposure on antigen-specific DC
accessory activity.
Having shown that the exposure of mice to UVB (1440 J/m2, -48 and -24 hrs)
caused the suppression of CH responses (Figures 3.1.1. and 3.1.2), and that
epicutaneous treatment with FITC resulted in the accumulation of FITC-bearing DC in the
auricular lymph nodes (Figure 3.1.3.b), it was decided to examine the effect of UVB on
the ability of DC to present antigen in vitro to sensitised LNC. Initial results (Figure
3.1.7) suggested that prior UVB exposure was having no effect on the ability of DC from
FITC- or oxazolone-sensitised mice to stimulate antigen proliferative responses from
FITC- or oxazolone-sensitised LNC. However, thymidine incorporation was low and the
antigen specificity of responses were not convincing. Titrating the proliferative response
led to an increase, from 2x10s to 5x10s cells/well, in the numbers of responder LNC used
(Figure 3.1.8). Using this adapted protocol, UVB failed to affect the ability of FITC-
sensitised DC to act as costimulatory cells on two separate occasions (Figure 3.1.9a and
b). This failure of UVB to suppress FITC-specific APC activity was shown over a range
of stimulator to responder ratios (Figure 3.1.1 la).
Similarly oxazolone-specific proliferative responses were unaffected by UVB.
Both oxazolone and FITC sensitised DC could stimulate proliferative responses from
oxazolone-sensitised LNC, though FITC DC were poorer accessory cells (Figure
3.1.10). This is in accordance with previous results, where FITC and oxazolone-bearing
DC showed a limited antigen non-specific stimulatory capacity (Jones et al. 1989).
However, UVB exposure prior to oxazolone sensitisation failed to influence materially
the ability of DC to initiate antigen-specific proliferative responses (Figure 3.1.10).
A number of groups have looked at the effect of UVB on LC function in vitro and
have shown that UVB has profound effects on the activity of DC. Irradiation of human
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epidermal cell suspensions (8-20% LC) and purified LC populations (70-90% LC) with
100-200J/m2 of UVB in vitro significantly inhibited their ability to stimulate primary
alloresponses, mitogen-induced proliferation and proliferative responses to recall antigens
(Rattis et al. 1995). Similarly, exposure of murine epidermal cell suspensions to a low
dose of UVB (25 J/nf) inhibits anti-CD3 induced proliferation of T cells (Tang and
Udey, 1991) while 250-2000 J/m2 abrogates EC antigen-specific accessory activity in a
dose dependent manner (Stingl et al. 1981). However, in vitro exposure of LC to 100
J/m2 of UVB is cytotoxic to LC, causing their eventual loss from cultures after 48-72 hrs
(Tang and Udey, 1992).
More relevant to this study is work on in vivo models. Bucana et al. (1994),
exposed mice to 400 J/m2 UVB on 4 consecutive days prior to LITC sensitisation and
showed that the accessory activity of enriched DC for LITC specific T cell lines was
reduced. The enriched DC cell population contained 10-30% DC following Metrizamide
centrifugation, and DC were used at a stimulator: responder cell ratio of 5:1. In the
present study, the enriched population contained 50-70% DC on basis of morphology and
was used at a ratio of 1:55 or 1:100. It is possible that the suppression of proliferative
responses reported by Bucana et al could be a result of UVB-induced changes in the large
number of non-DC contaminating the stimulator cell population. Alternatively the
responding cell population, which was LITC-specific T cell lines in the Bucana et al study
and LNC stimulated in vivo with LITC in our study, could interact differently with DC.
Chronic exposure to 8 kJ/m2 of UVB 3 times weekly for up to 32 weeks (Alcalay
and Kripke, 1991) caused a decrease in the ability of draining LNC populations to
transfer CH responses to syngeneic recipients at 4, 12 or 17 weeks. This was ascribed to
a reduced capacity of DLN cells to present antigen. However, because of the contrasting
protocols, e.g. acute versus chronic and low-dose versus high-dose exposure, it is
difficult to compare the results obtained in the chronic study with those presented here.
However, the same group have reported similar findings using a much lower dose of
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UVB (400 J/m2 on 4 consecutive days) prior to sensitisation (Okamoto and Kripke,
1987). DLN cells from UVB irradiated and sensitised mice, but not DLN cells from
control sensitised mice, induced antigen specific tolerance in unirradiated syngeneic
recipients (Okamoto and Kripke, 1987). Although a different UVB exposure protocol
was used compared to in the present study, the acute, low-dose exposure protocol allows
comparisons to be made. Since DLN cells, exposed to 1600 J/m2 of UVB over 4 days in
vivo, transfer antigen-specific tolerance in the Okamoto study, it seems plausible that
DLN cells in the present study, that were exposed to 2880 J/m2 over 2 days, would have
the same ability. Therefore, it would have been helpful here to have examined the ability
of DLN cells after low-dose immunosuppression to transfer CH responses to syngeneic
recipients.
4.1.5 The limitations of this study
In the absence of technical limitations the conclusion from this work is that UVB-
induced immunosuppression is not mediated by changes in the function of DC. However,
possible weaknesses in the experimental design should be discussed.
4.1.5.1 Is the induction of proliferation an adequate marker of APC
function?
The end-point for all functional analyses was the ability of DC to induce
proliferative responses, and to find out whether DC from mice that had received an
immunosuppressive dose of UVB were less able to stimulate antigen-specific immune
responses than DC from unirradiated animals. No difference in the antigen-specific
functional activity between DC from control or irradiated mice was found, even though
irradiated mice received doses of UVB which caused suppression of CH responses.
However, the ability of DC from irradiated mice to induce proliferative response may not
equate with their ability to induce functional effector cells. Most cutaneous immune
responses are T cell mediated. Therefore, since the description of the CD4+ T cell subsets
by Mosmann et al, (1986), there has been great interest in whether induction of tolerance
following UVB reflects a switch of effector mechanisms from a Thl to a Th2 response,
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manifesting itself in suppressed cutaneous immunity. Thl responses are critical in the
induction of DH responses. Macrophages are the principle effector cells in DH responses
and IFN-y production by Thl T cells is important in the stimulation of macrophage
function. It is thought that other cutaneous responses, for example CH, are mediated via
similar Thl mechanisms.
The evidence for a UVB-induced switch in immune responses is increasing.
Initial work showed that exposing LC to UVB caused them to induce antigen-specific
unresponsiveness and tolerance in Thl but not Th2 clones (Simon et al, 1991). The ability
of UVB to suppress Thl responses in vivo was demonstrated (Simon et al. 1994) using a
system similar to the one used in this study. Mice were exposed to UVB (200 J/m2 on
four consecutive days) and were then sensitised with a contact allergen through the
irradiated site, immediately following irradiation and again 24 hrs later. UVB treatment
was associated with suppressed CH responses and with the reduction of IFN-y and IL-2
production by draining LNC from irradiated mice in vitro (Simon et al, 1994).
UVB-induced IL-10, produced predominantly by keratinocytes in mice (Enk and
Katz, 1992) and by skin infiltrating CD1 lb macrophages in humans (Kang et al 1994)
may be important in switching to a Th2 response. Exposure of murine keratinocytes to
200 J/m2 UVB in vitro causes the secretion of IL-10 into supernatants (Rivas and Ullrich,
1992). Protein from irradiated but not from control keratinocyte supernatants blocked
IFN-y production by KLH-specific Thl cells during culture with APC and antigen (Rivas
and Ullrich, 1992). This activity was reversed using an antibody to IL-10. Similarly
intravenous injection of supernatants from UVB-irradiated keratinocytes reduced the
ability of splenic APC to present antigen to Thl but not to Th2 T cell clones, an activity
which was IL-10 dependent (Ullrich, 1994). The transferable suppressor T cells that are
found in the spleen following UVB treatment may be a Th2 effector T cell population.
The transfer of suppression of DH responses to syngeneic recipients by splenic cells from
irradiated mice was blocked by injecting the recipient mice with neutralising antibody to
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IL-10 and IL-4, or by treatment with the Thl-type cytokine IL-12 (Rivas and Ullrich,
1994; Schmitt et al. 1995), suggesting that splenic suppressor cells mediate their
suppressive activity through the secretion of Th2 cytokines.
Therefore although DC from UVB treated mice are able to induce proliferative
responses, it is possible that the quality of effector cells induced by those DC was
different from the quality of effector cells induced by DC from unirradiated mice. It
would have been interesting therefore to examine the supernatants of sensitised LNC
following incubation with DC from irradiated and non-irradiated mice, to see if their
cytokine profiles differed.
4.1.5.2 The different requirements of naive and sensitised LNC for
professional APC
T cells which express CD45RO, a marker of recent activation, have different APC
requirements to naive T cells (Bradley et al. 1993). They have less of a requirement for
professional APC, such as DC, and their effector function can be activated by non¬
professional APC in the periphery. Therefore it is plausible that the use of sensitised LNC
as responder cells in the functional assays in this study did not provide the most sensitive
read out system for subtle changes in APC function. Because the LNC population had
'experienced' the antigen previously it is possible that these cells were less dependent
upon costimulatory signals. If this was the case then UVB-induced changes in DC
function could have been masked because of the activation state of LNC.
4.1.6 The effect of UVB on the induction of effector cell
populations in the lymph nodes
In order to address the possible problems in the experimental protocol highlighted
previously, e.g. that the activation state of sensitised LNC was masking possible UVB-
induced changes in DC function it was decided to alter the methodology. In order to
examine the effect of UVB exposure on the induction of sensitised LNC populations in
the DLN, mice were exposed to an immunosuppressive dose of UVB prior to
epicutancous sensitisation and responder LNC were prepared from the DLN 7 days later.
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The ability of the responder LNC populations to proliferate in response to DC from FITC
or oxazolone sensitised mice was examined in vitro. LNC from mice which received
UVB treatment prior to sensitisation were equally able to proliferate in an antigen-specific
manner during culture with DC (Figure 3.1.12). This suggests that UVB fails to inhibit
the induction of antigen specific effector cells following sensitisation. However, like the
previous results it is impossible to know whether the LNC populations from irradiated
and non-irradiated mice differ functionally. In this respect it would be interesting to
examine their cytokine production in vitro. Other groups have found differences in the
ability of sensitised LNC from irradiated and non-irradiated mice to transfer CH
responses to syngeneic recipients, using doses of UVB similar to those used in this
thesis. This suggests that there are UVB-induced functional changes in LNC populations
following low-dose UVB (Okamoto and Kripke, 1987).
4.1.7 The effect of in vivo UVB exposure on DC activity as
accessory cells in MLR
The accessory cell function of DC in a primary allogeneic immune response was
examined. It was found that LNC prepared from BALB/c mice sensitised with oxazolone
could be stimulated to proliferate in an antigen non-specific manner using lymph node DC
enriched from unsensitised C3H/HeN mice. This assay was termed the allergen-activated
MLR (AAMLR) (Figure 3.1.15). It was shown that DC isolated lfom mice that had
received a suppressive dose of UVB (1440 J/m2, -24 and -48 hrs) displayed no loss in
their ability to act as accessory cells in the AAMLR (Figure 3.1.16). Similarly exposure
to a single higher dose (15 kJ/m2, -24hrs) failed to affect the accessory activity of DC in
this assay (Figure 3.1.17).
MLR are commonly used as a measure of DC APC function. The ability of skin-
derived DC to act as accessory cells in MLR is increased during their migration to the
DLN and LC cultured with keratinocytes or keratinocyte-derived cytokines show similar
changes (Romani et al. 1989). Therefore the effects of UVB on the costimulatory capacity
of DC have been assayed by MLR. As mentioned earlier in the Discussion (see section
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4.1.4) the exposure of human epidermal cell suspensions (8-20% LC) and purified LC
populations (70-90% LC) to 100-200 J/m2 of UVB in vitro significantly inhibits their
ability to stimulate primary alloresponses (Rattis et al. 1995). In another human study
enriched human blood DC were exposed to 300, 1000 or 3000 J/m2 of UVB in vitro
(Young et al. 1993), and the two higher doses resulted in a loss of accessory activity in
MLR.
Skin biopsies have been used an in vitro model of DC migration out of human
skin, and to investigate the effect of UVB on DC migration and function. Culture of
human skin biopsies resulted in the spontaneous migration of CDla+ cells out of the skin.
Some of these cells had Birbeck granules, a marker for LC, while others expressd
markers indicative of dermal DC (Richters et al. 1994). Exposure of skin biopsies to 75,
150 or 300 J/m2 of UVB reduced the numbers of LC migrating out of the skin on day 1
and 2 (Richters et al. 1996). UVB also caused a significant decrease in the ability of the
migratory population to induce MLR. The ability of splenic APC from C3H/HeN and
BALB/c mice to act as accessory cells in MLR was reduced following exposure to high
dose UVB (30 kJ/m2) (Kitajima and Imamura, 1992).
4.1.8 The effect of in vivo UVB exposure on DC phenotype
The expression of three markers (MHC class II, ICAM-1 and B7-2) which are
important in the physical interaction and signalling between antigen presenting cells and T
lymphocytes was examined. No changes in the percentage of DC expressing these
membrane determinants, or the density of expression of markers on DC were found after
exposure to UVB (Figure 3.1.27).
4.1.8.1 MHC class II
MHC class II expression is vital for cognate interactions between APC and T
cells. Antigen in the form of short peptide chains is presented to CD41 T cells in the
groove of the MHC class II molecule. The TCR on the cell surface of T cells recognises
specific peptide chains associated with the MHC class II complex. T cells which
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recognise specific antigen on an APC, and which receive the correct costimulatory signals
are induced to proliferate and differentiate.
Because of the importance of MHC class II in antigen presentation it was decided
to investigate whether the modulation of cutaneous immunity by UVB, was associated
with changes in MHC class II expression of DC in the DLN. In vivo exposure to
immunosuppressive doses of UVB in vivo failed to affect the proportion of DC
expressing MHC class II or the intensity of expression (Table 3.1.4, Figures 3.1.25 and
3.1.27). This failure of UVB to affect MHC class II expression agrees with a number of
other studies. Low-dose UVB (100 J/m2) inhibited culture-induced up-regulation of
ICAM-1, but not MHC class II, on murine LC (Tang and Udey, 1991). Similarly the
up-regulation of MHC class II expression on human LC during culture was unaffected by
exposure to 100 J/m2 UVB (Rattis et al. 1995). Higher doses of UVB (1000 and 3000
J/m2) caused a slight reduction in low-intensity but not high-intensity MHC class II
expression on human blood DC (Young et al. 1993). In the human skin equivalent model
(Richters et al. 1996), UVB exposure (75-300 J/m2, actual dose not stated) did not affect
the percentage of MHC class IT cells migrating out of the skin biopsies.
The work that is closest in terms of methodology to that undertaken for this thesis
is an in vivo study in which the phenotype of cells in lymph nodes draining UVB
exposed and contact sensitised skin were examined (Bucana et al. 1994). Mice were
exposed to 400 J/m2 of UVB on 4 consecutive days and were sensitised through the
irradiated site soon after the last irradiation. In agreement with previous studies by the
same group DLN cells from UVB irradiated and sensitised mice, but not DLN cells from
control sensitised mice, induced antigen specific tolerance in unirradiated syngeneic
recipients (Okamoto and Kripke, 1987). The percentage of MHC class IU FITC+ DC in
the draining lymph nodes of mice which were untreated or exposed to UVB prior to
FITC sensitisation was assessed. Prior treatment with UVB caused a slight increase from
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36-41% of MHC class IT FITC+ DC. In the present study, UVB failed to affect the
percentage of DC within the DLN that expressed MHC class II.
4.1.8.2 ICAM-1
ICAM-1 expression is important for antigen presentation as the interaction
between this molecule and LFA-1 is involved in the binding of APC and T cells and there
is also evidence for activation signals being induced by ICAM-l/LFA-1 interactions. The
importance of ICAM-1 expression has been demonstrated in mutant mice that have low
levels of ICAM-1 expression. Cells deficient in ICAM-1 showed reduced accessory
activity which was restored by the reintroduction of a functional ICAM-1 gene (Dang et
al. 1990). The up-regulation of ICAM-1, and other surface molecules, on lymph node DC
compared with epidermal LC (Cumberbatch et al. 1992) corresponds with increased APC
activity. Because ICAM-1 is a constituent of APC activity, a number of groups have
investigated the effect of UVB on expression of ICAM-1 on LC.
Exposure of murine LC to UVB in vitro caused a reduction in ICAM-1
expression. Freshly isolated murine LC were untreated or were exposed to 100 J/m2 of
UVB, prior to culture for 24, 48 or 72 hrs (Tang and Udey, 1992). Exposure to UVB
reduced the recovery of LC from culture at all timepoints and selectively inhibited the up-
regulation of ICAM-1 but not MHC class II expression on LC (Tang and Udey, 1992).
The effect of UVB on ICAM-1 expression by enriched human blood DC has also been
examined using higher doses of UVB. Exposure to 1000 or 3000 J/m2 of UVB in vitro
caused a dose-dependent inhibition of ICAM-1 up-regulation on DC during culture. The
inhibition of ICAM-1 up-regulation during culture may reflect DNA damage. People who
have xeroderma pigmentosum (XP) exhibit deficient DNA repair, and fibroblasts from
these individuals are more susceptible to UVB-induced suppression of IFN-y induced
ICAM-1 expression than fibroblasts from normal individuals (Krutman et al. 1994). This
may help to explain the differences seen following in vitro versus in vivo UVB exposure,
since in vitro UVB exposure is likely to result in more DNA damage to LC, than occurs
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following UVB-exposure in vivo. Irradiation with low doses of UVB light in vitro causes
cytotoxicity, particularly to LC which are very sensitive. Exposure to 100 J/nr of UVB
reduced the recovery of LC in 72 hr EC cultures from around 33% to 3% (Tang and
Udey, 1992). Therefore, the results obtained in vitro may reflect responses to cellular
injury. When animals are irradiated, UVB loses much of its energy as it penetrates
through the layers of stratum corneum. In addition since UVB causes the loss of LC from
the skin, via mediators such as TNF-a (Cumberbatch et al. 1994), it is plausible that LC
migrate out of the skin before they accumulate excessive DNA damage.
4.1.8.3 B7-2
B7-1 and B7-2 (CD86) are members of the immunoglobulin supergene family,
the genes of which have been cloned (Freeman et al. 1993; Azuma et al. 1993). The
expression of B7-1 and B7-2 on DC populations has been described in detail in section
1.5.2, and Table 1.2 provides a summary of changes in the expression of these molecules
during LC culture. Briefly, B7-1 is not expressed on murine or human LC (Table 1.1),
but is induced on cultured LC (Table 1.2). B7-2 is expressed at low levels on murine LC
(Table 1.1) and its expression is upregulated on these cells during culture (Table 1.2).
B7-1 is induced to lower levels during culture than B7-2, which is expressed at very high
levels following culture of LC (Larsen et al. 1992; Symington et al. 1993; Inaba et
al. 1994).
B7-1 and B7-2 function by binding to their ligands on T cells, CD28 and
CTLA-4. It is thought that costimulatory signals, such as those mediated by B7-1 and
B7-2, are vital for the induction of effector cells. T cells binding to APC via their TCR to
MHC/antigen complexes, will only be induced to differentiate and proliferate if they
receive the appropriate second signals, mediated by costimulatory molecules. In the
absence of these signals, the outcome is T cell anergy or cell death (Nickoloff and Turka,
1994). The relative contribution of B7-1 and B7-2 to DC APC activity has been discussed
in section 1.5.2. In the same section evidence was presented that signals mediated
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through B7-1 may induce Thl type immune responses, while B7-2 signals mediate Th2
responses (Kuchroo et al. 1995).
In this study, it was found that in vivo UVB exposure failed to alter the
expression of B7-2 on DC isolated from lymph nodes draining the site of exposure (Table
3.1.5 and Figure 3.1.26). This contrasts with results from other systems, where UVB
has been shown to alter the expression of this molecule. Murine epidermal LC were
exposed to 100 or 200 J/m2 of UVB in vitro (Weiss et al. 1995). Both doses inhibited the
ability of LC to up-regulate B7-1 or B7-2 during culture. This reduction in costimulatory
molecule expression by LC affected their function as APC in mixed epidermal cell
lymphocyte reactions (MECLR) (Weiss et al. 1995). EC suspensions which were
irradiated with 200 J/m2 of UVB prior to their use as accessory cells in MECLR were
poor stimulator cells compared with untreated EC. However, the addition of an anti-
CD28 monoclonal antibody which mimicked costimulatory signals by crosslinking
CD28, restored the accessory activity of the irradiated EC. Exposure of enriched human
blood DC to higher doses of UVB (1000 and 3000 J/m2) in vitro caused the dose-
dependent inhibition of B7-1 up-regulation during a MLR (Young et al. 1993). In the skin
equivalent model (Richters et al. 1996) exposure to UVB induced a small reduction in the
percentage of migrating cells which expressed B7-1 or B7-2, though the reduction was
generally less than 10%. The expression of B7-1 and B7-2 on 'large cells' in the migrated
population was analysed by indirect labelling using the alkaline phosphatase method and
direct microscopic examination. Staining with CD la and CD 14 showed the population of
large cells to be comprised of both LC and macrophages. Since the numbers of CDla+ LC
in the migrating population were reduced by around 10% following irradiation, it seems
likely that the reduction of B7-2 following irradiation reflects the increased proportion of
macrophages within the migrating population.
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4.1.9 Summary of the effect of in vivo UVB-exposure on DC
function and phenotype
On the basis of this study it is impossible to explain the immunosuppressive
effect of UVB in vivo through changes induced in the functional activity of DC. However
as discussed earlier (section 4.1.5.1), by examining only proliferative responses in this
study, more subtle changes in DC induced by UVB may have been ignored. There is
evidence that local exposure to UVB causes the preferential production of Th2 type
cytokines by DLN cells (Araneo etal. 1989; Simon et al. 1994). Irradiation may alter the
DC arriving in the DLN, or alternatively change the lymph node microenvironment,
causing the selective activation of a particular T cell subset. Therefore, measuring the
ability of DC to stimulate proliferative responses may be of less importance than
examining the functional activity of the effector T cells induced to proliferate by the DC.
In addition, by testing the function of DC in vitro, the effect of the lymph node
microenvironment is ignored and the results may not reflect the antigen-presenting activity
of DC in vivo.
It is believed that many of the DC found within the skin-draining lymph nodes
derive from epidermal LC. Therefore it is interesting that the susceptibility of LC to UVB
in vitro is not mirrored by similar changes in lymph node DC following exposure to UVB
in vivo. There may be a number of explanations for this observation. In the in vitro
studies, LC in suspension were exposed directly to UVB at doses that are cytotoxic.
Therefore, the results obtained in vitro may reflect responses to cellular injury.
When animals are irradiated, UVB loses much of its energy as it penetrates through the
layers of stratum corneum. Therefore, in addition to the direct damage to DNA that UVB
can cause, UVB induced mediators may be important, especially in the
immunosuppression following low doses of UVB. Secondly, in vitro and in vivo studies
could be examining different populations of APC. Some groups support the hypothesis
that UVB acts to 'trap' LC transiently in the epidermis via a TNF-a dependent mechanism
(Streilein, 1993). Results in the human skin equivalent model where exposure to UVB
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results in a minor drop, around 10%, in the numbers LC migrating out of the skin has
been used to support this theory (Richters et al, 1996). If this were the case then DC
accumulating in the DLN following UVB radiation might not be expected to show UVB-
induced changes, because the alterations in the kinetics of DC accumulation would result
in the accumulation of DC that had managed to avoid UVB-induced LC 'trapping' in the
skin. However UVB has been shown to reduce LC numbers in the skin (El-Ghorr et
al. 1994) and cause the accumulation of DC in the DLN (Moodycliffe et al. 1992), and
there is good evidence for TNF-a being an important mediator of UVB-induced LC
migration (Cumberbatch et al, 1994) and DC accumulation (Cumberbatch and Kimber,
1995; Moodycliffe et al, 1994). There is a greater breadth of evidence for UVB-induced
LC migration than LC 'trapping'. Therefore it is likely that similar populations of cells,
e.g. LC derived DC, are being examined in the in vitro and in vivo models. The only
difference may be in the dose of UVB that LC are being exposed to in each case.
As well as the lack of a UVB-induced suppression of effector function in DC in
vivo, it seems that UVB also failed to affect the phenotype of these cells. It is not possible
therefore on the basis of the expression of la, ICAM-1 or B7-2 to relate the
immunosuppressive properties of UVB in vivo to alterations in DC phenotype. The
results presented in this thesis contradict studies of UVB exposure in vitro, where UVB
altered ICAM-1 and B7-2 expression. However, the difference between in vivo and in
vitro UVB exposure are manifold and have been described previously. In vivo the
mechanical barrier of the skin quickly reduces the energy of UVB as it penetrates into the
epidermis and, together with the migratory potential of LC, is likely to protect LC from
serious UVB-induced DNA damage. This cannot be said for in vitro studies, except
perhaps for the skin equivalent model. In vitro UVB exposure, even following the low
doses used in most of the studies, is likely to result in DNA damage and cellular
cytotoxicity.
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However, common to all in vivo studies involving DC are problems with
identifying the derivation of DC in the DLN. Therefore, it could be argued that the DC
populations examined in this study do not represent cells which have been exposed to
UVB in the skin, but are instead derived from other sources. Earlier in this discussion,
the work of other groups (Macatonia et al. 1987; Kripke et al. 1990) which suggest that the
majority of DC draining sensitised sites are of cutaneous origin. However, the techniques
used in these studies are not universally endorsed and there is some controversy over the
interpretation of the results. These arguments centre on the ability of FITC to migrate to
the DLN without first binding to LC, or other migratory APC populations in the skin.
However, it seems likely that at least a proportion of FITC-bearing cells which
accumulate in DLN following epicutaneous application of this allergen are skin derived,
particularly those DC which express high intensity fluorescence (Macatonia etal 1987).
Therefore, if UVB exposure was altering the expression of MHC class II, ICAM-1 or
B7-2 on these cells, then it seems likely that these changes would have been seen within
enriched DC populations from DLN.
Similarly if the immunosuppression following UVB was mediated, as has been
suggested, by the accumulation of non-LC derived DC in the DLN, changes in the
expression of MHC class II, ICAM-1 and B7-2 would be expected. However there are
possible weaknesses in methodology associated with this observation. Firstly, the
analysis of surface expression was to a great extent limited to cells with the size and
scatter characteristics of DC within enriched DC populations. In most experiments DC-
depleted populations were also analysed and no differences were observed in the
expression of the three markers. However, because for the most part analyses were
restricted to large granular cells it is possible that changes in the other populations within
enriched and depleted populations went unobserved. The second weakness is related and
concerns the use of indirect single colour fluorescent staining. Without employing dual or
multi-colour staining, it is difficult to definitively identify cell populations, and thus,
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changes within DLN cell populations may not have been detected. However, the remit for
the study presented in this thesis was the examination of the role of DC in UVB-induced
immunosuppresson. From the evidence presented here it seems unlikely that changes in
MHC class II, ICAM-1 or B7-2 on DC following UVB exposure is responsible for the
immunosuppression seen after UVB exposure in vivo.
The number of molecules that could be examined in this study was limited. The
molecules that were chosen had been shown to be important in antigen presentation. Due
to their importance in antigen-presentation, it was felt that these molecules could be a
possible target for UVB-induced alterations in APC activity. UVB exposure in vivo did
not alter the expression of the three surface molecules examined here. However, it cannot
be concluded that UVB will not influence other surface molecules, such as B7-1 (CD80)
or heat stable antigen (HSA) both of which have costimulatory function (Larsen et
al. 1992; Liu et al. 1992).
The marked changes in LC phenotype and function induced by in vitro UVB
exposure are not apparent in DC populations in lymph nodes draining the site of exposure
to UVB in vivo. In vitro UVB results in a substantial decrease in LC accessory cell
activity and a reduction in the culture induced up-regulation of certain surface molecules.
If these UVB-induced changes which are seen in vitro are mirrored by DC migrating to
the DLN after irradiation in vivo, it would be possible to speculate that these DC would
fail to induce appropriate effector T cell responses. However, this seems not to be the
case since DC which accumulate in the DLN of C3H/HeN mice following irradiation
in vivo are identical in function and phenotype to DC from control mice. Caution must be
exercised therefore when using in vitro data to investigate the complex responses seen
in vivo after exposure to UVB.
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4.2 IL-6 in the draining lymph nodes and skin of contact
sensitised mice.
4.2.1 Introduction
The initial interest in this area arose from three observations which suggested that
IL-6 production in the DLN had an important role in the induction of effector cell
responses to contact allergens. These observations were discussed in the introduction to
the IL-6 results section (3.2.1) but for clarity will be restated here. The first observation
came from examining proliferative responses in the DLN during the induction phase of
contact sensitization. The local lymph node assay is a procedure used to identify the
sensitising potential of chemicals (Scholes et al. 1992). In this assay the potency of the
sensitising agent is measured as a function of the vigour of the primary T lymphocyte
proliferative response in lymph nodes draining the site of epicutaneous application, with
proliferative activity increasing with the strength of the sensitising chemical. The second
observation, this time in BALB/c mice, suggested that IL-6 production in the local lymph
node was important in the induction of proliferative responses (Hope et al. 1994) and that
in fact, the level of IL-6 production by LNC draining the sensitised site, could be used
instead of proliferative activity, as an end-point for the local lymph node assay (Dearman
et al. 1993). Finally, it was observed in BALB/c mice that DC provided the main source
of IL-6 within sensitised lymph node populations (Hope et al. 1995, Cumberbatch
etal. 1996). The evidence for DC being the main source of IL-6 in sensitised lymph
nodes will be discussed in more detail later in this section. Pulling together these studies
and others, a model of the induction of contact hypersensitivity can be proposed. The
migration of antigen-bearing LC from the skin, their maturation into potent APC, and
their accumulation in the DLN is well documented and has been discussed in the
introduction. In the lymph node DC present antigen to naive antigen-responsive T
lymphocytes, inducing them to proliferate and differentiate. This process is complex
involving physical interaction and signalling between cells. The role of MHC class II,
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ICAM-1 and B7-2 in this process has been discussed previously (sections 4.1.8.1,
4.1.8.2 and 4.1.8.3). Since IL-6 production by DC correlates strongly with proliferative
activity in the lymph node, it seems likely that soluble signalling is also important in
antigen presentation. IL-1 and IL-6 have particular importance in the early stages of T
lymphocyte activation because of their ability to induce IL-2 production and IL-2
responsiveness respectively (Van Snick, 1990). The production of IL-2, and the
expression of the IL-2 receptors by T lymphocytes, determines their ability to proliferate
and mature/differentiate into an antigen-specific effector cell. In summary, IL-6
production by lymph node DC during the induction phase of contact sensitisation is likely
to be important in the generation of effector T lymphocytes.
The evidence for the association of IL-6 production and proliferative activity in
DLN during the induction of contact sensitivity was gained in models using the BALB/c
strain of mice. This strain is UVB-resistant in both local and systemic models of UVB-
induced immunosuppression (Streilein and Bergstresser, 1988; Noonan and Hoffman,
1994), as discussed in the introduction (section 1.7.5). Having access to both UVB-
resistant (BALB/c) and susceptible (C3H/HeN) strains of mice, whose CH responses
were either unaffected, or modulated by UVB exposure, it was of interest to examine the
production of IL-6 by LNC in these strains and to determine whether the UVB-induced
suppression of CH responses in C3H/HeN mice was associated with changes in IL-6
production within lymph nodes of irradiated mice.
4.2.2 Strain differences in UVB-induced immunosuppression
To confirm previous observations of the respective susceptibility and resistance of
C3H/HeN and BALB/c mice to UVB (Streilein and Bergstresser, 1988, Noonan and
Hoffman, 1994), both strains were exposed to UVB (1440 J/m2, -48, -24 hrs) prior to
sensitisation with oxazolone. Six days later CH responses were elicited by ear-painting
with the same chemical. In Figure 3.2.1 the ears of mice were uncovered during UVB
irradiation while in Figure 3.2.2 the ears were protected. The change in protocol was
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implemented in response to UVB-induced damage to the ears of BALB/c mice which had
not been observed previously with C3H/HeN mice. Because the ear damage, which
involved swelling and flaking of the ears, corresponded with the elictation of CH
responses on day 6 following sensitisation, it was felt that it could be detrimental to the
end-point of the experiment. Therefore the experiment was repeated with the ears of mice
protected during irradiation, and the results of this experiment are shown in Figure 3.2.2.
In Figure 3.2.1a exposure of C3H/HeN mice to 1440 J/m2 of UVB 48 and 24
hours prior to sensitisation caused a 31% suppression of CH responses to oxazolone.
Exposure of BALB/c mice to the same dose of UVB failed to suppress CH responses and
instead caused a slight increase in allergen-induced ear swelling (Figure 3.2.1b). The
intensity of CH responses was similar in both strains with maximum increase in ear
swelling, following sensitisation being around 0.15 mm. However, because UVB was
causing actual physical damage to the ears of BALB/c, but not C3H/HeN mice, it makes
it impossible to compare CH responses between groups. Therefore, the experiment was
repeated with the mice anaesthetised, and their ears protected, during irradiation. All the
groups of mice were anaesthetised, whether they received UVB or not, to control for
possible effects of the anaesthetic. Figure 3.2.2a shows the results. Protecting the ears of
C3H/HeN mice does not seem to have affected the suppression of CH response
compared with Figure 3.2. la. In both experiments the mean allergen-induced ear
swelling of UVB treated C3H/HeN mice is around 0.11 mm. However, in the second
experiment (Figure 3.2.2a) the positive control for C3H/HeN mice is higher than the
positive control in the first C3H/HeN experiment (Figure 3.2.1a), around 0.18 and 0.15
mm respectively. Due to the higher positive control, the CH response of the C3H/HeN
mice was suppressed by 46% in Figure 3.2.2a. This level of suppression has been
reported previously for C3H/HeN mice following an identical protocol of UVB-exposure
(Moodycliffe et al. 1994). Using the same protocol with anaethesitisation and ear
protection, the suppression of CH responses in BALB/c mice was examined (Figure
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3.2.2b). It can be seen that in the absence of the UVB-induced ear damage which was
found in the first experiment (Figure 3.2.1), UVB exposure of BALB/c mice still failed to
suppress CH responses (Figure 3.2.2b). This confirms previous studies of CH
responses, which were not suppressed in BALB/c mice following exposure to doses of
UVB which caused the suppression of CH in C3H/HeN mice (Streilein and Bergstresser,
1988; Noonan and Hoffman, 1994). However, it is clear that the CH response in
BALB/c mice is particularly low, with the mean increase in ear thickness being around
0.05mm in both the positive and UVB-exposed groups (Figure 3.2.2b). The reason for
this is uncertain, and, had it been possible, it would have been worthwhile repeating this
experiment to confirm the findings following the induction of comparable CH responses
in both C3H/HeN and BALB/c mice. However, good evidence for the strain difference
between C3H/HeN and BALB/c exists (Streilein and Bergstresser, 1988; Noonan and
Hoffman, 1994), and this evidence has been supported, though due to the limited nature
of the experiments completed, not conclusively, by results presented here.
4.2.3 IL-6 production by draining lymph node cells
Since the ability of UVB to suppress CH responses was first investigated (Toews
et al. 1980) alterations in LC and LC-derived DC, have been central to a number of
hypotheses presented to explain the phenomenon. These have been covered in the
introduction (section 1.8.1.1). Because C3H/HeN and BALB/c mice show differing
responsiveness to UVB-induced immunosuppression, and IL-6 is important in the
induction of CH responses in BALB/c mice, it was of interest to determine whether UVB
affected the production of this cytokine in C3H/HeN and BALB/c mice. However, in
initial experiments examining IL-6 production in both strains, a marked and highly
reproducible pattern of IL-6 production emerged. Following sensitisation, proliferative
responses were induced to a similar extent in both strains, though proliferative responses
between individual experiments were highly variable (Table 3.2.1). There was, however,
a marked strain difference with respect to the ability of LNC to secrete IL-6 after skin
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sensitisation. LNC from BALB/c mice produced high levels of IL-6 in vitro with IL-6
levels peaking at around 8 ng/ml 3 days after sensitisation (Table 3.2.1). This is similar
to levels found following oxazolone sensitisation of BALB/c mice in a previous study
(Hope et al. 1994). In contrast, draining LNC from C3H/HeN mice secreted low or
undetectable levels of IL-6 when sensitised identically (Table 3.2.1). So unlike in
BALB/c mice where LNC proliferation is closely associated with IL-6 production (Hope
et al. 1994), in C3H/HeN mice LNC proliferative activity is not associated with IL-6
expression. The ability of sensitised LNC from C3H/HeN mice to proliferate in the
absence, or in the presence of very low levels of IL-6 activity, suggest either that IL-6
availability is not an absolute requirement for LNC activation, or that the low
concentrations of IL-6 secreted in culture by C3H/HeN LNC give sufficient costimulation
for T cell activation.
4.2.4 IL-6 production by sensitised LNC in other UVB-susceptible and
resistant mice.
Having shown a marked difference in the ability of sensitised LNC from
C3H/HeN and BALB/c mice to produce IL-6 following sensitisation, it was decided to
examine further UVB susceptible and resistant strains to determine whether the
differential ability of LNC to produce high concentrations of IL-6 following sensitisation
could provide a marker for the responsiveness of mice to the immunosuppressive effects
of UVB.
In order to investigate this issue, three strains of mice were chosen, namely
C57BL/6 (UVB-susceptible), DBA/2 (UVB susceptible) and AKR (UVB resistant) mice,
and IL-6 production and proliferative activity by LNC from each strain following
sensitisation was examined. Sensitisation induced proliferative responses by LNC in all
the strains tested (Figures 3.2.4, 3.2.5, 3.2.6). The magnitude of LNC proliferative
responses of C57BL/6 and AKR mice were comparable, although there were differences
in kinetics, with peak proliferation on day 2 and day 3 respectively (Figures 3.2.4 and
3.2.6). The proliferative activity of LNC from DBA/2 was higher (Figure 3.2.5), and
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displayed similar kinetics to the AKR strain (Figure 3.2.6), with peak activity on day 3
following sensitisation. However, none of the strains produced appreciable IL-6 activity,
and so the results do not support the absence of IL-6 activity in lymph nodes following
sensitisation, as being a marker of UVB susceptibility. Table 3.2.2 summarises the
conclusions from the local and systemic models (Noonan and Hoffman, 1994; Streilein
and Bergstresser, 1988) and the proliferative and IL-6 data from section 3.2.3.
However, there are a number of problems with this study which should be
discussed. These strains were classified as UVB-susceptible and resistant following the
work of Noonan and Hoffman, (1994), that characterised inbred mouse strains
susceptibility to UVB (low, intermediate and high) over a range of doses. C57BL/6 mice
were highly susceptible, DBA/2 and C3H/HeN mice were intermediately susceptible and
AKR and BALB/c mice showed low susceptibility (Noonan and Hoffman, 1994).
C57BL/6 mice were available from the Medical Microbiology Transgenic Unit,
Edinburgh University, while DBA/2 and AKR mice were only available commercially.
Being unable to get the numbers of DBA/2 and AKR mice needed to examine their
responsiveness to UVB in the acute model used generally in this thesis, meant relying on
the Noonan and Hoffman study for the classification of all the strains. However, there
are some problems which have become obvious following the use of this approach.
Firstly, the Noonan and Hoffman study uses a systemic model of UVB-induced
immunosuppression. The backs of mice were exposed to UVB over a dose range of
approximately 1.2-20 kJ/m2, which includes the doses used in routinely in the present
study (2.88 kJ/m2 total). However, sensitisation was through a non-irradiated site 3 days
after exposure to UVB, rather than 24 hrs later on the irradiated site that has been used in
this study. Therefore the Noonan and Hoffman study examined systemic
immunosuppression while the protocol used in this study examined the suppression of
local cutaneous immunity. However, since Noonan and Hoffman showed BALB/c and
C3H/HeN mice to have the same phenotype of UVB susceptibility in the systemic model,
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as had been shown in local models (Streilein and Bergstresser, 1988) it was decided to
use the systemic classification for C57BL/6, DBA/2 and AKR mice. While there is some
controversy in the literature about the status of these strains, there is agreement over
C3H/HeN, BALB/c and C57BL/6 mice. DBA/2 mice are however classified as UVB
susceptible in the systemic model (Noonan and Hoffman, 1994) and UVB resistant in the
local model (Streilein and Bergstrcsser, 1988), while AKR mice have only been studied
in the systemic model. Because of these problems this study has not definitively
addressed whether susceptibility to the local immunosuppression which follows UVB is
associated with an inability to produce IL-6 in the DLN.
Therefore the issue of whether IL-6 production, or lack of it, in the DLN is
associated with the resistance/susceptibility of inbred mice strains to UVB is still open.
However it would be interesting to speculate on the mechanisms by which IL-6 could
affect UVB responsiveness. Although IL-6 is important in the initial stages of antigen
presentation, LNC from mice that produce low levels of IL-6 following sensitisation
show comparable proliferative activity. Therefore it seems unlikely that the low levels of
IL-6 production are inhibiting the ability of DC to present antigen, as measured by the
induction of proliferative responses. This conclusion is fairly obvious especially as
C3H/HeN mice, which produce low levels of IL-6 following sensitisation, respond
normally to epicutaneous sensitisation. Therefore in the absence of UVB, the inability of
LNC to produce high levels of IL-6 following sensitisation, does not appear to be
detrimental to the induction of an immune response. This suggests that either IL-6 has
activity at the levels produced by C3H/HeN mice following sensitisation, or that there is
redundancy in IL-6 activity with another cytokine, either alone or in combination, being
able to mediate IL-6 activity.
However, the strain differences observed in UVB-induced immunosuppression
are interesting and a number of hypotheses have been put forward to explain the effect of
UVB on the cutaneous immune system, and the resistance of some mice strains and
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humans to the suppressive effects of irradiation (section 1.7.5). Because of problems
with the characterisation of the inbred strains used in this study, strain differences in IL-6
production cannot be proposed as a mediator of UVB susceptibility or suppression.
However, since such a dramatic strain difference exists it would be interesting to
speculate on functional differences in the effector cells induced in such polarised DLN
microenvironments.
4.2.5 IFN-y production by LNC during the induction of contact
sensitisation.
In order to determine whether the inability of C3H/HeN LNC was specific for
IL-6 or reflected a more generalised inability of LNC to secrete cytokines, the production
of IFN-y by LNC from both C3H/HeN and BALB/c mice following sensitisation was
examined. The results from three separate experiments are shown in Table 3.2.3, where
it can be seen that both proliferative activity and IFN-y levels were similar for C3H/HeN
and BALB/c mice. This suggests that sensitisation is inducing similar levels of T
lymphocyte activation in both strains. Although there was no significant difference in the
IFN-y levels between strains, the higher levels of production in BALB/c mice may reflect
slightly higher level of activation in the lymph nodes, though a comparison of the
proliferative activity of both strains does not support this.
4.2.6 DC accumulation in the local lymph nodes following sensitisation.
DC are the main source of IL-6 within BALB/c LNC populations. Complement-
depletion of DC from oxazolone-sensitised LNC suspensions reduces IL-6 activity by
more than 75% but does not affect proliferative responses (Hope et al 1995). If the same
method is used to deplete T cells, the proliferation but not the IL-6 production by LNC in
vitro is affected. Because DC are the main source of IL-6 within lymph nodes, the
number of DC that accumulated in the DLN of both strains following sensitisation was
examined. As stated in section 3.2.5 DC numbers were similar in both strains. Vehicle
sensitised C3H/HeN mice had a mean of 2759 DC per lymph node which rose to
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23479 DC per lymph node 18 hrs after sensitisation. Similarly BALB/c mice had means
of 2127 and 22920 DC per lymph node, respectively, following epicutaneous application
with vehicle and oxazolone. Therefore the lack of IL-6 production in C3H/HeN mice
does not reflect a paucity of DC in the DLN.
4.2.7 Intracellular IL-6 activity in LNC from C3H/HeN and BALB/c mice
LNC from C3H/HeN and BALB/c mice were sonicated to examine strain
differences in the intracellular levels of IL-6. Sonicating LNC immediately after removal
from C3H/HeN and BALB/c mice sensitised with oxazolone 3 days earlier, caused the
release of appreciable quantities of IL-6 into supernatants, while sonication of LNC from
mice treated with the vehicle alone resulted in less IL-6 activity in the supernatant. As
LNC from both strains contain detectable IL-6 protein, this suggests that both are capable
of translating IL-6 protein (Figure 3.2.8). The inability of oxazolone-sensitised LNC
from C3H/HeN mice to secrete IL-6 in vitro may be associated with a lack of IL-6
production, or may reflect a failure in the ability of cells to secrete IL-6. To investigate
this, oxazolone-sensitised LNC from C3H/HeN and BALB/c mice were cultured for 24
hrs and the concentration of IL-6 in the supernatants and sonicates was measured. The
inability of C3H/HeN mice to secrete IL-6 in culture was not associated with an
accumulation of intracellular IL-6 (section 3.2.6). Therefore it is likely that the low levels
of IL-6 produced by C3H/HeN LNC reflect a lack of IL-6 production by LNC, rather
than a failure in IL-6 secretion.
4.2.8 UVB-induced DC accumulation and IL-6 production
In agreement with previous studies (Moodycliffe etal 1992), we found UVB-
induced accumulation of DC in the local DLN of C3H/HeN mice and in addition recorded
comparable numbers of DC in the DLN of BALB/c mice following UVB (section 3.2.7).
However, at least in the BALB/c strain, these DC differ substantially from those which
migrate to the DLN after contact sensitisation. While LNC from sensitised BALB/c mice
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produce high levels of IL-6 and T cell derived IFN-y, LNC from UVB treated mice fail to
produce either cytokine (data not shown for IFN-y). This suggests that DC migration is
not in itself sufficient for all aspects of DC maturation and that another, possibly antigen
dependent, signal is required for IL-6 production by DC and the induction of IFN-y
production by T cells.
4.2.9 IL-6 production in the skin of C3H/HeN and BALB/c mice.
The kinetics of IL-6 production in the skin after treatment with oxazolone was
also investigated. Previous studies using contact allergens and irritants have shown that
IL-6 is induced by contact allergens but not irritants, when these chemicals are used at
doses which cause comparable inflammatory responses (Holliday et al. 1996). Similar
levels of IL-6 were produced constitutively in the skin of both C3H/HeN and BALB/c
mice (Figure 3.2.9). In both strains oxazolone treatment induced significant increases in
IL-6 production peaking 4 hours after sensitisation (Figures 3.2.9 and 3.2.10).
Therefore the lack of IL-6 secretion by sensitised LNC from C3H/HeN mice does not
reflect a systemic inability to produce the cytokine. IL-6 is produced constitutively in the
skin of BALB/c mice by LC (Cumberbatch et al. 1996). Keratinocytes do not produce the
cytokine consititutively but are induced to produce it following sensitisation (Shreiber et
al. 1992; Bos and Kapsenberg, 1993). This study has not addressed whether LC in the
skin of C3H/HeN mice have the ability to produce IL-6, although the fact that C3H/HeN
and BALB/c mice display constitutive cutaneous IL-6 activity is suggestive that they do.
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4.3 The effect of UVB on IL-6 production in the skin
UVB is a potent stimulator of cutaneous cytokine production, up-regulating the
expression of TNF-a, IL-10 and IL-6 (Kock et al. 1990; Grewe et al. 1995; Kirnbauer et
al. 1991). Since C3H/HeN and BALB/c mice display differing responsiveness to UVB, it
was of interest to see if this was reflected in differing effects of UVB on cutaneous
cytokine induction between strains.
The first experiment looked promising with UVB causing a significant increase in
untreated, AOO- and oxazolone-treated skin of C3H/HeN but not BALB/c mice (3.2.11).
However, when repeated there was no inter-strain differences in cutaneous IL-6 activity
following UVB (Figure 3.2.12). In this experiment the peak IL-6 levels were higher than
had been seen in previous experiments, with over 100 ng/g of tissue compared with the
usual 50 ng/g of tissue. However previous studies examining the induction of cutaneous
IL-6 by oxazolone in BALB/c mice have reported peak levels around 90 ng/g of tissue
(Holliday etal. 1996).
As discussed in section 3.2.9 there were differences in the protocol used to
quantify epidermal IL-6 activity which may explain the difference in the level of IL-6
detected, particularly between the experiments examining the effect of UVB on cutaneous
IL-6 production (Figures 3.2.11 and 3.2.12). The differences between the protocols used
are discussed in section 3.2.9. The main effects of the changed protocol used for the
experiments shown in Figures 3.2.10 and 3.2.12 were to reduce processing time and the
number of freeze thaw cycles and to increase the accuracy of tissue weights, and so may
explain the increased levels of IL-6 seen in these experiments.
4.3.1 Summary
The initial aim of this study was to examine strain differences in the effect of
UVB on IL-6 production, but the finding that C3H/HeN mice produced little or no IL-6
following sensitization forced a change of thinking. That there was such a dramatic
difference in IL-6 production between the two strains in IL-6 production, which in
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BALB/c mice at least, was strongly associated with primary T lymphocyte proliferative
responses and hence, from the findings of the local lymph node assay, to the strength of
CH responses, was of great interest. LNC proliferative responses and IFN-y production
by LNC from C3H/HeN mice were as vigorous as those in BALB/c mice, suggesting
that the low-level of IL-6 production was not affecting the induction of effector cell
populations under normal circumstances. Interestingly, UVB-induced DC accumulation
in the lymph nodes of BALB/c was not associated with IL-6 production, suggesting that
the induction of DC migration does not necessarily result in all aspects of DC maturation
at least in terms of IL-6 production.
Having started with the aim of determining the ability of UVB to modulate IL-6
production, the finding that C3H/HeN and BALB/c mice displayed such radical
differences in the production of this cytokine, led to the speculation that the ability to
produce this cytokine in the lymph node during the induction of CH may a marker of
resistance to UVB-induced immunosuppression and that conversely, a lack of IL-6
production in the DLN following sensitization could correlate with susceptibility to UVB.
To attempt to answer this a further two UVB-susceptible and one UVB resistant strain
were tested. In all strains sensitisation induced proliferative activity but little or no IL-6
production. These results suggest that IL-6 production by LNC does not correlate in any
way with the responsiveness of inbred mouse strains to UVB-induced
immunosuppression. However the problems in classifying the UVB susceptibility of the
strains means that no definitive conclusions can be made.
The low levels of IL-6 produced by LNC from C3H/HeN mice did not reflect low
numbers of DC accumulating in the lymph nodes of these mice following sensitisation. In
addition, sonication experiments suggested that LNC from C3H/HeN mice show lower
levels of IL-6 production than those from BALB/c mice.
The low levels of IL-6 produced by LNC from C3H/HeN mice did not reflect
reduced production of IL-6 systemically. C3H/HeN mice produced comparable or higher
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levels of cutaneous IL-6 than BALB/c mice following oxazolone sensitization.
Keratinocytes are likely to form the main source of IL-6 in the skin following
sensitisation, but do not produce the cytokine constitutively. The source of IL-6
production in the skin was not examined, though the constitutive IL-6 production in the
skin of C3H/HeN mice indicates that a non-keratinocyte source, probably LC, have the
ability to produce IL-6.
Although this study failed to show a conclusive link between IL-6 production and
UVB susceptibility, it did however produce a number of interesting findings. The
possible functional differences following the induction of effector cell populations, in the
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THE ROLE OF CIS-UROCANIC ACID IN UVB-
INDUCED IMMUNOSUPPRESSION
Michael B. Lappin.'Ali El-Ghorr.1 lan Kimber.2 Mary Norval1
'Edinburgh University. Edinburgh and 2Zeneca Central
Toxicology Laboratory. Macclesfield. U.K.
INTRODUCTION
UV radiauon causes many alterations in the skin, including loss of Langerhans' cells (LC)
and results also in the accumulation of dendritic cells (DC) in the lymph nodes draining the
site of irradiation.' One epidermal mediator which may be involved in the induction of
UVB effects on LC is cis-urocanic acid (ds-UCA), formed from the naturally occurring
trans-isomer following UV-exposure. It has been proposed that UCA acts as a
photoreceptor for UV-induced immunosuppression. The action spectrum of UV-induced
suppression of contact hypersensitivity is similar to the absorption spectrum of trans-UCA
and mice deficient in UCA are resistant to UV-induced immunosuppression. Cis-UCA also
has the ability to mimic some of the effects of UV-B such as suppression of delayed-tvpe
hypersensitivity responses to herpes simplex virus in mice and depletion of LC from the
epidermis.2 A murine monoclonal antibody, with specificity for ds-UCA has been
developed3 and was used in the present study to elucidate further the role of ds-UCA in
modulating immune responses in the skin.
EXPERIMENTAL OVERVIEW
Female C3H-HeN mice received intraperitoneal (i.p.) injections of anti-ds-UCA two
hours prior to irradiation with sub-erythemal doses (960 and 1440 J/m2) of broadband
UVB or ear painting with cis-UCA. Control mice were injected i.p. with an isotvpe
matched (mouse IgGl) monoclonal antibody of irrelevant specificity, or with phosphate
buffered saline (PBS) alone. Twenty four hours later, LC numbers in the ears were
measured by counting ATPase+ve cells in dorsal epidermal sheets (Figure 1). Forty eight
hours later. DC numbers in the draining auricular lymph nodes were measured by counting
DC microscopically after purification on metrizamide gradients (Figure 2).
RESULTS
Previous evidence has shown that exposure to UVB or ear painting with cis-UCA
significantly reduces the density of ATPase+ve LC in the epidermis.2 In the present study it
was found that the depletion of LC induced by either treatment was abrogated by prior i.p.
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Figure 1. Groups ot mice (n=4), received an l.p. injection of PBS. anti-cis-UCA or an irrelevant isotype
matched antibody. Two hours later the mice were irradiated with a single dose (960 J/m21 of broadband UVB
or were ear painted with cis-UCA. Control mice received anti-cis UCA but were not irradiated. Twenty tour
hours later the mice were killed and the ears removed. Dorsal epidermal sheets were prepared and stained for
ATPase activity. For each group the number of ATPase+ve cells m 40 fields of view (10 random fields per
dorsal epidermal sheet) were counted.
injection of anti-cis-UCA antibody (Figure 1). Injection of an irrelevant isotype matched
control antibody or vehicle alone, did not affect the depletion of ATPase +ve cells induced
by either treatment. The ability of anti-cis-UCA to block the depletion of ATPase+ve cells
in the epidermis was dose dependent (data not shown).
As has been demonstrated previously, exposing the ears to sub-erythemal doses of
UVB resulted in a significant increase in numbers of DC found within draining lymph
nodes 48 hours later (Figure 2a). Although ear painting with cis-UCA caused a decrease in
the number of ATPase TVe cells in the epidermis, it did not induce a subsequent increase in
the numbers of DC in the auricular lymph nodes (Figure 2a). In addition, prior injection of
the anti-cis-UCA monoclonal antibody did not influence UV-B induced accumulation of
DC in the auncuiar nodes (Figure 2b).
CONCLUSIONS
Following UVB irradiation, ds-UCA is an important mediator in reducing LC
numbers in the epidermis. However. cis-UCA is not involved in the UV-induced migration
of DC to the draining lymph node. The mechanism by which cis-UCA causes depletion of
ATPase+ve cells is unknown but published work has indicated that ds-UCA may act
through histamine-like receptors.2 Other mediators produced in the skin after UVB
irradiation may act to induce the migration of DC to the draining lymph nodes. There is
evidence that tumour necrosis factor-a(TNFa) production is induced in the epidermis after
UVB exposure and that this cytokine may promote migration of DC to the lymph nodes.4-5
It is possible that TNFa and cis-UCA may modulate immune responses by different
mechanisms and the possible interactions between the two mediators are being investigated
currently.
No UVB 960 J/m UVB 20ug/ear cis-UCA
a b
7000
Control ois-UCA trans-UCA UVB
Figure 2a. Groups of mice (n>6) were
painted with 100 pg of cis or trans-UCA
on both ears or received a smgle dose
(1440 J/m-) of UVB. Control mice
were ear painted with the vehicle alone
but were not irradiated.
PBS PBS anb-cis-UCA
No UVB 960 J/nfUVB
Figure 2b. Groups of mice (n=4) were
injected i.p. with PBS or anti-cis-UCA
(1:500 in PBS}. Two hours later mice
received a single dose (960 J/m-1 of
UVB. Control mice received anti- cis-
UCA but were not irradiated.
Forty eight hours later all mice were killed and the auricular lymph nodes were excised and pooled for each
group. Smgle cell suspensions were prepared by disaggregation through a 70 pm nylon mesh. Dendritic cells
were enriched bv density gradient centnfugation and counted by direct morphological examination using
light microscopy. For each group, five counts were made and the mean number of dendritic cells per lymph
node calculated.
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Abstract—C3H mice were irradiated three times a week for up to 6 weeks with either 500 J/m2 or
1000 J/m; broadband UVB (270-350 nm) or 3000 J/m2 narrowband UVB (31 1-312 nm; TL01 source).
Each dose was suberythemai to the mouse strain used. The number of Langerhans cells (LC) in the
epidermis was reduced by over 50% after 2 weeks of irradiation with the UVB source and by 20%
following TL01 irradiation. Continued irradiation for up to 6 weeks resulted in no further decrease in
LC numbers in the case of the UVB source but a steady decline to 40% in the case of the TL01 source.
Sunburn cells were detected following irradiation with both sources but the numbers were very low in
comparison with acute exposure. Ultraviolet-B exposure resulted in doubling of the thickness of the
epidermis throughout the 6 weeks of irradiation while TL0I exposure did not alter epidermal thickness.
Conversion of trans- to c/.v-urocanic acid (UCA) was observed with both UVB and TL01 sources. The
percentage of c/.v-UCA started to return to normal after 4 weeks of TL0I exposure despite continued
irradiation. As observed following a single exposure, the contact hypersensitivity (CH) response was
significantly reduced following 6 weeks of UVB irradiation but was unaffected by TL01 exposure,
indicating no correlation between civ-UCA levels and CH response. Total serum immunoglobulin levels
remained unchanged throughout the 6 weeks of UVB or TL0I irradiation but IgE titers significantly
increased in all cases in the first 2 weeks of irradiation, indicating a possible shift to a Tn: cytokine
profile. The IgE levels started to return to normal at later times. Thus chronic broadband UVB exposure
induces a number of cutaneous and systemic responses that are likely to be dose dependent, while
chronic TL01 exposure induces only some of the these responses.
Photochemistry mill Pliotohioloyy. Vol. 62. No. 2. pp. 326-332. 1965
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INTRODUCTION
The effect of UV irradiation on the immune system of mice
has been studied mainly using a single exposure, frequently
sufficient to induce erythema, or up to four consecutive daily
exposures followed by the examination of immunomodula-
tion. Acute broadband ultraviolet-B (UVB)t exposure (270-
350 nm) is known to suppress the contact hypersensitivity
(CH) response to contact sensitizers' and the delaved-type
hypersensitivity response to several infectious agents.2-' It
also reduces the number and function of epidermal Langer¬
hans cells (LC).2 On UV irradiation, a proportion of the nat¬
urally occurring rran.v-isomer of urocanic acid (UCA) found
in the stratum corneum is converted to c/.v-UCA." The topical
application of r/j-UCA has been shown to mimic some of
the effects of UV irradiation, suggesting that c/.s-UCA acts
as one of the mediators of UV-induced immunosuppres¬
sion. '-6 In some recent studies, a narrowband UV lamp
(TL01) emitting at 31 1-312 nm has been used rather than a
*To whom correspondence should he addressed.
) Abbreviations: CH. contact hypersensitivity; Ig, immunoglobulins;
IL. interleukin: LC. Langerhans cells; MED. minimal erythemal
dose; SBC. sunburn cells; UCA. urocanic acid; UVB. ultraviolet-
B radiation.
broadband UVB source. Minimal skin injury, as indicated
by the induction of edema and sunburn cells (SBC), was
found, although efficient conversion of tran.v-UCA to c/.v-
UCA was detected. Furthermore, a reduction in the density
of LC but not in their antigen presenting function was re¬
ported using the TL01 source.2
Little evidence is available, however, about the effects of
chronic suberythemai UVB exposure over a period of sev¬
eral weeks on the immune system and none about chronic
narrowband UVB exposure. High-dose chronic UV exposure
is known to lead to premature skin aging.,s For example,
combined chronic UVA (320-400 nm) and UVB irradiation
produces a significant increase in the ratio of type III to type
I collagen and an increase in tibronectin biosynthesis in the
skin of hairless Skh mice, accelerating the modifications ob¬
served during aging.'' Chronic UV exposure can also lead to
the development of skin tumors and a contribution of sup¬
pressed immunity to the oncogenic process is likely. Thus
high-dose chronic UVB exposure of nude mice (15 840 J/m2
three times a week for 20 weeks) has been reported to induce
skin tumors and to suppress basal splenic natural killer cell
activity."'
Balb/c mice chronically UVB irradiated with an erythemal
dose (2250 J/m2 three times a week) for 1-5 weeks showed
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a significant suppression of their delayed hypersensitivity re¬
sponse to Mycobacterium bovis." The antigen presenting ac¬
tivity of lymph node cells from chronically UVB-irradiated
C3H/HeN mice (8000 J/m: three times a week) was signif¬
icantly reduced following 4. 12 and 17 weeks of irradia¬
tion.'- A 90% reduction in the number of LC and Thy 1
epidermal dendritic cells was observed after 1 week of this
high-dose irradiation. The LC numbers started to return to
normal after 15 weeks of irradiation.'-'' Using a lower, but
still erythemal. dose of simulated solar UV radiation (2100
J/m: UVB and 40 000 J/m: UVA five times' a week) for 4
weeks reduced the density of LC in both albino and pig¬
mented mice and caused a significant reduction in the CH
response./J
The present study was performed in order to compare the
effects of chronic low-dose broadband UVB and narrowband
TL01 exposure with previously published data of acute and
high-dose chronic exposure on haired C3H mice. The num¬
ber of LC and SBC. the thickness of the epidermis and cis-
UCA conversion during chronic exposure were examined.
The CH response following 6 weeks of irradiation and the
serum immunoglobulins (Ig) were also investigated in order
to assess whether the Tm or Th: arms of the immune re¬
sponse were affected by UV exposure.
MATERIALS AND METHODS
Mice. Male C3H/HcN mice, aged 8—10 weeks, were used
throughout. They were bred and maintained in the departmental an¬
imal house where they were kept in a 12 h light-dark cycle (shielded
fluorescent light tubes) in standard mouse boxes and had unlimited
access to food and water. In some experiments, an electrical clipper
was used to shave the backs of the mice once a week immediately
prior to UV irradiation. Cervical dislocation was performed to kill
the mice.
t'V irradiation. Mice were exposed to one of two L'V sources as
already outlined.-' For broadband UVB exposure, a bank of two
TL20W/I2 lamps (Philips) was used with an output range of 270-
350 nm. peak 305 nm. irradiance 80 pAV/cmL For narrowband UVB
exposure, a single Philips TL01 lamp was employed, which emits
predominantly at 31 I—312 nm. and the total irradiance was 200 pAV/
cm-. The output of the sources was determined by Dr. Neil Gibbs
(University of Dundee) using a filtered photodiode meter, which was
calibrated against measurements made with a UV—visible spectro-
radiometer (model 742. Optronie Laboratories Inc.) across the spec¬
tral range 250—(00 nm. Each dose of UVB was either 500 J/m: or
1000 J/m: and each dose of TLOI was 3000 J/m-. AH UV irradia¬
tions were given three times a week (Monday, Wednesday and Fri¬
day). One minimal erythemal dose (MED) for this mouse strain was
1500 J/m; of UVB and 10080 J/m: of TLOI. For comparison, the
MED for human type II skin is approximately 900 J/m: of UVB and
5000 J/m: of TLOI. The biological effects of the UVB lamp are
therefore approximately six-fold that of the TLOI lamp."
ATPase staining of epidermal sheets. Three days after the last
irradiation, the ears of four mice were removed, split and epidermal
sheets were prepared from the dorsal side only by floating it epi¬
dermal side down in 0.76% tetrasodium ethvlenediamine tetraacetic
acid for 2 h at 37°C. Epidermal sheets were then carefully removed
with a scalpel blade and stained for ATPase using ADP as sub¬
strate.'" The specimens were coded and examined "blind" under
the microscope. The number of ATPasc- cells were counted in at
least 40 fields per group ( 1 field = 0.1 mm-).
SBC density and epidermal thickness. Single ears from each of
three mice in each group were removed 3 days alter the last irra¬
diation and were fixed in 10% formol saline before routine histo¬
logical processing. To avoid duplicate sectioning of the same SBC.
only every fifth 8 pan section was taken and stained with hematox¬
ylin and eosin. The stained sections were examined on a light mi¬
croscope attached to a See-Scan Image Analyser. This computer was
used to calculate the number of SBC per cm of interfollicular epi¬
dermis. Twelve sections were scored for SBC for each group. This
represented between 30 and 50 cm of interfollicular epidermis. For
each section, the number of SBC/cm was calculated and the data
were expressed as mean number of SBC/cm ± SEM. The SBC were
characterized as having a pvknotic nucleus surrounded by an eosin¬
ophilic and/or vacuolated cytoplasm. In addition the thickness of the
epidermis was also measured by the computer at approximately 100
sites per group. »
Analysis of UCA isomers. Single ears from each of three mice in
each group were collected 3 days after the last irradiation, weighed
and their concentration of (is- and trans-UCA analyzed by HPLC.
as already described.'6 The mean amount of each isomer as mea¬
sured in pg/g wet weight of ear and the percentage present as cis-
UCA was calculated for each group.
CH assay. In this experiment the backs of the mice were shaved
once a week and their ears were not protected from irradiation. The
CH response to oxazoione was measured by a standard technique 5
h after the last irradiation as outlined previously.' Briefly, nine mice
per group received a sensitizing dose of 50 pL 1% oxazoione in
acetone/olive oil mixture (4:1) on their shaved backs. A negative
control group received 50 pL of the vehicle alone. Six days after
the sensitization step, ear thicknesses were measured and all the
mice were challenged with 25 pL per ear of 0.25% oxazoione on
the dorsal surface. One day after the challenge, all the groups were
coded and the ear thicknesses were measured again. The mean in¬
crease in ear thickness for each individual mouse was first calculated
and then the mean increase for each group of mice.
Serum Ig. Three days after the last irradiation of each group,
serum was collected from a minimum of four mice per group and
pooled. An ELISA for serum IgE and one for total serum Ig were
developed. To measure IgE the plate was coated with 1/500 dilution
of the test serum sample in carbonate/bicarbonate buffer overnight
at 4°C. Phosphate-buffered saline containing 0.05% Tween 20 was
subsequently used as a wash and diluent. Rat anti-mouse IgE (Ser-
otec. UK) at 1/150 dilution was added to the plate and incubated
for 5 h at room temperature. After a second wash step. 1/500 anti-
rat Ig alkaline phosphatase conjugate (Sigma. UK) was placed in
the wells and an incubation carried out for 2 h at room temperature.
The substrate was then added after a wash step and allowed to de¬
velop. To measure total Ig. a goat anti-mouse Ig (Sigma. UK) was
used at 1/1000 to coat the plate overnight at 4°C. After a w ash step,
the test serum was added at 1/100 dilution and incubated at room
temperature for 3 h. Subsequently, a sheep anti-mouse Ig alkaline
phosphatase conjugate (Sigma. UK) was added at 1/1000 and in¬
cubated at room temperature for 2 h. The substrate was then added.
A sheep serum was used as a negative control serum. The mean
absorbance of four or six duplicate wells was calculated after sub¬
tracting the absorbance of the negative control.
Statistical analysis. The Student's /-test was used for analysis of
differences in mean responses between groups. Differences were
considered statistically significant if P < 0.05. The standard error
of the means is used in the figures.
RESULTS
The effect of the two UV sources on the number of
ATPase' cells
Only LC in the epidermis express the ATPase enzyme on
their cell surface. Ultraviolet-B irradiation with 500 J/m; or
1000 J/m: three times weekly resulted in approximately 50%
and 70% reduction in the density of ATPase" cells respec¬
tively after 2-3 weeks (Fig. I). This reduction was highly
significant and was maintained throughout the UVB irradi¬
ation period although there was a tendency for LC numbers
to increase as the number of exposures continued. Morpho¬
logically. between 20% and 40% of the LC appeared to lose
their dendrites following I—1 weeks of UVB exposure. Alter
5-6 weeks, however, this number was 7-10%. Exposure to
TLOI resulted in a steady decline in the density ot LC at the







Figure I. The effect of up to 6 weeks of UV irradiation on the
number of LC in murine epidermis. Ears were removed 3 days after
the last irradiation and epidermal sheets stained for ATPase enzyme.
Triangles represent 500 J/m: UVB. squares 1000 J/m: UVB and
circles 3000 J/m: TLOl exposure. The standard error of the mean at
each time point was <25. All values were significantly lower (P <
0.05") than nonirradiated age-matched controls (time point 0).
Weeks of irradiation
Figure 2. The number of SBC per cm of interfollicular epidermis
following irradiation with 500 J/m- UVB (triangles). 1000 J/m- UVB
(squares) or 3000 J/m: TLOl (circles). Bars represent the standard
error of the mean, n = 12. Three different values at time point 0
are quoted because three control groups were used, one for each
irradiation procedure: these three values are not significantly differ¬
ent from each other.
three time points tested (Fig. 1) but there was no effect on
the dendritic morphology of LC.
The effect of the ni o UV sources on SBC atul epidermal
thickness
Sunburn cells are an indication of the photodamage to the
skin following UV irradiation''' and are thought to represent
apoptotic cells. After 1 week of UVB exposure (500 J/m: or
1000 J/m-) SBC started to appear and their numbers in¬
creased with further exposure in a dose-dependent manner
(Fig. 2). One week of 3000 J/m: of TLOl exposure, however,
was not sufficient to induce many SBC. After 2 weeks of
TLOl. SBC did appear but their numbers remained lower
than those obtained following UVB exposure throughout the
irradiation period (Fig. 2). After 3 weeks of irradiation, the
numbers of SBC started to decline despite continued expo¬
sure with all three lamps. The maximum density of SBC
obtained after chronic irradiation was 0.58 SBC/cm. In con¬
trast. 24 h after one acute dose of 1500 J/m: UVB. 5.4 SBC/
cm were found.
The thickness of the epidermis is an indicator of the re¬
sponse of the skin to UV irradiation. Epidermal thickness
increased initially after both doses of broadband UVB irra¬
diation (Fig. 3). The overall increase with 1000 J/m; UVB
was significantly higher than with the 500 J/m: exposures
and led to doubling of the thickness of the epidermis in these
mice. After a slight (but significant) initial increase. TLOl
exposure did not markedly affect epidermal thickness (Fig.
3).
The effect of the Pro UV sources on UCA isomers
Chronic UVB exposure with 500 J/m: or 1000 J/m: in¬
creased the tt.v-UCA concentration in mouse ears from 10
pg/g wet weight of tissue to 54-75 pg/g or 160 pg/g, re¬
spectively (Fig. 4). This amount of i /.v-UCA was maintained
throughout the 6 weeks of irradiation and was equivalent to
25% and 38% of total UCA. respectively. Exposure to TLOl
was equally efficient at isomerizing UCA and 170 pg cis-
UCA per g of ear was detected after 1—3 weeks of irradia¬
tion. This was equivalent to 35% of total UCA in this ex¬
periment. However, after 5 weeks of TLOl exposure the cis-
UCA concentration was reduced to 100 pg/g (Fig. 4). The
total UCA concentration remained relatively constant
throughout the 6 weeks of irradiation.
Weeks of irradiation
Figure 3. The thickness of the epidermis following irradiation with
500 J/m: UVB (triangles). 1000 J/M UVB (squares) or 3000 J/m:
TL0I (circles) The standard error of (he mean at each time point
was <0.02. Using the UVB source all values were significantly high¬
er (P < 0.05) than nonirradiated controls (time point 0). but only
the time point at I week was significantly higher using the TLOl































Figure 4. The c/.y-UCA concentration in C3H mouse ears following
irradiation with 500 J/m; UVB (triangles), 1000 J/m: UVB (squares)
or 3000 J/m: TL01 (circles). The standard errors of all the points on
the figure were below 22 |xg/g. n = 3.
The effect of the two UV sources on the CH response
Six weeks of chronic UVB exposure with either 500 J/m2
or 1000 J/tn2 of mice with shaved bucks suppressed the CH
response to oxazolone by over 60% (Fig. 5). This was sta¬
tistically significant in both cases. In contrast. 6 weeks of
chronic TL01 exposure (3000 J/m:) had no effect on the CH
response to this sensitizer (Fig. 5). Three weeks of chronic
TL01 exposure also had no effect on the CH response (data
not shown).
The effect of the two UV sources on serum Ig
Both UVB and TL01 chronic irradiation resulted in a sub¬
stantial increase in serum IgE concentration after 1 or 2
weeks of exposure (Fig. 6a). Thereafter, serum IgE levels
gradually returned to normal. Higher titers of serum IgE





Figure 6. The serum IgE titers (a) and total Ig (b) following irra¬
diation with 500 J/m: UVB (triangles). 1000 J/m: UVB (squares) or
3000 J/m- TL0I (circles). The standard errors of all the points on
the figures were below 0.05 absorbance units (n = 6 for IgE and n












UV-B dose in J/m* TL01 dose in J/m*
Figure 5. The CH ear swelling response to oxazolone after 6 weeks
of irradiation with the UVB and TL0I lamps on shaved dorsal sur¬
faces of mice. The bars indicate (he standard error of the mean. "P
0.05 compared to nonirradiated controls, n = 9.
(3000 J/m:) and the 1000 J/m; UVB exposures than with the
500 J/m; UVB. Total serum Ig, however, remained constant
throughout the period of irradiation and with all exposures
tested (Fig. 6b).
DISCUSSION
The effect of multiple exposures of mice to broad- and
narrowband UVB was investigated. While each single dose
of irradiation was suberythemal. it was noted that, after 2
weeks' exposure of shaved mice to doses of 1000 J/m2
broadband UVB. the skin showed some reddening, before
pigmentation developed. The lower dose of broadband UVB
(500 J/m2) did not result in erythema, although tanning was
apparent after 3 weeks. Neither tanning nor erythema was
seen as a result of TL01 exposure.
As already noted following single doses of broadband
UVB or TL()1.J the density of LC in the epidermis was re¬
duced throughout the irradiation period with both sources.
The higher dose of broadband UVB resulted in a greater
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reduction in the number of LC. Broadband UVB also af¬
fected the dendritic processes of the LC more than TL01.
Other workers have shown that erythemal doses of chronic
UVB reduce LC density although a return to normal values
was noted after 15 weeks of treatment.13 We did not irradiate
animals beyond 6 weeks but after 4 weeks of UVB exposure
the-numbers of LC started to increase above the minimum
levels reached, indicating that LC may have started to re-
populate the epidermis. The dendritic morphology of these
cells also returned to normal after 6 weeks of UVB irradi¬
ation while 40% were rounded at the 4 weeks time point.
The SBC are thought to represent apoptotic keratinocytes.
induced in mammalian epidermis in a UV dose-dependent
manner.18 In the present study they were found following
broadband UVB and narrowband TL01 exposure, appearing
in small numbers when first tested after 1 week, and accu¬
mulating thereafter. Irradiation with the TL01 source was
slightly less effective than the UVB source at inducing SBC.
The number of SBC detected was very low in comparison
with acute UVB exposure. There may be a mechanism for
removing these dying cells from the epidermis within a few
days of their appearance. Alternatively, the cells that give
rise to SBC may become more resistant to UV damage after
chronic irradiation. In either case, the SBC started to dis¬
appear after 3 weeks of irradiation despite continued UV
exposure.
Minimal skin damage by the TL01 source is indicated by
the epidermis scarcely changing in thickness throughout the
study period, while the same was not true of the broadband
source. The thickness of the epidermis doubled after I week
of the 500 or 1000 J/m2 UVB exposure. This doubled epi¬
dermal thickness was maintained with the 1000 J/m2 dose
but was reduced to 1.5 times normal thickness with the 500
J/m2 dose after the second week. At the time of maximal
epidermal thickness, the ears of the mice looked red. as did
the backs in the case of shaved animals. Following this, pig¬
mentation developed, which presumably then helped to pro¬
tect the epidermis from further damage and resulted in the
slight reduction in epidermal thickness with the 500 J/m2
dose of UVB. One study utilizing the TL01 source has re¬
ported an increase in epidermal thickness after an accumu¬
lated dose of 100 000 J/m2 is reached.'1' This accumulated
dose is equivalent to 10 weeks of irradiation in .our experi¬
ments and was given to albino hairless Skh mice. For these
reasons no direct comparison can be made with the present
study. However, in agreement with our results, broadband
UVB was shown to be more efficient than the TL0I expo¬
sure at inducing thickening of the epidermis.'9 Other studies
have examined histological changes in Skh hairless mouse
skin following chronic broadband UVB irradiation and have
noted, for example, a thickening of the epidermis and an
increase in dermal cellularitv including inflammatory cells,
after 24 weeks of 300 J/m-' three times weekly.-0 The action
spectrum for epidermal thickening in Skh mice has a max¬
imum at 285 nm. with UVB being 50 times more efficient
than UVA in this respect." The spectrum for the increase in
dermal cellularity has a maximum at 295 nm." Skin thick¬
ening is thought to alter the quantity and spectrum of the
radiation reaching various layers of the skin, thus making
identification of specific chromophores difficult. One such
mediator of cutaneous photodamage that has been proposed
is non-heme iron, which could act by participating in the
formation of reactive oxygen species.-'" Reactive oxygen has
been implicated in UV-induced skin damage.22
The results from the UCA analysis were somewhat sur¬
prising in two respects. First, it has been noted that, in hu¬
man subjects following insolation-'-' and in guinea pigs fol¬
lowing irradiation with a hot quartz mercury arc lamp.-'" the
total amount of UCA in the epidermis increased several days
later. This was presumed to correlate with epidermal thick¬
ness. In support of this, the epidermal UCA content of black
and Asian skin is reported to be higher than that in Cauca¬
sian skin.25 However, in the present study, we found the total
UCA concentration remained unchanged throughout the ir¬
radiation period for both UV sources despite an increase in
epidermal thickness in the case of the UVB source. Recently,
by analyzing the epidermis from different sites of human
volunteers we have shown no increase in UCA concentration
in areas of the body frequently exposed to sunlight, such as
the forehead, compared with areas normally covered, such
as the upper thigh (G. Kavanagh. M. Norval. J. Crosby, un¬
published). Secondly, while there was an increase in the per¬
centage of ct.v-UCA following 1 week of irradiation with
both sources, this proportion did not increase thereafter with
further irradiations. Isomerization from trans- to ct.v-UCA is
known to proceed in a dose-dependent manner until the pho-
tostationarv state is reached when the ratio of the two iso¬
mers is approximately 1:1. A photostationarv state was prob¬
ably not achieved during the chronic irradiation—a maxi¬
mum of 35% ct.v-UCA was reached with the TL01 and 38%
with the UVB (1000 J/m2). Indeed, in the case of the TL0I
source, the concentration of ct.v-UCA began to fall with in¬
creasing number of exposures. This cannot be attributed to
increased epidermal thickening or tanning since these did not
occur with this lamp. We have shown previously that single
doses of TL01 and broadband UVB are equally efficient at
inducing isomerization of trans- to c/.v-UCA. In addition,
once the ct.v-UCA is formed, it persists in the epidermis for
at least 7 days, returning to background levels at 14 days."'
It is eliminated mainly by desquamation and in sweat, al¬
though there is some evidence that it is present transiently
in serum following irradiation.-'0 Therefore the dynamics of
chronic irradiation with regard to UCA content and per¬
centage c/.v-UCA may be rather different from that found
after single exposures. It would be interesting to analyze
histidase activity, as well as histidine and histamine concen¬
tration in epidermal samples to test changes in metabolic
pathways during the irradiation period. Finally the concept
of UCA acting as a "natural" sunscreen proposed by Zen-
isek et al.27 is not supported by our present study because
there is no increase in total UCA or ct.v-UCA concentration
with time, as might be expected from such a sunscreen.
Since 1983 when c/.v-UCA was first suggested as an epi¬
dermal mediator for the immunosuppressive effects of
UVB.' evidence has been accumulating to substantiate its
role in immunomodulation/'2'" although many other media¬
tors have also been implicated including DNA damage.2''
tumor necrosis factor a.'" interleukin-10" and prostaglan¬
dins.'2 In the present study the CH responses to oxazolone
were suppressed after 6 weeks of UVB irradiation (500 J/
m2 and 1000 J/m2) but were not suppressed after 3 or 6
weeks of TL0I irradiation. This result mimics that found
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after acute exposure.J The ears of the mice were not pro¬
tected during irradiation, thus exposing the sensitization and
elicitation sites to UV light. We have shown previously that
this makes no difference to the hypersensitivity response,
after a single dose of UV. when the ears are challenged
subsequently. In addition, perhaps UV exposure without
shielding of particular sites is closer to what happens natu¬
rally when animals are solar irradiated, frequently on a daily
basis. However, our model does not permit us to distinguish
between an effect of UV on the induction or elicitation of
the CH response.
As noted above, the TL01 exposure resulted in a loss of
LC in the epidermis and therefore, there appears to be no
correlation between reduced LC numbers and suppressed
CH. The compound c/.v-UCA is induced in the epidermis to
approximately the same extent with the two sources and this
implies that c"A-UCA may not be the main mediator that
determines the extent of CH responses in the case of chronic
irradiation. In support of this, we have shown, from an action
spectrum for trans to cis photoisomerization of UCA in hair¬
less mouse skin, that there is maximal activity at 300-315
nm,J while the action spectrum for suppression of CH peaks
at 260-280 nm.' Furthermore, a recent paper indicates that
different radiation sources, which all induce approximately
35% c/.v-UCA in the epidermis, varied in their ability to sup¬
press CH with only three sources emitting short wavelengths
being effective.-'"' Instead a correlation between the severity
of edema and degree of CH suppression was found. It is
likely that the interaction of t'A-UCA with cells in the epi¬
dermis and elsewhere is complex, and perhaps more steps
are required in the process besides the simple presence of
tu-UCA. For example an appropriate receptor for cA-UCA
may be of critical importance and irradiation at certain wave¬
lengths may block its action.'"'
Serum IgE concentrations were investigated in the present
study as an indicator of TH2 activity. Production of the cy¬
tokine interleukin (IL)-4 from Th: cells induces activated B
cells to switch isotype and produce IgE. Immunoglobulin E
is particularly important in hypersensitivity reactions in the
skin where it causes mast cell degranulation in the presence
of antigen, resulting in histamine release. It has been shown
that irradiation of mice with high doses of UVB changes the
array of cytokine secretion from a Tm to a Th: pattern with
inhibition of IL-2 synthesis and enhancement of 1L-4 and
IL-6.-'5 In addition, low-dose UVB inhibits the capacity of
purified LC to induce proliferation of TH, cells while not
affecting their ability to stimulate TH2 cells.16 Both sources
induced increased serum IgE concentration soon after the
UV exposures started. This level returned to normal despite
continued exposure. In contrast, total Ig levels in the sera of
irradiated mice remained constant, indicating that isotype
switching had occurred. It would be worthwhile to analyze
the cytokine profile of activated T cells during chronic ir¬
radiation to find out whether the IgE results reflect IL-4 pro¬
duction. In conclusion, the two UVB sources used in this
study demonstrate different immunomodulatory properties
on chronic irradiation, which may indicate the wavelength
dependency of some of their effects.
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Abstract This article reviews the role of dendritic
ceils in cutaneous immunity. Langerhans cells (LC)
found in the epidermis are the best-characterized den¬
dritic cell population. They have the ability to process
antigen in the periphery, transport it to the draining
lymph nodes (DLN) where they are able to cluster with,
and activate, antigen-specific naive T cells. During mi¬
gration LC undergo phenotvpic and functional changes
which enable them to perform this function. There are
other less well-characterized dendritic cells including
dendritic epidermal T cells, dermal dendrocytes and
dermal 'LC-Iike' cells. Although there is no evidence
that dendritic epidermal T cells (DETC) can present
antigen or migrate to lymph nodes, they do influence
the intensity of cutaneous immune responses to chemi¬
cal haptens. Antigen-presenting cells (APC) in the der¬
mis may provide alternative routes of antigen presen¬
tation which could be important in the regulation of
skin immune responses. Therefore, dendritic cells are
vital for the induction of immune responses to antigens
encountered via the skin. LC are particularly impor¬
tant in primary immune responses due to their ability
to activate naive T cells. The faster kinetics of sec¬
ondary responses, and the ability of nonprofessional
APC to induce effector function in previously activated
cells, suggest that antigen presentation in the DLN
may be less important in responses to previously en¬
countered antigens. In these seondarv responses, den¬
dritic and nondendritic APC in the skin may directly
induce effector functions from antigen-specific recir¬
culating cells.
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Dendritic cells in the skin
The concept that the skin has its own associated immune
system was first proposed in 1978 [1]. Langerhans cells
(LC) are a constituent part of the skin immune system
(SIS), and are found regularly spaced throughout the epi¬
dermis, forming a semicontinuous network via long den¬
dritic processes. LC are defined by their dendritic mor¬
phology and the presence of a unique intracytoplasmic or¬
ganelle. the Birbeck granule [2], In addition to the appear¬
ance of LC, they are distinguished by their phenotype. be¬
ing the only population in normal epidermis to express
MHC class II (a molecule involved in the presentation of
exogenous antigen to T cells). They originate from bone
marrow progenitors, as indicated by their CD45 expres¬
sion, but are not T-cell derived since they lack the CD3
marker [3]. Human LC express CD la and stain faintly
with anti-CDlc (Table 1) [4], CD1 molecules show simi¬
larities to MHC class I, and may be involved in the pre¬
sentation of antigen to y/8 T cells.
Another population of dendritic cells (DC) in the skin
is the dendritic epidermal T cell (DETC) which comprise
1-2% of the epidermal cells in rodents [5. 6]. They are
bone-marrow-derived (CD45+), belong to the T-cell lin¬
eage (Thy-1+ and CD3+), and express the y/8 T-cell recep¬
tor (TCR) (Table 1). DETC do not express CD4 or CD8
antigens [5], or MHC class II [3]. Their T-cell lineage is
confirmed by evidence that the numbers of DETC are sig¬
nificantly reduced in athymic nude mice and that they
proliferate in vitro when stimulated with a mixture of con-
canavalin A and interleukin-2 (IL-2) [5]. y/8 T-cells are
interesting because they recognize a limited set of epi¬
topes including heat shock proteins (HSP), MHC-like
molecules and mycobacterial antigens [7]. However, be¬
cause HSP are produced by both bacterial and mammalian
cells, and are highly conserved in both, it has been sug-
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Table 1 Phenotype of dendritic cells in the skin (•/ expression, x no expression)
Surface marker Murine LC Human LC DETC Dermal Dermal
dendrocyte 'LC-like'
MHC class II ^ [114, 115] / [116] x [7] ^ [10] / [12]
MHC class I / [115] / [12]
CD45 / [117] / [118] /[5] / [12]
CD3 x [119] ✓[7] x [12]
Thy-1 x [119] / [120, 121]
y8 TCR x [117] / [122]




ICAM-3 (CD50) ✓ [65]
LFA-1 CDlla-/CD18+
(CD 11 a/CD 18) [61]
MAC-1 / [119] v' [126] x [124] CDl lb- [12]
(CD1 lb/CD 18)
pi 50/95 / [127] / [126] / [12]
(CD1 lc/CD18)
LFA-3 (CD58) ^ Weak [128]
al (VLA-1 with y aipi weak
(31 chain) on 40% LC [129]
x [130]
cc2 (VLA-2- with / a2pi weak
pl chain) on 40% LC [129]
x [130]
a3 (VLA-3 with •/ a3pi weak
pi chain) on 40% LC [129]
x [130]
a4 (VLA-4 with / [58] ^ Weak [128]
Pl chain) / a4pi [129]
a5 (VLA-5 with / coPl [129]
pl chain) x a5pi [65]
a.6 (VLA-6 with ^ Weak [128]
Pl chain) / a6pi [129]
Pl / [130]
CDla ✓ [4] y [124] / [131]
CDlb ✓ [4]




E-cadherin ✓ [55] / [133]
FcyRl (CD64)
FcyRII (CD32) / [117] ✓ [131]
FcyRIII (CD 16) / [117]
FceRI / [134]
FceRII (CD23) x [117] ✓ [134]
eBP (MAC-2) ✓ [134]
CD80 (B7-1) x [93. 94] x [95]
CD86 (B7-2) / Weak [93]
x [65]
Factor XIII / [10]
gested that y/8 T cells may be involved in autoimmune re- A third type of DC present in the skin is the dermal
sponses [7]. It has also been proposed that DETC are in¬ dendrocyte. These cells have been characterized to some
volved in the induction of tolerance [8], and that the ratio extent by their phenotype (Table 1). In human skin they
of DETC to LC in the epidermis influences the intensity. are factor XIII antigen", sometimes express class II anti¬
but not the duration, of sensitization in mice [9]. gen [10] and are CD la", CDlb+ and CDlc" [11]. Factor
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XIII is involved in scab formation, crosslinking fibrin with
structural proteins, which leads to the conclusion that der¬
mal dendrocytes may be of importance in wound healing.
Dermal dendrocytes surrounding the microvasculature in
the skin have been called veil cells [10]. Both populations
share a common phenotype, but while dermal dendrocytes
show both 'dendritic' and 'fibroblast-like' morphology,
veil cells are thought to show only 'fibroblast-like' mor¬
phology [10], It has been suggested that dermal dendro¬
cytes are immature precursors of LC. If LC are conti¬
nuously being replaced by blood-borne bone-marrow-de¬
rived DC precursors, then veil cells which are concen¬
trated around the microvasculature, may be DC precursors
entering the skin. Besides the dermal dendrocytes, there
are other cells in the dermis of mice which express MHC
class II, with one subset showing an LC-'like' phenotype
(Table 1) [12],
Cutaneous immune responses
Contact hypersensitivity (CH) responses are commonly
used as a model to test an animal's or a human's ability to
mount a cutaneous immune response. To induce contact
sensitivity, the experimental animal is sensitized to a spe¬
cific hapten by painting a solution containing the chemi¬
cal onto the skin. Haptens are small molecules which by
themselves are nonimmunogenic, but which can act as
epitopes when bound to a protein 'carrier'. In the skin
haptens acquire immunogenicity by binding to endoge¬
nous proteins, which results in the generation of a hap-
ten/protein-specific immune response. Approximately 5
days after the original hapten sensitization, the animal is
challenged with a subinflammatory concentration of hap¬
ten which within 24 h leads to the generation of a cell-me¬
diated inflammatory response at the site of application.
The site of challenge is usually the ears or the foot pad. as
it is easy to quantitate the inflammatory reaction by mea¬
suring the increase in ear or footpad thickness. Delayed
hypersensitivity (DH) responses are broadly similar, but
they differ from CH in that the antigen is not a hapten and
is administered intradermally. DH inflammatory reactions
are characterized by the infiltration of mononuclear cells
into the dermis with less cellular infiltration into the epi¬
dermis compared with CH responses.
Evidence suggesting that Langerhans cells play
an important role in cutaneous immunity
The first clues that LC are involved in cutaneous immu¬
nity came from experiments examining contact sensitivity
responses in mice. When haptens were applied through
sites naturally deficient in LC expression, such as the ham¬
ster cheek pouch epithelium and mouse tail skin, specific
unresponsiveness to hapten challenge was observed [13.
15], It was noted that a regime of UVB treatment could
artifically deplete LC from normal skin sites [13]. Four
consecutive doses of UVB radiation (100 J/m; per day)
caused a highly significant depletion of ATPase+ epider¬
mal LC in mice [13]. Haptens applied to UVB-treated
skin induced hapten-specific unresponsiveness on subse¬
quent exposure at an unirradiated site [13]. The ability of
UVB to induce unresponsiveness was dependent on the
strain of mouse used, leading to the classification of UVB
'susceptible' and 'resistant' strains. The evidence for this
is not as strong as it once was, since resistant strains show
significant reduction of CH responses when mice are sen¬
sitized with optimal doses of hapten via irradiated skin
[16].
These results led to the hypothesis that the suppression
of CH is directly related to loss of the epidermal LC.
However, there are a number of observations which sug¬
gest that other factors are involved also. Firstly, LC are
depleted from the epidermis of both susceptible and resis¬
tant mouse strains following low-dose UVB treatment
[17]. However, resistant mice are able to generate re¬
sponses to haptens encountered through the depleted skin.
Thus, there may be other antigen-presentation pathways
available for cutaneous immunity, a concept which is ex¬
plored more fully later in this review. Secondly, specific
tolerance is generated to haptens applied through irradi¬
ated skin. This was demonstrated in mice first sensitized
to a hapten through skin naturally deficient in LC. or irra¬
diated skin, which showed suppressed immune responses
even after they were sensitized again through normal skin
prior to challenge [13]. Tolerance generated in this way is
associated with the induction of regulatory/suppressor T
cells which can transfer suppression of CH [18] and DH
responses [19]. Antigen presentation may be taking place
but there are likely to be differences in the presentation of
antigen encountered via skin depleted of LC (at least in
susceptible strains). Thirdly, the immunosuppression gen¬
erated by UVB is not always confined to skin sites de¬
pleted of LC. To examine the local and systemic effects of
UVB. mice were exposed to a suppressive dose of UVB.
and a contact sensitizer was then painted on to the irradi¬
ated site or a distant unirradiated site [20]. When the sen¬
sitizer was painted on the skin immediately after the last
irradiation, immunosuppression was limited to haptens
applied directly to the irradiated site. However. 3 days af¬
ter the last exposure, there was systemic immunosuppres¬
sion to haptens applied via unirradiated skin. This evi¬
dence suggests that UVB exerts systemic as well as local
effects on cutaneous immunity, possibly via soluble medi¬
ators.
Antigen processing in the epidermis
The first stage in the recognition of antigen by the immune
system is the processing of that antigen by antigen pre-
senting-cells (APC). Processing refers to the internaliza¬
tion and degradation of antigen into immunogenic peptide
fragments that can be presented with MHC molecules: it
takes place intracellular^ in acidified endosomes/lyso-
somes. although the exact compartment where peptides
and MHC class II associate has not been fully defined.
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Freshly isolated murine LC are able to process and pre¬
sent the protein ovalbumin (OVA) in its native form, to an
OVA peptide-specific MHC-restricted T-cell hybridoma
in vitro, an ability which is lost during culture [21]. LC
taken from the epidermis and cultured for 72 h are much
less efficient at processing native OVA [21]. Similarly, the
ability to process antigen from Leishmania major (L. major)
amastigotes is found in freshly isolated murine epidermal
LC, but is lost after 12 h in culture [22]. Haptens such as
nickel are able to bind MHC class Il-associated peptides
directly [23], suggesting that antigen processing may not
be required for all forms of contact sensitization.
As LC have phagocytic activity when freshly isolated,
it seems likely that epidermal LC have the capacity to
process native antigen in vivo. In contrast, like cultured
LC, murine lymph node DC are generally poorly phago¬
cytic, although freshly isolated splenic DC show phago¬
cytic activity for zymosan and latex beads [24]. Prior to
the work on freshly isolated LC, the lack of phagocytic
activity in lymphoid DC led to speculation about the iden¬
tity of the cell population that processed antigen in the
epidermis with the suggestion that keratinocytes may pro¬
vide this function [25, 26]. Since freshly isolated LC are
capable of phagocytosis, it seems unlikely that epidermal
LC would require a source of peptides. However, process¬
ing by keratinocytes may affect the immune response, de¬
pending on whether the peptide fragments are degraded,
released into the extracellular matrix or presented on the
surface of keratinocytes. Although keratinocytes do not
express MHC class II molecules constitutively, they can
be induced to do so by interferon-y (IFNy) [27], MHC
class II-bearing keratinocytes can provide accessory func¬
tion for T cells that have been stimulated previously with
superantigens or anti-CD3 monoclonal antibody [27].
Keratinocytes are therefore equipped to play an important
role in secondary, but not primary, immune responses.
Birbeck granules: markers of antigen processing?
The endocytosis of the CD1 molecule on human LC has
been demonstrated using immunogold-labelled anti-CD 1
monoclonal antibody and electron microscopy [28. 29].
LC were incubated at various temperatures. At 4°C there
was diffuse labelling over the entire cell surface. When
the temperature was raised to 15°C. the cell surface la¬
belling was concentrated in clathrin-coated pits and there
was internalization of the label in endosomes. At 37° C
lysosomes were labelled, and isolated labelled Birbeck
granules were visible in the cytoplasm. Another study has
examined the endocytosis of la antigen by Birbeck gran¬
ule-like structures in murine DC [30]. Gold-labelled la
molecules were internalized within Birbeck granules when
LC were incubated at 21°C. After 30 min the Birbeck
granules disappeared, and the gold label was associated
with lysosomes and vacuoles, with aggregates of gold
particles on the cell surface. The experiments suggest that
Birbeck granules may be important in receptor-mediated
endocytosis and intracellular antigen processing. How¬
ever, there is some evidence that Birbeck granules may
not be an absolute requirement for the functional activity
of LC. A healthy male subject whose LC lack Birbeck
granules has been identified [31]. The LC were present in
normal numbers in the skin and expressed CD la and
MHC class II. Functionally, the LC were normal as mea¬
sured by their ability to induce CH responses in vivo and
alloresponses in vitro.
Induction of LC migration
To induce a primary immune response, antigen processed
by epidermal cells has to be transported to the local drain¬
ing lymph node (DLN), where competent antigen-bearing
APC can stimulate MHC-restricted proliferation and dif¬
ferentiation of antigen-specific T-cell clones. There is
good evidence, that will be presented later in this section,
that antigen-bearing LC are able to transport antigen to
the DLN. Certainly. LC are capable of migration out of
the skin. A number of stimuli cause a loss of LC from the
epidermis including exposure to low-dose UVB radiation
and skin painting with contact sensitizers [14], Depletion
of murine epidermal LC using these treatments results in
a subsequent accumulation of LC and/or DC in the lymph
nodes draining the treated site [32. 33], which has been at¬
tributed to an influx of DC from the skin. However, skin
painting with haptens causes a smaller influx of DC into
lymph nodes that drain nonsensitized sites, in addition to
inducing an increase in DC numbers in DLNs [34], This
suggests that sensitization may induce systemic LC mi¬
gration from untreated skin sites. Alternatively, the sys¬
temic effects may be due to entry of non-LC-derived DC
into lymph nodes.
Keratinocytes provide the necessary microenviron-
ment of the epidermis by producing cytokines which are
thought to play an important role in LC migration and dif¬
ferentiation. In response to various stimuli, including
UVB radiation and contract sensitizers, keratinocytes ex¬
press a wide variety of cytokines [35], Using PCR. it has
been shown that topical exposure of mice to contact sen¬
sitizers results in increased epidermal mRNA for IL-la.
IL-ip. GM-CSF, TNFa. macrophage inflammatory pro-
tein-2 (MIP-2), interferon-induced protein-10 (IP-10) and
MHC class II [36. 37], Tolerogens and chemical irritants
also induce an increase in epidermal mRNA for a number
of these cytokines [37].
The induction of IL-lp by contact sensitizers is inter¬
esting. The earliest change in cytokine mRNA expression
in the epidermis is IL-lp, found 15 min after hapten ap¬
plication [37], This precedes TNFa mRNA expression
which is found after 30 min [37]. Depletion of epidermal
cell subsets revealed that IL-lp activity is mainly re¬
stricted to LC [36]. When IL-ip is injected intradermallv.
it causes similar changes in cytokine production to those
that occur after sensitization, with increased expression of
mRNA for IL-la, MIP-2, IL-10. TNFa and MHC class
II. while intradermal injection of IL-1 a or TNFa does not
affect the cytokine pattern [38]. In addition, a neutralizing
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antibody to IL-lp is able to block sensitization [38], sug¬
gesting that LC-derived IL-1 (3 is an important initiation
signal for the induction of contact sensitization.
The role of TNFa in the migration of LC from the epi¬
dermis is controversial. TNFa is induced in human ker-
atinocytes after exposure to UVB radiation [39] and its
expression is upregulated by sensitizing chemicals [36],
Intradermal injection of TNFa causes an accumulation of
DC in the DLN of mice [40] and a decrease in epidermal
LC numbers [41]. Accumulation of DC in the DLN in¬
duced by UVB irradiation, contact sensitizers and contact
irritants is blocked by pretreatment with neutralizing anti¬
bodies to TNFa [42, 43]. Evidence suggests that TNFa
may also mediate migration of DC out of the intestine,
measured by counting numbers of DC in lymph collected
from the thoracic duct of mesenteric-lymphadenectomized
rats [44], Injection of 50 mg endotoxin caused an 8-15
fold increase in DC numbers in the lymph 10—15 h after
injection. As with the epidermis, an injection of neutraliz¬
ing antibody directed against TNFa into these rats prior to
the endotoxin abrogated the effects of TNFa. However, in
contrast to these results. TNFa has been suggested to act
on LC by immobilizing them in the epidermis, as an in¬
tradermal injection of TNFa prior to sensitization pre¬
vented hapten-induced loss of LC from the epidermis, and
so blocked the induction of CH [45].
Other mediators may be involved in reducing the num¬
ber of LC in the epidermis. One. which may be specific to
UVB-induced depletion, is cA-urocanic acid (cis-UCA).
Trans-\JCA is found in the stratum comeum of the epi¬
dermis and is isomerized to cis-UCA by UVB irradiation.
The cA-form is more soluble, being found transiently in
the serum of mice after irradiation [46], C/s-UCA mimics
some UVB-induced effects on the immune system and
causes depletion of LC from the epidermis of mice. The
latter effect seems to be specific, as the reduction is abro¬
gated by prior administration of a monoclonal antibody to
c/s-UCA [47]. However, unlike UVB radiation. c/s-UCA
applied topically to the skin of mice does not induce an
accumulation of DC in the DLN [33],
The most compelling evidence for epidermal LC mi¬
grating to the DLN after antigen challenge, is shown in a
model using nu/nu BALB/C mice grafted with skin from
C3H mice [48], When the BALB/c mice were contact
sensitized with fluorescein isothiocyanate (FITC) through
the graft tissue, the cells binding FITC in the DLN were
found to be derived from the C3H graft. Isolated FITC-
binding cells from the DLN of BALB/c mice were able to
induce a CH response in C3H but not in BALB/c mice. In
the same study it was found that at least some of the
FITC-binding cells found in the DLN contained Birbeck
granules, a feature used to identify epidermal LC. There¬
fore. it can be concluded that some APC in the DLN are
derived from cells in the skin and are LC in origin. How¬
ever. in another study there were very few donor MHC
class II+ cells in lymph nodes draining allogeneic skin
grafts [49]. Also. FITC painted on to allogeneic grafts
could be found associated with recipient MHC class II+
cells in the DLN. suggesting that some of the FITC
reaches the lymph node without binding donor APC in the
epidermis [49].
FITC has proved to be a useful hapten in migration
studies. It can be painted on to the skin of a mouse and
FITC-bearing DC can be visualised in the local DLN. In¬
creasing the dose of FITC increases both the number of DC
in the DLN [50] and also the amount of FITC displayed
on the surface of the DC [51]. Treatment of mice with
monoclonal antibody to MHC class II depletes la* cells in
the spleen and lymph nodes but not Ia+ LC in the skin
[52]. Skin painting of these mice with FITC resulted in
the appearance of la* FITC bearing cells in the lymph
nodes that could stimulate an FITC-specific hvbridoma in
an MHC class Il-restricted manner [52].
Although FITC rapidly associates with proteins in
vivo, it has been claimed that FITC an move freely to
lymph nodes without necessarily binding to LC in the epi¬
dermis. After ear painting, FITC found in the DLN is as¬
sociated predominantly with interdigitating dendritic cells
(IDC). Therefore, free FITC entering lymph nodes would
have to bind IDC with a high affinity. Although FITC is
popular because it can be visualized, other antigens have
also been used to study migration. L. major amastigotes.
administered intradermally. induce migration of DC from
the skin to the DLN. DC isolated from these nodes were
immunostimulatory for L. major-specific T cells [22]. In
other studies in sheep and cattle, the afferent lymph veiled
cells (ALVC) draining a site challenged intradermally
with antigen were collected and used to induce antigen-
specific proliferation [53. 54], ALVC are discussed below
where this evidence is reviewed more fully.
Mechanisms of LC migration
Although much is unknown about the mechanism of LC
migration, it is likely that adhesion molecules play a role.
It has been postulated that the migration signal acts to al¬
ter the phenotvpe of the epidermal LC. causing them to
exit from the epidermis. Recent evidence has shown that
LC bind to keratinocytes via E-cadherin and that the ex¬
pression of this molecule is downregulated on LC during
culture (Table 2) [55]. Since keratinocytes are the pre¬
dominant cell population in the epidermis [56], E-cad¬
herin could tether LC in the epidermis and may influence
the morphology of LC in the epidermis. Cytokine signals,
which could include TNFa and GM-CSF. may induce the
downregulation of E-cadherin. weaken adhesive bonds
between LC and keratinocytes. and allow migration of LC
from the epidermis. 1CAM-1. and to a lesser extent LFA-
1. may have roles in the migration of LC to local lymph
nodes. Intravenous injection of monoclonal antibodies di¬
rected against these molecules caused a reduction in the
numbers of FITC* la* DC found in lymph nodes after
FITC skin painting, and an inhibition of the induction of
CH [57]. Molecules that have been ascribed roles in the
homing and recirculation of cell populations, are upregu¬
lated on LC during culture. There is increased expression
of the surface molecules CD44 and a4 integrin (the
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Table 2 Phenotype of various
dendritic cell populations in
comparison with freshly iso¬
lated LC [T expression upregu-
lated (compared with LC), 1
expression downregulated
(compared with LC), S expres¬
sion, x no expression]




















T Lymph node DC [78]
T Cultured LC and spleen
DC [119]
T Spleen DC [61]
T Spleen and thymic DC [115]
Spleen DC [61]
T Lymph node DC [79]
/ Spleen DC [137]
4- Spleen DC and cultured LC
[119]
y Spleen DC [137]
/ Cultured LC [127]
t Cultured LC [93]
T Cultured LC [93]
i Cultured LC [93]
T Cultured LC [93]
T Cultured LC [93]
-J- Skin-associated lvmph node
DC [138]
T Cultured LC [135]
T Cultured LC [135]
/ Blood DC [136]
/ Blood DC and lymph node
DC [118]
/ Blood and tonsil DC [125]
/ Weak blood and tonsil DC [125]
✓ [65]
y Blood DC [136]
/ Weak on blood DC [136]
/ Blood DC [136]
•/ 25% of spleen DC [126]
/ Blood DC [1361
x Blood DC [136]
y Weak on blood DC [136]
x Blood DC [136]
/ [65]
,/ Cultured LC [138]
1 Cultured LC [138]
T Cultured LC [95]
/ CD34+ progenitors cultured in
GM-CSF andTNFa [99]
i Cultured LC [133]
a-chain of LPAM-l/VLA-4) and ICAM-1 [58], CD44 is a
transmembrane glycoprotein with a molecular weight
around 85 kDa [59], Evidence points to this molecule be¬
ing involved in cell recirculation by binding specific car¬
bohydrate residues on high endothelial venules [60], VLA-
4 has two ligands, VCAM-1 a cell adhesion molecule in¬
duced on endothelium by inflammatory mediators, and the
extracellular matrix protein, fibronectin [60], Adhesive
interactions between these molecules on differentiated LC
and their ligands may play a role in the migration of LC to
the DLN. "
Differentiation of LC
The cytokines produced by keratinocytes after treatment
with haptens or UVB are important in the differentiation
of LC into lymphoid DC. Differentiation of murine LC in
vitro requires the presence of GM-CSF, produced by con¬
taminating keratinocytes [61]. Culturing highly purified
murine LC in GM-CSF increases their ability to stimulate
mixed lymphocyte reactions (MLR) and LC purified from
bulk epidermal cell cultures, where contaminating ker¬
atinocytes provide cytokines, are also good stimulators of
MLR [62]. This ability is not only due to improved via¬
bility and increased la expression [62], If LC are cultured
in the presence of both GM-CSF and IL-1. a twofold en¬
hancement in their capacity to stimulate MLR is induced
compared with LC cultured in GM-CSF alone [62]. Fur¬
ther evidence of a role for GM-CSF in the differentia¬
tion/maturation of LC is provided by the inability of LC
from unprimed mice to induce an immune response to a
tumour-associated antigen, unless the cells are preincu-
bated with GM-CSF [63], Preincubation of unprimed LC
with IL-lcc, TNFa, IFNy and TGFp does not affect their
ability to induce a response and, indeed, some combina¬
tions of cytokines cause a reduction in the immune re¬
sponse [63]. If murine LC are cultured in TNFa alone, the
viability of the cells is maintained but they do not mature
functionally and are poor stimulators of MLR [64], How¬
ever, TNF does induce LC differentiation, causing the
downregulation of macropinocytosis [65], Culture of hu-
man DC progenitors, CD34+ cells isolated from peripheral
blood, in GM-CSF and TNFa causes their differentiation
into cells with DC activity [66].
Other immunomodulatory cell populations in the skin
LC are the principle APC in the skin, but there is evidence
that other cells can present antigen and affect cutaneous
immune responses. Their contribution to functional anti¬
gen presentation may be masked by LC under normal cir¬
cumstances. However, when the efficiency of antigen pre¬
sentation by LC is impaired by UVB radiation for exam¬
ple, then the alternative APC may become important.
One cell population of mice and rats, the Thy-1+ den¬
dritic epidermal T cells (DETC), may induce suppressive
immune responses [67] and the ratio of DETC to LC in
the epidermis influences sensitization [9]. Thy-1+ DETC
do not express la on the cell surface [17] making MHC
class Il-restricted antigen presentation unlikely, and there
is evidence that Thy-1+ DETC do not migrate to the DLN
[41, 68], Intravenous administration of haptenated Thy-1 +
cells into mice suppresses the induction of CH responses
[67, 69]. While in a normal cutaneous response, these
suppressor circuits may act to limit an inflammatory cas¬
cade, in LC-depleted skin the major signal from the skin
may be to suppress the response. It is therefore possible
that UVB may be acting via populations other than the LC
to induce immunosuppression of cutaneous immunity.
Secondary antigen-presentation pathways have also been
proposed as an explanation for the UVB resistance found
in certain strains of mice. It has been suggested that UV-
resistant mice possess a second antigen-presentation path¬
way, separate from epidermal LC, possibly mediated by
DC in the dermis [70]. Tape-stripped skin which is selec¬
tively depleted of epidermal cells, is able to support CH in
UVB-resistant, but not UVB-sensitive, mice. However
surgical excision of hapten-painted skin within 1 h of ap¬
plication. which removes both the dermis and epidermis,
prevents the induction of CH. Recently, it has been shown
that dermal cells, haptenated in vitro, from UVB-exposed
UV-resistant mice can transfer CH responses to naive
mice. In contrast haptenated dermal cells from UVB-ex-
posed UV-susceptible strains are unable to transfer CH
and instead induce tolerance [71]. Around 2% of cells in
dermal cell suspensions normally express MHC class II;
after UVB exposure this drops to around 1.4% in both re¬
sistant and susceptible strains [71]. However, the results
suggest that in resistant strains the dermal population is
able to provide a secondary antigen-presenting pathway,
while in susceptible strains these cells induce tolerance.
MHC class II+ LC-like interstitial dendritic antigen-pre¬
senting cells have been differentiated from dermal macro¬
phages [12], Morphology and phenotype were used to dis¬
tinguish these subsets, with the CD lib'1', Ly6c (mono¬
cyte/endothelial antigen) subset, thought to be dermal
macrophages, having no APC function in syngeneic MLR.
The LC-like cells are found in the perivascular and inter¬
stitial dermis of resistant and susceptible strains [12].
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Other cell populations, not necessarily dendritic, may
be involved in presentation of antigen from the skin. One
type which appears in the human epidermis during the
elicitation phase of the CH response, consists of CD1~
OKM5+ (CD36 monocyte/platelet marker) MHC class II+
cells [72], They have been found not to suppress the CH
response and have been shown to be responsible for up to
50% of antigen-presentation capacity during hypersensi¬
tivity responses [72], However, a cell population with the
same phenotype, which is found in the epidermis after ir¬
radiation by certain wavelengths of UV (UVB and UVC)
[73], activates a suppressor T-cell population [74]. In an¬
other study, UVB induced a loss of cells with LC markers
and the appearance of MHC class II+, CD la-, CD36+ (on
60% of CD la- MHC class II+ cells), CDllb+ macro¬
phages which may have antigen-presenting activity [75].
Neutrophils (MHC class II", CD1 lbT, GR-1+), macrophage-
like APC (MHC class IIlllgh, CDllb+) and macrophages
(MHC class II|0W, CD lib") infiltrate into the murine epi¬
dermis after exposure to UVB [76].
Veiled cells
After an appropriate signal, LC migrate into the afferent
lymphatics where they are described as veiled cells (due
to their long actively moving processes which resemble
veils). In one study the afferent lymph ducts of calves
were cannulated. enabling the ALVC to be studied [54],
The ability of the ALVC draining from the site of intra¬
dermal antigen challenge [variable surface glycoprotein
(VSG) from Trypanosoma brucei] to stimulate peripheral
blood mononuclear cell (PBMC) proliferation, was mea¬
sured in monozygotic bovine twins. It was found that they
induce proliferation in PBMC from VSG-immunized
calves, as rapidly as 30 min after intradermal application
of antigens. There was no proliferation of PBMC from
VSG-naive calves. Similar work has been carried out in
sheep, using the protein antigens OVA and purified pro¬
tein derivative (PPD) from bacillus Calmette Guerin [53],
There was a marked proliferation of OVA- and PPD-spe-
cific T-cell lines when incubated with afferent lymph cells
from OVA- and PPD-challenged animals. Afferent lymph
cells collected prior to challenge did not induce signifi¬
cant proliferation in the antigen-specific T-cell lines. The
stimulation was antigen specific as the afferent lymph
cells of OVA-challenged sheep did not induce prolifera¬
tion of PPD-specific T cells, and vice versa. In addition,
the ability of ALVC to cluster with primary resting T cells
has been described, a property not shared by nonprofes¬
sional APC and one of the reasons why antigen presenta¬
tion by DC is essential for the initiation of primary re¬
sponses.
The draining lymph node
The veiled cells drain into the paracortical area of lymph
nodes where they are called IDC as their dendritic projec-
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tions show extensive contact with surrounding cells. The
IDC present antigen in a MHC-restricted manner to T
cells in the local lymph nodes. T cells which are specific
for the antigen/MHC complex and which receive the cor¬
rect signals from the APC (soluble signals and cell-cell in¬
teraction) are induced to proliferative and differentiate.
The changes in the phenotype and function of DC as
they migrate to the DLN are thought to be similar to the
changes seen in vitro when freshly isolated epidermal LC
are cultured. Evidence has been presented in an earlier
section showing that LC lose their ability to process na¬
tive peptide after being cultured for 72 h [21]. However,
cultured LC are significantly better at stimulating autolo¬
gous and allogeneic T-cell responses than are freshly iso¬
lated LC. These changes in function are likely to be due to
alterations in the phenotype of LC during their migration
from the skin and their differentiation into DC. The phe¬
notype of IDC after migration in vivo is similar to the
phenotype of LC after differentiation in culture. MHC
class II is upregulated on cultured LC [77] and DC iso¬
lated from lymph nodes show increased expression com¬
pared with epidermal LC [78]. Similarly, ICAM-1 is up-
regulated on cultured epidermal LC [58] and DC isolated
from lymph nodes have higher levels of ICAM-1 than LC
isolated from the epidermis (Table 2) [79], There are also
changes in morphology during culture with the majority
of LC losing Birbeck granules [80].
Antigen presentation
Antigen presentation is a complex interaction requiring
recognition by the T cell receptor (TCR) of peptide antigen
bound in the groove of an MHC molecule. Other signals
are also required and are provided by soluble cytokines
and adhesive associations between the APC and the T
cells. During a T-ceil/APC interaction, binding of the TCR
to the peptide/MHC complex occurs and there are interac¬
tions between a variety of adhesion molecules on the T
cell and the APC and their ligands [81].
The ability of DC to initiate primary immune re¬
sponses can be explained, in part, by their capacity to
form stable clusters with resting antigen-specific T cells.
Splenic DC from mice form clusters with T cells and B
cells in vitro in the absence of exogenous antigen [82],
while other APC can only cluster with sensitized T cells
[83], Antigen-independent adhesion between T cells and
the APC precedes antigen-dependent clustering, and may
allow DC to 'sample' different T cells [84]. In vitro assays
have shown that clustering occurs prior to, and is essential
for. T-cell proliferation [85], The interaction between LFA-
1 and its ligands ICAM-1,2,3 and CD2 and LFA-3 may be
important in this first stage of antigen presentation. How¬
ever, antibodies to LFA-1 fail to block antigen-indepen¬
dent clustering of murine spleen DC although they do
block the function of clusters by causing a decrease in cell
proliferation and cluster stability [86].
The importance of ICAM-1 expression in antigen pre¬
sentation has been shown by examining the function of
mutant APC from mice which had an 80-95% reduction
in ICAM-1 expression [87], The ICAM-1low APC had a
greatly impaired ability to present antigen to T cells. Re-
constitution of ICAM-1 by transfection of the gene into
these cells restored normal antigen presentation. ICAM-1
induced important costimulatory signals through the LFA-
1 molecule on T cells [88], The ICAM-l/LFA-1 interac¬
tion is also necessary in the clustering of T cells with
other cells [89], and some groups have suggested that
antigen-independent adhesion is the first step toward
recognition of the antigen/MHC complex by T cells [81].
There has been much interest recently in the costimu¬
latory functions of members of the B7 family which are
ligands for CD28 and CTLA-4 on T cells. B7-2 (CD86)
expression is found within 24 h of activation of human B
cells, while B7-1 (CD80) expression peaks several days
later [90]. B7-2 is found on peripheral blood DC [91],
resting human monocytes and on activated T cells. B cells
and NK cells [92]. CD28 is expressed widely on both hu¬
man and mouse resting T cells, while CTLA-4 expression
seems to be limited to activated T cells [90]. While both
B7-1 and B7-2 are ligands for CD28 and CTLA-4, in vivo
interactions may be influenced by the availability of the
ligands. B7-2 is found constitutively at low levels on
murine epidermal LC. and after 24 h in culture there is a
dramatic upregulation in its expression (Table 2) [93]. B7-
1 is not found on epidermal LC normally, but it is induced
(to lower levels than B7-2) during culture [93-95], and is
present on splenic DC [94],
The upregulation of B7-1 and B7-2 during LC culture
and their expression on lymphoid DC suggest the involve¬
ment of keratinocyte-derived cytokines. B7-2 upregula¬
tion can be partially decreased during culture in the pres¬
ence of an anti-GM-CSF antibody [93], which may reflect
a minor role for GM-CSF in the induction of B7-2. Alter¬
natively, the isolated LC may have received a signal to
upregulate B7-2 expression during isolation which then
may be difficult to reverse [93], Lipopolysaccharide does
not seem to upregulate B7-2 on DC although it does in¬
crease the expression of B7-2 on macrophages and B cells
[96].
Therefore, both B7-1 and B7-2 are expressed on DC in
lymphoid tissue with upregulation during in vitro culture
of LC, and a connection with APC activity. Freshly iso¬
lated LC are less able to stimulate alloresponses than cul¬
tured LC [94, 95. 97] and cultured LC induce allore¬
sponses similar to freshly isolated LC when B7-1 and B7-
2 interactions are blocked using CTLA4-Ig [95], CTLA4-
Ig is a fusion protein with the extracellular portion of
CTLA-4 spliced to the constant region of the human IgG 1
molecule, which acts as a soluble ligand for B7-1 and B7-
2 [98], Interestingly, the alloresponse induced by fresh or
cultured LC can be abrogated using CTLA4-Ig and anti-
ICAM-1 [95]. The available evidence suggests that CD86
may be the more important costimulatory molecule in al¬
loresponses. The ability of human DC, obtained by cultur-
ing CD34+ peripheral blood progenitor cells with GM-
CSF and TNFa. to induce alloresponses is inhibited by
monoclonal antibodies against CD28 [99]. However.
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though monoclonal antibodies against CD80 have little
effect on the alloresponse, monoclonal antibodies against
CD86 suppress the alloresponse by 70% [99]. When used
together, monoclonal antibodies to CD80 and CD86 cause
a 90% reduction in alloresponse [99]. CTLA4-Ig binding
is completely inhibited in the presence of monocionals to
CD80 and CD86, suggesting that there is not a third lig-
and for CTLA-4 on DC.
Due to these and other changes in phenotype summa¬
rized in Table 2, IDC and cultured LC become specialized
at presenting antigen to T cells, and are efficient at acti¬
vating unprimed lymph node cells and in the induction of
ailoresponses in vitro [21], It has been stated that DC are
important in the induction of primary immune responses,
and good evidence for the role of DC in primary immune
responses has been provided using a transgenic mouse
model [100]. Transgenic mice were bred that differed in
the amounts of I-E MHC expressed on the surface of the
major APC populations (DC, B cells and macrophages)
[100]. These mice were then immunized with an I-E-re-
stricted peptide antigen. After 8 days the CD4+ T cells
were removed from lymph nodes draining the site of im¬
munization and cultured with the immunizing antigen.
There was a correlation between the in vitro proliferative
response of the CD4+ T cells and the percentage of I-E-
expressing cells in the mouse. However, there was no cor¬
relation between I-E expression on B cells or macro¬
phages, and the size of the CD4 T-cell recall response.
The fate of the cutaneous DC
DC are not found in the efferent lymph [101] and there are
few FITC-bearing DC left in the DLN 6 days after skin
painting [102]. It seems likely that some system in the
lymph nodes allows the DC to be destroyed without caus¬
ing damage to the surrounding cells. The clearance of
large numbers of inflammatory cells during the resolution
of acute inflammation may involve apoptosis of the effec¬
tor cells followed by ingestion by macrophages [103]. It is
possible that DC in the DLN, starved of keratinocyte-de-
rived growth factors which would maintain their viability,
undergo apoptosis and are then removed by macrophages
without damaging lymph node tissue. Other mechanisms
may also act to clear DC from lymph nodes such as acti¬
vated NK-like cells, or hapten/peptide specific antibody.
Production of a cutaneous immune response
T cells that recognize, and bind to, the specific antigen/
MHC complex on the IDC and receive the necessary co-
stimulatory signals, are induced to proliferate. Activation
signals also induce differentiation of the T cells which un¬
dergo changes in both morphology and phenotype. These
T cells exit the lymph node in the efferent lymph and en¬
ter the bloodstream via the thoracic duct. Recently, acti¬
vated CD45RO+ T cells, the so called memory subset,
have been shown to exhibit specialized recirculation pat¬
terns. In the sheep the loss of L-selectin on these cells
means that they are less likely to recirculate to peripheral
lymph nodes and instead they circulate preferentially
through tissue sites including the skin [104],
Commonly, cutaneous immune responses are studied
using CH and DH responses as models. The inflammatory
response generated during challenge with antigen in both
these systems is associated with infiltration of mononu¬
clear cells into the skin. Two subsets of CD4 Th cells have
been identified in the mouse: Thl and Th2 cells [105].
Thl responses mediate cell-mediated immunity, including
CH and DH responses, which are dependent on IFNy
[106, 107]. The cytokines produced by Th2 cells are im¬
portant in B-cell activation and differentiation and there¬
fore these cells preferentially stimulate humoral immu¬
nity. Interestingly, the ability of UVB to suppress sensiti-
zation to haptens corresponds to a loss of production of
Thl-type cytokines by lymph node cells taken from
lymph nodes draining irradiated skin [108], Although a
corresponding increase in Th2-type cytokines has not
been detected, it is possible that UVB induces a functional
inactivation of Thl-type cells. In support of this it has
been shown that the ability of splenic T cells from UV-
treated animals to transfer immunosuppression of DH re¬
sponses to normal recipients, can be blocked by neutraliz¬
ing antibodies to IL-4 or IL-10 given 4 and 24 h after
transfer [109]. Therefore the suppressive action of these T
cells on cell-mediated DH responses requires the produc¬
tion of Th2-type cytokines by the T cells.
Secondary cutaneous responses
The antigen-presenting pathway that has been described.
LC processing antigen in the periphery and presentation
to specific T cells in the DLN, is relevant to all cutaneous
immune responses. However, this mechanism may be aug¬
mented by alternative antigen-presentation pathways in a
secondary response, where there will be a pool of acti¬
vated or semi-activated T cells specific for the antigen.
Earlier, it was noted that subpopulations of these cells
show preferential recirculation to tissue sites including the
skin. Therefore in a secondary response, T cells could en¬
counter antigen in the periphery bound to LC or other
antigen-presenting cell populations such as B cells, macro¬
phages and keratinocytes. Memory/activated T cells ex¬
pressing CD45RO can be activated by a wide range of
APC, while activation of naive T cells requires DC [110].
Therefore skin-homing populations of T cells, after being
presented with antigen in the periphery, could release in¬
flammatory factors that initiate a cascade response lead¬
ing to the migration of effector cells through the endothe¬
lium into the skin.
There is some evidence that endothelial cells could
present antigen to circulating T cells in the bloodstream.
This mechanism would allow for antigen-specific migra¬
tion of T cells into inflammed tissues. Endothelial cells do
not express MHC class II constitutively but this molecule
is highly upregulated during infection and allogeneic
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transplant rejection [111]. Although cultured cells from
virtually any organ can be induced to express MHC class
II, endothelial cells are interesting because of the high de¬
gree to which class II can be upregulated by cytokines
such as IFNyand IL-1 [112], As well as adhesive interac¬
tions, soluble mediators may be important in antigen pre¬
sentation. However, cytokines in the blood stream would
be rapidly washed away from the inflammatory site. It has
been suggested that proteoglycans expressed on endothe¬
lial cells might act to bind and present soluble cytokines
to circulating leucocytes [113]. Cytokines bind proteogly¬
cans at low-intermediate affinity and some cytokines can
specifically bind the glycosaminoglycan sidechains of
proteoglycan [113]. Therefore, it is possible that antigen
could be presented by endothelial cells in the postcapil¬
lary venules to recirculating 'memory' T cells.
Conclusion
The DC of the skin are very important in the production of
skin immune responses. The migration of antigen-bearing
LC from the epidermis to the DLN and their differentia¬
tion into efficient antigen-presenting cells are vital for the
induction of primary immune responses. Other antigen-
bearing cells, including dermal dendritic cells, may mi¬
grate in a similar fashion, and may influence immune re¬
sponses. The faster kinetics of secondary responses sug¬
gest that antigen presentation in the DLN may not be as
important as in primary responses. In this case it is likely
that DC in the skin, together with other APC, initiate and
influence the effector response.
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Abstract
Following the application of sensitizing chemicals to the skin, hapten-bearing
Langerhans cells (LC) and possibly other cutaneous dendritic cells (DC) migrate to
the draining lymph nodes (DLN) of mice and induce the proliferation of antigen
specific effector T cells. This migration of DC to the DLN is required for the
induction of primary immune responses. In certain strains of mice irradiation with
ultraviolet-B light (UVB) before sensitization results in the suppression of contact
hypersensitivity responses. In vitro investigations have suggested that one influence
of UVB is to modify the ability of Langerhans cells (LC) to present antigen. In the
present investigation putative UVB-induced alterations in lymph node DC in vivo
were examined. Lymph node DC were analysed following exposure of C3H/HeN
mice to an immunosuppressive dose of UVB (1440J/m2) 48 and 24 hrs prior to skin
painting with the sensitizers fluorescein isothiocyanate or oxazolone. In functional
studies, DC prepared from the DLN of contact sensitized mice were examined for
their ability to induce hapten-specific secondary T lymphocyte proliferative responses
or mixed lymphocyte reactions in vitro. In neither case was the activity of DC
influenced by local exposure to an immunosuppressive dose of UVB. The migration
of LC from the epidermis to the draining lymph node in response to contact
sensitization is associated with increased expression of several membrane
determinants necessary for effective antigen presentation, including intercellular
adhesion molecule-1 (ICAM-1; CD54), B7-2 (CD86) and la antigen. The expression
of these molecules was identical on DC isolated from the DLN of UVB irradiated and
from control, unirradiated mice. Thus the immunosuppressive effect of UVB on the
cutaneous immune system may not necessarily reflect changes in the antigen
presenting DC that accumulate in the DLN following skin sensitization.
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Cutaneous exposure to contact sensitizers induces the migration of antigen-bearing
LC from the epidermis into the afferent lymph and their accumulation as
immunostimulatory DC in the DLN (1,2). During migration, LC are subject to changes
in both phenotype and function. They become efficient antigen presenting cells and
acquire the ability to cluster with, and activate, naive T lymphocytes (3). The ability of
DC to induce the expansion of an effector T cell population from naive T cells in the
DLN is required for the initiation of primary immune responses. The changes that DC
undergo during their migration to the DLN are thougnt to be mirrored by culturing
freshly isolated epidermal LC in vitro for several days in the presence of keratinocytes
or appropriate epidermal cytokines (4).
Irradiation with ultraviolet B light (UVB) compromises primary cutaneous immune
responses in certain strains of mice. These changes correspond to the induction of
anergy or antigen-specific unresponsiveness to a variety of antigens, including skin
allergens (5). Initially after exposure of susceptible strains to low doses of UVB, the
immunosuppression is limited to sensitizers applied locally to the irradiated site (6). It
has been known for many years that following UVB irradiation, there is a reduction in
the number of LC in the epidermis (7). In addition an increased number of DC
accumulate in lymph nodes draining the site of exposure (8). If irradiation is performed
prior to skin painting with fluorescein isothiocyanate (FITC) a skin-sensitizing
fluorochrome, then a proportion of the increased number of DC found in the DLN bear
FITC (8). It seems likely that this hapten-bearing population consists of LC-derived
DC, although DC originating from other cutaneous antigen presenting cell populations
may be present also.
In vitro studies have shown clearly that UVB is able to inhibit culture-induced
expression of a variety of important LC surface molecules, and their activity as antigen-
presenting cells (9). As primary immune responses are induced in lymph nodes
draining the skin, and lymph node DC are considered essential for the stimulation of
naive T lymphocytes, we have questioned in the present study whether irradiation of
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C3H/HeN mice with a dose of UVB sufficient to cause the suppression of both contact
sensitivity (CH) (10) and delayed-type hypersensitivity responses (11), is associated
with changes in the function or phenotype of DC in the DLN. The function of the DC
was analysed in two ways. First, the ability of oxazolone and FITC bearing DC from
control and irradiated mice to initiate antigen specific secondary proliferative responses
by sensitized lymph node cells (LNC) was measured. Second, the ability of DC from
unirradiated and irradiated mice to act as allostimulators in a primary mixed lymphocyte
reaction was examined. In addition, the phenotypic characteristics of the DC in DLN
from irradiated and unirradiated skin were compaied. Three determinants were analysed
la, ICAM-1 and B7-2. Ia was examined due to its role in presentation of antigen to
CD4+ T lymphocytes. ICAM-1, is an adhesion molecule known to facilitate the antigen-
independent interaction between DC and T lymphocytes (12). Furthermore, expression
by LC of this determinant may be important in guiding their directed movement to, and
accumulation in, DLN (13), and B7-2 (CD86) provides an important second signal for




Female C3H/HeN and BALB/c mice, aged 6-8 weeks, were obtained from the specific
pathogen-free animal breeding facility at the Medical Microbiology Transgenic Unit,
University of Edinburgh.
Contact sensitizers
Fluorescein isothiocyanate (FITC) and 4-ethoxymethylene-2-phenyloxazol-5-one
(oxazalone) were obtained from Sigma-Aldrich Co. (Poole, UK). FITC was dissolved
in 1:1 acetone:dibutylphthalate at 2.5% w/v and oxazolone was made up in the same
vehicle at 1% and 0.25% w/v.
UV Source and exposure
Mice (C3H/HeN strain) were irradiated under two Philips TL-20W/12 bulbs with an
output range of 270-350nm, peak 305nm, emitting 80mW/ cm2. The output of this
source was determined using a filtered photodiode meter, calibrated against
measurements made with a UV-visible spectroradiometer (model 742, Optronic
Laboratories Inc.) across the spectral range 250-400nm. The tube to target distance was
16 cm. One minimal erythemal dose for C3H/HeN mice under these conditions was
1500 J/nr. To measure the effect of UVB on CH responses the shaved backs of mice
were exposed to the 2 doses of 1440 J/m2 UVB, 48 and 24 hours prior to sensitization.
For this experiment the mice were anesthetised by i.p. injection of 0.1 ml sterile
distilled water containing 0.83 mg/ml hypnovel (Roche, Welwyn Garden City, UK)
and 1.67 mg/ml hypnorm (Janssen Pharmaceutical, Oxford, UK). During the
irradiation the mice were contained in a perspex box and their heads were covered with
aluminium foil to protect the ears from UVB exposure. Control groups were
anesthetised but were not exposed to UVB. In all the other experiments unanesthetised
mice were exposed to the same dose of UVB (2xl440J/m2) while being contained in
separate compartments of a perspex box to prevent shielding by littermates.
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Measurement of CH responses
The backs of C3H/HeN mice were shaved and the mice anesthetised as described
previously. One group (n=7) was exposed to the standard dose of UVB (UVB), while
the two other groups were unirradiated. Twenty fours later the group exposed to UVB
%
and one of the unirradiated control groups were sensitized on the back with 50pl 1%
oxazolone, the backs of the final group were painted with 50pl vehicle. Seven days later
the ears of each mouse were measured using an engineers micrometer (Draper SM-510,
Japan) and challenged with 25pl 0.25% oxazolone in vehicle. Twenty four hours later
the ears of each mouse were remeasured, the increase in ear thickness was calculated,
and the results expressed as the mean challenge-induced increase of ear thickness in
mm"2± standard error.
Enrichment ofDC
The method of Macatonia et al (2) was followed in outline. In brief, groups of mice
(n=10-15) were exposed to 25pl of the relevant sensitizer, or to an equal volume of
vehicle alone, on the dorsum of both ears. In some experiments mice were exposed at
the same site to 1440 J/m: UVB radiation 48 and 24 hours prior to sensitization. At 18-
24 hours after sensitization, mice were killed and their draining auricular lymph nodes
excised and pooled for each experimental group. A single cell suspension of LNC was
prepared by mechanical disaggregation through 200-mesh stainless steel gauze (J.
Stanier and Co. Manchester, UK.). Cells were washed and viable cells counted by
exclusion of 0.5% trypan blue. Cells were resuspended in RPMI-1640 (Gibco BRL,
Paisley, Scotland) supplemented with 25mM HEPES, 100 i.u./ml penicillin, 200pg/ml
streptomycin, 2mM L-glutamine, lOOpg/ml gentamicin and 10% heat-inactivated fetal
calf serum (RPMI-FCS). DC enriched populations were prepared by density gradient
centrifugation on Metrizamide (Nygaard, Oslo, Norway). Briefly LNC were adjusted to
5xl06 cells/ml in RPMI-FCS and 8ml of the cell suspension were gently underlayed
with 2ml of 14.5% Metrizamide in RPMI-FCS and centrifuged for 20 minutes (600g) at
room temperature. The low buoyant density population (DC+) that accumulated at the
interface was collected and washed twice with RPMI-FCS. This population comprised
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50-70% DC by morphology using light microscopy. Analysis of these enriched DC
populations by flow cytometry revealed a corresponding population of large granular
cells with high membrane la expression. In some experiments the pellet, which
comprised LNC depleted of DC (DC-), was collected and washed in RPMI-FCS. This
population contained around 2% of cells with DC morphology. Flow cytometric
analysis confirmed that around 2% of cells in this population had DC characteristics-
large granular cells with high la expression.
Identification of FITC-bearing cells in the DLN
DC+ and DC- cells were prepared as above from the DLN of mice sensitized with 2.5%
FITC or 1% oxazolone 18 hours previously. A minimum of 104 cells from each
population analysed using a Coulter XL flow cytometer. Non-viable cells were gated
out, and background controls were set at 1% using DC+ and DC- populations isolated
from the DLN of oxazolone sensitized mice. DC were identified by forward and side
angle light scatter characteristics. The percentage of DC bearing FITC and the intensity
of staining were recorded.
Lymphocyte proliferation assay
The method described by Jones et al (15) was used. The ears of C3H/HeN mice were
painted with 25pl of FITC or oxazolone. Seven days later the mice were killed, and
LNC were prepared from the auricular lymph nodes and used as responder populations.
They were resuspended at 5xl06 cells/ml in RPMI-FCS and lOOpl of cells added per
well in a round bottomed 96-well plate (Nunclon, Roskilde, Denmark). DC were
enriched as described above from C3H/HeN mice sensitized with FITC or oxazolone
18 hours previously. These enriched DC+ populations were added to wells to provide a
DC:responder ratio of either 1:40, 1:55 or 1:100. The effect of UVB was analysed
using DC+ populations from mice given the standard irradiation protocol prior to
sensitization compared with DC from mice that received no irradiation. Plates were
cultured for 48 hours in a humidified atmosphere of 5% CO, in air, and 18 hours prior
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to culture termination 0.7pCi 3H-methyl thymidine (Amersham Life Science, Little
Chalfont, UK) was added to all wells. The cells were harvested using an automatic cell
harvester (Dynatech) and 3H-methyl thymidine incorporation measured by (S-scintillation
counting. Results were expressed as the mean cpm+ standard deviation (s.d.) from 5
replicate cultures.
Mixed lymphocyte reaction
Responder LNC were prepared from pooled auricular lymph nodes isolated from
BALB/c strain mice (n=3-5) which had been painted 48 hours earlier with 1%
oxazolone on the dorsum of both ears. LNC were prepared as described above and
cultured at 1.5xl05 cells/ml in RPMI/FCS. DC+ populations were prepared from the
auricular lymph nodes of unsensitized C3H/HeN mice (n=10-15) exposed to low dose
(1440 J/m2, -48, -24 hours) or high dose (15 kJ/m2, -24 hours) UVB treatment.
Control DC+ populations were enriched from the skin draining lymph nodes of
unirradiated and unsensitized mice (n=10). Cells with DC morphology were counted
and a known number of C3H/HeN DC were cultured with BALB/c responder LNC at
various stimulator: responder ratios. DC populations were also used as stimulators.
These cells were cultured alone or with BALB/c LNC at matching stimulatonresponder
ratios as for the DC+. Plates were cultured for 120 hours in a humidified atmosphere of
5% C02 in air. 3H-methyl thymidine (Amersham Life Science) was added to all wells
for the last 24 hours of culture. The cells were then harvested and the thymidine
incoiporation was measured as described above.
Phenotypic analyses
DC were enriched, as described above, from the auricular lymph nodes of C3H/HeN
mice 18-24 hours after sensitization with oxazolone (n=10-15). In some experiments
mice were exposed to UVB 48 and 24 hours before sensitization. A minimum of 105
DC were incubated on ice for 30 minutes with the appropriate isotype control, rat IgG2a
specific for human MHC class I or rat IgG2b raised against dinitrophenyl (Serotec,
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Oxford, UK), or with monoclonal antibodies recognising la, B7-2 or ICAM-1. Rat-
anti-mouse monoclonal antibodies recognising la (Serotec, Oxford, UK) and B7-2
(CD86) (Pharmingen, San Diego, USA) both IgG2a isotype were purchased, and the
ICAM-1 monoclonal, IgG2b isotype, was acquired as a hybridoma culture supernatant
(16). The cells were washed once with 2ml of RPMI-FCS and incubated with an
affinity purified F(ab')2 rabbit anti rat IgG-FITC conjugate (Serotec, Oxford, UK) for
30 minutes on ice. Finally, the cells were washed once more in RPMI-FGS, fixed in
1% formyl saline and analysed using a Coulter XL flow cytometer. Non-viable cells
were gated out, and isotype controls were routinely set at 1%. DC were identified by
forward and side angle light scatter characteristics. The percentage of DC expressing
each marker and the density of expression (mean fluorescence intensity) of the marker
were recorded. A minimum of 5000 events were accumulated using logarithmic
amplification of fluorescence intensity.
Statistics
P values were calculated using an unpaired Students t-test in Statworks 1.1.
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Results
Effect of UVB on contact hypersensitivity responses in C3H/HeN mice
As has been shown previously (10), exposure of mice to 1440 J/m2 UVB on
two successive days prior to sensitization with oxazolone resulted in a reduction in
contact hypersensitivity measured as a function of challenge-induced increases in ear
thickness from 11.14±1.34 to 5.83±1.25 mm2 24 hours after oxazolone challenge.
This represents a 47% suppression of hapten-specific ear swelling (p=0.01).
Identification ofhapten-bearing DC in the DLN ofsensitized mice
To determine whether the accumulation of DC in the DLN after sensitization
could be attributed to an influx of DC from the skin, mice were painted on the dorsum
of both ears with FITC or oxazolone; 18 hours later draining auricular lymph nodes
were removed and DC" and DC+ populations were prepared. Background fluorescence
levels were set at 1 % on DC" and DC+ populations from oxazolone sensitized mice.
Around 28% of LNC in the DC" population had FITC on their surface but the intensity
of staining was low with a mean fluorescence of 1.12 on a log10 scale (data not shown).
Around 37% of all the cells in the DC enriched population had FITC on their surface
and the intensity of staining was high with a mean fluorescence of 24.7 on a log10 scale
(Fig 1). In addition, 73% of cells in this population with DC size and granularity
characteristics bore FITC (data not shown).
Effect of UVB on the ability ofDC to stimulate in vitro secondary lymphocyte
proliferative responses
Initial experiments to optimise the system resulted in the use of responder cells
at 5x10s cells/well and enriched DC at 1:55 stimulator to responder ratio, which
produced a response of around 15000 CPM (data not shown). When DC" populations
were used as stimulator cells, they failed to induce proliferative responses over
background.
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Fig 2 shows the results of two independent experiments in which enriched
FITC-DC isolated from control and UVB irradiated mice were used to stimulate the
proliferation of LNC from FITC-sensitized mice. In the first experiment (Fig 2a) there
was no significant difference between the accessory cell activity of DC isolated from
control or irradiated mice. In the second experiment (Fig 2b) there was a statistically
significant difference (p=0.03) between the proliferative responses induced by DC from
control and irradiated mice. However, differences were very modest, a 16% reduction
in proliferation when DC from irradiated mice were used as stimulator cells compared
with DC from control mice. In two further experiments, oxazolone bearing DC from
UVB irradiated mice induced equivalent antigen-specific proliferative responses to
oxazolone-DC from unirradiated mice (data not shown). These experiments were
identical to those shown in Fig 2, except that the responder cells were used at a
concentration of 2.5x10s cells/well.
Since the assays shown in Fig 2 were conducted using concentrations of DC
that provoked good proliferative responses, it was decided to determine the effect of
UVB on proliferation when DC numbers were limiting. In fig 3, DC were used at 2
stimulatoriresponder ratios, 1:100 and 1:55, and the antigen specificity of the response
was examined by using oxazolone and FITC-bearing DC as stimulator cells for LNC
from oxazolone-sensitized mice. Figure 3a shows the proliferative response of LNC
cultured in the presence of oxazolone-bearing DC from conU'ol and irradiated mice.
Oxazolone-bearing DC stimulated good proliferative responses by LNC from mice
sensitized with oxazolone in a dose-dependent manner. UVB treatment did not inhibit
this ability. The failure of UVB to affect the accessory activity of DC was seen when
DC were present at both stimulator.responder ratios. The hapten specificity of the
response is shown in Fig 3b. Although FITC bearing DC were able to induce limited
antigen non-specific proliferative responses from oxazolone sensitized LNC, their
capacity to induce proliferation was poor when compared with the antigen specific
proliferative responses illustrated in Fig 3a.
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Effect of UVB on the stimulatory capacity ofDC in antigen primed primary mixed
lymphocyte reaction
When enriched DC from C3H mice were cultured with LNC from BALB/c mice
sensitized previously with oxazolone, significant proliferative responses were seen
using a range of stimulator to responder cell concentrations (1:15 to 1:100) (Fig 4). The
stimulation of alloresponses was dependent upon the presence of DC, as stimulator
populations depleted of DC failed to induce proliferative responses (Fig 4). However,
when DC were isolated from mice given a suppressive dose of UVB radiation, their
ability to induce alloresponses was unimpaired. Even exposing mice to much higher
doses of UVB 15 kJ/m2 24 hours prior to enrichment of DC from the draining lymph
nodes failed to effect the function of the DC as allostimulator cells (Fig 5).
Ia, ICAM-l and B7-2 expression on DC enrichedfrom the lymph nodes of
unirradiated, sensitized and UVB irradiated sensitized mice
The migration of LC from the skin and their accumulation as immunostimulatory DC
in the draining lymph nodes is accompanied by the increased expression of several
membrane determinants considered necessary for the effective induction of T
lymphocyte responses including Ia, ICAM-l and B7-2. Exposure of mice to UVB
under conditions that result in immunosuppression of CH failed to influence the
expression by lymph node DC of any of these determinants (Fig 6). For each of the
three determinants tested, UVB treatment did not affect the % of DC expressing the
determinant, or the density of expression.
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Discussion
UVB exposure causes the suppression of cutaneous immune responses to a variety
of agents. It has been hypothesised that UVB exposure affects antigen-presenting cell
populations in the skin, causing them to induce inappropriate effector responses
following their migration to DLN. In order to investigate whether altered DC
populations could be mediators of UVB-induced immunosuppression, the phenotype
and function of DC populations in the DLN were examined after exposure to UVB light
in vivo.
Although the presence of FITC-bearing DC in the DLN of FITC-sensitized mice is
not necessarily a marker for epidermal derivation, it is likely, though still a matter of
some contention, that the majority of these DC cells bind FITC in the skin prior to their
migration to the DLN. Macatonia etal (17) reported two populations of FITC+ DC in
the DLN after skin painting, one with low levels of FITC and another intensely
fluorescent population. The DC bearing high levels of FITC first appeared 2-8 hrs after
skin painting and induced T cell proliferation, the other population appeared 30 minutes
after skin painting but were unable to induce proliferative responses. Kripke etal {1)
reported two populations of FITC+ DC in the DLN after skin painting; 75% of these DC
expressed the antigen F4/80 a marker of LC but not lymph node DC which suggests
they are a skin derived population. The remaining 25% of the DC did not express F4/80
and may represent a resident lymph node population. These and other studies suggest
that the majority of DC in the DLN after skin painting with a contact sensitizer are skin
derived, and therefore it was considered that they constitute an appropriate antigen
presenting cell population with which to examine the immunomodulatory effects of
UVB in vivo.
Using an immunosuppressive dose of UVB, the ability of FITC or oxazolone-
bearing DC to initiate antigen-specific proliferation in vitro was examined. Initial results
confirmed the ability of both FITC and oxazolone-bearing DC to initiate antigen-specific
proliferation of LNC from contact sensitized mice, and in accordance with previous
results, FITC and oxazolone-bearing DC showed a limited antigen non-specific
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stimulatory capacity (data not shown for oxazolone-bearing DC) (15). However, UVB
failed to influence materially the ability of DC to initiate antigen specific proliferative
responses. This contradicts the results of Bucana et al (18) where exposure of mice to
400 J/m2 UVB on 4 consecutive days prior to FITC sensitization reduced the ability of
%
enriched DC to induce proliferative responses in FITC specific T cell lines. After
metrizamide gradient enrichment, the cell population contained 10-30% DC and was
used at a ratio of stimulator: responder cells of 5:1. In our study, the enriched
population contained 50-70% DC on basis of morphology and was used at a ratio of
1:55 or 1:100. It is possible that the suppression of proliferative responses reported by
Bucana et al could be a result of UVB-induced changes in the large number of non-DC
contaminating the stimulator cell population in the assay. Alternatively the responding
cell population, which was FITC-specific T cell lines in the Bucana et al study and LNC
stimulated in vivo with FITC in our study, could interact differently with DC through,
perhaps, the differential expression of various co-stimulatory molecules.
The accessory cell function of DC in a primary allogeneic immune response was
examined also. It was found that LNC prepared from BALB/c mice sensitized with
oxazolone could be stimulated to proliferate in an antigen non-specific manner using
lymph node DC enriched from unscnsitized C3H/HeN mice. It was shown that DC
isolated from mice that had received a suppressive dose of UVB displayed no loss in
their ability to act as accessory cells.
In addition, the expression of three markers (MHC class II, ICAM-1 and B7-2)
which are important in the physical interaction and signalling between antigen
presenting cells and T lymphocytes was examined. No changes in the percentage of DC
expressing these membrane determinants or the density of expression were found after
exposure to UVB.
A number of studies have documented the effects of in vitro UVB exposure on
epidermal LC. Irradiation of human epidermal cell suspensions (8-20% LC) and
purified LC populations (70-90% LC) with 100-200J/m2 of UVB in vitro significantly
inhibits their ability to stimulate primary alloresponses, mitogen-induced proliferation
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and proliferative responses to recall antigens (19). Similarly, exposure of murine
epidermal cell suspensions to a low dose of UVB (25 J/m2) inhibits anti-CD3 induced
proliferation of T cells, while 100-200 J/m2 abrogates completely their stimulatory
capacity (9). It has also been demonstrated in vitro that UVB (50-100 J/m2) inhibits the
up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by LC that is
normally induced during culture (9) or during the migration of LC to the DLN
following skin sensitization (20). However, in vitro exposure of LC to 100 J/m2 of
UVB is cytotoxic to LC, causing their eventual loss from cultures after 48-72 hours
(21).
It is believed that many of the DC found within the skin-draining lymph nodes derive
from epidermal LC. Therefore it is interesting that the susceptibility of LC to UVB in
vitro is not mirrored by similar changes in lymph node DC following exposure to UVB
in vivo. There may be a number of explanations for this observation. In the in vitro
studies, LC in suspension were exposed directly to UVB at doses that are cytotoxic.
Therefore, the results obtained in vitro may reflect responses to cellular injury.
When animals are irradiated, UVB loses much of its energy as it penetrates through the
layers of stratum corneum. Therefore, in addition to the direct damage to DNA that
UVB can cause, UVB induced mediators may be important, especially in the
immunosuppression following low doses of UVB. Secondly, LC that are directly
damaged by UVB may be unable to migrate to DLN. Low doses of UVB inhibit the
migration of cells out of human skin explants in vitro, and the proportion of the
migrating cells expressing the LC marker CD la are slightly reduced (22). Finally, it has
been proposed that many of the DC which accumulate in DLN are of dermal rather than
epidermal origin, though this has not been shown directly.
It is not possible therefore on the basis of immunostimulatory activity and expression
of la, ICAM-1 or B7-2 to reconcile the immunosuppressive properties of UVB in vivo
on the basis of alterations in DC phenotype or function. However, the measurements
performed in this study could have failed to detect more subtle changes in DC induced
by UVB. There is evidence that local exposure to UVB causes the preferential
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production of Th2 type cytokines by DLN cells (23,24). Irradiation may alter the DC
arriving in the DLN, or alternatively change the lymph node microenvironment, causing
the selective activation of a particular T cell subset. Therefore, measuring the ability of
DC to stimulate proliferative responses may be of less importance than examining the
functional activity of the effector T cells induced to proliferate by the DC. In addition,
although UVB did not alter the expression of the three surface molecules examined
here, it cannot be concluded that UVB will not influence other surface molecules, such
as B7-1 (CD80) and heat stable antigen both of which have costimulatory function
(25). Finally, by testing the function of DC in vitro, the effect of the lymph node
microenvironment is ignored and the results may not reflect the antigen-presenting
activity of DC in vivo.
These data reveal that the marked changes in LC phenotype and function induced by
in vitro UVB exposure are not apparent in DC populations in lymph nodes draining the
site of exposure to UVB in vivo. In vitro UVB results in a substantial decrease in LC
accessory cell activity and a reduction in the culture induced up-regulation of certain
surface molecules. If these UVB-induced changes which are seen in vitro were
mirrored by DC migrating to the DLN after irradiation in vivo, it would be possible to
speculate that these DC would fail to induce appropriate effector T cell responses.
However, this seems not to be the case since DC which accumulate in the DLN of
C3H/HeN mice following irradiation in vivo are identical in function and phenotype to
DC from control mice. Caution must be exercised therefore when using in vitro data to
investigate the complex responses seen in vivo after exposure to UVB.
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Figure 1. The expression of FITC on DC enriched from the DLN following skin
painting with FITC. Mice were ear painted with oxazolone or FITC. 18 hours later
enriched oxazolone (filled area) and FITC (open area) bearing DC populations
were prepared from lymph nodes and their fluorescence was analysed using a flow
cytometer.
Figure 2. The effect of UVB on the ability of DC enriched from mice sensitized
with FITC to stimulate FITC specific lymphoproliferation in vitro. The results
from two separate experiments are shown in Figure 2a and 2b. FITC sensitized
responder LNC were cultured alone (T~D. with FITC bearing DC from unirradiated
mice (E2), or FITC bearing DC from mice exposed to UVB (2880 J/m2 total) prior
to skin painting (HD. The cells were cultured for 48 hours and ^H-methyl
thymidine was added to all wells 18 hours prior to termination of culture. The
results are expressed as mean CPM±SD for 5 replicate cultures. The proliferative
CPM for DC cultured alone were below 500.
Figure 3. The effect of UVB on the ability of DC enriched from mice sensitized
with oxazolone or FITC to stimulate oxazolone specific lymphoproliferation
in vitro. In Figure 3a, oxazolone sensitized responder LNC were cultured alone
O. with oxazolone bearing DC from unirradiated mice (EJ), or oxazolone bearing
DC from mice exposed to UVB (2880 J/m2 total) prior to skin painting (U).
Figure 3b is the same except that FITC bearing DC from unirradiated mice or
FITC bearing DC from mice exposed to UVB prior to skin painting (H) were used
instead of oxazolone bearing DC. The cells w^ra cultured for 48 hours and 3F(-
methyl thymidine was added to all wells 18 hours prior to termination of culture.
The results are expressed as mean CPM±SD for 5 replicate cultures. The
proliferative CPM for DC cultured alone were below 500.
Figure 4. The effect of low dose UVB on the allostimulatory capacity of enriched
DC in vitro. Responder LNC from oxazolone sensitized BALB/c mice were
cultured alone or with various numbers of DC enriched (DC+) from unirradiated
C3H mice (■) or UVB (2880 J/m2 total) irradiated C3H mice (A)- Responder
LNC were also cultured with DC depleted (DC-) populations from unirradiated
(□) and UVB irradiated mice (A). The cells were cultured for 120 hours and 3H-
methyl thymidine was added to all wells 24 hours prior to termination of the
culture. The results are expressed as mean CPM±SD for 5 replicate cultures. The
proliferative CPM for DC+ and DC- cells cultured alone were below 500 CPM.
Figure 5. The effect of high dose UVB on the allostimulatory capacity of enriched
DC in vitro. Responder LNC from oxazolone sensitized BALB/c mice were
cultured alone or with various numbers of DC enriched (DC+) from unirradiated
C3H mice (■) or UVB (15 kJ/m2 total) irradiated C3H mice (A>- Responder LNC
were also cultured with DC depleted (DC-) populations from unirradiated (□) and
UVB irradiated mice (/^). The cells were cultured for 120 hours and 3H-methyl
thymidine was added to all wells 24 hours prior to termination of the culture. The
results are expressed as mean CPM±SD for 5 replicate cultures. The proliferative
CPM for DC+ and DC— cells cultured alone were below 500.
Figure 6. The effect of local UVB exposure on the phenotype of DC enriched
from the draining lymph node. Mice were unirradiated or exposed to UVB (2880
J/m2 total) prior to ear painting with oxazolone. DC were enriched from draining
lymph nodes 18-24 hours later. The phenotype of the DC was analysed using flow
cytometric analysis. Ia (a), ICAM-1 (b) and B7-2 (c) expression on DC from
control (thick solid line ) and UVB irradiated mice (thin solid line) was examined.
The appropriate isotype controls were included for control DC (thick hatched line)
and UVB DC (dotted line). One representative experiment is shown, the results
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SUMMARY
The ability of draining lymph node cells (LNC) from BALB/c and
C3H/HeN mouse strains to elaborate interleukin-6 (IL-6) in vitro
following topical exposure to the contact sensitiser, oxazolone, has been
compared. Consistent with previous investigations it was found that
during 24 hr culture LNC prepared from sensitised BALB/c mice
expressed high levels of IL-6 (around 8-10ng/ml); the main or exclusive
source of which is believed to be dendritic cells (DC). In contrast,
draining LNC from C3H/HeN mice exposed in an identical way to
oxazolone produced significantly lower levels of IL-6 (=0.3ng/ml), just
above the limits of detection for the assay (0.15ng/ml). The LNC
proliferative responses and interferon-y (IFN-y) production in vitro were
comparable in both strains. The lack of IL-6 production by C3H/HeN
mice was not due to a lack of DC within LNC populations as similar
numbers of DC accumulated in the draining lymph nodes (DLN) of both
strains following sensitisation. The differences in IL-6 production in the
DLN of C3H/HeN and BALB/c mice did not reflect congenital variation
between these strains with respect to IL-6 production per se as similar
levels of spontaneous and inducible expression of this cytokine in the skin
were measured in BALB/c and C3H/HeN mice following, respectively,
topical exposure to vehicle alone or to oxazolone. In addition, when LNC
from oxazolone treated mice were disrupted by sonication, more IL-6 was
released into the supernatant by LNC from C3H/HeN mice (~2.2ng/ml),
than by BALB/c LNC (~lng/ml). The concentration of intracellular IL-6 in
C3H/HeN LNC fell to 0.7 ng/ml after in vitro culture for 24 hrs, while in
BALB/c the concentration was maintained at similar levels. These data
indicate significant strain variations in terms of the ability of draining LNC
to elaborate IL-6 following immune stimulation. The possible association




The induction phase of allergic contact dermatitis follows the exposure of
susceptible individuals to a sensitising chemical and results in the appearance of
an antigen specific effector T cell population in the periphery. After topical
application of a sensitising chemical to the skin, haptenated endogenous
proteins are processed and immunogenic epitopes displayed on the surface of
Langerhans cells (LC) in the epidermis. Changes induced in the epidermal
microenvironment by exposure to the chemical allergens causes LC, some of
which bear antigen, to migrate from the epidermis and into the afferent
lymphatics. The LC then move to the draining lymph nodes (DLN) where they
accumulate as immunostimulatory dendritic cells (DC)1>2. During migration LC
undergo changes in phenotype and function. They become efficient APC and
acquire the ability to cluster with and activate naive antigen-responsive T cells 3.
This ability to induce the proliferation and differentiation of naive T cell clones
into antigen-specific effector T cells is vital for the induction of primary immune
responses.
Interleukin-6 (IL-6) is a cytokine produced by a wide variety of cells in
response to injury, infection and a range of cytokines. It acts on a number of
cell populations and tissues, with its main effects being the stimulation of
growth and differentiation of B and T lymphocytes, the initiation of acute phase
protein production by hepatocytes and the induction of responsiveness to
Interleukin-3 (EL-3) in bone marrow stem cells 4. The induction phase of skin
sensitisation in BALB/c mice is characterised by the stimulation of proliferative
responses in lymph nodes draining the site of exposure and an associated
production of IL-6 5. The DC that accumulate in the DLN following
sensitisation represent the predominant source of this cytokine6. These DC are
central to the initiation of immune responses and their ability to produce IL-6 is
3
of interest because of the role of this cytokine in inducing (interleukin-2) IL-2
responsiveness in T lymphocytes 4.
Since IL-6 is important in the early stages of T cell activation, the purpose of
these investigations was to investigate the relationship between IL-6 production
by lymph node cells (LNC) in vitro, the proliferation of these LNC and DC
accumulation in the lymph nodes of two strains of mice following contact
sensitisation. The two strains chosen were C3H/HeN and BALB/c that show,
respectively, susceptibility and resistance to the immunosuppressive effect of




Female C3H/HeN and BALB/c strains of mice, aged 6-8 weeks, were obtained
from the specific pathogen-free animal breeding facility at the Medical
Microbiology Transgenic Unit, University of Edinburgh.
Contact sensitiser
Oxazolone (4-ethoxymethelene-2-phenyloxazol-5-one) was obtained from
Sigma Aldrich Co. (Poole, UK). It was used at 1% w/v in 4:1 acetonerolive oil
(AOO).
Enrichment ofdendritic cells
The method of Macatonia et al2 was followed in outline. DC were enriched
from the pooled peripheral lymph nodes (auricular, auxiliary, inguinal and
popliteal) of untreated mice (n=6-10) or from pooled auricular lymph nodes of
mice (n=10-15) 18 hrs after ear painting with 25pl of 1% oxazolone. A single
cell suspension of LNC was prepared by mechanical dissagregation through
200 mesh stainless steel gauze (J. Stanier & Co. Manchester, UK), viable cells
were counted by exclusion of 0.5% trypan blue and were resuspended in
RPMI-1640 (Gibco BRL, Paisley, Scotland) supplemented with 25mM
HEPES, 100 i.u./ml penicillin, 200|ig/ml streptomycin, lOOpg/ml gentamicin,
2mM L-glutamine and 10% heat-inactivated foetal calf serum (FCS) (RPMI-
FCS). DC-enriched populations were prepared by density gradient
centrifugation on Metrizamide (Nygaard, Oslo, Norway). Briefly, LNC were
adjusted to 5xl06 cells/ml in RPMI-FCS and 8ml of the cell suspension were
gently underlayed with 2ml of 14.5% Metrizamide in RPMI-FCS and
centrifuged for 20 minutes (600g) at room temperature. The low buoyant
density population (DC+) that accumulated at the interface was collected and
washed twice with RPMI-FCS. Cells with DC morphology (large granular
cells with dendrites) were counted using a hemocytometer and the results were
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expressed as the number of DC per lymph node± standard deviation (SD) from
5 separate counts.
IL-6 and Interferon-y (IFN-y) production and proliferation ofdraining lymph
node cells
Groups of mice (n=5) received either 25pl of oxazolone or an equal volume of
vehicle alone (n=10) on the dorsum of both ears. At various times thereafter (2,
3 and 5 days), mice were killed and their auricular lymph nodes excised and
pooled for each experimental group. Single cell suspensions of LNC were
prepared by mechanical disaggregation as described previously, cells were
washed and resuspended in RPMI-FCS. Viable cell counts were performed by
exclusion of 0.5% trypan blue. Cells were resuspended at lxlO7 per ml in
RPMI-FCS and seeded into separate plates for measurement of cytokine
production and LNC proliferation. To analyse cytokine production, 1ml of cell
suspension from each group was cultured for 24 or 48 hours in 24-well tissue
culture plates (Costar, Cambridge, Ma.). Culture was terminated by
centrifugation and the supernatants were stored at -70°C until analysis as
described below. To measure proliferation, 5 aliquots of 200jal of LNC at
lxlO7 cells/ml were seeded into 96-well round bottomed tissue culture plates
(Nunc, Roskilde, Denmark). Cells were cultured for 24 hours with lpCi/well
3H-methyl thymidine (3H-methyl thymidine, 5mCi/5ml. Amersham
International pic, UK.). The cultures were terminated by automatic harvesting
and 3H-methyl thymidine incorporation measured as counts per minute (CPM)
using a liquid scintillation analyser (Canberra Packard, Zurich, Switzerland).
The data are presented as the mean CPM±SD from 5 replicate cultures.
Intracellular IL-6 content ofdraining LNC
Mice received either 25pl of oxazolone (n=10-15) or an equal volume of vehicle
alone (n=10-15) on the dorsum of both ears. Three days later groups of mice
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were killed and their auricular lymph nodes excised and pooled. Single cell
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suspensions were prepared as above and cells resuspended at 2x10 LNC in
lml of RPMI/FCS. The cell suspensions were put on ice and sonicated for
3x10 second cycles (Soniprep 150). Finally, the suspensions were microfuged
at 1.5xl04g for 5min, the supernatant was collected and stored at -70°C until
analysis for IL-6 by enzyme linked immunosorbent assay (ELISA). In some
experiments the cells were cultured for 24 hrs in RPMI-FCS at lxlO7 cells/ml.
Following this period in culture the cells were pooled and washed, before being
resuspended at 2xl08 cells/ml and sonicated as described above.
Kinetics ofcytokine production in the skin
The backs of mice were shaved 24 hours prior to sensitisation. Mice were
treated with lOOpl of oxazolone, the same volume of AOO or were untreated.
Groups of mice (n=4) were killed 0, 1, 2, 4, 8 or 24 hrs later, and samples
of skin weighing between 0.04 and O.lg were collected from the treated site.
Each sample was chopped finely, weighed and resuspended in lml of RPMI-
FCS medium in a 1.5ml eppendorf (Alpha Laboratories, Eastleigh, UK).
Each eppendorf was snap frozen in liquid nitrogen, thawed, and the contents
were homogenised with a tissue grinder. The homogenised sample was snap
frozen again, thawed and the contents sonicated for 10 seconds (Soniprep 150,
Sanyo). Debris was removed by centrifugation (5min at 1.5xl04g) and the
supernatant assayed for IL-6 by ELISA. The results are expressed as nanogram
of cytokine per gram of original tissue (ng/g).
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Measurement of IL-6 by cytokine-specific ELISA
IL-6 concentration was analysed using a sandwich ELISA described previously
9. Briefly, plastic microtitre plates (Nunc, Copenhagen, Denmark) were coated
overnight at 4°C with 50pl/well of 2.5 pg/ml rat monoclonal anti-mouse-IL-6
(Genzyme, West Mailing, UK) diluted in 0.1M carbonate buffer (pH 9.6).
Plates were blocked with lOOpl/well of 10% FCS in phosphate-buffered saline
(PBS; pH 7.2) and incubated at 37°C for 30 minutes. Following the blocking
step the recombinant murine IL-6 (Genzyme) was serially diluted in RPMI-FCS
and 100 pi were added to triplicate wells. Sample supernatants were also plated
out in triplicate (lOOplAvell) and the plates incubated at room temperature (RT)
for 2hrs. Next, lOOplAvell of goat anti-murine-IL-6 (R&D Systems,
Abingdon, UK) at 8pg/ml diluted in RPMI-FCS were added to each well and
the plates incubated at RT for 2hrs. The plates were then incubated for 2hrs at
RT with lOOgl/well of 1:500 dilution of donkey anti-goat IgG/horseradish
peroxidase conjugate (Serotec, Oxford, UK) in RPMI-FCS. Following each
incubation, the plates were washed three times with PBS containing 0.05%
Tween 20. The enzyme substrate (o-phenylenediamine dihydrochloride and
urea hydrogen peroxide) was added. The enzyme reaction was stopped after 15
minutes by addition of 50pl/well of 0.5M citric acid. The optical density (OD) of
each sample was measured using a plate reader (Dynatech, UK) at 450nm and a
standard curve plotted using the ODpsonm against the concentration of IL-6 in
ng/ml on a log scale. The standard curve was used to calculate the concentration




IFN-y was analysed by ELISA, using a method described previously 10.
Briefly, plastic microtitre plates (Nunc, Copenhagen, Denmark) were coated
overnight at 4°C with lOOpl/well of 0.5gg/ml rat anti-murine-IFN-y (Genzyme)
diluted in 0.1M carbonate buffer (pH 9.6). Plates were blocked with lOOpl/well
of 5% FCS in PBS and incubated at 37°C for 30 minutes. Following the
blocking step the recombinant murine IFN-y (Genzyme) was serially diluted in
RPMI-FCS and 100 pi were added to triplicate wells. Sample supernatants were
also plated out in triplicate (lOOgl/well) and the plates incubated at room
temperature (RT) for 2hrs. Next, lOOpl/well of goat anti-murine-IFN-y
(Genzyme) at 8pg/ml diluted in RPMI-FCS were added to each well and the
plates incubated at RT for 2hrs. The plates were then incubated for 2hrs at RT
with lOOpl/well of 1:500 dilution of donkey anti-goat IgG/horseradish
peroxidase conjugate (Serotec, Oxford, UK) in RPMI-FCS. Following each
incubation, the plates were washed three times with PBS containing 0.05%
Tween 20. The final steps were as described above for IL-6. The limit of
detection for IFN-y was 0.15 ng/ml.
UV Source and exposure
Mice (C3H/HeN and BALB/c) were irradiated under two Philips TL-20W/12
bulbs with an output range of 270-350nm, peak 305nm, emitting 80mW/ cm2.
The output of this source was determined using a filtered photodiode meter,
calibrated against measurements made with a UV-visible spectroradiometer
(model 742, Optronic Laboratories Inc.) across the spectral range 250-400nm.
The tube to target distance was 16 cm. One minimal erythemal dose for
C3H/HeN mice under these conditions was 1500 J/m2.
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Measurement of contact hypersensitivity responses
To measure the effect of UVB on CH responses the shaved backs of mice were
exposed to two doses of 1440 J/m2 UVB, 48 and 24 hours prior to
sensitisation. The irradiated group and one of the unirradiated control groups
were sensitised on the back with 50gl 1 % oxazolone. The backs of the final
group were painted with 50gl of vehicle alone (AOO). Five days later the ears
of each mouse were measured using an engineers micrometer (Draper SM-510,
Japan) and challenged by epicutaneous application of 25gl of 0.25% oxazolone
in vehicle on the dorsum of each ear. Twenty four hours later the ears were
measured again, the increase in ear thickness calculated and the results
expressed as the mean increase of ear thickness for the group in mm 2± standard
error.
The effect of UVB on IL-6 production and intracellular IL-6 levels
Groups of mice (n=5) were exposed to a single dose of 1440 J/m2 UVB using
the UVB source described above, or were not irradiated (n=3). One, three and
five days later the auricular lymph nodes from irradiated animals and the
peripheral lymph nodes from unirradiated animals were collected and pooled for
each group. Proliferation, IL-6 production and intracellular IL-6 content were
measured as described previously.
Statistics
The Mann-Whitney test was used to analyse differences between groups. These
were considered significant if p<0.05.
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RESULTS
Proliferation and IL-6 production by LNC in vitro
In both C3H/HeN and BALB/c strains, the kinetics of oxazolone induced
proliferation were similar, peaking at 2-3 days after sensitisation and
decreasing by 5 days (Fig la and b). Peak responses were around 65000 CPM
for C3H/HeN mice and 38000 CPM for BALB/c mice. Despite exhibiting
vigorous proliferation, LNC from C3H/HeN mice produced very small
amounts of IL-6; 0.3-0.4 ng/ml on days 2 and 3, and below the limits of
detection (<0.15 ng/ml) by day 5 after sensitisation (Fig la). In contrast, while
LNC from BALB/c mice produced low levels of IL-6, 0.3 and <0.15 ng/ml on
day 2 and 5 respectively, they produced comparatively large amounts of IL-6
(8-10 ng/ml) on day 3 after ear painting with oxazolone (Fig lb). Proliferative
responses were below 5000 CPM and the concentration of IL-6 in supernatants
was below detectable levels (0.15 ng/ml) at all times following vehicle treatment
(data not shown).
This experiment was performed with similar results on four separate
occasions. The data for the day 3 timepoint are presented in Table 1. It can be
seen that the LNC proliferative responses induced by oxazolone were highly
variable in both strains (20000-70000 CPM). However the mean proliferative
responses for both strains were around 40000 CPM and there was no
significant inter-strain difference. There was considerably less variability in
cytokine levels, with C3H/HeN mice producing low to undetectable levels and
BALB/c mice producing significantly (p<0.025) higher amounts of IL-6 in each
of the 4 independent experiments. Similar levels of IL-6 production following
oxazolone sensitisation of BALB/c mice have been reported previously5.
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IFN-y production by LNC
To determine whether the strain differences in IL-6 secretion were a reflection
of reduced cytokine production per se in C3H/HeN mice, the production by
sensitised LNC of IFN-y was examined. The kinetics of IFN-y production by
LNC were similar to those for IL-6 production, with peak levels 2-3 days
following sensitisation. C3H/HeN mice produced 0.66 and 0.58 ng/ml of IFN-
y 2 and 3 days respectively following oxazolone sensitisation. At the same time
points BALB/c LNC produced 1 and 1.06 ng/ml of the cytokine. By day 5
following oxazolone sensitisation the IFN-y production by both strains was
below detectable levels (0.15 ng/ml). Table 2 shows C3H/HeN and BALB/c
LNC proliferative responses and IFN-y production 3 days after oxazolone
sensitisation in three separate experiments. There was no significant differences
between strains with respect to IFN-y levels in the LNC supernatants, with
C3H/HeN mice producing a mean of 0.65±0.13 and BALB/c mice producing
0.95±0.42 ng/ml of IFN-y. Therefore, unlike IL-6, IFN-y production by LNC
was similar for both C3H/HeN and BALB/c mice.
DC numbers in naive and sensitised lymph nodes
Since IL-6 produced by allergen-activated LNC populations is derived
predominantly from DC 6, it was decided to examine DC numbers in the
draining lymph nodes of C3H/HeN and BALB/c mice following sensitisation
with oxazolone. In both strains, treatment with oxazolone induced a comparable
increase in DC numbers in the DLN 18 hrs later. In C3H/HeN mice DC
numbers increased from a mean of 2759 to 23479 per node, whereas in
BALB/c mice identical treatment caused an increase in mean DC numbers from
2127 to 22920 per node.
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IL-6 content of oxazolone-sensitised LNC
Immediate sonication of LNC taken from both strains 3 days after sensitisation
with oxazolone resulted in detectable levels of IL-6 in the supernatant (Fig 2).
EL-6 levels were higher in LNC from sensitised C3H/HeN and BALB/c mice,
compared with LNC from vehicle-treated controls. In addition, sonication of
LNC from sensitised C3H/HeN mice resulted in higher levels of IL-6 being
released into supernatant than were released from B ALB/c LNC after identical
treatment.
In order to investigate further the strain differences in IL-6 secretion,
C3H/HeN and BALB/c mice were sensitised with oxazolone and 3 days later
LNC were prepared and cultured for 24 hrs. Again, there was a marked
difference in the secretion of IL-6 by the two strains, with IL-6 being below the
detectable limits in the supernatants from C3H/HeN LNC (<0.15 ng/ml) and
present at high concentrations (4.3 ng/ml) in the supernatants from BALB/c
LNC. Sonication of the cells after 24 hrs released 0.72 and 2.38 ng/ml of IL-6
into the supernatant from C3H/HeN and BALB/c LNC respectively.
Cutaneous IL-6 production by C3H/HeN and BALB/c mice
IL-6 is produced constitutively by epidermal LC 11 and keratinocytes can be
induced to synthesise IL-6 12. Fig 3 shows that similar amounts of IL-6 were
produced constitutively in the skin by both C3H/HeN (3.83±0.97 ng/g of
tissue±SD, n=4) and BALB/c mice (3.37+0.58 ng/g of tissue±SD, n=4).
Painting the skin of C3H/HEN or BALB/c mice with vehicle did not cause a
substantial increase in IL-6 production over constitutive levels. In C3H/HeN
mice, sensitisation with 1% oxazolone induced significant increases (when
compared with vehicle controls) in IL-6 levels (p<0.025) at all timepoints
except 0 hr. In BALB/c mice, oxazolone induced a significant increase
(p<0.025) in IL-6 levels compared to the vehicle control at all timepoints. The
kinetics, but not the magnitude, of IL-6 production were similar in both strains,
with IL-6 levels in each instance peaking 4-8 hours post-sensitisation and
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decreasing by 24 hrs (Fig 3). C3H/HeN mice produced higher levels of IL-6
following sensitisation than did BALB/c mice. At the peak 4 hour timepoint,
skin from C3H/HeN mice contained almost twice as much IL-6 than skin from
BALB/c mice (36 ng/g and 20 ng/g tissue respectively). This experiment has
been repeated on a separate occasion for each strain with similar results.
Suppression of CH responses by low-dose UVB
C3H/HeN and BALB/c mice have been characterised as being, respectively,
UVB-resistant and susceptible in a number of different studies using a variety
of UVB exposures and CH regimens 8,n. To confirm that these mice display
consistent differences in susceptibility to UVB in our hands, we exposed the
backs of mice to 2x1440 J/m2 of broadband UVB 48 and 24 hrs prior to
sensitisation on the irradiated site with oxazolone. The irradiation resulted in a
significant (p=0.05) 31% reduction in ear swelling in C3H/HeN mice
challenged with oxazolone (Fig 4a). In Fig 4b it can be seen that exposure of
BALB/c mice to the same dose of UVB failed to cause a significant suppression
of contact hypersensitivity. Therefore, using the standard immunosuppressive
protocol employed here, C3H/HeN mice were found to be susceptible and
BALB/c mice resistant to the local suppression of CH responses by UVB.
IL-6 production and intracellular levels of IL-6 following UVB
Exposure to UV has been reported previously to result in the accumulation of
DC in the DLN 14. In the present study, exposure to a single dose of 1440 J/m2
of UVB caused a comparable increase in DC numbers in DLN of both strains
18 hrs later. In C3H/HeN mice DC numbers rose from 2083 to 7524 DC/LN,
and from 2530 DC/LN to 6223 DC/LN in BALB/c mice.
Though UVB caused an accumulation of DC in the DLN, LNC from lymph
nodes draining irradiated skin failed to produce appreciable levels of IL-6 in




Here we report a marked strain difference with respect to the ability of
LNC to secrete IL-6 after skin sensitisation. LNC from BALB/c mice produced
high levels of IL-6 in vitro with IL-6 levels peaking 3 days after sensitisation.
In contrast, draining LNC from C3H/HeN mice secreted low or undetectable
levels of IL-6 when sensitised identically. Proliferative responses and IFN-y
secretion by both strains were comparable, suggesting either that IL-6
availability is not an absolute requirement for LNC activation, or that the low
concentrations of IL-6 secreted in culture by C3H/HeN LNC give sufficient
co-stimulation for T cell activation.
The kinetics of IL-6 production in the skin after treatment with
oxazolone was also investigated. Previous studies using contact allergens and
irritants have shown that IL-6 is induced by contact allergens but not irritants,
when these chemicals are used at doses which cause comparable inflammatory
responses 15. Similar levels of IL-6 were produced constitutively in the skin of
both C3H/HeN and BALB/c mice. In both strains oxazolone treatment induced
significant increases in IL-6 production peaking 4 hours after sensitisation.
Therefore the lack of IL-6 secretion by sensitised LNC from C3H/HeN mice
does not reflect a systemic inability to produce IL-6. Both keratinocytes and LC
are able to produce IL-6 n'12. This study has not addressed whether LC in the
skin of C3H/HeN mice have the ability to produce IL-6, as has been reported
for LC from BALB/c mice 16.
DC are the main source of IL-6 within LNC populations. Complement-
depletion of DC from oxazolone-sensitised LNC suspensions reduces IL-6
activity by more than 75% but does not affect proliferative responses6. If the
same method is used to deplete T cells, the proliferation but the not IL-6
production by LNC in vitro is affected. Because DC are the main source of IL-6
within lymph nodes, the number of DC that accumulated in the DLN of both
strains following sensitisation was examined. Treatment with oxazolone
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resulted in the accumulation of similar numbers of DC in both C3H/HeN and
BALB/c mice. Therefore the lack of IL-6 production in C3H/HeN mice does
not reflect a paucity of DC in the DLN.
LNC from C3H/HeN and BALB/c mice were sonicated to examine
strain differences in the intracellular levels of IL-6. Sonicating LNC
immediately after removal from oxazolone treated C3H/HeN and BALB/c mice
caused the release of appreciable quantities of IL-6 into supernatants, while
sonication of LNC from mice treated with the vehicle alone resulted in less IL-6
activity in the supernatant, suggesting that LNC from both strains are capable of
translating IL-6 protein. The inability of oxazolone-sensitised LNC from
C3H/HeN mice to secrete IL-6 in vitro may be associated with a lack of IL-6
production, or may reflect a failure in the ability of cells to secrete IL-6. To
investigate this, oxazolone-sensitised LNC from C3H/HeN and BALB/c mice
were cultured for 24 hrs and the concentration of IL-6 in the supernatants and
sonicates was measured. The inability of C3H/HeN mice to secrete IL-6 in
culture was not associated with an accumulation of intracellular IL-6. Therefore
it is likely that the low levels of IL-6 produced by C3H/HeN LNC reflect a lack
of IL-6 production by LNC, rather than a failure in IL-6 secretion.
C3H/HeN and BALB/c mice show, respectively, susceptibility and
resistance to the immunosuppressive effect of UVB on CH responses8. In
C3H/HeN mice exposure to 1440 J/m2 of UVB 48 and 24 hours prior to
sensitisation caused a 31% suppression of CH responses to oxazolone. In our
hands CH responses were not suppressed in BALB/c mice following exposure
to the same dose of UVB. The basis for this strain difference is unclear, but
UVB may act by altering the DC population that migrates from irradiated skin to
the DLN. This being the case it is interesting that DC from C3H/HeN and
BALB/c mice display such marked differences in their ability to produce IL-6
following sensitisation.
In agreement with previous studies 17, we found UVB-induced
accumulation of DC in the local DLN of C3H/HeN mice and in addition
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recorded comparable numbers of DC in the DLN of BALB/c mice following
UVB. However, at least in the BALB/c strain, these DC differ substantially
from those which migrate to the DLN after contact sensitisation. While LNC
from sensitised BALB/c mice produce high levels of IL-6 and T cell derived
IFN-y, LNC from UVB treated mice fail to produce either cytokine (data not
shown for IFN-y). This suggests that DC migration is not in itself sufficient for
all aspects of DC maturation and that an antigen dependent signal is required for
IL-6 production by DC and the induction of IFN-y production by T cells.
In conclusion, we have shown that in C^H/HeN mice oxazolone
induced DC accumulation in the DLN but, unlike DC from BALB/c mice, DC
from C3H/HeN mice produced extremely low levels of IL-6. The lack of IL-6
production by C3H/HeN LNC did not affect LNC proliferative activity
in vitro. The marked difference in DC activity following sensitisation is
interesting and may result in functional differences in the induction of effector
cell populations in these strains.
Further work is required to investigate the association of IL-6
production by DC in the DLN and the susceptibility of these mice to UVB-
induced immunosuppression. Initially it would be informative to characterise
the ability of DC from other UVB susceptible and resistant strains to produce
IL-6 following contact sensitisation. This work would confirm if IL-6
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Figure 1. Kinetics of IL-6 production and proliferative activity of C3H/HeN (a) and
BALB/c (b) LNC in vitro. LNC were taken from oxazolone treated mice and cultured for 24
hours. Proliferative responses in CPM+SD (closed circle) and IL-6 production in ng/ml±SD
(open circle) are shown. SD's below 4000 CPM for the proliferative data and below 0.8
ng/ml for the IL-6 data are not shown. Limit of detection for IL-6 = 0.15 ng/ml.
Figure 2. Intracellular IL-6 content of LNC from C3H/HeN and BALB/c mice. The results
show IL-6 levels (ng/ml±SD) in supernatants following sonication of LNC. Draining LNC
were removed from mice 3d after skin painting with oxazolone (Ox) or vehicle (AOO). IL-6
was below detectable levels in sonicates of C3H/HeN LNC from AOO treated mice.
Figure 3. Kinetics of IL-6 production in the skin of C3H (triangles) and BALB/c mice
(circles) after painting with oxazolone (closed) and AOO (open); control (naive) mice were
untreated. IL-6 levels are shown as ng per gram tissue±SD. SD's less than 1 ng/g not shown.
Limit of detection for IL-6 = 0.15 ng/ml.
Figure 4. Suppression of CH responses to oxazolone by UVB in C3H/HeN (a) and BALB/c
mice (b). Mice were exposed to UVB (1440 J/m2, -48 and-24 hrs) or were unirradiated,
prior to epicutaneous application of vehicle (AOO) or oxazolone (Ox) on the same site. Five
days later the ears of all mice were challenged with oxazolone and the results expressed as




















66730 0.16 36727 8.00
22838 0.26 30779 8.10
63816 0.35 72199 7.10
22265 0.15 20365 10.5
mean±SEM 43912112347 0.2310.05 40018111242 8.4210.72
Table 1. Strain differences in LNC proliferative activity and IL-6 production in vitro
following oxazolone sensitization. Three days after ear painting with oxazolone
auricular lymph nodes were removed, single cell suspensions of LNC prepared and
cultured for 24 hours. The proliferative activity was analysed by 3H-thymidine
incorporation and supernatants were examined for IL-6 activity by ELISA. The mean
CPM (n=5) and mean IL-6 (n=3) levels from four separate experiments are shown for
each strain. In the final row these figures have been used to provide the mean
proliferative response and IL-6 concentration ± SEM for the four separate experiments









66730 0.80 30779 1.06
63816 0.58 34613 0.49
15338 0.57 72199 1.31
mean±SEM 48628±16666 0.65±0.08 45864±13214 0.95±0.24
Table 2 Strain differences in LNC proliferative activity and IFN-y production in vitro
following oxazolone sensitization. Three days after ear painting with oxazolone,
auricular lymph nodes were removed, single cell suspensions of LNC were prepared
and cultured for 24 hours. The proliferative activity was analysed by 3H-thymidine
incorporation and supernatants were examined for IFN-y activity by ELISA. The mean
CPM (n=5) and mean IFN-y (n=3) levels from three separate experiments are shown
for each strain. In the final row these figures have been used to provide the mean
proliferative response and IFN-y concentration 1 SEM for the three separate









Time following exposure (days)
 
THE ROLE OF CIS-UROCANIC ACID IN UVB-INDUCED IMMUNOSUPPRESSION.
M. B. Lappinl, A. EI-Ghorr*, I. Kimber2, M. Norval K
1 Edinburgh University, Edinburgh and 2 Zeneca, Macclesfield, U.K.
UV radiation causes many alterations in skin including loss of Langerhans cells (LC) and
also results in accumulation of dendritic cells (DC) in the lymph nodes draining the site of
irradiation. One epidermal mediator which may be involved in the immunomodulation is
cis-urocanic acid (ds-UCA), formed from the naturally occurring trans-isomer on UV
exposure. In this study the role of ds-UCA in epidermal LC depletion and DC
accumulation in the lymph nodes was examined. Mice were painted on the ears with ds-
UCA or UVB irradiated (144 mJ/cnr2) on their shaved backs; in some cases pre-treatment
by intraperitoneal injection of a monoclonal antibody with specificity for cjs-UCA was
carried out 2 h previously. Mice were ki^ed 24 h later. The number of LC in the epidermal
sheets prepared from the ears was counted using ATPase staining, and the number of DC in
the lymph nodes estimated following metrizamide purification. UVB exposure or ds-UCA
caused a substantial reduction in epidermal LC numbers and the depletion was abrogated in
both cases by pre-treatment with the anti-cis-UCA antibody. UVB exposure, but not ds-
UCA, induced DC accumulation in lymph nodes, and this migration was not affected by the
anti-ds-UCA antibody. Thus cis-UCA is an important mediator of some, but not all, the
effects of UVB on the immune system.
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IL-6 PRODUCTION BY DRAINING LYMPH NODE CELLS IN UVB RESISTANT
AND UVB SUSCEPTIBLE STRAINS OF MICE. M.B. Lappin. R.J. Dearman1 M.
Norval, I. Kimbcr1. Department of Medical Microbiology, University of Edinburgh
Medical School, Edinburgh. Seneca, Central Toxicology Laboratory, Alderley Park,
Cheshire
The induction phase of skin sensitization in mice is characterized by the stimulation
of proliferative responses in lymph nodes draining the site of exposure. Proliferative
activity has been shown previously to be associated with the production by draining
lymph node cells (LNC) of interleukin-6 (IL-6); the main source of which appears to
be dendritic cells. As IL-6 is known to be an important costimulator in T lymphocyte
activation, we have compared the production by LNC of this cytokine in two strains of
mice, BALB/c and C3H-HeN, which are considered, respectively, to display resistance
or susceptibility to ultraviolet B (UVB)-mediated immunosuppression. Mice were
treated on the dorsum of both ears with 1% oxazalone (Ox) in 4:1 acetone:olive oil
(AOO), or with AOO alone. Three days later draining (auricular) lymph nodes were
excised and a single cell suspension of LNC prepared. LNC were cultured for 24 or 48
hours. The concentration of IL-6 (pg/ml) in tne supernatants was measured by
enzyme-linked immunosorbent assay. Exposure of either strain of mice to vehicle
Alone failed to stimulate the production of detectable levels (150 pg/ml) of IL-6.
Sensitization of BALB/c strain mice with Ox provoked a vigorous proliferative
response by LNC (measured by incorporation of radiolabelied thymidine) and high
levels of IL-6. In contrast, although LNC prepared from sensitized C3H-HeN mice
exhibited comparable proliferative activity, the production of IL-6 was substantially
less. These data reveal marked strain differences in the stimulation of IL-6 responses
during the induction of skin sensitization and suggest an association between induced
levels of this cytokine and susceptibility to UVB-mediated immunosuppression.
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OP82 CYTOKINE EXPRESSION AND CELL MOBILISATION IN RAT
LUNG INFLAMMATION
C.M.M. Williams. 'I..Smith. +B. F.Flanagan. 'L. S.Clegg and
J.W.Coleman
Dept of Pharmacology., ^Dept of Immunology.. Unhersity of
Liverpool L69 3BX. and "Research Dept. Knoll Pharmaceuticals. NG2
3AA. Nottingham.
We investigated kinetics of mRNA expression for IL-5. IL-6 TNF-a.
MIP-2 and IFN-y by bronchoalveolar (BAL) cells and patterns of cell
infiltration into the bronchoalveolar lumen in a rat model of Sephadex-
induced lung inflammation. Semi-quantitative analysis by RT-PCR of
RNA extracted from BAL cells from Sephadex treated rats revealed
significant increases in cytokine mRNA. IL-5 mRNA peaked at 48-72
hr. IL-6 mRNA peaked at 48 hr. TNF-a mRNA remained elevated
from 6 to 72 hr. MIP-2 mRNA peaked at 24hr, and IFN-y mRNA was
elevated from 24-72 hr. Mononuclear cells reached peak values three
days after the Sephadex injection whilst neutrophils peaked at 24-48
hr and eosinophils at 72 hr post-treatment. Similarities between the
patterns of neutrophilia, eosinophils and cytokine mRNA expression
seen here compared to those observed in human asthma suggests that
this model may prove valuable for further investigation of the role of
cytokines in inflammatory lung disease.
OP85 of worst Ti wok Ntc rosis F \c iok-\lpii\ in worst
C ENTRAL CORNtA tXPLANTS. DEN tl.OPWtNT OF \\ ELISA FOR THE
Ql ANTITATION OF WTNFo.
I De KeseP. A/. Sekine-Okano . R Lucas' I) Rungger . D. Pallet' (I
P.. (JrcnP. P. A/. Leuenberger. and P. Rungger-Brandle
fnnogenetic.s \ . L. Zwijnaarde. Belgium: Electron Microscopy Lab .
Dept. Ophthalmology. Geneva. Switzerland. l)ept Pathol . CMC
Geneva. Switzerland: Dept. Animal Biol. Cniv. Geneva. Sw itzerland
To accurately determine mTNF levels in various biological fluids and
cell culture supernatants. a mTNF ELISA was developed. The ELISA
uses a rabbit anti-mTNF polyclonal antibody as capturing antibody, and
as detection antibody (biotinylated). The detection limit of thetossay is
15 pg ml: the measuring range lies beween 31 and 3000 pg. ml.
The utility of the assay was demonstrated by examining the capability
of corneal cells to release mTNF upon lipopolysaccharide (LPS)
stimulation and investigating whether mTNF production could be
modulated by pharmacological agents. LPS stimulated mTNF release
into culture medium. Addition of budesonide or prednisolone inhibited
the release of LPS-stimulated mTNF. while cyclosporin A had no effect.
Conclusions. Upon L.PS stimulation of epithelial cells from mouse
central cornea. mTNF is produced and released into the medium.
Corticosteroids, such as prednisolone and budesonide. effectively inhibit
mTNF production.
QP83 INDUCED INTERLEUKIN-6 (IL-6) PRODUCTION IN THE SKIN
AND LYMPH NODES OF UVB RESISTANT AND SUSCEPTIBLE
MICE.
MB Lappin. RJ Dcarman1. M Norvai. I Kimber'.
Department of Medical Microbiology, University of Edinburgh.
1 Zeneca. Central Toxicology Laboratory. Alderlev Park. Cheshire.
Mice of BALB/c and C3H/HeN strains are considered to be resistant
and susceptible respectively to suppression of contact hypersensitivity
induced by UVB irradiation. It has been demonstrated previously that
topical exposure of BALB/c mice to the contact allergen oxazolone
stimulated vigorous IL-6 production ( = I0()()()pg/ml i by draining
lymph node cells (LNC) on culture in vitro, the major source of the
cytokine being dendritic cells. We now report that while exposure of
C3H/He.N mice to oxazolonc under identical conditions results in
proliferative responses of LNC of equivalent magnitude to those
observed with LNC from BALB/c mice. IL-6 production was. by
comparison, profoundly reduced (= 3(X)pg/ml). These differences do
not reflect a generalised strain difference in IL-6 production as
BALB/c and C3H mice exhibit similar levels of constitutive and
oxazolone-indueed IL-6 expression in the skin. The data reveal an
interesting association between susceptibility to UVB and IL-6
expression by LNC.
OP86 CRYPTOCOCCAL ENVELOPE * COMPONENTS INDUCE
DIFFERENT TNF-a LEVELS IN HUMAN MONOCYTES.
W. Chaka. J. Scharringa, V. Vaishnav'. R. Cherniak*. A. Verheul. J.
Verhoef, H. Snippe and I.M. Hoepelman. Eijkman-Winkler Institute.
Utrecht University, The Netherlands, and Georgia State University,
Atlanta, Georgia, USA.
Crs'ptococcus neoformans enhances HIV replication in peripheral blood
mononuclear cells (PBMC) probably by the induction of cytokines.
Therefore, we studied the ability of whole ervptococci (CN), the
capsular polysaccharide glucuronoxvlomannan iGXM). and the minor
carbohydrate antigens, galactoxvlomannan t.GalXM) and two manno-
protein fractions (MP1 and MP2) to induce TNF-a secretion in PBMC.
CN and the purified components were opsonised either with heat-
inactivated or non-treated human pooled serum (HPS) and subsequently
incubated with PBMC. CN and all the components induced TNF-a as
determined by ELISA, but differences between the amount of TNF-a
evoked and the required opsonin was observed. MP2 was the most
potent TNF-a inducer. TNF-a induction by CN. GXM and GalXM was
complement dependent. In contrast. MP2 induced TNF-a when
opsonised with either heat inactivated HPS. HPS or agammaglobu-
linaemic serum. TNF-a production induced by MP2 could be blocked
by two anti-CD 14 monoclonal antibodies whilst isotvpe immuno¬
globulins did not. These results suggest that possibly the activation by
MP2 of PBMC to release TNF-a involves the CD 14 receptor.
QP84 ANTIGEN-INDUCED T CELL INFLUX AND CHANGES IN
CYTOKINE mRNA IN THE BROWN NORWAY RAT LUNG.
S Underwood, D Noble, C Lawrence. M Foster. S Webber
and J-A Karlsson.
Rhone-Poulenc Rorer, Dagenham Research Centre, Essex RM10 7XS.
Cytokines secreted by Th2-type CD4"r ■ T lymphocytes are
implicated as mediators of allergic airway inflammation in asthma.
IL-4 induces IgE class switching and IL-5 promotes airway
eosinophilia which is implicated in the pathogenesis of airway
inflammation and hyperreactivity.
Brown Norway rats (group size n = 5) were challenged with
inhaled antigen (ovalbumin) and inflammatory changes in the lung were
studied 24 hours later. There was an influx of CD4+ T cells
(+ 64 %, p < 0.01) and eosinophils (+ 607 %, p < 0.001) into the lung
tissue, but no change in the number of CD8+ T cells mRNA was
extracted from lung tissue and reverse transcribed. PCR revealed
increased expression of mRNA for IL-4 and IL-5, but not the
Thl cytokine IFNy The increase in airway resistance induced by
aerosolized acetylcholine (20 nM, 8 sec) was potentiated (+ 16 ± 5 %
in unchallenged rats, + 68 ± 15 % in challenged rats, p < 0.01)
demonstrating that the airways were hyperreactive.
These data suggest that CD4+ T cells of a Th2 phenotype may be
involved in the orchestration of allergic airway inflammation in the
Brown Norway rat. This model allows further definition of the
pro-inflammatory roles of CD4"1" T cells in the pathology of asthma
OP87 INFLUENCE OF DEXAMETHASONE ON ALLERGEN-
ACTIVATED LYMPH NODE CELL INTERFERON-7
EXPRESSION
R J Dearman and I Kimber. Zeneca Central Toxicology Laboratory,
Alderley Park. Macclesfield, Cheshire, SK10 4TJ.
We have demonstrated previously that draining lymph node cells
(LNC) prepared from mice exposed topically to the contact allergen
oxazolone secrete substantial amounts of the T helper I (Thi) cytokine
interferon y (IFN-7; measured by enzyme-linked immunosorbent
assay) and display significant proliferative activity (analyzed by 24hr
incorporation of radiolabeled thymidine). Culture of LNC with
2/zg/ml of the T cell mitogen concanavalin A potentiated markedly
both thymidine incorporation and IFN-7 expression. We have now
examined the influence of the synthetic glucocorticoid dexamethasone
on LNC IFN-7 production and proliferation. Under conditions of
exposure where proliferative activity was unaffected, dexamethasone
(0.1 to 100^M) inhibited profoundly spontaneous and mitogen-
augmented IFN-7 production by LNC. These data demonstrate that
dexamethasone modulates the secretion in vitro of murine I FN-y in
a manner analogous to that reported previously for the production of
human IFN-7 in vivo and in vitro.
Cytokines
'
the epidermis and marked proliferation and activation of vessels in the
sip dermis with an inflammatory infiltrate consisting mainly of eosinophilic
ranulocytes in BN and mononuclear cells in Lewis and Wistar rats. In BN
id Lewis rats and less so in Wistar rats, HCB caused a dose-dependent
itivation of endothelial cells of lung venules. At the ultrastructural level,
-le endothelial cells were characterized by a marked proliferation of Golgi
-nd RER and resembled high endothelial venules (HEV) in lymph nodes
-nd were therefore called HEV-like. The observation that HCB causes strain-
-ependent lesions in skin and lung, makes an immune etiology conceivable.
-324 INHIBITORY EFFECTS OF PENICILLIN G (PCG) AND
LATAMOXEF (LMOX) ON ANAPHYLACTIC REACTIONS
INDUCED BY THEIR PROTEIN CONJUGATES IN GUINEA
PIGS
>1 Katsutani, T Aoki, H Shionoya and F Sagami. Department of Drug
Safety Research, Eisai Co., Ltd., Gifu. Japan. Sponsor: G K Hanasono
■Since anaphylactic reactions are known to be inhibited by the existence of
l hapten, it is of interest to examine the inhibitory potential of a drag on
anaphylactic reactions in animal models, in relation to prediction of incidence
of anaphylactic reactions in clinical use. Cutaneous anaphylactic reactions
were provoked by intravenous administration of the corresponding antibiotic-
ovalbumin (OVA) conjugate in guinea pigs passively sensitized with antise¬
rum to PCG or LMOX. Inhibition reactions were assessed by co-administra¬
tion of one of the drags at doses of 1, 10 and 100 mg/kg with the respective
antibiotic-OVA conjugate. LMOX inhibited the reactions from the lowest
dose tested, whereas the reactions were not affected by administration of
PCG at the highest dose. These results coincide with the previously reported
in vitro inhibitory effects of these antibiotics on ELISA for antibiotic-specific
antibody analysis", and suggest a possible mechanism for the higher incidence
of clinical anaphylactic reactions caused by PCG than by a new-generation
cephalosporin, LMOX.
1) Katsutani, N. and Shionoya, H. (1993). Int. Arch. Allergy Immunol.
100, 128-134.
326 THE EFFECTS OF DIETHYLSTILBESTROL (DES) IN THE
BROWN NORWAY RAT MODEL OF AUTOIMMUNE
DISEASE
N. Harper, L. F. Butterworth. D. W. David, and K. L. White Jr. Dept.
Pharmucol./Toxicol. Medical College of Virginia, Virginia Commonwealth
Univ., Richmond, VA
The Brown Norway (BN) rat develops an autoimmune disease that is similar
to human systemic lupus erythematosis (SLE) but will do so only after
chemical exposure to immunomodulatory agents such as mercuric chloride
(HgCl2). Like humans with SLE, the BN rat is predisposed to respond immu¬
nologically with TH2 response that is directed towards antibody production
rather than cell-mediated immune functions; this may be the mechanism by
which chemicals induce autoimmune disease in this model. Since estrogen
induces a polyclonal activation of B-cells and is implicated in the development
of some autoimmune disorders, it was hypothesized that chemicals with
estrogenic activity will exacerbate autoimmune disease in the BN rat. DES,
a drag with potent estrogenic activity, was used to test the hypothesis. Initial
time course studies showed that female Brown Norway rats gavaged with
DES (50 mg/kg/day) had increased serum titers of IgE which peaked at week
4. A dose-response study showed that IgE and anti-DNP IgG titers increased
in a dose-dependent manner and peaked at a dose of 50 p.g/kg/day. Increases
in anti-dsDNA IgG and anti-laminin IgG were also observed. The percentage
of spenocytes expressing of MHC II were increased and the IL-2 receptor
expression was decreased at all doses. The results show that DES increases
serum immunoglobulin titers which may exacerbate the onset of autoimmune
disease in this model.
325 THE EFFECTS OF TWO MECHANISTICALLY DISTINCT
COMPOUNDS ON THE CYTOKINE PRODUCTION BY AN IN
VITRO T CELL SYSTEM
B P Lawrence, M Meyer, E A Dearstyne, D J Reed, and N 1 Kerkvliet.
Depts. of Agricultural Chemistry, Biochemistry & Biophysics, and
Environmental Health Sciences Center, Oregon State University, Corvallis,
OR
The immune system is a potential target for the toxic effects of many environ¬
mental and pharmacologic agents. Moreover, the alteration of growth factors
and cytokines has been shown to be the target of chemical-induced toxicity.
We used antigen-specific helper T (TH) clones as an in vitro model system
study the effects of two mechanistically distinct chemicals on cytokine pro¬
duction. 1,2-Dichloroethane (DCE) is widely used as an industrial solvent
and insecticidal fumigant. 17p-Estradiol (17fi-Es) is a hormone and is also
the prototype for a class of estrogen-like chemicals found in the environment.
We have examined the effects of DCE and 17(3-Es exposure on cytokine
production by both THl-type and TH2-type murine cell lines. Cells were
activated with antigen and irradiated syngeneic antigen presenting cells in
the absence or presence of DCE or 17(3-Es, and the release of cytokines into
culture supernatants was measured over a 72 h timecourse. DCE (0.1 to 1.0
rnM) caused a dose-dependent increase in the production of interferon gamma
(IFN-y) by the TH1 cell line F1.A.2, and 50% increase in both interleukin
(IL)-4 and IL-6 by the TH2 cell line 10.5.17. These effects were also observed
when the polyclonal T cell activator anti-CD3 was used to activate TH clones.
Preliminary studies have shown that 17(3-Es (10 nM) treatment decreased
IFN-y production by F1.A.2 cells, but not by another TH1 cell line. 17(3-Es
did not alter IL-6 production but did suppress IL-4 production by two different
Th2 cell lines (F4 and 10.5.17). The results from these studies suggest that /7~\
both DCE and 17|3-Es are capable of modulating T cell cytokine production. ^ J
Supported by NIH Grant ES00040 (NIK and DJR). '
327 CELLULAR IMMUNE MEDIATION OF HALOTHANE
INDUCED HEPATOTOXICITY
S M Furst and A J Gandolfi. Department of Anesthesiology, University of
Arizona. Tucson, AZ
Halothane, once the anesthetic of choice for general anesthesia, has declined
in use since its association with liver complications with a high potential
for lethality. There is ample evidence suggesting halothane hepatitis is an
idiosyncratic autoimmune reaction brought about by the formation of neoanti-
gens that have been generated by covalent binding of a halothane biotransfor¬
mation intermediate. The guinea pig is being developed as a sensitive animal
model to investigate an immune-mediated mechanism for halothane hepatitis.
Male Hartley guinea pigs were exposed to 1.0% halothane, 40% oxygen for
4 hr. Kupffer cells and lymphocytes were isolated on various days post¬
exposure. Lymphocyte transformation tests (LTT) using various TFA-anti-
gens as well as Kupffer cells were performed. Using gel electrophoresis and
Western blotting techniques, it has been demonstrated that Kupffer cells
obtained from halothane treated guinea pigs do carry TFA-adducts as recog¬
nized by an anti-TFA antibody. Bands were most prominent by day 2 with
the majority diminishing by day seven. No TFA-adducts were detected in
any other organ macrophages isolated indicating the immune response to be
initiated within the liver by Kupffer cells. The LTT showed a four-fold
increase in splenocyte proliferation in response to TFA-guinea pig albumin
(GSA). Peak levels of sensitization were observed in splenocytes isolated
from guinea pigs 28 days after the animals were exposed to halothane.
Stimulation occurred after second and third exposures as well. No significant
increase in proliferation could be detected with TFA-lysine or GSA. A ten¬
fold increase in splenocyte proliferation also occurred in response to Kupffer
cells from halothane exposed animals. Autologous splenocytes demonstrated
more of a response from treated vs control animals and this could be blocked
using anti-MHC II antibody indicating the involvement of MHC II. These
results demonstrate Kupffer cells to be the initial ceils that present altered
proteins in the liver to cells of the immune system. This study provides good
evidence that halothane hepatitis is mediated by a cellular immune response.
(Sponsored by Procter & Gamble Pharmaceuticals).
328 IMMUNOTOXICITY OF ULTRAVIOLET (UV) B
IRRADIATION: CORRELATION WITH INTERLEUKIN 6 (IL-
6) PRODUCTION
M B Lappin1, R J Dearman2, 1 Kimber and M Norval1. 'Department of
Medical Microbiology, University of Edinburgh, Scotland; 'Zeneca
Central Toxicology Laboratory, Macclesfield, England
Susceptibility to UVB-mediated immunotoxicity is known to differ among
strains of mice. In the present study we have examined the association
between susceptibility to UVB irradiation-induced inhibition of contact sensi¬
tization and the production of IL-6 following topical exposure to a contact
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allergen. Two strains of mice. BALB/c and C3H/HeN. have been compared
■hat display, respectively, low and medium/high sensitivity to the immunosup¬
pressive effects of UVB light. Topical exposure of BALB/c and C3H/HeN
■nice to a skin sensitizing concentration (1 %) of the contact allergen oxazolone
■induced vigorous proliferative responses by draining lymph node cells (LNC)
of comparable magnitude. Under these same conditions of exposure very
substantial differences in the production by draining LNC of IL-6 (measured
-by enzyme-linked immunosorbent assay) were observed. Whereas supema-
-tants prepared from cultures of BALB/c LNC contained approximately 10ng/
ml IL-6, those from C3H/HeN LNC contained on average 0.3ng/ml. Such
differences do not, however, reflect a generalized strain variation with respect
to IL-6 expression as in each case treatment with oxazolone induced similar
increases in the production of this cytokine in the skin. The data reveal an
interesting association between susceptibility to UVB-mediated immunosup¬
pression and the ability of activated LNC to elaborate IL-6.
329 c-NAPHTHYLISOTHIOCYANATE STIMULATES
NEUTROPHILS TO RELEASE PROTEASES THAT ARE
TOXIC TO HEPATOCYTES IN VITRO
D A Hill and R A Roth. Dept. of Pharm./ Tox., Inst, for Environ. Tox.,
Michigan State University, East Lansing, Ml
Administration of a-naphthylisothiocyanate (ANIT) to rats causes neutrophil-
dependent necrosis of bile duct epithelial and periportal parenchymal cells.
Previous studies demonstrated that ANIT can activate neutrophils. We
hypothesized that proteolytic enzymes from ANIT-treated neutrophils would
damage hepatocytes (HCs) in vitro. To test this hypothesis, neutrophils were
isolated from Sprague Dawley rats and incubated with ANIT for 18 hours.
ANIT (6-50 uM) was not toxic to neutrophils as indicated by lactate dehydro¬
genase release into culture medium. The conditioned medium from ANIT-
treated neutrophils (ANCM) was collected, centrifuged, added to isolated
HCs and incubated for 8, 16 or 24 hours. Toxicity of HC cultures was
indicated by alanine aminotransferase (ALT) release. Conditioned medium
collected from neutrophils exposed to 50 or 25 uM ANIT for 16 to 24 hours
caused a pronounced release of ALT from HC cultures. The addition of
alpha-1-antitrypsin or trypsin/chymotrypsin inhibitor to ANCM-treated HC
cultures afforded protection from toxicity. These data suggest that ANIT
stimulates neutrophils to release proteases which cause hepatocellular damage
in vitro. (Supported by NIH grant ES04139).
330 THE EFFECT OF BE INHALATION ON HUMORAL AND
CELL-MEDIATED IMMUNITY IN THE C3H MOUSE
J M Benson1. E B Barr', D E Bice', K J Nikula', S. M. Clarke2, S. M.
Thurlow2, and D. E. Hilmas2. 'Inhalation Toxicology Research Institute,
Albuquerque NM; 1DynCorp of Colorado, Inc. Golden. CO
The purpose of this study was to determine the effect of inhaled Be on
humoral and cell-mediated Be-specific immunity in the C3H mouse. Groups
of female C3H mice were exposed pemasally to Be metal aerosols under
conditions resulting in initial lung burdens of 10, 20 and 40 micrograms Be/
lung. Before sacrifice, mice were challenged by intradermal injection of
BeSO, in the footpad to evaluate Be-induced delayed-type hypersensitivity.
Mice were sacrificed 7,60, 120 and 240 days later for evaluation of histopatho-
logical changes in lung, lung lymphocyte proliferation in response to Be
challenge in vitro, and for quantitation of concentrations of Be-specific IgG
in serum. Be inhalation resulted in chronic granulomatous pneumonia with
multiple discrete interstitial aggregates of lymphocytes. Bronchiole-associ¬
ated and perivascular lymphocytes were also increased. The severity of the
lesions increased with time and Be lung burden. Immunohistochemical stain¬
ing of lungs from the high dose mice at 240 days post exposure indicated that
the majority of the lymphocytes in the aggregates were B cells. Intradermal
challenge of mice with Be did not increase footpad thickness at any time
post exposure. Isolated lung lymphocytes proliferated in response to the
mitogen, phytohemagglutinin. but not in response to Be. Be-specific IgG
was detected in 1/7 high-dose mice by 7 days post exposure and 1/6 medium
dose and 4/6 high dose mice at 240 days post exposure. Results suggest that
Be inhalation affects humoral rather than cell-mediated immunity in the C3H
mouse. (Research supported by the Office of Health and Environmental
Research, U.S. Department of Energy, under Contract No. DE-AC04-
76EV01013.]
331 SYSTEMIC PRIMING ENHANCES PULMONARY IMMUNITY
AGAINST RICIN IN MICE
D M Walters, P V Lemley, and D A Creasia. United States Army Medical
Research Institute of Infectious Diseases, Frederick, MD
Although vaccines have been developed that protect from lethality induced
by ricin, we have thus far been unable to induce mucosal immunity against
ricin to protect the respiratory tract. In order to better understand the humoral
response to ricin vaccine, both systemicaily and in the respiratory tract, we
immunized mice intra muscularly (im), intratracheally (itr), or both 2x with
ricin A-chain, challenged them 2 weeks later with a lethal ricin aerosol
(~LG»), and compared anti-ricin IgG and IgA in serum and bronchoalveolar
lavage fluid (BALF) before and after ricin aerosol exposure. Mice that were
systemically immunized, but not exposed to a ricin aerosol, had 1:10,000
lgG titers, but no detectable IgA in the serum, and had 1:10 lgG titers, and
no detectable IgA in BALF. On the other hand, mice that were systemically
immunized and exposed to ricin aerosol, had 1:100 lgG titers and 1:100 IgA
titers in the serum. BALF from this group of mice contained lgG and IgA
titers of 1:100. Mice that were immunized itr had lgG titers of 1:1000, but
no IgA in the serum, and had IgG and IgA titers of 1:100 in BAX-F. Mice
immunized only itr did not survive ricin aerosol exposure. Thus, the data
presented here suggest that in order to induce pulmonary immunity against
ricin, animals must first be systemically immunized and boosted via the
respiratory tract.
332 INDUCTION OF PULMONARY ANTI-RICIN IgA BY A
RICIN-CHOLERA TOXIN B-CHAIN CONJUGATE
D A Creasia, D M Walters, and H B Hines. United States Army Medical
Research Institute of Infectious Diseases, Frederick MD
Some toxins, such as have a direct necrotizing effect when in contact with
respiratory mucosal tissue. Although a humoral immune response (IgG) can,
and has been, elicited in response to systemic administration of ricin, the
humoral response induces a ricin-specific circulating IgG in the serum, but
no respiratory IgA is induced to protect the respiratory mucosa. To address
this problem, we coupled the known mucosal immunogen, cholera toxin (CT)
B subunit, to ricin by a modification of the methods published for covalently
linking N-2 fluorenyl succinamic acid to carrier protein. The resulting ricin-
cholera mucosal immunogen was purified to a single HPLC peak and was
used to immunize mice both systemically and via the respiratory tract for
comparison. Both subcutaneously administered ricin-CT conjugate and ricin
toxoid (25 p.g/mouse, 3x, biweekly) induced anti-ricin IgG in both serum
(SI: 10,000) and bronchoalveolar lavage fluid (BALF) (SI: 10,000), but
no IgA in either serum or BALF. Ricin-CT conjugate and ricin toxoid adminis¬
tered via the respiratory tract (intratracheal instillation) produced anti-ricin
specific IgA and IgG response in BALF(SI: 1000, and IgG titer(sl: 1000),
but no IgA titer in serum. When each group was challenged with a lethal
ricin aerosol (~18p.g/L), only the systemically immunized mice survived.
333 NITRIC OXIDE PRODUCTION INCREASES IN THE
ABSENCE OF ENDOGENOUS GLUCOCORTICOIDS
P. Preziosi and P. Navarra. Institute of Pharmacology, Catholic University
Medical School, Lgo F. Vito I - 00168 Rome, Italy
The subacute toxic effects of the anticancer drug hydroxyurea (HU) are
markedly increased in adrenalectomized (ADX) rats (80-100% lethality after
5 days of oral treatment with 300-800 mg/kg/day), but these animals can
be fully protected against these effects by administration of exogenous gluco¬
corticoids (GCs) (e.g. dexamethasone 100 gmg/kg/day). Considering the
multiplicity of effects exerted by GCs, this protection might be attributed to
several mechanisms.
In studies on enhanced HU toxicity in ADX rats, we found that whole-
body nitric oxide (NO) is markedly increased after ADX. Plasma levels of
L-citrulline, which is co-produced with NO in equimolar amounts as a result
of NO-synthase breakdown of L-arginine, were used as an index of circulating
NO concentrations in intact (I) and ADX rats. The following results emerged:
Mean plasma L-citrulline pm SEM (expressed in pM) (n = 5) after treatment
with vehicle (V) was 11.24 pm 0.66 in I rats and 45,900 pm 100 in ADX
rats; after HU 10 mg/kg: 12.33 pm 0.32 in I rats and 47,900 pm 420 in ADX
rats (the latter, p < 0.01 v.r V treatment); after HU 100 mg/kg: 30.44 pm
1.5 in I rats and 60,770 pm 670 in ADX rats (both, p < 0.01 v.t V treatment);
after HU 800 mg/kg: 178 pm 1.1 in I rats and 90,480 pm 500 in ADX rats
(both, p < 0.01 v.v V treatment).
Glucocorticoid protection against HU toxicity in ADX rats may depend
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TH2 CYTOKINE mRNA EXPRESSION IN PRIMARY CUTANEOUS CD30-
POSITIVE LYMPHOPROLIFERATIVE DISORDERS: SUCCESSFUL
TREATMENT WITH RECOMBINANT INTERFERON-?. Hiroaki Yagi. Yoshiki
Tokura. Fukumi Furakawa. Masahiro Takigawa. Departmcnl of Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan
The administration of recombinant interferon-? (rlFN-y) has been approved for the
treatment of patients with mycosis fungoides in Japan. We examined therapeutic
elficacy of riFN-y and alterations of cytokine profile of skin-infiltrating cells in
primary cutaneous CD30-positive lymphoproliferative disorders. rlFN-y was
injected intravenously or locally in two cases of Ki-l-positive lymphoma (KiL)
and two cases of lymphomatoid papulosis type A (LyP). In ail cases, except tor
one KiL. the skin lesions were improved and the numbers of skin-infiltrating
CD30-positive cells were remarkably decreased after the injection of rlFN-y. RT-
PCR was performed for detecting cytokine mRNA of the dermal infiltrating ceils
in three KiL and three LyP. mRNA for IL-4 and IL-10 was detected in ail six
cases, whereas mRNA for IL-2 and that for IFN-ywere transcribed in two and
one cases, respectively. Compared with normal controls from ten healthy
donors, the cytokine profile of dermal infiltrating cells in these cases was
revealed to show Th2-type skewing. In four cases treated with rIFN-y. mRNA
expression was compared before and after the administration of rlFN-y. In three
cases with a good therapeutic response to rIFN-y. the transcription of mRNA for
IL-4 and IL-10 was downmodulated by the injection of rIFN-y. These findings
suggest that the skin-infiltrating cells in primary cutaneous CD30-positive
lymphoproliferative disorders have a cytokine profile of Th2 and that the
administration of rlFN-y improves the disease condition by inhibiting the
growth of Th2 tumor cells.
THE EFFECT OF IN VIVO ULTRAVIOLET-B EXPOSURE ON ACCESSORY
FUNCTION AND THE PHENOTYPE OF LYMPH NODE DENDRITIC CELLS
DURING THE INDUCTION PHASE OF CONTACT SENSITIZATION. Marv Norval.
Michael B. Lappin. Ian Kimher. Department of Medical Microbiology, University of
Edinburgh Medical Schooi. Edinburgh, Scotland. 'Zeneca, Central Toxicology
Laboratory, Macclesfield, UK.
Exposure to low doses of uitraviolet-B (UVB) irradiauon before sensiuzauon results in
suppressed contact hvpersensiuviry responses. In vitro investigations have suggested that
one influence of UVB light is to modify the function of Langerhans ceils (LC) as anugen
presenting cells. To investigate further the effect of UVB on LC activity, changes in
LC-denved lymph node dendnuc cells (DC) were studied following exposure of
C3H/HeN mice to an immunosuppressive dose of UVB (1440J/m*) 48 and 24 hrs prior
to skin sensiuzauon with fluorescein Lsothiocyanate (FITC) or oxazoione. in functional
studies the ability of DC prepared from the draining lymph nodes of contact sensitized
mice were examined for their ability to induce hapten-specific secondary T lymphocyte
proiiferauve responses or mixed lympnocyte responses. In neither case was the activity
of DC affected by local exposure to an immunosuppressive dose of UVB. The migrauon
of LC from the epidermis to the draining lymph node in response to contact sensiuzation
is associated with a rapid increase m the expression of several membrane determinants
necessary for effecuve anugen presentation, including intercellular adhesion molecule-1
(ICAM-1; CD54), B7-2 (CD86) and la anugen. The expression of these molecules was
idenucai on DC isolated from UVB irradiated and from control unirradiated mice. It is
concluded that the immunosuppressive effect of UVB on the cutaneous immune system
may not necessarily reflect changes in LC phenotype or funcuon.
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TREATMENT OF MITOGEN IN THE MURINE LOCAL LYMPH NODE ASSAY :
ABILITY TO DISCRIMINATE BETWEEN ALLERGENS AND IRRITANTS.
Jong-Ho Park. Ja»-Sook Koh. Kvuno-Mee Yang. Won-Jae ParK. Safety &
Analysis Research Center. Pacific Corporation. Kyounggi-do, Korea.
The murine local lymph node assay has been generally used as a method of
identifying the contact allergens, in which sensitizing activity was measured as a
function of induced proliferative responses in lymph nodes draining the site of
application. But according to recent studies, non-sensitizing irritants, such as SOS.
also caused lymphocyte proliferation. In this study, tested irritants, i.e. sodium dodecyt
sulfates<SDS), triton X-100, also induce lymphocyte proliferation, which was not
distinguishable from the results with allergens. To develop the method of
discrimination between allergens and irritants, we used mitogens concanavalin A and
phytohemagglutlnin A(PHA) of vanous concentrations, and the results were compared
to non-treated lymphocyte proliferation. As a result, we observed that the mitogens at
very low concentrations, below 0.5 pg/ml, remarkably stimulated lymphocytes in
allergen group ; 0.5 pg/ml of mitogen induced more than tenfold greater proliferation
rate than that of the non-treated group. But In vehicle control and irritant group, the
proliferation rate was less than fivefold at the same concentration of the mitogens.
These results show that treatment with mitogens of low concentrations is a useful
method of discrimination between allergens and Irritants.
694
IMMUNOPROTECTION AGAINST A MURINE CD4' T CELL LYMPHOMA IS
MEDIATED BY TUMOR-SPECIFIC CYTOTOXIC T CELLS. C. Berger, S. Yang.
A, Fclli. M. Perez & R, Edclson. Depart of Dermatology, Yale Univ. 8c Columbia
Univ., New Haven, CT & NY, NY.
The 2B4.11 hybridoma is a fusion product of the BW5147 thymoma and pigeon
cytochrome c primed T lymphoblasts, and serves as a munne model ofT cell lymphoma.
We have previously shown that immunoprotection against lethal tumor challenge occurs
irter immunization of mice with 8-methoxypsoraien and uitraviolet A (8-MOP UVA)
treated tumor cells. This immunoprotection is now shown to be mediated by induction
of CD8" cytotoxic T cells that specifically lyse the tumor ceils.
Tumor cells (5-10xl06 ceils) were treated with 200 ng/8 MOP and 1 J/cm2 UV A and
injected 2x/wk for 4 wk. Mice were challenged with 5x10° viable tumor cells. Immune
mice were sacnficed and the spienoevtes phenotyped and cultured with y-irraaiated
tumor and IL2. Cytotoxicity was determined in a 5lchromium release assay.
Control mice (N=10) died within 4 wk. Two of 15 treated mice died (13%) at 5 wk,
and the remainder survived without disease. Splenocytes from treated mice were 85%
CD8' and were cytotoxic for 2B4 11 tumor targets (40-66% lysis). Cytolysis of the
BW5417, C10.9 hybndoma and natural killer cell RMA-S targets was 13%.
The results confirm that immunoprotection to lethal tumor challenge is mediated by
rumor-specific cytolytic CD8 cells induced alter immunization with 8 MOP-UV A
treated tumor ceils. The murnie model predicts that similar tumor immunity may be
induced in cutaneous T ceil lympnoma patients treated by photopheresis. CD8* anti¬
tumor T ceils may be used to isolate and characterize class I associated tumor peptides.
695
CUTANEOUS T CELL LYMPHOMA LYMPHOCYTES EXPRESS CELL
SURFACE HEAT SHOCK PROTEIN Zuming Dong. Richard Edelson. Emil
Bisaccia. and Carole Berger. Department of Dermatology, Yale Univ. and Mornstown
Memorial Hospital, New Haven C7 and Morristown, NJ.
BE2, a monoclonal antibody, recognizes a monomeric 78 kd cell surface protein on
lymphocytes from patients with cutaneous T cell lymphoma (CTCL), adult T cell
leukemia, Epstein-Barr virus (EB V-B) transformed B cell lines, and activated normal
lymphocytes. The ubiquitous expression of the BE2 molecule on the cell surface of
CTCL tumor cells allowed its use as a diagnostic and prognostic reagent and
suggested that it played an important role in the immunobiology of the malignancy.
The BE2 protein was isolated and purified by 1 and 2 dimensional electrophoresis
and sequenced. The sequence was highly homologous to the 78 kd heat shock protein
(HSP), BIP, an endoplasmic reticulum (ER) chaperonin. The relationship between
BIP and BE2 was supported by the demonstration that BE2 strongly binds to ATP.
However, polyclonal and monoclonal reagents that recognize 70 and 78 kd HSP do
not detect the BE2 antigen on the surface of CTCL or EB V-B lymphocytes.
BE2 may represent a novel member of the HSP family that is modified for cell
surface expression and may serve as a cytoplasm to cell surface chaperonin for
peptides and proteins including empty class I MHC heavy chain and T cell receptor
molecules. These findings may provide the basis for definition of a new route for
exogenous and endogenous peptide transport, between the cell surface and the ER.
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IMMUNOCYTES TRIGGER INDUCTION OF FULLY EVOLVED PSORIATIC PLAQUES (PP
SKIN) USING SCID .VOCE : HUMAN SKIN XENOGRAFTS. BJ. NickololT. T. Wronc-Smith.
Departments of Pathology and Dermatology, University of Michigan, Ann Arbor, MI.
Recent studies have implicated a key role for various immunocytes including T cells and anugen-
presenung cells (APCs) in the pathogenesis of psoriasis. However, due to the lack of an appropriate
animal model it has not been possible to definitively establish that the psonauc phenotype can be
transferred by specific immunocytes. To fill this experimental void, keratome samples (including
dermis and epidermis) of symptomless (PN) skin of psonauc pauents (N=4) were transplanted onto
SCID mice. 3-4 weeks following engraftment. 200 pi containing vanous stimuli were injected
intradermally either once or twice, and the grafts harvested 2-4 weeks later. Stimuli included: PBS
(control); GM-CSF (400 pg); IFN-y (1 pg); superanugens (SA; SEB and SEC2); LPS (1 fig); and
autologous immunocytes (1-2 x 106 cells) including either PP skin-denved dermal dendritic (DD)
cells and T cells; or Ficoll-Hypaque derived blood mononuclear cells (FH cells) cultured with or
without SA and IL-2. While some increase in eptdermai thickness occurred with the soluble
mediators, full-fledged psoriatic plaques were evident only with the immunocyte-containing cellular
iniecuons. Maximal epidermal thickness measurements (microns) are: PP skin pre-transplant = 513 ±
97; PN skin pre-transplants = 121 + 14; PN skin post-transplant after injection with; PBS = 125 ± 16;
GM-CSF = 174 ± 12; IFN-y = 176 ± 16; SA = 216 ± 32; LPS = 218 ± 25; DD = 289 ± 22; FH-
unacuvatcd = 359 ± 35: FH-activatcd = 522 + 63. Microscopic and immunohistochemtcaJ analysis of
PN skin injected with FH cells revealed unequivocal hallmarks of PP skin including thick
parakeratouc scale, prominent elongation of rete pegs, loss of granular cell layer, suprabastlar mitotic
figures, and infiltrauon of human T cells (predominantly CD8) in epidermis with dermal accumulauon
of APCs as well as CD4 postuvc T cells. Lesional kcraunocytes were diffusely positive for
proliferating cell nuclear antigen, as well as being ICAM-1 and HLA-DR positive.
In summary, this is the first demonstrauon using an animal model that complete phenotypic
conversion of PN skin to PP skin can be accomplished. Moreover, the plaques were directly caused by
njecnon of immunocytcs into the dermis, which re-distributed themselves in a non-random fashion to
recapitulate cnurciy the appropriate microscopic appearance of idiopathic psoriatic lesions.
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UVB IRRADIATION-ENHANCED IL-6 PRODUCTION AND mRNA EXPRESSION IS
MEDIATED BY IL-1a IN CULTURED HUMAN KERATINOCYTES. Jin Ho Chuna. Sana Ho
Youn. Woo Seok Koh. Hee Chul Eun. Kwano Hvun Cho. Kvuno Chan Park and Jai II Youn.
Department of Dermatology, Seoul National University College of Medicine. Seoul, Korea.
Ultraviolet B radiation may trigger cutaneous inflammatory responses by directly inducing
epidermal keratinocytes to elaborate specific cytokines, such as IL-1 and IL-6. Because IL-1 is
a potent inducer of IL-6, one may speculate that the release of IL-6 by keratinocytes following
UV exposure is mediated via the release of IL-1 in an autocrine or paracrine manner. The
purpose of this 6tudy was to evaluate the effects of UVB on IL-1a and IL-6 mRNA expression
by keratinocytes, and to investigate whether this UVB irradiation-enhanced IL-6 was mediated
by IL-1<x
We demonstrated that UVB inadiation upregulated the IL-1 a mRNA at a lower dose £15mJ/cm2) and then downregulated IL-1a mRNA expression at high doses (30 - 40 mJ/cm ).
The kinetic profile of IL-1 a mRNA expression showed a biphasic response, the early increase
by 1 h after UV and the secondary increase at 6 h after UV. On the other hand, the
expression of IL-6 mRNA was increased with increasing doses of UVB (0 - 45 mJ/cm ), and
showed a single peak at 6 h post-UV. These results may indicate that UVB radiation could
regulate the expression of IL-1 a and IL-6 mRNA in keratirxx^tes by different mechanisms.
We have demonstrated that anti-human IL-1 a antibody inhibited the UV-induced IL-6
production and mRNA expression in cultured keratinocyte. The addition of recombinant IL-1 a
to the medium increased the IL-6 synthesis, and augmented IL-6 production and mRNA
expression in cultured human keratinocytes by UVB irradiation. These results support the
hypothesis that UVB Irradiation-enhanced IL-6 production and mRNA expression may be
mediated by IL-1cl
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MATERNAL AUTOIMMUNE RESPONSE TO RECOMBINANT RO/SSA AND
LA/SSB PROTEINS IN JAPANESE NEONATAL LUPUS ERYTHEMATOSUS.
S. Miyaqawa*, T. Fukumoto*, K, Hashimoto5,, T, Hachiya1, A. Yoshioka1, and
T. Shirai* Departments of 'Dermatology and , ! Pediatrics, Nara Medical
University, Nara; and ' InaLaboratory, Medical & Biological Laboratories Co,
Nagoya, Japan
Background: Neonatal lupus erythematosus (NLE) is a syndrome characterized
by dermatitis and congenital heart block (CHB). The disease is mostly associated
with transplacental passage of maternal anti-Ro/SSA and/or La/SSB antibodies.
Objective: To examine maternal autoimmune response to recombinant
Ro/SSAand La/SSB proteins in NLE with a single ethnic background.
Methods: This study examined 12 NLE infants and their mothers. Serum
samples were tested by enzyme-linked immunosorbent assay for reactivity withfull-
length recombinant human 60-kd Ro/SSA, 52-kd Ro/SSA, and 48-kd La/SSB
proteins.
Results: All 10 infants with skin lesions and/or CHB had maternal antibodies
reactive to both the 60- and 52-kd Ro/SSA polypeptide components of the Ro/SSA
particle. Anti-60-kd Ro/SSA without anti-52-kd Ro/SSA, or vice versa, was found in
mothers of infants who had only hepatic manifestation of NLE. Nine of 12 NLE
infants had anti-48-kd La/SSB.
Conclusion: In the majority of Japanese infants with NLE, maternal anti-Ro/SSA
autoimmune response was directed against both of 60-kd and 52-kd recombinant
Ro/SSA proteins. There was no profile of anti-Ro/SSA and La/SSB response unique
to mothers of children with CHB or cutaneous manifestations of NLE.
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INDUCTION OF TNFct EXPRESSION BY UV. DNA DAMAGE AND UROCANIC
ACID. Adrienne O'Connor. Jeannie Kibitel. Jon Klein. Bruce Beutler* and Daniel
Yarosh. Applied Genetics Inc., Freeport, New York and *Howard Hughes Medical
Institute, UT Southwest Medical Center. Dallas, Texas
Keratinocytes elaborate an array of cytokines after exposure to UV, including TNFa.
We tested the hypothesis that modulation of DNA damage and repair would alter the
expression of this cytokine. The cell line XP12BE (SV40-transformed fibroblasts from
xeroderma pigmentosum complementation group A) was chosen for study in order to
eliminate endogenous DNA repair. Several clones were selected after co-transfection
with one plasmid carrying the TNFa promoter linked to the CAT gene, and a second
plasmid containing the nea gene for selection for resistance to G418. Both UV-B and
UV-C induced CAT at doses lower than those reported for repair-proficient cells.
Increasing repair of cyclobutane pyrimidine dimers by treatment of UV-B irradiated
cells with T4N5 liposomes encapsulating the DNA repair enzyme T4 endonuclease V
reduced expression of CAT. On the other hand, production of double-stranded breaks
by treatment with Hind III restriction enzyme encapsulated in liposomes produced only
a modest increase in CAT. Liposomes containing heat-inactivated enzymes did not
produce these responses. No difference was found in CAT expression between cells
incubated with 0.04% trans-urocanic acid and those incubated with 0.04% UV-B-
irradiated urocanic acid (50% cis- and 50% trans- isomer). These results suggest that
DNA damage, such as UV-induced photoproducts (e.g. cyclobutane pyrimidine dimers)
and double stranded breaks, can induce TNFa expression.
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RECOVERY FROM THE IMPAIRED TH1 RESPONSES IN ATOPIC DERMATITIS PATIENTS
BY IL-12 OR ANTI IL-4, ANTI IL-10 ANTIBODIES. Kazushi Urano. Takashi
Matsuyama, Rie Urano, Itsuro Matsuo, Muneo Qhkido, Hideyuki Ozawa*,
Sonoko Habu*, and Takashi Nishimura*, Department of Dermatology and
♦Department of Immunology, Tokai University School of Medicine,
Isehara, Japan.
The impaired Thl immune response and enhanced Th2 response have been
considered as one of the causative factors of atopic dermatits(AD).
IL-12 has a capability of stimulating Thl response and inhibits Th2
response. We have already reported that the addition of IL-12 with
Dermatophagoises pteronyssinus antigen into the culture of peripheral
blood nomonuclear cells(PBMC) from AD patients recovered the IFN-f
production to normal level. In the present study, we ask whether anti
IL-4 mAb and anti IL-10 mAb in addition to IL-12 can modulate the
impaired Thl response of AD patients in terms of superantigen induced
IFN-f production of activated T cells. Culture of PBMC from healthy
donors with staphylococcal enterotoxin A or anti CD3 antibody caused
the high levels production of IFN-f. In contrast, PBMC from AD patients
produced low levels of I FN-/. However, the simultaneous addition of
anti IL-4 and anti IL-10 mAbs into the culture of PBMC from AD patients
resulted in the high level of I FN-/ production. PBMC from AD patients
spontaneously produced IL-4 but not IFN-f, indicating IL-4 might be a
key inhibitory factor for IFN-f production. These results suggested
that abnormally activated Th2 type cytokines suppress the Th-1 derived
IFN-f production in AD patients and IL-12 may become an effective
therapeutic reagent for AD.
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INTERLEUKIN 12 (IL-12) BREAKS UV-INDUCED TOLERANCE. Agatha
Schwarz. Steohan Grabbe. Yoshinori Araeane. Kirsten Sandkuhl. Helee Riemann.
Thomas Luger. Marek Rubin*. Giorgio Trinchieri*. and Thomas Schwarz. Ludwig
Boltzmann Institute for Cellbiology and Immunobiology, Department of Dermatology,
University MOnster, Miinster, Germany, *The Wistar Institute, Philadelphia PA
We recently showed that intraperitoneal (i.p.) injection of IL-12 prevents UVB-
induced local suppression of contact hypersensitivity (CHS). Since application of
haptens on UVB-exposed skin does not only result in the failure to induce CHS but also
induces hapten specific tolerance, we studied whether IL-12 can break UV-induced
tolerance. C3H/HeN mice were sensitized with dinitrofluorobenzene (DNFB) through
skin exposed to low dose UVB on 4 d and ear challenge performed 5 d later. UV-
treated mice resensitized 14 d after the first challenge through non-UV-exposed skin
displayed hapten-specific tolerance, whereas UV-exposed mice injected i.p. with IL-12
before /-^sensitization produced a significant ear swelling response suggesting that IL-
12 can break UV-induced tolerance. Whereas adoptive transfer of spleen cells from
UV-irradiated mice inhibited sensitization of the recipient mice, no inhibitory effect was
observed after transfer of spleen cells from UV-exposed and IL-12 treated mice.
Depletion ofeither CD4+ or CD8+ T-cells revealed that UV-induced suppression is
transferred via CD8+ cells. To determine whether EL-12 overcomes tolerance by
inhibiting CD8"r" suppressor cells or by activating CD4+ effector cells, splenocytes from
UV-exposed, DNFB treated and IL-12 injected mice were depleted from CD4+ cells
and transferred into naive mice which were subsequently sensitized. Transfer ofCD4
depleted splenocytes from UV-irradiated and EL-12 treated mice still resulted in lack of
suppression of sensitization in recipient animals suggesting that IL-12 rather acts on
CD8+ suppressor cells than on CD4+ effector cells.
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INTERLEUKIN-6 PRODUCTION IN THE SKIN AND LYMPH NODES OF UVB
RESISTANT AND SUSCEPTIBLE MICE. Michael B. Lanpin. Rebecca J. Dearman1.
Mary Norval. Ian Kimher1. Department of Medical Microbiology, University ot
Edinburgh Medical School, Edinburgh, Scotland. 1 Zeneca, Central Toxicology
Laboratory, Macclesfield, UK.
Mice of BALB/c and C3H/HeN strains are considered to be resistant and susceptible
respectively to suppression of contact hypersensitivity induced by UVB irradiation. We
have compared here the ability of draining lymph node cells (LNC) from BALB/c and
C3H/HeN strains to elaborate interleukin-6 (IL-6) in vitro following topical exposure to
the contact sensitizer, oxazolone. Consistent with previous investigations it was found
that LNC prepared from sensitized BALB/c mice produced high levels of IL-6 in the
culture medium (around 8-10ng/mi); the main or exclusive source of which is believed
to be dendritic cells (DC). In contrast, draining LNC from C3H/HeN mice exposed in
an identical way to oxazolone produced only low levels of IL-6 («0.3ng/ral). Such
differences were not attributable to congenital variation between these strains with
respect to IL-6 production as comparable levels of spontaneous and inducible
cutaneous expression of this cytokine were measured in BALB/c and C3H/HeN mice
following, respectively, topical exposure to vehicle alone or oxazolone. In addition
when LNC from oxazolone treated C3H/HeN mice were disrupted by sonication, IL-6
was released into the supernatant (=2.2ng/ml), suggesting a failure in cytokine
secretion rather than production. These data indicate that there may exist an association
between susceptibility to the immunosuppressive effects of UVB irradiation and the
ability of skin draining lymph node cells to synthesize and/or secrete IL-6 following
immune activation.
